
























This copy has been supplied by the Library of the University of Otago on the understanding that 
the following conditions will be observed: 
 
1. To comply with s56 of the Copyright Act 1994 [NZ], this thesis copy must only be used for 
the purposes of research or private study. 
 
2. The author's permission must be obtained before any material in the thesis is reproduced, 
unless such reproduction falls within the fair dealing guidelines of the Copyright Act 1994.  
Due acknowledgement must be made to the author in any citation. 
 











Paul Andrew Benjes 
A thesis presented for the degree of 
Doctor of Philosophy 
at the 
University of Otago, 








To My Family 
Jeanette, Peter and Anthony 
and 
Dearest Friends 










The regioselectivity of N-alkylation in unsymmetrical imidazoles was studied. 
The ambident nature of imidazole was scrutinised in an examination of 
substrate (ie. substituent(s)), alkylating agent, and medium effects on the ratios of 
isomeric N-alkylated products obtained under standardised alkylation conditions. 
To this end various 4-mono- and 4-nitro-5-substituted-imidazoles were 
synthesised and subsequently treated with alkylating reagents in both "neutral" 
(ethanolic) and basic (aqueous sodium hydroxide) reaction media to produce 
isomeric products in proportions rigorously determined by 1 H nmr analysis. 
A number of factors were shown to affect the product ratios. It is generally 
accepted that the free base is methylated by an SE2' process while the imidazole 
anion obeys SE2cB kinetics. The ratios of 1-alkyl-4- : 1-alkyl-5-substituted products 
determined from reaction in basic medium depend largely on polar and steric 
factors. Electron-withdrawing groups in the 4(5)-position render the more remote 
nitrogen the least deactivated to electrophilic attack. Correlation of the results 
obtained is much better with cr1 or crm than with crp substituent constants, 
indicating that the major effect of the substituent is inductive. Sterk effects play a 
very significant role in the overall regiochemistry of alkylation. An increased 
preference for the less-hindered nitrogen is demonstrated as both the size of the 
substituent and the size of the incoming electrophile increases. In "neutral" 
conditions matters are more complex. Certainly steric effects can be seen, but the 
expected electronic effects are overcome by a dominant tautomeric effect when 
the substituent is an electron-withdrawing group. KT values were determined for 
a number of substrates and these demonstrate that the 4-substituted tautomer is 
dominant when the substituent is electron-withdrawing, and even though this is 
the less-reactive tautomer in an 5E2' reaction, it still controls the product ratio, 
leading to high proportions of 1-alkyl-5-substituted imidazole in the product 
mixture. 
Diazomethane methylation was also briefly examined. Substitution is 
predominantly at the nitrogen proximate to an electron-withdrawing group, and 
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GENERAL PROJECT AIMS 
Since the discovery of imidazole by Debus in the middle of last century, great 
stores of knowledge have accumulated on the properties, physical and chemical, 
of the class of compounds known as the azoles. Pioneered by such men as Pyman 
and van Auwers, N-alkylation of azoles is fast becoming a well understood and 
much utilised route to N-alkylazoles. 
While detailed qualitative and quantitative studies have been performed for 
the pyrazole, triazole and tetrazole ring systems, such a systematic treatment of 
imidazole has been overlooked, despite the wealth of published material 
describing its use. 
The aim of this project then, was to undertake such a treatment, examining N-
alkylation from both qualitative and quantitative perspectives in an effort to gain 
fuller understanding of, and hopefully derive empiricisms for, the N-alkylation 
process as it pertains to the imidazole ring system. 
For publication and importantly to provide an explicit introduction to the 
factors influential in product determination, a comprehensive review of N-
alkylation of the azoles was essayed and is presented in Chapter 1. 
The N-alkylation reactions of the unsymmetrical imidazoles prepared for this 
purpose were divided into two categories for individual treatment in this 
discourse : reactions of the "neutral" or free-base imidazoles (section 3.2.3.2) and 
reaction of their conjugate anions in basic medium (section 3.2.3.1). 
CHAPTER 1 
A REVIEW OF N-ALKYLATION 






A REVIEW OF N-ALKYLATION OF NITROGEN AZOLES 
Ll Introduction 
Azoles are five-membered heteroaromatic ring systems containing one or 
more heteroatoms, at least one of which must be nitrogen. The azoles under 
consideration in this article are those derived from pyrrole by replacement of one 
or more carbon atoms with pyridine-like nitrogen atoms. The parent azoles of 
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Relative to pyrrole, these azoles are considerably deactivated with respect to 
electrophilic substitution as a direct result of the incorporation of one or more 
electron-attracting nitrogen atoms into the ring nucleus. Within the azole ring 
are two types of nitrogen atoms with distinct electronic properties : the pyrrole-
type (electron-releasing), and the pyridine-type (electron-atracting). The multiply-
bonded, pyridine-like nitrogen atoms have nucleophilic character and hence are 
the preferred site for electrophilic attack in the neutral azole. Subsequent or 
concerted deprotonation which may follow such attacks further facilitates this 
reaction by giving rise to neutral products. In addition, the inherent deactivation 
of the azole ring may be offset by deprotonation of the azole prior to reaction with 
the electrophilic reagent. Thus, numerous examples of electrophilic attack at the 
ring nitrogen are known : alkylation (this chapter), acyiation 1-3, arylation 2, 4, 
nitration 5, 6, halogenation 7, 8, silylation 9, 10, sulfonation ll, 12, amination 13, 14, 
stannylation 15, 16, metal complexation 17 and salt formation 18, and oxidation 19. 
This article focuses in particular on N-alkylation and endeavours to discuss this 
process from a mechanistic viewpoint. General synthetic methods, including 
regiospecific syntheses of unsymmetrical N-alkyl azoles involving both direct 
and indirect (strategic) alkylation are also briefly reviewed. Attention is directed 






affecting the rate and regioselectivity of attack. Such orienting effects include the 
roles of azole substituents, alkylating agents and the reaction medium. 
N-alkyl azoles are important in chemical and biochemical research, both as 
useful synthetic intermediates and in their own right as biologically active 
substrates. Accordingly, a knowledge of the factors which lead to their formation 
is crucial in any synthetic strategy. 
Classic examples of biologically important N-alkyl azoles are tindazole (6) (1-
[(2-ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole) and metronidazole (7) ((2-
methyl-5-nitroimidazol-1-yl)-2-ethanol) which are widely used in the treatment 
of protozoal infections such as trichomoniasis 20-22• Other N-alkylated products 
similarly derived from 2-methyl-4(5)-nitroimidazole (8) are of great utility as 
chemotherapeutic agents : the 1-alkyl-4-nitro derivatives of (8) are gaining 
pharmocological significance as immunosuppressants 23, and potential 
radiosensitizers 24• 
2 
N-alkyl-1,2,4-triazoles have recently been found to be very effective 
antimycotics 25 and agricultural fungicides 26, in particular the N-hydroxyethyl 27 
and mercaptotriazole derivatives 28 • Bistriazole (9), prepared from 1,2,4-triazole 
and dichlorodiphenylmethane, is a potent herbicide 29. Of the tetrazole series, 
N,N'-dialkylated tetrazolium salts are widely used in biochemistry 30, medicine 
31 and agriculture 32. Tetrazolylalkanoic acids (10) show anti-inflammatory and 
plant growth regulatory activity, while cephalosporin derivatives containing N-
substituted tetrazole rings display antibacterial properties 33. Various N-
(aminoethyl)azoles are important synthetic intermediates in the preparation of 
pharmacologically active compounds: the imidazolyl derivatives are used to 
prepare antihypertensives 34, 35, while the benzimidazolyl analogues are used to 
prepare antipyretic and sedatory phenothiazines 36 and ureas with diuretic, 
analgesic, antitumoral and cardiovascular properties 37-40. 
N-alkylated azoles are of considerable importance as intermediates in synthetic 
chemistry. Often when dealing with N-unsubstituted azoles as substrates for 
various reactions, problems may arise in the form of poor solubility of substrates 
(products) in the common range of organic solvents, difficulties in product 
isolation and purification, the formation of diverse side-products, and even 
complete non-reaction. Many, if not all, of these problems may be eliminated if 
the azole is N-alkylated prior to undergoing reaction. Numerous examples of the 
use of alkyl and functionalised alkyl protecting groups are reported in the 
literature, particularly in many derivatization reactions involving 
organometallic reagents 41 . Examples of reported protecting groups for the 
imidazole and benzimidazole ring nitrogen in 2-derivatisation reactions include 
tert- butyl 42, benzyl 42-44, trityl (triphenylmethyl) 45, alkoxymethyl 46 (eg. 






so (eg. methoxyethoxymethyl 49), vinyl 51, [2-(trimethylsilyl)ethoxy ]methyl 52, 53, 
(dialkylamino)methyl (eg. (dimethylamino)methyl 41, 54), 1-eth~xyethyl 55, and 
hydroxymethyl 56. 
3 
In the choice of protecting species for a particular reaction, several criteria 
must be considered. Most importantly , the protecting group must be readily 
introduced into the azole moiety and also readily removed, preferably under 
mild conditions, upon completion of the desired reaction. The protected azole 
derivative should be stable under the particular reaction conditions, inert to 
subsequent synthetic manipulations and unaffected by purification procedures. 
Particularly in the case of a-derivatisation, the steric properties of the protecting 
group need to be considered. Unfortunately, in terms of general applicability, 
most species are deficient in some respect or another by failing to meet all the 
necessary criteria. The above imidazole and benzimidazole protecting groups are 
listed in an approximate order of versatility, beginning with the least versatile, 
non-functionalised t- butyl group. 
Protecting groups are also synthetically useful in alkylation strategies 
involving unsymmetrical imidazoles. As a consequence of unsymmetrical C-
substitution, the kinetics of electrophilic attack are controlled to a significant 
extent by the electronic and steric properties of the substituent. These effects may 
operate either in concert or in opposition, with the net result that attack will 
generally occur preferentially at one of the two nitrogen atoms. To direct 
alkylation therefore to the kinetically less-favoured nitrogen, strategies can be 
devised whereby the preferred nitrogen is regiospecifically blocked with a suitable 
protecting group, typically a bulky, sterically demanding species. Subsequent 
alkylation of the desired nitrogen creates a quaternised imidazolium 
intermediate which is then hydrolysed in the fin:al deprotection step. 1,5-
Disubstituted imidazole derivatives have been prepared in this manner. Trityl 57, 
58, phenacyl 59, benzyloxymethyl 60 and t- butoxymethyl 61 blocking groups have 
been used to prepare 3-substituted-L-histidines, while pivaloyloxymethyl 62 has 
been used to synthesise 3-substituted histamines. 
A final example of the importance of N-alkyl azoles as synthetic intermediates, 
is the versatility of N-(a-aminoalkyl)benzotriazole (11) (R=Rl=R2=H). Katritzky 
and co-workers have reported numerous synthetic transformations involving 
derivatives (11). A summary of these is reported 63. Some examples include the 
mono-, 64, 65 and dialkylation 66 of aromatic and heteroaromatic amines, 
conversion of secondary into tertiary 67 and primary into seco~dary 68 aliphatic 
amines, enamine 63 and dienamine 69 synthesis and the preparation of 










The mechanism of alkylation, indeed electrophilic substitution in general, is 
dependent upon the reaction conditions, in that the reaction pathway is 
determined by the reacting species. N-unsubstituted azoles, ie. those containing a 
free NH group, exhibit add-base properties and can exist in solution as the 
neutral azole (free base) (12) or as its resonance delocalised conjugate species, the 
cationic acid (13) and the anionic base (14) (Scheme 1 ). 
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The reacting species present in solution are dependent upon the pKa and 
pKBH+ of the azole, which in turn depend on (i) the physical and electronic 
properties of the azole itself, imparted by both the nature and position of any ring 
substituents, and (ii) the solvation characteristics of the reaction medium. The 
basicities and acidities of the parent azoles in water are shown in Table 1 (s. 1.4). 
Excluding for a moment the participation of ring substituents, there are two 
effects operating as a function of the aza substituents (annular nitrogens), which 
profoundly affect basicity. A mesomeric effect acts to increase the electron density 
on the nitrogen atom and thereby increase the basicity, and secondly, in 
opposition to this, a negative inductive effect operates as a result of the 
electronegative nature of the aza substituent(s). 
The extent to which these effects operate depends on the relative positions of 
the nitrogens in the azole ring. Where they are in a 1,2 orientation, as in pyrazole 
(1), the inductive effect predominates, while in 1,3-positions the mesomeric effect 
is dominant, as in imidazole (2). Thus the charge in the imidazolium cation is 








on basicity is illustrated by comparing the pKBH+ value of imidazole (7.0) with 
that of pyrazole (2.5). The addition of further nitrogen atoms into the ring 
nucleus is strongly base-weakening; the pKBH+ value of tetrazole is negative (-
3.0) . Since basicity is directly related to nucleophilicity, it becomes a useful 
quantitative measure of the reactivity of azoles towards electrophilic reagents. 
Thus a general trend of decreasing reactivity with successive aza substitutions in 
the azole ring is expected. 
Ring carbon substituents contribute to overall basicity. Electron-releasing 
substituents, such as alkoxide, amino and to a lesser extent alkyl groups, act to 
increase the electron density on the multiply bonded nitrogen atom(s), thereby 
increasing basicity. This is a consequence of mesomeric effects and hence is 
strongest from the a.- and y-positions. The converse is true for electron-attracting 
substituents, such as nitro, carboxy and halogeno groups, whose effect is largely 
inductive and hence particularly strong from the a-position. Annelation 
decreases basicity slightly, dropping pKBH+ values by approximately 1.5 pK units 
70; the pKBH+ value of benzimidazole is 5.69 while that of indazole is 1.39 71 . 
Alkyl groups substituted at a ring nitrogen can affect basicity, but the direction of 
the effect is dependent on the proximity of the alkylated nitrogen to the N-
protonation site 72. N-methylation, for example, has little effect o~ the basicity of 
imidazole (1-methylimidazole pKBH+=6.90 corr. cf. imidazole pKBH+=6.95 72) 
while it markedly diminishes the basicity of pyrazole (1-methylpyrazole pKBH+= 
1.79 corr. cf. pyrazole pKBH+=2.52 72). This difference between the two diazoles is 
assigned to steric hindrance to solvation of the pyrazolium cation owing to the 
adjacent N-methyl group 73. 
The nature of the solvent also contributes significantly to azole basicity. 
Basicity (and conversely acidity) can be viewed in an alternative way : the 
direction of acid-base equilibria is controlled to a large extent by 'electrostatic 
proximity effects' 74 where the dominant effect is the relief of destabilisation 
imparted either to the neutral base or ion (conjugate acid or base) by electrostatic 
repulsion between either adjacent NH+ pair centres or adjacent lone-pair 
electrons. Solvation, particularly in polar hydroxylic solvents, results in an 
attenuation of these effects, the degree of which is dependent on the solvent. The 
basicity of imidazole increases substantially on moving from water to acetonitrile 
71 
As mentioned in the previous section, the azoles under discussion contain 
two or more annular nitrogen atoms belonging to two distinct electronic types. In 
the neutral N-unsubstituted species electrophilic attack is expected to occur at the 
orthogonally disposed lone pair of the multiply bonded nitrogen atom. Attack at 
the pyrrole-like NH group is unlikely as it would necessarily involve the 





frequently accompanied by proton loss from the NH group, either in a 
















The orientation of the reaction product(s) ((15),(16)), is related to the 






Annular tautomerism (eg. Scheme 3) involves rapid proton exchange 
between two annular nitrogen atoms, facilitated either by the solvent itself, as is 
the case in neutral protic solvents such as water, or by intermolecular 
participation of other azole molecules (19), as in neutral aprotic solvents. 
Except in unsubstituted and symmetrically substituted imidazoles and 
pyrazoles, azole derivatives in solution generally show a predominance of one 
tautomer (ie. Kp=l, where KT= [18]/[17] ). The position of equilibrium is 
dependent on such factors as the nature and position of any substituents, and 
particularly in the cases of triazole (1,2,3- and 1,2,4-) and tetrazole, on intrinsic 
'electrostatic proximity effects' 74 and associated solvent field effects. In solution, 
provided that both. tautomers form a com."'llon cation, the less basic tautomer 
predominates 75. In general, the predominant tautomer is that with the largest 
dipole moment due to increased stabilisation by solvation 75, 76. 
Thus, when considering the alkylation of the free base, the orientation of 
products (15),(16) may result from reaction of the major and/ or the minor 
tautomer, depending on the reactivity of each towards the electrophile. 
On the other hand, with alkylation in basic media (Scheme 4), such that pH> 
pKa of the azole derivative, the reacting species is the mesomeric, ambident 
anion and again b.~e orientation of products (20),(21) is dependent on the steric 
and electronic factors imparted by the ring substituents. Compared with the free 
base, the conjugate anion is considerably more susceptible to electrophilic attack. 
For this reason especially, alkylation in basic medium is the most common 
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Azoles already carrying a substituent on nitrogen can undergo further 
substitution, typically by alkyl halides, to form quaternary salts (Scheme 5 ). Since 
mono-N-alkylated azoles have basicities comparable with their parent free base, 
quaternisation is found to be more prevalent in reactions involving alkylation in 
neutral media, especially when excess alkylating reagent is used. Imidazoles are 
more reactive than pyrazoles due to the larger degree of stabilisation afforded by 
the 1,3-orientation of the nitrogen atoms. Triazoles and tetrazoles are much more 
difficult to quaternise and require the use of stronger alkylating agents. For 
example 1-substituted-1,2,3-triazoles can be quaternised with methyl p-
toluenesulfonate, whereas the 2-substituted compounds can only be quaternised 










N-Unsubstituted azoles can undergo substitutive alkylation via Michael 
addition on unsaturated reagents sufficiently activated to nucleophilic attack 78. 
Such a process is illustrated in Scheme 6 (Z is an activating group). For example 
N-unsubstituted pyrazoles and imidazoles readily undergo addition reactions 
with acetylenecarboxylic and dicarboxylic esters 79 and acrylonitrile 80 to form 
addition products. Although acidic and basic catalysts have been used to effect 
additions, these prove unnecessary in many cases. 
In many instances, such as the reaction of azoles with acetylenic compounds, 
reaction conditions make it unlikely that the alkylation mechanism follows a 
simple electrophilic addition pathway. 3,5-Dimethylpyrazole reacts with dimethyl 
acetylenedicarboxylate (DMAD) in carbon tetrachloride to produce mainly the 1:1 
cis addition product (22) which further reacts with DMAD, in ether containing a 




product (23) 81; where the reagent contains an activated carbon-carbon triple 
bond, two successive additions can occur if the intermediate alkene is of 
sufficient reactivity. In the absence of a basic catalyst both (23) and an isomeric 
compound are produced 81 . Reaction of pyrazole with methyl propiolate in 
neutral conditions gives (24), while in basic conditions a 2:1 adduct is isolated 81. 
On the other hand, when methyl ethynyl ketone reacts with pyrazole, a 2:1 
addition product, 1,1-pyrazolylbutanone (25), is formed where the double 
addition of the substrate occurs at the same carbon atom 82. N-Substituted-4-
nitroimidazoles have been regiospecifically prepared in near quantitative yields 
by treating the unsubstituted substrate with the appropriate Michael acceptor (eg. 
acrylonitrile, acrylic acid, methyl vinyl ketone and ethyl acrylate) in solvent at 
elevated temperature irrespective of the reaction conditions; near quantitative 
yields were obtained in DMSO-pyridine at 135-140°C for 10 hours 83. More 
recently, treatment of 2-methyl-4-nitroimidazole with the same Michael 
acceptors in acetonitrile with catalytic quantities of potassium fluoride gave the 
N-alkyl-2-methyl-4-nitroimidazoles almost quantitatively after only 0.5 hour at 
80°C 84. 
Though this discussion of the alkylation of azoles is focussed on annular N-
substitution only, it should be realised that competitive exocyclic alkylation is 
often observed at ring substituents, particularly those with N, 0 or S centres, and 
less frequently at annular carbon. The alkylation of pyrazolones has been 
extensively studied, particularly in connection with the synthesis of antipyrine 
(2,3-dimethyl-1-phenyl-3-pyrazolin-5-one), and its analogues 85. The existence of 
substituent tautomerism in 1,3-dialkylpyrazol-5-ones means that alkylation in 
basic medium, for example the methylation of 3-methyl-1-phenylpyrazol-5-one 
86, can give rise to the products of N-, 0- and even C-substitution (Scheme 7). 
Alkylation of the isomeric 1,5-dialkylpyrazol-3-ones under the same conditions, 
however, can yield only the N-alkyl and 0-alkyl derivatives since C-4 is no 
longer activated towards electrophilic attack (Scheme 7). 
Recent alkylation studies 87 have found that imidazoles substituted at the 2-
position react with soft alkylating electrophiles under alkaline conditions to 
produce modest yields of 4(5)-alkylated derivatives together with the N-alkylated 
products. The proportion of C-alkylation was observed to be dependent on the 
hard-soft character of the alkylating agent: as one might expect on the basis of 
HSAB theory, soft electrophiles favour C-substitution while h~rd electrophiles 
favour N-substitution. Reaction of 2,2' -biimidazole with benzyl bromide gave 
16% C-alkyl and 23% N-alkyl products while reaction with p- methoxybenzyl 
chloride gave 31 % and 20% respectively. Similarly, in the basic alkylation of N-
substituted pyrrolones 88, the ratio of C- to 0-alkylation is increased by the use of 






tetrahydrofuran produces 100% C,C-dimethylation while methyl p-
toluenesulfonate in dimethylimidazolidinone (DMI) yields 100% .of the 0-methyl 
product. 
1.2.2 Diazoies 
1.2.2.1 Imidazoles, Benzimidazoles 
Of all the azoles, the mechanisms of alkylation of imidazoles have been the 
most extensively studied. As they are the most basic members of the series, they 
are particularly susceptible to attack by electrophilic reagents. The reaction 
pathway is determined by the nature of the reacting species under the particular 
reaction conditions. Hence, in theory, four transition states (26)-(29) can be 
postulated; two representing possible reaction pathways for the neutral imidazole 
(SE2, SE2'), one for the conjugate base (SE2cB) and one for the conjugate acid 
(SE2cA) 89. 
. . 
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(26) (27) (28) (29) 
A transition state of the latter type, (29), can be immediately disregarded. It 
would be unfavoured and indeed electrophilic substitutions of imidazolium 
appear never to have been reported in the literature. Similarly, as discussed 
earlier (s. 1.2.1), attack by the electrophile at the NH nitrogen in an SE2 pathway is 
unfavourable since it requires a disruption of aromaticity in the transition state. 
For this reason, a transition state of type (26) can be eliminated, with the 
conclusion reached that alkylation of the neutral imidazole proceeds in an SE2' 
process (Scheme 8). Mono-N-alkylated derivatives can undergo further reaction 
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The classical alkylations of imidazoles involved reaction of the free base with 
excess ,alkylating agent, typically alkyl halides or sulfates, at elevated 
temperatures, often in a sealed tube. These alkylations were never particularly 
successful; yields were generally low and contamination of the product mixture 
with quaternised side-products was observed. As an example consider the 
reaction of imidazole with excess methyl iodide (Scheme 9). Under the 
conditions of reaction, the desired product of alkylation, 1-methylimidazole (30) 
pKBH+ = pKBH+(imidazole), is initially very susceptible to further alkylation 
producing the quaternary salt (33). At the same time, generated acid, HI, increases 
the pH of the medium until alkylation of imidazole, or for that matter 1-
methylimidazole, is prohibited by the formation of the deactivated imidazolium 
salts (31),(32). Thus low yields of mono-N-alkylated products are frequently 
obtained in instances where excess alkylating agent is used to effect alkylation of 
the free base. 
Even when only a single equivalent of alkylating agent is used and the 
reaction carried out neat or in solvent, a degree of quaternisation can occur 90. 
Consequently, alkylation by reaction of the free base is not the most favoured 
method of synthesis of mono-N-alkylated imidazoles. 
The most common, and synthetically most useful route to alkylated 
imidazoles is the generation and subsequent alkylation of the imidazole anion 
through an SE2cB process (Scheme 10). Such a reaction sequence operates when 
imidazoles are alkylated in basic media, and the process usually leads to good 
yields of mono-N-alkylated products. Reaction tinder basic conditions prevents 
the protonation of the azole by the acid by-product and also significantly reduces 
the chances of subsequent quaternisation. Generation of the imidazole anion can 
be accomplished in various ways, typically involving reaction in the presence of 
an alkali metal oxide or hydroxide, or an in-situ generated alkali metal alkoxide, 
in solvents such as water, alcohol, dioxane, dimethylformamide, acetone or 
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As indicated earlier, the alkylation of unsymmetrical azoles can result in the 
formation of more than one monoalkylated product, irrespective of which 
mechanism, SE2" or SE2cB, is operating. The orientation of reaction products is 
potentially dependent on numerous factors; the reaction conditions and hence 
reaction mechanism, the steric and electronic effects of ring substituents, the 
structure of the alkylating agent, the tautomeric nature of the azole, and the 
effects of quaternary salt formation and decomposition. 
In basic medium, the mechanism (SE2cB) involves the imidazole anion and 
the two possible products (35), (36) (Scheme 11), are obtained in a ratio that 
reflects the steric and electronic effects of the substituent, R, and those of the 
alkylat~ng agent. In this case quaternisation effects are reduced and tautomeric 
effects are eliminated due to the formation of the common mesomeric anion 
(34). 
















Substituents at C-4 or C-5 greatly influence the regioselectivity of alkylation at 
annular nitrogen. Electron-attracting groups, the effect operating largely through 
inductive withdrawal, decrease the rate of alkylation by deactivating the ring to 
eiectrophiiic attack. Since the effect is most intenseiy felt in the position a- to the 
substituent, attack is directed, if possible, to the remote nitrogen (36). Mesomeric 
electron-releasing groups activate the imidazole to electrophilic attack by 
increasing the electron density at the a- and y- positions. Since the nitrogens in 
imidazole are a- and y- relative to the substituent, one would expect that 
regioselectivity would be influenced primarily by inductive effects. Thus a 
preponderance of (35) is to be expected. Sterk effects are significant, especially if 
combined with those of the alkylating agent. Such effects are again largest at the 





the sterically less hindered isomer (36). Clearly then, steric and electronic effects 
are additive when the substituent is electron-withdrawing and opposing when it 
is electron-releasing. Table 2 (s. 1.4) shows some representative isomer ratios for 
the alkylation of some 4(5)-substituted imidazoles in alkaline and neutral 
conditions. Thus for example, in an 5E2cB process, 4-nitroimidazole (Table 2) is 
methylated to yield predominantly 1-methyl-4-nitroimidazole (8.6:1). Imidazole-
4-carboxamide and derivatives (4-CONHR, R=H, CH3, C6Hs) 91 ar~ alkylated by 
dimethyl sulfate and methyl, ethyl and propyl iodides in basic medium to yield 
only 1-alkylimidazole-4-carboxamides. Similarly, (E) and (Z) isomers of ethyl 3-
(lH-imidazol-4(5)-yl}-2-propenoate (urocanic acid ethyl ester) were methylated 
under heterogeneous base conditions (methyl iodide/KHC03/ acetone) to 
produce the ethyl esters of (E)- and (Z)-3-{lH-imidazol-4-yl}-2-propenoic acid only 
in high yield (80% and 70% respectively) 92. 
In neutral medium, matters become more complex with the introduction of 
tautom.eric effects. The orientation of reaction products in an 5E2' process is 
dependent on which tautomer, major or minor, is preferentially undergoing 
attack (Scheme 12). The choice of reacting tautomer is the result of competition 
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Much of the initial work on the alkylation of imidazoles was carried out by 
Ridd and co-workers 89, 93, 94. Their studies have provided a sound basis for the 
interpretation of the results of methylation of 4(5)-substituted imidazoles, 
particularly with regard to the reaction of the free base. Observation of the 
methylation of 4(5)-nitroimidazole with dimethyl sulfate under 5E2' and 5E2CB 
conditions enabled them to reach a number of interesting conclusions. It was 
established that the reactions obeyed second order kinetics, that is, first order with 
. 2 o2N'[f N 0.22 x 1 o· 
") I -,_.J 
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Figure 1. Rate coefficients (dm3 mol -1 s-1) for methylation of 4-









respect to both the methylating agent and either 4-nitroimidazole or its conjugate 
anion: 
rate = k2 [ Me2S04 ] [Im-] (SE2cB) 
rate = k2 [ Me2S04] [ ImH ] (SE2') 
The rate of SE2cB methylation was found to exceed SE2' reaction by a factor of 
103. 
With regard to product orientation, Ridd observed that the ratio of the 
nucleophilic activities of the two nitrogens was much smaller than the ratio of 
their basicities; for the SE2CB mechanism the ratios are 8 .and 400 respectively. On 
the assumption that a linear free-energy relationship exists between the reaction 
rates and the relevant equilibria, the relationship 
k °" K-a 
was found to hold where a=0.3, k is the rate coefficient for reaction at one 
nitrogen atom and K is the corresponding acidic equilibrium constant. The 
kinetic results are expressed in Figure 1. 
Consistent with earlier discussion, methylation of imidazoles bearing an 
electron-withdrawing substituent in the 4- or 5-position, in an SE2cB process gave 
mainly 1-methyl-4-nitroimidazole. Further, it was concluded that for the same 
imidazoles in an SE2' process, the major tautomer should be the 4-R compound 
while the 5-R compound should be predominant in imidazoles bearing an 
electron-releasing substituent. Charton 95, 96 later validated this conclusion when 
he derived empirical equations which correlated pKa values with Hammett 
coefficients in 4(5)-substituted iniJdazoles. He similarly proposed that 
withdrawing groups (crm>O) favour 4-substitution while releasing groups (crm<O) 
favour 5-substitution. This was quantified such that a prediction could be made 
about the position of tautomeric equilibrium for any unsymm_etrically 
substituted imidazole, provided that Lip is known, using the relationship 





where A and B refer to the 4- and 5-tautomers. Unfortunately, the range of 
substituents upon which this is based is very limited and discrepancies are 
known. Acidity function measurements of frozen tautomeric derivatives 
provide one of the most useful procedures for studying tautomeric equilibria of 
heterocycles 97. Typically the method involves pKa determinations of both N-
methyl derivatives of the tautomeric substrate, where the ratio of the dissociation 
constants approximates KT. Values of KT for a number of 4(5)-substituted 
imidazoles are summarised in the literature 98. 
It is apparent from the isomeric ratios in Table 2 (s. 1.4), that the most reactive 
tautomer is not necessarily the one which undergoes alkylation preferentially. 
For instance, the SE2' methylation of 4-nitroimidazole and 4-bromoimidazole by 
dimethyl sulfate in ethanol (Table 2), is almost regiospecific for the formation of 
the 1-methyl-5-substituted isomer (50:1 and 11.5:1 in favour, respectively). KT 
Values estimated for 4-nitroimidazole (400-500:1 89, 99) and 4-bromoimidazole (47 
± 7 (s. 3.3.3.1 and Table 14), 63-152:1 98) indicate that the 4-tautomer is by far the 
major species in solution. Thus the orientation of methylation can only be 
accounted for in terms of reaction of the majority species, and not the more 
reactive species, giving rise to the major product. 
Quite clearly then the trends in product orientation can to a large degree, be 
ascribed to the alkylation mechanism in operation. In fact, complete reversal in 
isomer ratios is frequently observed in the transition from SE2cB to SE2' 
alkylations. In line with this observation, Ridd et al. 94 made the following 
generalisations with regard to methylation. Firstly, the transition between the 
two reaction mechanisms occurs at 
pH = pKa-3 
for negatively substituted imidazoles ie. in or near the pH range 6-11. Secondly, 
for any substituted imidazole where O<a<l, a change in mechanism (SE2cB to 
SE2') will change the main product of substitt1.tion. Sterk factors are not 
considered in this formulation which may explain the discrepancies that appear 
in some instances. The methylation of 4(5)-phenylimidazole is such a case. In 
others, the mechanism operating may not be that which is assumed. Ridd 94 
observed literature ratios near unity for the methylation of 4(5)-
halogenoimidazoles in alkali, contrary to prediction. Quite possibly in this 
instance, the heterogeneous reaction medium is allowing methylation to occur 
by an SE2' process, where a proportion of the substrate is dissolved in the 
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dimethyl sulfate phase (as the author suggests) or perhaps quaternising alkylation 
is occurring on the isomeric product dissolved in this phase. 
Marked discrepancies are noted in the alkylation of imidazoles by 
diazomethane (Table 2). The orientation of methylation using diazomethane is 
difficult to explain since the mechanism is still in doubt. Ratios seem to resemble 
loosely those obtained in neutral (dimethyl sulfate-ethanol) medium, 
particularly where the 4(5)-substituent is strongly withdrawing ie. predominant 
formation of the 1-alkyl-5-substituted isomer is observed (Table 2). A recent 
example in the literature is the methylation of 2-(2-methyl-4-thiazolyl)-4(5)-
nitromidazole 100; reaction with dimethyl sulfate in basic medium yielded the 1-
methyl-4-nitro- derivative, while treatment with diazomethane gave the 1-
methyl-5-nitro- isomer only. The mechanism may however differ from SE2~. One 
interpretation suggests the methylations involve proton transfer from the 
substrate to the diazomethane to generate the methyldiazonium cation (Scheme 
13) which may then form the solvated ion-pair (37) or (38) with electrostatically 
defined orientation 101. If methylation occurs through (38) in an SNl type 
reaction, orientation is predominantly determined by electrostatic interaction 
between the methyl cation and the atom of greatest electron density (not 
necessarily that with greatest nucleophilicity) in the mesomeric anion. On the 
other hand an SN2 process involving (37) possesses a rate-determining step 
dependent on the nucleophilicity of the ambident anion. Thus product 
orientation is dependent on the SN characteristics of the transition state which 
are largely determined by the reaction medium. 
Arndt's classical interpretation of diazomethane methylation 102-104 is based 
on the postulate of "direct methylation", whereby the acidic hydrogen is replaced 
directly by the methyl group. Thus in terms of azole methylation, the isomeric 
ratio is dependent on the dynamic acidity of the tautomers; that with the largest 
dynamic acidity produces the greatest proportion of isomeric product (Scheme 
13). This picture fits in nicely with the observed preference for methylation at the 
nitrogen adjacent to an electron-withdrawing substituent. The mechanism of 
diazomethane methylation requires further study as the theory does not 
satisfactorily explain many of the results found in the literature (refer also s. 
1.2.2.2). 
Quaternisation may play a significant role in determining the overall isomeric 
product ratio. Alkylations, typically those involving alkyl hali?es in neutral 
medium, are prone to a degree of quaternisation dependent on the reaction 
conditions and the steric and electronic properties of the substrate. Most 
quaternisation reactions involving annular nitrogen and alkylating agent 
proceed by an SN2 mechanism, usually giving rise to products reflecting kinetic 




published 105• The rate of quaternisation is controlled by the basicity of the 
heterocycle 106 ; the effects of N-aryl substituents on rate constants for the 
quaternisation of imidazoles have been correlated using a Hammett equation 107• 
Quaternisation in itself can affect the ratio of products since the isomers will 
show disparate reactivity towards further electrophilic attack. It is also possible 
that dequaternisation can lead to complications in rationalising product ratios. 
The thermolysis of quaternary imidazolium salts has been studied 108. Although 
the de<;omposition of these salts typically requires elevated temperatures (>200 
~C) at reduced pressure, it is feasible that a degree of dequaternisation may occur 
under base catalysed (SE2cB) or thermolysis ( 5E2' /reflux) conditions. The rate of 
such decompositions was found to be dependent on the nature of the N-alkyl 
substituents and on the nucleophilicity and size of the attacking nucleophile, ie. 
the rate is consistent with an SN2 mechanism. In unsymmetrically substituted 
imidazoles this effect would act to reduce the predominance of the major product 
by inducing isomerisation in the reverse direction. For example, consider the 
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In the decomposition step, electron-withdrawing groups favour cleavage at the 
adjacent nitrogen-carbon bond resulting in the formation of 1-methyl-4-
nitroimidazole (39), the minor product in 5E2' methylation. Thermolysis 
experiments on 1,3-dimethyl-4-nitro- and 1,3-dimethyl-4-phe~ylimidazolium 
iodides (220-260 °Cat <2 mmHg 108) produced product ratios of 12:1 and 9:1 
respectively, in favour of the 1-methyl-4-substituted imidazole. Similarly, 
Vanelle et al 109 observed the complete thermal isomerisation of 1-methyl-2-




























bromobenzene at elevated temperature (156 °C) with a catalytic amount of 
methyl iodide. 
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Recently, Bhujanga Rao et al 110 observed the quantitative, base-catalysed 
isomerisation of tindazole derivatives to give their 4-nitro isomers (Scheme 15). 
The reaction was carried out in refluxing alcohol and is believed to take place by 
an N-dealkylation/N-realkylation process to give the kinetically and 
thermodynamically preferred 4-nitro derivative. A restriction was found in that 
the isomerisation was facile only with the strongly withdrawing N-alkyl- or -
arylethyl sulfone group. 
To complete the discussion on factors affecting the rate and distribution of 
reactiop. products, it remains to examine briefly the effect of the alkylating agent 
and the characteristics of the reaction medium. As intimated earlier, the size of 
the incoming electrophile largely determines the degree of steric interaction at 
the possible reaction sites. Observing the reaction from the perspective of the 
alkylating agent, alkylation results from the nucleophilic attack, typically SN2, of 
the heterocyclic system on the alkylating agent. Steric considerations in this 
reaction are complicated as the structure of the transition state, in addition to the 
size of the electrophile, must be taken into account. It is generally accepted that a 
spectrum of transition states is possible depending on the relative degrees of 
bond-forming and bond-breaking involved. In the Menschutkin reaction a 
change in transition state character is noted, from a 'tight' SN2 type, with for 
example p- nitrobenzyl bromide, to a 'loose' carbonium type, with the p-
methoxy compound, as the reactive site becomes increasingly capable of 
supporting a positive charge 111. Thus, steric hindrance to nucleophilic attack 
would be greater in the 'tight' transition state and one would expect therefore that 
the regioselectivity of attack by the ambident substrate would differ according to 
the transition state characteristics of the particular alkylation reaction. The nature 
of the leaving group is linked intimately with this effect. A study of the 
methylation of 2-substituted pyridines with methyl iodide and methyl 
fluorosulfonate 112 has shown that the latter is less subject to steric effects. In 
accordance with this result is Thornton's proposal 113 that a decrease in basicity of 
the leaving group moves the transition state closer to the reactants, and hence 
subjects the reaction to more stringent steric effects. Other factors such as the 
possibility of weak complexation between the incoming electrophile and ring 
substituents, particularly phenyl groups 114, could also exert s_ome influence on 
re gioselecti vi ty. 
The energetics of reaction can be dominated by factors other than the reactant 
structures 115 ; transition state structure and stability are also dependent to a large 
degree on the nature of the reaction solvent; solvation effects are more important 













































involving the 'loose' carbonium type transition state are expected to be more 
facile in polar protic solvents. Alkylations involving an ionic nucleophile, and 
hence reaction of the deprotonated azole, are expected to show marked increases 
in rate by moving from polar protic to polar aprotic solvents as commonly 
observed in SN2 reactions 117. On the other hand, in quaternisations and neutral 
alkylations, where the nucleophile is the uncharged free base, such a rate 
enhancement is not expected. A change in solvent can affect the distribution of 
products by altering the structure of the transition state in compliance with the 
SN2 salvation rule 118. However, solvation effects on relative rates are usually 
small and hence product ratios are generally somewhat insensitive to solvent 
variations. The possibility of a side-reaction between alkylating agent and 
solvent, for example methyl iodide with tetrahydrofuran or dimethoxyethane 
119, may account for anomalies in the literature. In such a case, the identity of the 
alkylating agent is changed and a variation in product ratio is observed. In the 
above example it is suggested that methyl iodide reacts with the ethers to form a 
methyloxonium ion. 
Alkylation of substrates in neutral (SE2') medium, in the presence of Lewis 
acids (refers. 1.2.2.2) or the alkylation of azole salts in non-aqueous solvents 
(SE2cB) (refers. 1.2.4), can markedly effect isomer ratios. The azole derivatives in 
these conditions can exist in various forms depending on concentration and 
temperature : as free species, solvent-separated, intimate (ion)-pairs or more 
complex agglomerates. Under these circumstances, the ratio of products must 
depend on the degree and site of cation coordination to the substrate. The degree 
of ion aggregation is dependent on such factors as substrate concentration and 
temperature (as mentioned above), but more importantly on solvent polarity and 
the nature of the counterion 120-123. Ion association is enhanced in solvents of 
low polarity containing soft cations, particularly those with small ionic radii in 
addition to 'low' electropositivity (eg. Li+, Mg2+, zn2+ ). As solvent polarity 
decrea~es, so too does its cation-solvating ability, with the result that the degree of 
ion association (and hence steric hindrance to electrophilic attack) is greater. Thus 
the nature of the base used to effect SE2cB conditions can exert considerable 
influence on the regioselectivity of alkylation. An interesting example of cation 
induced regioselectivity is the reaction of various alkali metal salts of a recently 
characterised multidentate, imidazole-containing macrocycle, with benzyl 
bromide in anhydrous DMF 124 (Scheme 16). N-benzylation oc_curs at the outer 
peripheral nitrogens when lithium or sodium salts are reacted, while those of the 
larger alkali metals, K, Rb and Cs, give exclusively the product resulting from 
alkylation of the inward facing nitrogen atoms. Regioselectivity is attributed to 
metal ion directed alkylation at the uncomplexed annular nitrogen; where the 
cations are small (Li, Na) internal ion chelation directs alkylation to the 
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periphery, whereas K, Rb, and Cs ions being unable to fit the macrocyclic cavity, 
direct alkylation to the interior nitrogens. 
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Benzimidazoles, too, are readily alkylated in neutral or basic medium. For the 
alkylation of unsymmetrical benzimidazoles the same criteria apply as in the 
uncondensed compounds, although the extent of quaternary salt formation is 
less since they are less basic; annelation decreases the basicity of an azole by 
approximately 1.5 pK units 70. Product ratios in the alkylation of 5(6)-substitiuted 
benzimidazoles are free of steric considerations and depend on the inductive and 
resonance electronic effects of the substituent. These effects are reduced in 
comparison to substituent effects in uncondensed imidazoles. It is noted, 
however, that in 2-substituted benzimidazoles, the greater the electron-
withdrawing properties of the 2-substituent, the more sensitive the azole is to the 
electronic effects of the substituents in the benzenoid fragment 125. Alkylation of 
5(6)-nitrobenzimidazole with dimethyl sulfate in basic medium yields a ratio of 
1,5-:1,6- close to 1:1, while alkyl halides give mainly the 1,5-isomer 126. Ethylation 
in neutral medium with diethyl sulfate gives a higher proportion of the 1,6-
isomer. The substituents in 4(7)-substituted benzimidazoles have .a much greater 
' directing effect. Electronic effects are increased and steric interactions arise due to 
the proximity of the 4(7)-position to the reactive sites. Methylation of 4(7)-
nitrobenzimidazole in basic medium by dimethyl sulfate 127 yields a mixture of 
1,4- and 1,7-isomers in a ratio (1,4-:1,7-) of nearly 6:1, as one might expect. 
Methylation and benzylation under SE2' conditions also yielded the 1,4-isomer 
predominantly, in ratios exceeding 3:1. Investigation of the latter has lead to the 
conclusion that peri- interactions dominate in the prototropic equilibrium of 
4(7)-nitrobenzimidazole (Scheme 17). Tautomerism is restricted due to 
stabilisation of the 7-nitro tautomer (40) by chelation of the imino hydrogen with 
the nitro group 128. 
In addition to the electrophilic substitution mechanisms, it is possible to effect 
alkylation by a free radical process, though in general the radical alkylation of 
azoles has been little studied. Recently Adebayo et al 129 reported that the anions 
of 2- and 4-nitroimidazole underwent SRNl reactions with a range of 
halogenonitroalkanes. For example p- nitrobenzyl chloride and 2-halo-2-
nitropropane give the corresponding N-nitroalkyl derivatives by this process 
(Scheme 18). The alkylation was found to be regioselective and gave good yields 
of the 1-alkyl-4-nitroimidazoles. The nucleophilic attack by th~ nitroimidazole 
anions on the radical intermediate is under kinetic control, with regiospecific 
reaction at the more nucleophilic, remote nitrogen atom. In SRNl reactions 
almost exclusive formation of products via the most nucleophilic centre is 
usually observed 130, 131 . The rates of radical substitution, as they are in 
electrophilic substitution, are affected by steric interactions. 
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Radical alkylations are also effected under oxidising conditions. It was 
observed that nitroimidazole anions underwent oxidative addition to the anion 
of 2-nitropropane using catalytic quantities of potassium ferricyanide and sodium 
persulfate as oxidants 129. Regioselectivity is again observed, the key step in the 
radical mechanism is identical to that in the SRNl reactions (Scheme 19). 
1.2.2.2 Pyrazoles, Indazoles 
Pyrazoles and indazoles, being 1,2-diazoles, exhibit markedly decreased basicity 
compared to the 1,3-diazoles and consequently they are less reactive towards 
electrophilic reagents. Nevertheless, N-alkylation occurs readily and is perhaps 
the most studied of all reactions in the pyrazole series 132-135. Pyrazoles have been 
alkylated using alkyl halides, substituted alkyl halides (eg. alkyl bromoacetates), 
dialkyl sulfates, arenesulfonates, and diazomethane. More recently, trialkyl 
phosphates 136, 137 and dimethylformamide dialkyl acetals 138, 139 have been used 
to prepare N-alkylpyrazoles in good yields. 
Unsymmetrical pyrazoles, like unsymmetrical imidazoles, can give rise to two 
isomeric N-monoalkylated products, and the distribution of products is similarly 
dependent on the factors discussed in the previous section. The mechanisms of 
N-alkylation in pyrazoles have received scant attention. In neutral medium the 
reaction probably follows an SE2' process while in strongly alkaline conditions it 
almost certainly involves the pyrazolate anion in an 5E2cB process (Scheme 20) 















Substituent effects on the reactivity and regioselectivity of electrophilic attack 
follow the same general trends outlined in the previous section. While the 
acidities of imidazole and pyrazole in solution are comparable, pyrazole is a 
much weaker base, a direct result of the vicinal regiochemistry of. the annular 






account, the electronic effects of ring substituents in N-unsubstituted pyrazoles 
loosely follow a Hammett relationship 73, 140. Electron-attracting groups are thus 
deactivating and should direct attack to the more remote nitrogen while electron-
releasing groups activate the azole to electrophilic attack and enhance the 
nucleophilicity of the vicinal nitrogen. Large substituents and large alkylating 
agents would similarly direct alkylation to the more remote, sterically less-
hindered nitrogen. 
In basic medium these electronic and steric directing effects are uncomplicated 
by tautomeric considerations and the reduced likelihood of quaternary salt 
intermediacy. Quaternisation of pyrazoles in 5E2cB conditions can be discounted 
due to the marked decrease in basicity observed upon N-substitution. 
Results obtained by Grimmett et al 134 for the methylation of various 3(5)-
substituted and 3,5-disubstituted pyrazoles (Table 3 (s. 1.4)) with dimethyl sulfate 
in sodium methoxide, show that steric factors are more important than electronic 
factors. A preference is shown for attack at the less hindered nitrogen where a 
sterically demanding (phenyl) substituent is present, even in cases when there is 
a strongly directing electronic effect acting in opposition. For example, (Table 3) 3-
nitropyrazole is methylated in basic medium to give mainly 1-methyl-3-
nitropyrazole in a ratio of close to 4:1 (1,3-:1,5-), while 3-nitro-5-phenylpyrazole 
exhibits reversed isomer distribution with the predominant formation of 1-
methyl-5-nitro-3-phenylpyrazole. Malhotra and co-workers endeavoured to 
regioselectively N-1-benzylate 3-substituted-5-chloro-4-formylpyrazoles in basic 
media (PhCH2Br /K2C03/DMF) on the basis of sensitivity to the steric nature of 
the 3-substituent 141 . While methyl and phenyl groups resulted in a 1:1 isomeric 
mixture (N-1-benzyl- : N-2-benzyl-), isopropyl and tert- butyl substituents elicited 
1.5:1 and 4:1 mixtures respectively. 
The electronic effects of para- substituents in the basic methylation of 3(5)-
arylpyrazoles have also been examined 134. With steric effects constant, a 
Hammett treatment concluded that inductive effects are more important and 
that the reaction is facilitated by electron-release from the aryl ring. Electron-
withdrawing groups increase the proportion of the 1,3-isomer while the converse 
is true for electron-releasing groups. Product ratios (1,3-/1,5-) range from 2.50 
(methyl) to 5.00 (nitro). 
In the neutral alkylation of substituted pyrazoles, the tautomeric nature of the 
substrate cannot be ignored, as indicated by the results of me~ylation of 3(5)-
nitropyrazole with dimethyl sulfate in methanol (Table 3). A ratio only 
marginally in favour of the 1,3-isomer is obtained, though both steric and 
electronic effects would favour the complete predominance of 1-methyl-3-
nitropyrazole. The major tautomer under the reaction conditions is likely to be 





















Figure 2. Site attack percentages for benzylation of 3,5-disubstituted 







of this tautomer would yield the 1-methyl-5-nitro product. Unlike the neutral 
methylation of 4-nitroimidazole however (refer s. 1.2.2.1), reaction of the major 
tautomer is offset by competing effects which account for the product ratio 
observed. Sterk effects are again very dominant; the neutral methylation of 3-
nitro-5-phenylpyrazole provides almost exclusively 1-methyl-5-nitro-3-
phenylpyrazole. A further example of tautomeric influence on product 
orientation is the alkylation of methyl 5-methylpyrazole-3-carboxylate with 
methyl iodide 142 where predominant formation of the 1,5-dimethyl product is 
observed. One rationale for this result 132 describes reaction of the dominant 
tautomeric form (41) which is stabilised by a non-covalent interaction between 
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However, Tarrago et al 143 observed contrasting results for the benzylation of 
the ethyl ester in neutral medium. A mixture of both isomers was obtained with 
the 1,3-dimethyl product predominating (1.9:1 in favour). Interpretation of this 
result together with the product ratios obtained in the benzylatiorts of other 5-
methyl-3-substituted pyrazoles lead to the following conclusion : alkylation 
produces the less hindered isomer unless the substituent has a lone-pair (in the 
ortho position) in close proximity to the adjacent nitrogen atom (Figure 2). 
It is proposed that an intramolecular lone-pair cooperative effect is operating, 
of the type observed by Deady in the alkylation of 2,2/-biimidazole derivatives 144. 
In a fashion similar to the a-effect, non-vicinal lone-pair effects acting through 
space, appear to enhance the nucleophilicity of the proximate nitrogen atom and 
perhaps act to stabilise the transition state of the alkylation reaction. Thus under 
neutral conditions any stabilisation imparted to a tautomer of the type (41) by 
hydrogen-bonding appears to be offset by the enhanced reactivity of the other 
tautomer conferred by a lone-pair cooperative effect. 
Quaternisation in pyrazoles and indazoles, and with it the possibility of 























benzimidazoles, and can realistically only be considered in the interpretation of 
results for neutral alkylations. The basicity of pyrazoles markedly diminishes 
once the substrate has undergone N-substitution 72; steric crowding of the 
adjacent nucleophilic nitrogen substantially reduces the rate and facility of 
quateri;t.ary alkylation. The rates of quaternisation of N-arylpyrazoles with 
dimethyl sulfate in sulfolane are reported 145. When compared with results 
obtained in an analogous study on N-arylimidazoles 107, it was found that the 
electronic effects of the N-substituent on the rate of quaternisation are greater in 
pyrazoles as one might expect considering the a-position of the quaternising 
centre. Further, N-substituted pyrazoles are considerably less reactive than the 
corresponding imidazoles. A case in point, 1-phenylimidazole is almost 4000 
times more reactive than 1-phenylpyrazole 145. 
The possibility of the involvement of a quaternary salt intermediate in neutral 
alkylation conditions was investigated by Grimmett et al 134. While their results 
do not directly implicate such involvement, they do not rule out the possibility. 
Quaternisation can also be effected by reaction with a double alkylating agent 
to form fused pyrazole derivatives. Pyrazolidino[l,2-a]pyrazoles such as (42) can 
be prepared by reaction of the appropriate pyrazole with 1,3-dichloropropane or 1-
chloro-3-propanol 146. 
Further to the discussion (refer s. 1.2.2.1) on the role of the reaction medium in 
product orientation, the effect of Lewis acids on the regiochemistry of alkylation 
has been studied 147. Ethyl 5(3)-cyanopyrazole-4-carboxylate (43) was alkylated 
with isobutylene in acetonitrile, in the presence of catalytic p-toluenesulfonic acid 
monohydrate, to yield ethyl 1-t- butyl-5-cyanopyrazole-4-carboxylate (44) with 
high regioselectivity; the ratio of 5-cyano ester (44) to 3-cyano ester (45) exceeds 
90:1 (Scheme 22). 
The effects of Lewis acids were examined in the reaction and the ratios, 
(44):(45), obtained were as follows : aluminium chloride (1:99), boron trifluoride 
etherate (1:23), stannic chloride (1:2) and zinc chloride (10:1). Clearly a correlation 
exists between Lewis acid strength and the regioselectivity of alkylation; the 
reversal of regioselectivity noted in the presence of strong Lewis acids indicates 
that strong coordination occurs between the Lewis acid and the nitrogen lone-
pair, thereby directing alkylation to the adjacent nitrogen. Thus it was deduced 
that the dominant tautomer of (43) has the imino hydrogen attached to the 
nitrogen atom remote from the substituents. This conclusion ~s further 
supported by the results of basic methylation with methyl iodide, in which the 
isomer with the same orientation as (45) predominated by a factor of 3-4:1. 
Diazomethane has been used to methylate pyrazoles. Previous studies have 
suggested that the orientation of methyl substitution appears to favour the 





of a series of methyl pyrazole-3-carboxylates substituted at the 4- or 5-positions 
with phenyl groups, or at the 5-position with a methyl group, took place mainly 
next to the ester group 142. Product ratios, though, show variance with reaction 
conditions 148, 149. The mechanism for diazomethane alkylation is unknown but 
it is theorized that it may involve reaction of the heterocyclic anion with the 
resulting methyldiazonium cation (refers. 1.2.2.1). It follows then that this 
process should give rise to a product distribution similar to that found in 5E2cB 
alkylations, but this is seldom the case. The results for diazomethane 
methylation in acetonitrile are displayed in Table 3. Methylation of 3-
nitropyrazole, for example, produces a majority of the 1-methyl-5-nitro isomer in 
total contrast to basic reaction with dimethyl sulfate. In the absence of strongly 
electron-withdrawing groups there appears to be very little specificity in the 
direction of alkylation. The phenyl group directs rather more methylation to the 
less-hindered nitrogen, but not to the extent found in neutral or basic conditions. 
Thus steric effects appear to be present but these are small in comparison with 
dimethyl sulfate reactions. 
Studies on the methylation of substituted indazoles have been updated by 
Palmer 150 (basic medium) and Jaffari 151 (neutral medium). 
In basic medium, the methylations of various 3-, 5-, 6- and 7-substituted 
indazoles with methyl iodide lead to mixtures of both 1- and 2-methyl products 
150; the product ratio seems to be more dependent on substituent steric effects (3-
and 7-positions) than electronic effects. Unsubstituted, 5- and 6-nitroindazoles 
produce equal proportions of both isomers, so it appears that strongly polar 
substituents in the benzenoid ring exert a minimal electronic effect on 
regioselectivity. Interestingly, 3-ethyl- and 3-phenylindazole are 
stereoelectronically equivalent. The methylatiori ratios are 2.3:1 and 2.8:1 (1-
methyl-:2-methyl-) respectively. It is speculated that a steric interaction between 
the phenyl group and the 4-H forces the phenyl ring into an out-of-plane 
conformation, thus reducing the net steric effect to a level comparable to that of 
the ethyl group. This should be apparent in the proton NMR spectrum of the 
substrate but the authors did not mention this. 
Methylation of 4-, 5-, 6- and 7-nitroindazole with methyl iodide and methyl p-
toluenesulfonate 151 under neutral 5E2' conditions gave predominantly the 2-
methyl derivative in all cases, with the exception of 5-nitroindazole which gave 
the 1-methyl derivative as the main product. Clearly the dom!nant directing 
effects here are electronic, although they are offset by steric effects and possibly 
peri- interactions (refer s. 1.2.2.1) in the case of 7-nitroindazole. While inductive 
effects probably control regioselectivity in 4-substituted indazoles, resonance 
effects dominate from the 5- and 6- positions. On the grounds that the major 








the 1-H tautomer of 6-nitroindazole and the 2-H tautomer of 5-nitroindazole; this 




The introduction of a third nitrogen into the azole ring further serves to 
reduce reactivity towards electrophilic attack, though the P-orientation of N-4 
with respect to N-1 and N-2 softens this inductive effect so that the basicity of 
1,2,4-triazole in aqueous solution is only slightly less than that of pyrazole (Table 
1 (s. 1.4)). While other electrophilic N-substitutions are difficult to bring about, 
most notably nitration, sulfonation and oxidation, N-alkylation reactions occur 
readily particularly in basic medium where the substrate is present as the triazole 
anion. 
Typical alkylations of 1,2,4-triazoles carried out in basic conditions with alkyl 
and allyl halides, or in neutral conditions with diazomethane, afford selective 
(though generally not exclusive) substitution at N-1 rather than N-4 152 (Table 4 
(s. 1.4)). The ratio varies with the nature of the alkylating agent and solvent but 
frequently lies in the range 2.3:1 to 19:1. Clearly, once substituents are introduced 
into the 3- and 5-positions, ring symmetry is lost and the regioselectivity of 
alkyiation is complicated by the resultant disparity between N-1 and N-2 brought 
about by contiguous steric and electronic effects. 
The selective alkylation in (un)substituted 1,2,4-triazoles at N-1 or N-2 in 
preference to N-4 is rigorously established in the literature 14, 153-156 and can be 
attribu~ed to a number of kinetically controlled factors. Substitution is statistically 
favoured at the vicinal nitrogens but more importantly, their nucleophilicities 
are enhanced relative to N-4 because of an a-effect. The extent of this 
enhancement, and hence their nucleophilic reactivity, is controlled by the 
salvation characteristics of the reaction medium. 
Little mechanistic work has been done on the N-alkylation of 1,2,4-triazoles, 
especially the reactions of the neutral azole. Bentley et al proposed recently that 
regioselectivity is dominated; not by kinetically controlled meehanisms, but by 
thermodynamic control 154. Following the work of Lantzsch and Reubke on the 
thermal, base-catalysed isomerisations (N-4-alkyl to N-1-alkyl) of P-
hydroxyethyltriazoles 157, kinetic and equilibrium studies were undertaken on 
the same rearrangements of P,P-diphenyl-P-hydroxyethyltriazole and other P-
hydroxyethyl derivatives (46) under similar conditions 154. In all examples it was 


































found that at 150°C in the presence of a strong base, isomerisation approached an 
equilibrium mixture consisting of 99.4 ± 0.2% of the N-1-alkylated derivative (48) 
and 0.6% of the isomeric N-4-alkylated product (47). Their results seem to 
indicate that the base-catalysed reactions occurvia the nucleophilic displacement 
of the triazole anion in a dissociation-recombination process under 
thermodynamic control (Scheme 23). Further it was found that the position of 
equilibrium was somewhat independent of the alkyl group; the presence of the 
hydroxyethyl stem is not necessary to institute the isomerisation. Analogous 
isomerisations of tindazole derivatives to give the thermodynamically preferred 
product were noted by Bhujanga Rao and co-workers no (refer s. 1.2.2.1). 
However, rearrangement was only observed with N-alkyl groups containing the 
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In support of this conclusion are Carlsen's studies on similar non-base-
catalysed thermal rearrangements of chiral 4-alkyl-3,5-diphenyl-1,2,4-triazoles 158. 
Thermolysis of 4-{(S)-(+)-2-butyl}-3,5-diphenyl-1,2,4-triazole (49), (neat) under 
reduced pressure, yielded a mixture of isomerised 1-{(R)-(-)-2-butyl}-3,5-diphenyl-
1,2,4-triazole (50) and its 1-{(S)-(+)-2-butyl}- enantiomer (51) (37% combined yield) 
together with an appreciable amount of N-unsubstituted 3,5-d~phenyl-1,2,4-
triazole (52) (43%) (Scheme 24). 
Two facts, namely that a degree of racemisation (ca. 30%) is associated with the 
rearrangement, and that the reaction is accompanied by the formation of an 
elimination product (52), are indicative of a thermodynamically controlled 









process proceeds either by a mono- or bimolecular ion-pair mechanism (Scheme 













The ion-pair mechanism involves quaternisation and subsequent 
decomposition to produce the thermodynamically favoured N-1-alkyl isomer. 
Quaternisations of 1,2,4-triazoles, commonly with alkyl halides or alkyl p-
toluenesulfonates 159, generally take place so that the N-substituents are in a 1,3-
orientation. Thus a triazole alkylated at N-1 is quaternised at N-4 and vice versa. 
Clearly though, quaternisation of an unsymmetrical N-4-substituted triazole can 
give rise to two possible quaternary salts. The regioselectivity of the reaction is 
dependent on the same factors as they apply to mono-N-alkylation (refers. 1.2.2.1 
and below); 4,5-dimethyl-3-methylthio-1,2,4-triazole reacts with methyl iodide to 
produce the triazolium salt (53) 160, while methylation of 4-methyl-3-methylthio-
5-phenyl-1,2,4-triazole with dimethyl sulfate yields the quaternary salt (54) 161. 
Further alkylation of quaternary 1,2,4-triazolium salts to give diquaternised 
products is possible if the intermediate salt is sufficiently reactive or if 
particularly strong alkylating agents are used. Thus 4-ethyl-1-:methyl-1,2,4-
triazolium tetrafluoroborate (55) is diquaternised with trimethyloxonium 
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The significance of the quaternisation-decomposition process as an effect 
contributing to the observed overall distribution of isomeric mono-N-alkylation 




ignored. Indeed, cleavage of the triazole ring has been observed following 
treatment of triazolium salts with concentrated alkali 160. Under neutral 
conditions, the likelihood of participation is increased but still minor since 
alkylations of this sort produce low overall yields of desired products. 
Thus, in terms of general synthetic utility, neutral alkylations are less practical. 
Product orientations are frequently reversed, in that N-4-alkylation gives rise to 
the major product. Comparative alkylations of N-unsubstituted amino-1,2,4-
triazoles in neutral and basic medium have been reported 156, 163. Neutral 
reaction of 5-amino-3-phenyl-1,2,4-triazole with methyl iodide 163 gives a product 
mixture comprising all three N-alkyl isomers with the N-4-methyl compound in 
greatest proportion; the ratio, N-1:N-2:N-4, is 35:20:45 in 30% overall yield. At the 
same time, reaction of the triazole anion results in predominantly N-1 and N-2 
methylation, the ratio now 55:40:5 in 70% overall yield. Similarly, neutral 
methylation of 3-halotriazoles with dimethyl sulfate gives a mixture of the N-1-, 
N-2- and N-4-methyl products, of which the last forms in yields of up to 60% 164, 
165. This preponderance of N-4 alkylation may well be explained in terms of 
reaction of the major tautomer(s) in an SE2' type process. Both theoretical 166-168 
and experimental 169 studies on prototropic tautomerism show that N-1-H and 
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Substituent effects on the orientation of N-alkylation products have been well 
documented 153, 170. Uda and co-workers have studied the methylation of 25 
unsubstituted, 3-mono- and 3,5-disubstituted-1,2,4-triazoles (with methyl iodide 
in aqueous sodium hydroxide and diazomethane in methanol) with particular 
emphasis on isomeric distribution. In all cases almost exclusive methylation 
occurred at N-1 as expected on the grounds of ambident nucleophilicity (refer 
above); all ratios (N-l(N-2):N-4) range in excess of 4:1 (Table 4). Particularly low 
proportions of N-4-alkyl products were noted with 3,5-disubsti_tuted substrates 
due to steric effects acting from both positions adjacent to N-4. Steric effects 
outweigh electronic effects in the regioselective control of alkylation at N-1 and 
N-2 in unsymmetrical triazoles. Electronic effects however, are dominant in two 
types of substrates : in those 3,5-disubstituted triazoles where the substituent 






which possess a lone pair(s) in a position ortho to the site of attachment. In 3-(ex,-
pyridyl)- and 3-(cx.-pyridyl)-5-substituted-1,2,4-triazoles an anomalous increase in 
the proportion of 2-methylation was observed. A lone-pair electrostatic effect of 
the type proposed by Tarrago 143, in explanation for the same observation in 
analogous substituted pyrazoles (refers. 1.2.2.2), is invoked. Thus enhancement 
of the nucleophilicity of adjacent nitrogens N-2 and N-4 is expected accounting 
for the predominant 2-methylation and increased 4-methylation (Table 4). Use of 
diazomethane as a methylating agent produces ratios which closely resemble 
those obtained in the basic methyl iodide reactions, with the exception of 3-(ex,-
pyridyl)- derivatives which show a greater bias towards 2-methylation. The 2-H 
tautomers are preferred in these cases 170 and it is thought that the 
methyldiazonium cation is captured in preference by N-2 in cooperation with the 
cx.-pyridyl nitrogen. 
1.2.3.2 1,2,3-Triazoles, Benzotriazoles 
The regiochemical aspects of N-alkylation of 1,2,3-Triazoles have received 
little direct attention and indeed some confusion is evident in the literature, in 
part a result of the unreliability of isomer identification in work predating the 
advent of nmr spectroscopic techniques. Their condensed benzo analogues, 
however, have fared better in recent years. The substitutive N-alkylation and 
associated isomeric equilibria of benzotriazoles have been the subject of 
considerable research by Katritzky and co-workers 171-174. Of the uncondensed 
1,2,3-triazoles, Tanaka and Miller 175 produced a study of the factors controlling 
the regioselectivity of N-alkylation of triazole anions by halide displacement and 
by Michael addition to unsaturates. It is essentially the conclusions drawn by the 
above researchers which are presented and discussed here. 
1,2,3-triazoles readily undergo alkylations by the usual range of alkylating 
agents and, in terms of overall product yields, the most satisfactory results arise 
from reaction of the more nucleophilic triazole anion. In theory alkylation of 
unsubstituted or 4,5-symmetrically disubstituted triazoles can give rise to two 
isomeric products while three are possible in unsymmetrical substrates. 
Theoretical CNDO calculations of atomic charge densities, geometry and 
relative bond energies were used in an attempt to rationalise regioselectivity in 
the reactions of 1,2,3-triazole (anion and free base) as a nucleophile 175. On the 
basis of the ground state electron densities nucleophilic attack should be led by 
the nitrogen furthest removed from ring substituents. In the unsubstituted 
triazole, N-2 is predicted to be the most nucleophilic site in the anion as opposed 




however, predict that the charge densities in the anion, though very similar, are 
marginally greater on N-1(N-3) 176. 
Considering firstly the triazole anion, it is apparent that alkylation is not in 
fact led by N-2 in the unsubstituted substrate. Gold alkylated the anion with 
propyl and allyl bromides to yield the N-1-alkyl and N-2-alkyl products in a ratio 
of 4:1 177. It appears therefore that the nucleophilicities of N-1(N-3) and N-2 are 
indeed' similar, with perhaps a slight bias towards N-1, thereby producing ratios 
somewhat in excess of the statistically expected 2:1. 
Introduction of a substituent(s) into the ring has a marked effect on product 
orientation. Upon examination of the results of halide displacement alkylations 
of various substituted triazole anions (Table 5 (s. 1.4)), it is apparent that both N-1 
and N-2 substitution occur, seemingly with a preference for the latter. Triazoles 
bearing a single substituent at position 4 (eg. nitro, phenyl) appear to undergo 
alkylation only at N-1 and N-2, largely in response to a steric effect. Isomer ratios 
obtained for the basic alkylations of 4-nitro-1,2,3-triazole 178 favour 2-substitution, 
with the interesting exception of reactions with ethyl bromoacetate and benzyl 
chloride (Table 5). Alkylation of 4-phenyl-1,2,3-triazole again occurs 
predominantly at N-2, irrespective of medium effects (Table 6 (s. 1.4)). 
With the results at hand it is exceedingly difficult to rationalise 
regioselectivity, since the precise natures of all factors contributing to positional 
nucleophilicity are uncertain. Very clearly, substituent steric effects are 
prominent. Alkylation, while limited to N-1 and N-2 in 4-substituted triazoles, is 
further restricted to N-2 in 4,5-disubstituted substrates, particularly where both 
the 4- and 5-substituents are 'large'. Indeed, 4-aryl-5-triphenylphosphonium-
1,2,3-triazole ylide is ethylated with ethyl iodide or ethyl chloroacetate to yield the 
2-ethyl product only 179. Under circumstances where the 4- and 5-substituents are 
somewhat less sterically demanding, and the triazole is unsymmetrical, three 
isomeric products may arise (Table 5). 
Electronic effects, however, particularly the annular effects associated with the 
vicinal nitrogens, are harder to define. Intuitively, one would suspect that 
substituent electronic effects are only minor. In 4-substituted triazoles, electron 
release or withdrawal by the substituent is ostensibly offset or reinforced 
respectively at N-2 by the strong inductive withdrawal of the adjacent nitrogens 
N-1 and N-3. Consequently N-1 should be more electron rich and hence give rise 
to the majority product. In concurrence, CNDO calculations for various 4-
substituted1,2,3-triazole anions by Tanaka and Miller (4-cyano~, 4-vinyl- 175 and 4-
phosphonium-1,2,3-triazole ylide 179) and the authors (4-nitro- and 4-phenyl- 176), 
in each case predict higher charge density at N-1. Nevertheless, a preference for 
N-2-substitution is observed in many cases, particularly in basic alkylations 




investigated the conjugate addition reactions of 1,2,3-triazole anions with a 
number of acetylenic compounds and found that alkylation proceeded 
exclusively at the 2-position to give a mixture of cis- and trans- 2-triazolyl 
products. 
31 
It is unclear what role, if any, lone-pair electrostatic field effects play in N-
alkylation. Perhaps some added stabilisation is imparted to the transition states of 
those reactions involving electrophiles less capable of supporting a developing 
positive charge. Clearly, the intensity of such an effect would be dependent on the 
electronic properties of the ring, as determined by the ring substituent(s) and the 
nature of the solvent. It is apparent from the data in Table 6 that the character of 
the reaction medium (solvent and base) used to effect alkylation exerts 
considerable influence on regioselectivity. It is well known that ion-association 
with the ambident azole nucleophile can appreciably affect the orientation of 
substitution (refer s. 1.2.2.1). This is exemplified in this case by Gilchrist 180 who 
alkylated the silver salts of 4,5-diphenyl-1,2,3-triazole in chloroform and obtained 
significantly larger proportions of N-1-alkyl products than one would normally 
expect under the circumstances (Table 5). 
The difficulty in explaining definitively the direction of alkylation raises the 
possibility of thermodynamic control in the reaction pathway, either via 
isomerisation through a dissociation-recombination process or through 
quaternisation and subsequent decomposition, to give the thermodynamically 
favoured isomer. Acylation studies 181, 182 have shown that isomerisation of 1-
acyl-1,2,3-triazoles occurs at temperatures exceeding 100°C to produce the 2-acyl 
isomers almost exclusively, and thus it appears likely that the N-2-alkylated 
triazole is the thermodynamically preferred product. However under the halide 
displacement conditions used by Tanaka and Miller (solvent at 75°Ct 
equilibration was discounted; kinetic control was proved experimentally by in 
situ nmr analysis. Studies on the isomerisation of N-arylmethylbenzotriazoles at 
elevated temperature (175-250°C) 173, show that the N-benzylated derivative is 
least able to undergo rearrangement in a dissociation-recombination process due 
to the lower stability of the positively charged intermediate (refer below). Hence it 
is highly improbable that such a rearrangement could occur with N-alkyl 
substituents under the comparatively mild alkylation conditions used. In 
confirmation, experiments were carried out to gauge the facility of isomerisation 
of N-methyl-4-nitrotriazole 178. A mixture of 1-methyl- and 2-methyl-4-nitro-
1,2,3-triazole was left standing at room temperature for two years, in the absence 
of solvent, after which the proportion of the N-2 isomer was seen to have 
increased from 60 to 74%, while, on maintaining this mixture at 120°C in 
dimethyl sulfoxide for eight hours, an increase of 4-5% was observed. 
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The conjugate addition reactions, however, may be more susceptible to 
thermodynamic control since the electrophiles are much more capable of 
supporting the positive charge incurred in the dissociation step. This might 
explain the greater preference for N-2-substitution common to these reactions. 
32 
A quaternisation-decomposition process, in· any event, cannot account for the 
prominence of N-2-alkylation in basic medium (or N-1-alkylation in neutral 
medium (refer below)), since quaternisations of 1-substituted-1,2,3-triazoles 
produce only the 1,3-disubstituted-triazolium salts (56) (Scheme 28) 183. It is much 
more difficult to quaternise the corresponding 2-substituted triazoles; they 
require the use of powerful alkylating agents. 2-Methyl-1,2,3-triazole is unreactive 
towards methyl iodide, dimethyl sulfate and p- toluenesulfonate, but is efficiently 
alkylated with methyl fluorosulfonate to give the 1,2-dimethyl-1,2,3-triazolium 
salt (57) 77. 
Halide displacement alkylations of the free base derivatives of 1,2,3-triazoles 
consistently produce the N-1-substituted product in greatest proportion, unless 
prohibitive steric effects are present. This is in accordance with both the CNDO 
calculations, which predict greatest nucleophilicity at N-1, and the experimental 
evidence which indicates that 2-H-1,2,3-triazole is the favoured tautomer in 
aqueous solution. The 2-H tautomer is preferred primarily because electrostatic 
lone-pair effects destabilise the 1-H tautomer 74. The tautomeric equilibrium is 
very solvent dependent; attenuation of lone-pair repulsion in aqueous solution 
results in a value of KT=2 184; 2-H-1,2,3-triazole predominates by a factor of 4 in 
dichlorornethane and 32 in toluene 185. The proportion of 1(3)-H-1,2,3-triazole 
increases with concentration 185, 186. 
Importantly, with regard to a rationale behind N-1 substitution in the neutral 
triazole, coupled to the prevalence of the 2-H tautomer in solution is the 
energetic advantage of electrophilic attack at N-1 in the 1-H tautomer. First 
recognised by Gold 177, the activated complex (58) (or the transition state if 
alkylation and deprotonation are concerted) has greater stability than (59) arising 
from attack at N-2. 
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Benzotriazoles undergo alkylation and substitutive alkylation predominantly at 




in agreement with experiment, predicting considerably higher charge densities 
(relative to the 2-position) at N-1 and N-3 in the benzotriazole anion and in both 
the 1-H and 2-H tautomers. 
Sterk (peri) effects from benzenoid substituents at the C-4- and C-7 positions 
increase the proportion of 2-alkylated product. 5,6-Dimethylbenzotriazole is 
methylated with dimethyl sulfate in aqueous sodium hydroxide to yield a 
mixture of 1- and 2-methyl derivatives in the ratio 3.3:1 (N-1:N-2) 188, while 
4,5,6,7-tetrachlorobenzotriazole under the same conditions gives the 2-
methylated compound as the major product 189. Similarly, Michael additions of 
benzotriazole 190 and 4,5,6,7-tetrachlorobenzotriazole 189 to acrylic acid and related 
compounds produce exclusively the 1- and 2-substituted adducts respectively. 
The Mannich reaction of benzotriazoles with formaldehyde and primary and 
secondary amines to give 1-substituted products is well known 191, 192 . The 
solution isomerism apparent in N-(N',N'-dialkylaminoalkyl)benzotriazoles has 
been studied 193, and recently reinvestigated by Katritzky et al. 171, 172. Whereas 1-
hydro~ymethyl- and 1-chloromethylbenzotriazole exist purely as the 1-isomers in 
solution, almost all solutions of the Mannich bases contain mixtures of the two 
isomers in ratios favouring the thermodynamically preferred 1-isomer. Typical 
ratios are in the range 2.3:1 to 9:1. The thermodynamic stability of the 1-isomer is 
in accordance with the idea of an 'annelation effect' proposed by Haj6s and 
Messmer 194-196, which simply stated predicts that the isomer with the highest 
degree of aromaticity is energetically preferred. Thus N-1-substituted 
benzotriazole has greater stability since substitution at N-1 retains the 1t-sextet of 
the benzenoid ring. 
The mechanism for the alkyl rearrangement, first suggested by Lindsay-Smith 
and Sadd 193 was proven by Katritzky and co-workers 171 to be an intermolecular 
dissociation-recombination process, (Scheme 29), proceeding smoothly at 

















The rate of isomerisation, while clearly dependent on temperature, is also 
greatly dependent on the degree of stabilisation provided to either of the 
intermediate ions. Thus, energies of activation are lower in solvents of high 
polarity where the benzenoid substituents are electron-withdrawing, and the 
aminoalkyl substituents are electron-releasing. 
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The isomer proportions are found to be dependent on solvent polarity and 
substituent effects, and relatively insensitive to temperature variation. Increasing 
the polarity of the solvent increases the proportion of the 1-isomer beyond the 
statistical 2:1 ratio (the isomers are of nearly equal stablility in non-polar 
solvents), while increasing the bulk of the aminoalkyl substituents (and/ or the 4-
or 7-substituents in the benzotriazole ring) increases the proportion of the 2-
isomer as a result of peri-interactions. Electronic effects appear minor, though 
strongly electron-withdrawing groups in the ring favour alkylation at the remote 
nitrogen 174. Electron-releasing or electron-withdrawing aminoalkyl groups do 
not appear to have any effect on the position of thermodynamic equlibrium. 
The facility of thermal interconversion diminishes with the degree of stability 
of the positively charged intermediate ions. Thus in the corresponding sulfur 197 
and ox,ygen 198 analogues, the isomers equlibrate less rapidly. N-Di- (particularly 
+Mp- substituted) and -tri-arylmethylbenzotriazoles can undergo rearrangement 
but require high temperatures (175-250°C). Monoarylmethyl derivatives however 
(eg. N-benzylbenzotriazole), are unable to isomerise even under these conditions 
173 
1.2.4 Tetrazoles 
Tetrazoles, despite being the least basic of the the azoles discussed in this 
chapter (Table 1 (s. 1.4)), readily undergo electrophilic substitution at nitrogen 
with a wide range of electrophiles. A great deal of data is available in the 
literature on the alkylation of tetrazoles and 5-substituted tetrazoles, though the 
bulk of the regiochemical and mechanistic work was restricted to 5-aryltetrazoles 
untii Spear conducted a systematic study on the positional selectivity of basic 
methylation in a series of fifteen 5-substituted tetrazoles 199. Much of the 
alkylation work predating this study is cited therein. Again, due to the 
complication of tautomeric equilibria, alkylation studies on the free base have for 
the most part been neglected. 
Tetrazoles, as both the free base and the anion, can alkylate either at N-1 or N-
2, commonly to produce mixtures in proportions dependent, inter alia , on the 
nature of the 5-substituent. In spite of the fact that many of the isomer ratios 




dependence on both steric and electronic factors is obvious (Table .7 (s. 1.4)). 
Regioselectivity can be defined generally as follows: electronic effects are 
dominant, such that electron-releasing substituents at C-5 favour alkylation at N-
1, while electron-withdrawing substituents favour N-2-alkylation. Sterk effects 
on positional selectivity are superimposed and orient attack to N-2, though these 
may be mitigated to a sizable degree if the 5-substituent is strongly electron-
releasing. 
Thus, for example, in the methylation study undertaken by Spear 199 the 
sodium salts of unsubstituted, 5-methyl- and 5-aminotetrazole gave a mixture 
with the 1-methyl isomer predominant, while strong inductive withdrawal by 
substituents such as halo, nitro, trifluoromethyl and cyano directed methylation 
to give the 2-methyl derivative as the major product. 
An attempt to correlate log(N2/N1 methylation ratios) with Hammett cr 
constants (crp-) was largely unsuccessful; the electronic and steric effects could not 
be qualitatively separated. Ratio dependence on the electronic nature of the 5-
substituent has been clearly demonstrated in 5-aryltetrazoles. A linear correlation 
was found between isomer distribution (log k1 /k2 , where k1 and k2 are the rate 
constants for the formation of 1-methyl- and 2-methyl-5-(p-
substituted)phenyltetrazoles respectively), and Hammett cr values for para-
substituents in the methylation of the sodium salts of various 5-aryltetrazoles 
with methyl iodide in aqueous ethanol 2°0. The cr0 value for methoxide and the 
crp- value for nitro was required implying not only that the alkylation is charge-
controlled but also that electron-withdrawing substituents exert greater influence 
on regioselectivity than electron-releasing substituents. Linear correlations have 
also been observed in the alkylations of the potassium salts of substituted 5-
phenyltetrazoles with dimethyl sulfate 201 and ethyl bromoacetate 202 in 
acetonitrile, and the triethylammonium salts with benzonitrile N-(p-
nitrophenyl)imide in benzene 114. The rate constants calculated 201 (refer below) 
also correlate with the <Jp constants of the substituents. Thus the rate of alkylation 
decreases with an increase in the electron-withdrawing character of the para-
substi~ent in the phenyl ring. 
Interestingly, 5-phenyltetrazole imposes a greater steric restriction on N-1-
substitution than ortho- derivatised substrates 200 : o- chloro and o- methyl 
derivatives produce N-2:N-1 ratios of 1:1 and 1.3:1 cf. 2.2:1 generated by 5-
phenyltetrazole. It has been suggested that substituents at 2~- a~d 6~-positions 
twist the phenyl and tetrazole rings out of plane and perhaps allow weak 
complexation to occur between the orthogonal 1t-cloud of the aryl ring and the 
incoming electrophile 114. In view of this conformational change an 
enhancement of N-1-alkylation is expected. 
. 
~/ 
' ' r 
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To provide an insight into the relative importance of electronic effects as a 
factor contributing to positional selectivity, semi-empirical quantum mechanical 
calculations of atomic charge densities have been performed on the tetrazolate 
and various 5-substituted tetrazolate anions 199, 203, 204. Although values vary 
considerably according to the method of calculation, it is clear that the electron 
density at N-1(4) appears to be substantially greater than at N-2(3), thus predicting 
in theory at least, that N-1(4) is the more nucleophilic site. However, all methods 
agree that the electron density distribution (N2:N1 charge ratios) is not affected to 
a degree entirely consistent with the marked substituent effect on regioselectivity. 
Other factors considered influential in the selectivity of alkylation (specific 
solvation, counterion association, and temperature effects), have been proposed 
in the course of extensive research into the mechanism of N-alkylation in para-
substituted 5-phenyltetrazolate salts 201, 202, 205-208. 
The results of this work can be summarised as follows. Kinetic studies on the 
alkylation of salts of 5-phenyltetrazole with dimethyl sulfate 205-207 and ethyl 
bromoacetate 202 in anhydrous acetonitrile reveal that reaction of the tetrazolate 
anion is second-order overall and first-order in each of the components. Under 
the conditions of reaction the alkali metal salts of 5-phenyltetrazole exist in the 
form of free ions (ie. are non-associated in substrate concentrations of less than 
10-3 M' and at temperatures in the range 10-35°C), and give rise to nearly identical 
second-order rate constants, inferring that irrespective of the nature of the cation, 
the reactive species is the tetrazolate anion. Two factors, namely product ratio 
variance with temperature and the nature of the cation, dispel the possibility of a 
synchronous bimolecular nucleophilic substitution process, and lead to the 
conclusion that alkylation occurs via a two-step mechanism (Scheme 30; T-·Cat+ 
is the phenyltetrazole salt, T- is the tetrazolate anion, R is the alkylating agent, A-
·Cat+ is the ion-pair intermediate, l<d, is the dissociation constant for the salt, k1 
and k -1 are the rate constants for the forward and reverse reactions for the 
formation of the intermediate, and k2 and k3 are the rate constants for the 
formation of the isomers T1 and T2 ). 
Lr1 
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In the first (rate determining) step, the alkylating agent reacts with the tetrazolate 
anion to form an unstable (non-isolable) ion-pair intermediate which, prior to 
subsequent rapid conversion into the the two reaction products, undergoes a 
degree of coordination with the counterion at the more nucleophilic nitrogen 
(N-1) to produce the increased proportions of 2-alkylated product observed in the 
cation series Cs+, K+, Na+ at 35°C (refers. 1.2.2.1). Product ratios vary with 
temperature according to the following relationship : 
Nl 1 A2 
log N2 = ~E . RT + log At 
where ~E = E1 - E2 is the difference between the partial activation energies for the 
formation of the two isomers T1 and T2; At and A2 are preexponential factors. 
Arguments in favour of the proposed two-stage mechanism lie in the variance of 
~E with the para- substituent, while at the same time, for all members of the 
reaction series the enthalpies of activation are practically equal, and furthermore, 
the sharp increase in aromaticity which occurs in the transition from tetrazole to 
its anion 203 would facilitate the formation of the intermediate. 
It is interesting to note that comparison of the alkylation of these substrates 
with dimethyl sulfate 201 and ethyl bromoacetate 202 shows that while the 
reaction rate decreases by approximately an order of magnitude in the latter 
reaction, selectivity, particularly in para- substituted 5-phenyltetrazoles, changes 
only slightly. 
Solvent effects, however, are more pronounced. When the effects of specific 
solvation on the rate and selectivity of methylation of the salts of 5-
phenyltetrazoles were investigated 208, it was found that in aqueous acetonitrile 
the rate of alkylation decreased as the water content increased, while the 
proportion of the N-2-methylated product increased irrespective of the nature of 
the counterion. Thus specific solvation by water at N-1 prevents cationic 
coordination and at the same time hinders the position to electrophilic attack. 
Phase transfer catalytic conditions (two-phase dichloromethane and water) with 
tetrabutylammonium bromide catalyst showed that selectivity of methylation 
with methyl iodide, which is shown to occur in the organic phase, is very similar 
to results obtained under homogeneous conditions. On the other hand 
selectivities with dimethyl sulfate were contrary (no linear correlation was found 
to exist between log Nl/N2 and cr constants), the reason being that alkylation 





transfer catalyst. ie. occurs in both the organic and aqueous phases and at the 
interface. 
Information on the alkylation of the free bases of tetrazoles is scarce. 
Diazomethane methylations however, have been reported 209-211 (Table 7), and 
in general, ratios favour the N-2-methylation product. Tautomeric studies, 
through experimental and theoretical dipole moments, lH and 13C nmr 
spectroscopy 212, suggest that the 1-H(4-H) tautomer is the predominant form of 
the free base in "neutral" solution, and CNDO calculations 203 predict greatest 
electron density at N-1 and N-4, which is consistent with evidence that 
protonation occurs at N-4 in tetrazole 213, 214. Hence it would seem likely that N-
1(4) is the preferred site of electrophilic attack, subject to the steric requirements 
of the alkylating agent. 
Isomerisation of N-alkyltetrazoles by reaction with excess alkyl halide or p-
benzenesulfonate has been reported at temperatures greater than 70°C 215. The 
process, though reversible, is essentially uni-directional to form the 
thermodynamically preferred 2-alkyl isomer and proceeds via a proposed 
quaternisation-decomposition mechanism (Scheme 31). 1,5-Disubstituted 
tetrazoles quaternise at the 4-position, but powerful alkylating agents (eg. 
triethyloxonium tetrafluoroborate 216) and/ or high temperatures 215 give a 
mixture of 1,4,5-trisubstituted and 1,3,5-trisubstituted tetrazolium salts, the 
former in greater proportion. The minor product, the intermediate 1,3,5- salt (61), 
is less stable than the corresponding 1,4,5- salt (60) and decomposes at 
temperatures below 70°C (cf. ca. 140°C for 1,4,5- salt) to form the 2,5-disubstituted 
derivative. The process is quantitative at 130°C; no isomerisation is observed 
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Under the mild reaction conditions of the above alkylations, thermodynamic 
equilibration is unlikely, and indeed, kinetic control was proven (by product 
analysis after a few percent conversion) in the methylation of substrates with 





Very recently. alkylation experiments have been performed on the protonated 
tetrazolium species 217-219. Reaction of 5-substituted tetrazoles with secondary 
(isopropyl, cyclohexyl) and tertiary (tert- butyl) alcohols 217, and related olefins 
(propene, isobutene, cyclohexene) 218 in concentrated (96%) sulfuric acid at room 
temperature, selectively gave N-2-alkylated products in high yields. It is theorised 
that under such extreme acid conditions the symmetrical tetrazolium species 
(protonated at N(4)), undergoes alkylation at either of the two equivalent 
nucleophilic nitrogens (N(2), N(3)), with subsequent or concerted deprotonation 
to yield the 2-alkyltetrazolium product. The alkylating species in the reaction 
medium are probably the inductively stabilised and reactive carbocation 
intermediates formed by dehydration of the secondary and tertiary alcohols, and 
protonation of the corresponding olefins (Scheme 32). Experiments in 
phosphoric acid at decreasing acidity (87 and 71 %) are consistent with this 
proposed mechanism, producing isomeric 2- and 1-tert- butyltetrazole in ratios 
ca. 15:1 and 5:1 respectively, in response to a decrease in the degree of 
protonation of tetrazole. Further, the regioselectivity of these alkylations is 
independent of the steric and electronic nature of the 5-substituents. 
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Apparently at odds with this compelling argument, however, is the reaction of 
the primary alcohol, isobutanol, with 5-substituted tetrazoles in 96% sulfuric acid 
219. While 2-tert- butyl- and 2-sec- butyl-5-substituted tetrazoles were isolated, as 
one would expect on the grounds of known carbocation behaviour, 1-tert- butyl-
5-substituted tetrazoles were also isolated in yields sensitive to the steric and 
electronic character of the 5-substituent (refer Table 7). 
Regiospecific 1-alkylation has been obtained by selectively blocking the 2-
position with a tri-n-butylstannyl group 15. 5-Substituted tetrazoles treated with 
bis(tri-n-butyltin)oxide are stannylated at N-2 and undergo al~ylation with alkyl 
halides, sulfates, p- toluenesulfonates at room temperature, with concomitant 
loss of the stannyl group, to give predominantly 1-alkylated products, in 
proportions again dependent on the electronic and steric properties of the 5-
substituent. 
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Novel alkylations of 5-alkyl-2-tri-n-butylstannyl- and 5-alkyl-2-
trimethylsilyltetrazoles with alkyl cyanoformates 16 selectively produce the 2,5-
dialkylated derivatives presumably by the mechanism proposed by Vida 220 ie. 
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via acylation at N-1 to produce an unstable intermediate, (62), which then 
subsequently rearranges with simultaneous loss of carbon dioxide to give the 2-
alkyl isomer (Scheme 33). The minor alkylation product accordingly forms via 
displacement of the trialkylstannyl(silyl) group at N-2 followed similarly by 
decarboxylative rearrangement. Reactions of alkyl chloroformates with 5-aryl-
and 5-alkoxyalkyltetrazoles on the other hand, are prone to degree of competitive 
rearrangement in the form of a Huisgen-type reaction 221 to give 1,3,4-oxadiazole 
side-products. 
1.3 Synthesis 
It is eminently clear from the above discussion that the methodologies of 
synthesis of N-alkylazoles are wide-ranging. In a given circumstance the method 
of choice must resolve the inherent problems of reactivity, monoselectivity (if 
desired) and regioselectivity. In consequence, the general applicability of many of 
the reported alkylation procedures becomes severely limited. When addressing 
these problems one must be cognizant of the fact that the azole can exist in 
various forms dependent on the reaction environment, and these determine at 
the outset, the reaction pathway, and to a considerable extent the regioselectivity 
of the alkylation. 
Leaving aside regioselectivity for the moment, very simply, alkylations can be 
categorised into two basic types: those involving reaction of the free base 
("neutral" conditions) and those involving reaction of the deprotonated azole 
anion ("basic" conditions). 
Free base alkylations, whether neat or in solvent, are characterised in general 
by incomplete reaction (even where the reagent is in excess), and overreaction 
(particularly at elevated temperatures) to produce quaternised azolium side-
products. Though the extent of the latter may be reduced by the choice of an 
appropriate solvent (ethanol is reported to encourage quaternisation 222 while 
aprotic solvents supposedly minimise the process 223), overall product yields are 
often low despite the use of forcing reaction conditions. 
Alkylation of the deprotonated azole is by far the most common route to 
mono-N-alkylated azoles. Milder reaction conditions are required as the azole 
anion has greater nucleophilicity, and susceptibility to overreaction is much 






one-pot synthesis. The reaction typically involves the addition of the alkylating 
agent to the substrate predissolved in a basic solution, commonly alkali metal 
hydroxide or alkoxide in a polar solvent 132. While yields are generally higher 
than those obtained in neutral alkylations, they are still far from quantitative. 
This is particularly evident in reaction systems where the alkylating agents are 
unstable in the presence of base and/ or hydroxylic solvents (eg. alkyl halides: 
secondary and tertiary reagents are especially vulnerable to such attack). Alkyl 
(and substituted alkyl) halides, sulfates, tosylates and diazoalkanes are the most 
frequently used reagents in alkylation reactions 132, the more powerful alkyl 
fluorosulfonates, trialkyloxonium tetrafluoroborates 224, alkyl triflates and 
mesylates 57, 225 are favoured where substrate reactivity is low, as for example in 
azole quaternisation. More recently trialkylphosphates 136, 137, 
alkoxyphosphonium salts 226, dimethylformamide dialkyl acetals 138, 139, trialkyl 
orthoformates 138, alkyl cyanoformates 16 and dialkyl carbonates 227 have been 
used displaying varying yield improvements and substrate limitations. 
Separating the (aqueous) base from the alkylating agent in a bi-phasic system, 
in the presence of an appropriate phase-transfer catalyst, affords considerably 
increased yields of mono-N-alkylated product under mild (room temperature) 
conditions. Phase-transfer catalysis, in application to heterocyclic systems, has 
been comprehensively reviewed 228. 
Phase-transfer catalytic conditions may involve a liquid-liquid heterogeneous 
system, typically aqueous alkali and non-polar organic with quaternary 
ammonium salt catalysts. Solid-liquid systems, however, using anhydrous solid 
bases and catalysts in non-hydroxylic solvents are particularly desirable for 
alkylations of substrates bearing functionality labile to hydrolysis (eg. potassium 
tert- butoxide in anhydrous ether with 18-crown-6 catalyst 229, and sodium 
hydroxide in anhydrous toluene (or potassium carbonate in xylene 230) with 
tetrabutylammonium hydrogensulfate 231 ). Solid-liquid phase-transfer catalysis 
in the absence of solvent reportedly affords high yields of N-alkylated azole 
product with advantageous avoidance of quaternisation 232-234. Similar 
alkylations involving a suspended base and performed in the absence of phase-
transfer catalysts have also shown appreciable effectiveness in improving yields 
(eg. powdered potassium hydroxide in acetone 235, and dimethyl sulfoxide 236). 
Still greater and more uniformly improved yields have been obtained by 
separating the deprotonation and alkylation steps since contact between 
alkylating agent and base (aqueous alkali) under phase-transfer conditions, 
though reduced, still exists. Searcey et al. generated stable, crystalline 
tetraalkylammonium salts of nitroimidazoles and subsequent to isolation, 
treated these salts with halo compounds in anhydrous and/ or non-protic 




alkylated nitroimidazoles obtained by this method consistently exceeded those 
obtained by phase-transfer and the traditional alkali salt route. The work of 
Begtrup and Larsen takes this concept a step further and has been applied to 
silylation and acylation as well as alkylation 238. The separation of the 
deprotonation and nucleophilic substitution/ displacement steps (Scheme 34) 
allows for greater control of reaction conditions and the problems (eg. 
monoselectivity) associated with the alkylation process. 
CNH Base cN- RX CNR Solvent 1 Solvent 2 
Scheme 34. 
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In most cases these problems can be solved by using the appropriate combination 
of alkylating agent, solvent, reaction time and temperature. These reaction 
parameters possess individual 'reaction capabilities' or 'reaction potentials' 
which appear to be roughly additive. In the course of a systematic study, 
involving the alkylation of isolated azole sodium salts, these alkylation 
potentials have been quantified by normalisation to pKa units (based upon an 
arbitrary figure given to methyl iodide) and are related to the pKa of the azole 
such that monoalkylation will occur in 75% yield if the following relationship is 
satisfied: 
20 - { Pa (RX) + Pa (solv) + Pa (t) + Pa (T)} ~ pKa(azole) 
where Pa terms are the alkylation potentials of the alkylating agent, solvent, 
reaction time and temperature respectively 238. Similarly dialkylation (ie. 
quaternisation) will take place if 
20 - { Pq (RX) + Pq (solv) + Pq (t) + Pq (T)} ~ pKBH+(alkylazole) 
where Pq terms are the analogous quaternisation potentials. Alkylation and 
quaternisation potentials for methylating agents (methyl iodide (arbitrary) and 
dimethyl sulfate), benzylating agents (benzyl chloride, bromide and iodide) and 







under 'standard' reaction conditions (20°C for 72 h) are tabulated in the 
publication 238• 
Dialkylation is thus avoided by ensuring that the sum of the alkylation 
potentials is less than the pKaH+ of the alkylazole. In those situations where 20 
minus the sum of the reaction potentials unavoidably approaches the pKaH+ of 
the alkylazole (ie. where the pK difference between the azole anion and the 
alkylazole is small), quaternisation can be minimised by using only 
stoichiometric quantities of the alkylating agent, a solvent which completely 
solubilises the azole anion, and by using the smallest possible sum of reaction 
potentials. 
In the syntheses of N-alkylazoles from ambident substrates, alkylation may 
lead to, mixtures of isomeric products where one in particular is desired 
regiospecifically. Substantial control over product distribution can be achieved by 
considering the effects of reaction conditions on regioselectivity as discussed in 
the preceding sections. However, in many cases the desired product is the 
kinetically (and perhaps thermodynamically) less favoured isomer irrespective of 
the conditions of alkylation, and commonly the reaction is in fact regiospecific in 
the formation of the second isomer. In such cases this regioselectivity can be used 
to advantage in the preparation of the desired product by utilising a synthetic 
strategy involving the regiospecific blockage (protection) of the preferred 
alkylation site, either via cation coordination (refer s. 1.2.2.1 ) or substitution 
with a suitable protecting group (refers. 1.1).The latter method has been described 
with reference to the strategic N-alkylation of azoles using the p- methoxybenzyl 









Table 1. pKa and pKBH+ values of parent azoles in water 71 . 
pKa pKBH+ 
Imidazole 14.17 7.0 
Benzimidazole 12.9 5.69 
Pyrazole 14.21 2.52 
Indazole 13.8 1.39 
1,2,3-Triazole 9.26 1.17 
Benzotriazole 8.2 
1,2,4-Triazole 10.04 2.45 
Tetrazole 4.86 -3.01 
Table 2. Isomer ratios A from the N-methylation of 4-substituted 
imidazoles (from Schofield 240 unless otherwise stated). 
Imidazole Mel Me2S04 CH2N2 Me2S04/0H- Ag+ salt/Mel 
I 
4-Br - 1: 11.5 B 1: 2.6 B 2.6: 1 B 
4-Me 2:1 1.4: 1 B 1: 1 B 1.2: 1 B 
4-N02 - 1: 50 B 1: 16 B 8.6: 1 B C 
4-Ph - 4.0: 1 B 1:2 7.3: 1 B,D 
4-CN - - - 2.9: 1 
4-CHO - 1: 3.6 B 1: 4.4 B 1: 1 B 
A 1,4-Isomer: 1,5-isomer. 
B P.A. Benjes, unpublished results 241 . Neutral alkylations carried out in refluxing ethanol, 2 
hours. Basic alkylations carried out in aqueous 10% NaOH, room temperature, stirring 2 
hours. Ratios determined by nmr analysis. 
C 1,4-Isomer only. 
D Me2S04/NaOEt in Ethanol. 
Table 3. Isomer ratios A of N-substituted pyrazoles from alkylation 
experiments 134. 
Substituents Reaction conditions 
R3 R5 Me2S04/MeOH B Me2S04/N aOMe C 
Et H 1.47 0.40 
Ph H 6.25 3.16, 3.74 D 
Ph Me 4.07 3.17 
N02 H 1.25 E 4.10 E, 3.90 D 
N02 Ph 0.01 0.45 
A 1,3-Isomer : 1,5-isomer (calculated by g.l.c. analysis). 
B Neutral conditions. 
C Basic conditions. 
D Methylation with Mel/NaNH2 46. 



















Table 4. Isomer ratios from the alkylations of (un)substituted 1,2,4-
triazoles. 
1,2,4-Triazole Conds. a Ratios b Conds. a Ratios b 
R3 R5 
H H A 4.8: 1 B 6.7: 1 
CH3 CH3 A 9:1 B 13.2: 1 
Ph Ph A 49: 1 B 99: 1 
CH3 H A 3.5: 3.2: 1 B 5.1: 5: 1 
SCH3 H A 4.8: 2.5: 1 B 5: 5.1: 1 
iso-C3H7 H A 9.3 :4: 1 B 10.8: 8.2: 1 
Ph H A 13: 6: 1 B · 15.5 : 8.5 : 1 
a-pyridyl H A 3.4: 2.8: 1 B 0.9: 3.9: 1 
P-pyridyl H A 25: 7.3: 1 B 23.7: 8.7: 1 
Ph SCH3 A 11.2: 7.8: 1 B 14.8: 9.3: 1 
p-N02C6H4 SCH3 A 16.5: 7.5: 1 B 22.7: 9.7: 1 
a-pyridyl SCH3 A 2.1: 4: 1 B 0.9: 4.3: 1 
P-pyridyl SCH3 A 10.2: 5.5: 1 B 16.3: 7.8: 1 
N02 H C C D 23: 3: 1 
H H E 5.7: 1 F 2.3: 1 
H H G .C 
45 
a Reaction conditions: A Mel in aqueous NaOH 153; B CH2N2 in methanot 153; C Me2S04 
in aqueous NaOH 242; D DMF dimethyl acetal in toluene 139; E PhCH2Cl in xylene (phase 
transfer conditions) 230; F Ph2CHCl in xylene (phase transfer conditions) 230; G Ph3CC1 in 
xylene (phase transfer conditions) 230. 
b Isomer ratios for unsubstituted or symmetrically substituted triazoles are N-1-: N-4-alkyl-. 
Ratios for unsymmetrical triazoles are N-1-: N-2-: N-4-alkyl. 
c N-1-Alkyl isomer only. 
Table 5. Isomer ratios from the alkylations of (un)substituted 1,2,3-
triazoles. 
1,2,3-Triazole Conds. a Ratios b Conds. a Ratios b 
R4 R5 
H H A 4:1 B 4.9: 1 
C 13.3: 1 D 4: 1 
E 4:1 F 11.5: 1 
G 2.7: 1 H 1.5:1 
N02 H I 0.7: 1 J 0.8: 1 
K 0.4: 1 L 2:1 
M 1.9:1 N 0.5: 1 
Br Br 0 1:1 
p-ClC6ff4 P(Ph)J+ p C 
Ph P(Ph)J+ Q C 
Ph Ph R d s 0.7: 1 
T 0.2: 1 u 0.3: 1 
CH3 Ph V 8.6: 3.9: 1 e 
Cl CN w 0.3: 0.2: 1 e X C 
H H y C z d 
AA d 
N02 H AB 0.05: 1 AC 0.2: 1 
AD 0.8: 1 AE 0.7: 1 
Br Br AF C 
p-ClC6lf4 P(Ph)3+ AG C 
CH300C CH300C AH C AI C 











a Reaction conditions : A n-C3H7Br /Na+ salt/methanol 177; B n-C3H7Br / Ag+ salt/benzene 
177; C n-C3H7Br/neat 177; D CH2=CHCH2Br/Na+salt/methanol 177; E 
CH2=CHCH2Br/ Ag+ salt/benzene 177; F CH2=CHCH2Br/neat 177; G 
ClCH2CH2CN/Na+ salt/ethanol 177; H C2H500CCH2Br/Na+ salt/ethanol 177; I 
CHJI, CH3CH2Br, (CH3)2S04/Na+ salt/acetone 178; J n-C3H7Br/Na+ salt/acetone 178; K 
iso-C3H7Br/Na+ salt/acetone 178; L C2H500CCH2Br/Na+ salt/acetone 178; M 
C6H5CH2Cl/Na+ salt/acetone 178; N C6H5COCH2Br/Na+ salt/acetone 178; 0 
(CH3)2S04/aq. NaOH 243; P CH3CH21/chloroform 179; Q C2H500CCH2Cl/chloroform 
179; R CHJI/ Ag+ salt/chloroform 180; S CH3CH21/ Ag+ salt/chloroform 180; T iso-
C3H71/ Ag+ salt/chloroform 180; U CH2N2/diethyl ether 180; V CH31/ Ag+ 
salt/chloroform 180; W (CH3)2NCH(OCH3)2/n:eat 244; X (CH3)2NCH(OC2H5)2/neat 
244; Y CH2=CHCN/Triton B/dioxan 177; Z CH2=CHN02/chloroform 177; AA 
CH2=CHCOOH/neat 177; AB C4H90CH=CH2/HJP04/chloroform 178; AC 
C4H90CH=CH2/neat 178; AD CH2=CHCN/KOH 178; AE C6H5COCCH/(Et)3N 178; AF 
(CH3)2C=CHCOCH3/neat 243; AG HCCCOOC2H5/ethanol 179; AH 
HCCCOOC2H5/(Et)3N/acetone 175; AI CH300CCOOCH3/(Et)3N/ac~tone 175. 
b N-1-Alkyl : N-2-alkyl. 
c N-2-Alkyl isomer only. 
d N-1-Alkyl isomer only. 






















a C2H500CCH2Cl in solvent and base conditions stated. 
b N-1-Alkyl : N-2-alkyl. 










Table 7. Isomer ratios from the alkylations of (un)substituted tetrazoles. ·;, 
Tetrazole Conds. a Ratio b Conds. a Ratio b 
R5 
H A 1.6: 1 B C 
C 7.8: 1d o· C 
- ,( 
CH3 B C C 0.2: 1d 
E 2.2: 1 F 1.5: 1 
G 0.2: 1 
CF3 B C C c,d 
E C F C 
iso- C3H7 A 1.1: 1 
tert- C4H9' A 0.4: 1 
Cl E 0.1: 1 
Br H 0.3: 1 I 0.2: 1 
NH2 A 1.4: 1 B C 
F 3.1: 1 I 1.1:1 
J 0.7: 1 K 1.6:1 
N02 A 0.2: 1 
CN A 0.2: 1 
CH300CCH2 L 1:1 M 0.5: 1 
N 0.3: 1 
C2H500CCH2 0 0.7: 1 p 0.3: 1 
Q 0.7: 1 
r 
Ph A 0.3: 1 B C 
C c,d D C 
F C 
p- OCH3C6H4 A 0.4: 1 
p- N02C6H4 A 0.2: 1 
C~50CH2 R 0.7: 1 
C6fi5CH2, R 1.1: 1 





a Reaction conditions: A CH3l/Na+ salt/acetone: water (4:1) 199; B (CH3)3COH/96% 
H2S04 217; C (CH3)2CHCH20H/96% H2S04 219; D CH3CH=CH2, (CH3)2C=CH2, 
cyclohexene/95% H2S04 218; E C2H500CCH2Br/(Et)3N+ salt/acetone 245; F 
CH300CCH2C1/K+ salt/methanol 246; G CH2N2/95% ethanol-diethyl ether 210; H 
CH300CCH2C1/(Et)3N+ salt/acetone 245; I CH2N2/diethyl ether 209; J 
C6H5CH2Cl/Na+ salt/ethanol-water (2: 1) 247; K (CH3)2S04/aqueous NaOH 209; L 
CH3I/(Et)3N+ salt/acetone 245; M CH3CH2I/(Et)3N+ salt/acetone 245; N iso-
C3H7l/(Et)3N+ salt/acetone 245; 0 CH3l/(Et)3N+ salt/DMF 248; P CH3CH2l/(Et)3N+ 
salt/DMF 248; Q C6H5CH2Cl/(Et)3N+ salt/DMF 248; R CH3I/K2C03/acetonitrile 249. 
b N-1-Alkyl : N-2-alkyl. 
c N-2-Alkyl isomer only. 
d Ratios are N-1-tert- butyl- : N-2-tert- butyl-; Yield of N-2-sec- butyl- products, R5=H (30%), 
CH3 (22%), CF3 (14%), and Ph (20%). 
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PREPARATION OF STARTING MATERIALS 
2~1 Introduction 
For the purpose of investigating the effects of substituent on product 
determination, a variety of unsymmetrically 4(5)-mono-, 2,4(5)-di- and 4,5-di-
substituted imidazoles were synthesised. Substrates were chosen so that a range 
in electronic and steric properties were imparted to the imidazole ring system by 
the substituent(s). 
Accordingly, 4-phenyl-, 4-p- methoxyphenyl-, 4-p- chlorophenyl-, 4-p-
nitrophenyl-, 4-methyl-, 2,4-dimethyl-, 4-bromo-, 4-iodo-, 4-chloro-, 4-nitro-, 5-
bromo-4-nitro-, 5-iodo-4-nitro-, 4-hydroxymethyl-, -4-carbaldehyde, -4-
carboxamide, methyl -4-carboxylate, 5-methylthio-4-nitro-, 4-nitro-5-phenylthio-, 
5-methylsulfinyl-4-nitro- and 5-methylsulfonyl-4-nitro-imidazole were prepared 
by known and modified methodologies, through ring synthesis, ring 
functionalisation and substituent transformation as described herein. 
All starting compounds were purified prior to involvement in alkylation 
experiments, and their nmr data were acquired for characterisation and 
subsequent comparison (Chapter 4). 
Metallation and metal-halogen exchange regimes were investigated as routes 
to the synthesis of 4-substituted imidazoles, with particular reference to 4-
cyanoimidazole. The results obtained in the metal-halogen exchange 
experiments, in conjunction with literature findings, were viewed and discussed 
from a Hard and Soft Acids and Bases (HSAB) perspective. 
2~2 Discussion 
4-Phenyl- and 4'-substituted 4-phenylimidazoles 
The method chosen for the preparation of 4-phenylimidazole and its para-
substituted analogues was that originally developed by Bredereck and Theilig 250, 
251 . They had prepared 4,5-disubstituted imidazoles in good yields (40-90%), 
through the interaction of a.-dicarbonyls, a.-ketol esters, a-hydroxy- (acyloins), a.-




















In this way, 4-phenyl-, 4-(4'-methoxyphenyl)-, 4-(4'-chlorophenyl)- and 4-(4'-
nitrophenyl)imidazole were synthesised by reaction of the corresponding para-
substituted phenacyl bromide 252 with formamide at 150-160°C. The yields 
obtained, (25, 22, 18 and 23% respectively), were lower than expected; Iradyan and 
Torosyan achieved a 57-61 % yield of 4-phenylimidazole in the cyclocondensation 
of phenacyl bromide with formamide 253. 
It is generally accepted 250 that the initial step in the cyclocondensation 
sequence is the conversion of the a-halogenoketone into an a-hydroxyketone. 
An evidentially supported 254 reaction pathway for the production of 4-
substituted or 4,5-disubstituted imidazoles via an a-formamidoketone 
intermediate has been proposed 251• This pathway, adapted for the formation of 4-
phenylimidazoles, is shown in Scheme 36. 
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As an alternative to the ring synthesis of the para-nitro derivative, direct 
nitration of 4-phenylimidazole in mixed acids was attempted. It has been 
observed that nitration of phenyl substituted imidazoles occurs predominantly in 
the para position of the phenyl nucleus 255• 4-Phenylimidazolium nitrate is 
reported to undergo nitration, upon exposure to concentrated sulfuric acid at 
100°C, to afford 4-para-nitrophenyl- and 4-ortho-nitrophenylimidazole in 69 and 
,, 
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25% yields respectively 256. Further, the introduction of a second nitro group into 
the imidazole ring at the 4(5)-position proceeds readily when the nitrates of 
nitrophenylimidazoles are treated similarly with hot concentrated sulfuric acid 
256 
Using 1.5 stoichiometric equivalents of fuming nitric acid and reaction 
temperatures above 0°C gave 4-nitro-5-(4'-nitrophenyl)imidazole as the major 
product in 78% yield following recrystallisation from EtOH (m. pt. >280°C; lit. m. 
pt. 293°C 256). Dinitration and para-substitution was evidenced by the 1H nmr 
spectrum which showed the symmetrical AA'BB' pattern typical of para-
disubstituted phenyl derivatives, and a single one-proton singlet in the aromatic 
region: OH (DMSO) 8.01 (lH, s, H-2), 7.93-7.98 (2H, m, H-2',6'), 8.31-8.36 (2H, m, H-
3\5'). lH nmr analysis of the crude product revealed the presence of a small 
quantity of ortho- or meta-substituted dinitrated compound, though no attempt 
was made to isolate it. 
Since imidazoles are exclusively nitrated at the 4(5)-position in mixed acids 255, 
nitration of 4(5)-phenyl- or 4(5)-para-nitrophenylimidazole was held to occur at 
the 5(4)-position. A confirmatory signal at o 135.5 in the lH decoupled carbon 
spectrum was observed as a large doublet (lJcH = 216 Hz) in the lH coupled 
spectrum, indicating 2-unsubstitution. 
Reducing the amount of fuming nitric acid in the mixed acid medium to half 
an equivalent afforded, after stirring 2 hours at 0°C, both para-
nitrophenylimidazole and the dinitrated product in roughly equal proportions 
(in 20% combined yield). The absence of 4-nitro-5-phenylimidazole and 
apprec,iable ortho- or meta- substituted phenylimidazoles in the product mixture 
demonstrates that the rate of nitration of the imidazolium ion is slower than the 
phenyl nucleus, and that the imidazolium group is predominantly para 
directing. 
Further modification of the reaction conditions to reduce the degree of 
dinitration was not attempted. 
4-Methylimidazole 
4-Methylimidazole was obtained as the relatively inexpensive, commercially 
available product (98% quoted purity). Microanalytical purity was achieved 
through large scale vacuum distillation. 
Classical synthesis of 4-methylimidazole, carried out by Windaus and Knoop 
257 and more recently by Liggett and Hofmann 258, involved reaction of D-glucose 
with ammoniacal zinc hydroxide solution. It is believed that under these 
conditi_ons D-glucose is hydrolysed and the hydrolytic products, pyruvaldehyde 
52 
and formaldehyde, undergo subsequent Radziszewski cyclocondensation 259 with 
ammonia to produce the zinc salt of 4-methylimidazole. 
2,4-Dimethylimidazole 
2,4-Dimethylimidazole can be synthesised in a number of ways. A classical 
Radziszewski method would involve condensation of an cx.-dicarbonyl, 
pyruvaldehyde in this instance, with ammonia and acetaldehyde 260. Yields for 
this type of condensation are generally low but can be improved somewhat by 
carrying out the reaction in glacial acetic acid medium, with ammonium acetate 
as the source of ammonia 259. 
Gre;;tter yields have been achieved using the Weidenhagen method 259, a 
variant of the Radziszewski condensation. Here an cx.-hydroxyketone or acyloin is 
oxidised in the presence of copper (II) to the corresponding cx.-dicarbonyl. 
Cyclocondensation with ammonia and an appropriate aldehyde forms the 



















Accordingly, 2,4-dimethylimidazole was synthesised using acetoxyacetone and 
acetaldehyde in the presence of copper (II) acetate and ammonium hydroxide 
following the Weidenhagen method described by Lipshutz 261 (Scheme 37). 
Decomposition of the copper (I) salt with hydrogen sulfide afforded the product 
in 45% overall yield (cf. 60% 261 ). 
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4-Haloimidazoles 
The halogenation of azoles has very recently been the subject of extensive 
review 262• Imidazoles undergoing electrophilic halogenation have a great 
propensity to polyhalogenate at all vacant ring sites. Thus many of the 
preparations of monohalogenated imidazoles reported involve polyhalogenation 
and subsequent reduction. 
Imidazole is polybrominated easily using a variety of reagents and reaction 
conditions. Brominations utilising molecular bromine or N-bromoimides 
dissolved in organic solvents, or alkaline hypobromite solutions are successful in 
this regard 262. For example, 2,4,5-tribromoimidazole is the sole product from 
treatment of imidazole with excess bromine in chloroform 263 while 1.1 
stoichiometric equivalents of N-bromosuccinimide at room temperature in 
dimethylformamide produced 4-bromoimidazole (32%), 4,5-dibromoimidazole 
(6%) and 2,4,5-tribromoimidazole (3%) 264. 
The kinetics of molecular bromination have been studied 265 and indicate a 
rate-determining bimolecular process between the imidazole free base and 
bromine giving rise to a conventional Whelarid intermediate. The product of 
monobromination, 4-bromoimidazole, undergoes facile polybromination 
presumably as a consequence of its lower pKa, 
It was deemed appropriate, therefore, to emulate Balaban and Pyman in their 
preparation of 4-bromoimidazole 263. 2,4,5-Tribromoimidazole was synthesised 
and subsequently reduced by refluxing in 20% sodium sulfite solution (Scheme 
38). 4-Bromoimidazole was found to be the only product and was obtained in 32% 















While bromination can involve substitution of both the free base and 
conjugi;lte anionic species, iodination requires that imidazole be in its 
deprotonated form; as evidenced by the inactivity of 1-substituted imidazoles in 
the presence of iodine. The rate-determining step is thought to be proton 
abstraction from a sigma-complex (Scheme 39). 
H 1
ftt. [fN ltN - H+ 12 + -~ -- ~ ~ - .)) + BH --- --N fast N slow N 
Scheme 39. 
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Again, polyiodination is observed and is difficult to control. Imidazole is easily 
triodinated in the presence of iodine and aqueous alkali 266, while diiodination 
predominates if control is exerted over the rate of addition of iodine and base. It 
has been established 267, 268 that diiodination of imidazole occurs regioselectively 
under basic conditions to produce 4,5-diiodoimidazole. 
Following the regime outlined above for the synthesis of 4-bromoimidazole, 
imidazole was diiodinated in an iodine-potassium iodide solution with the 
portionwise addition of sodium carbonate, and the product reduced in refluxing 
sodium sulfite solution 269 (Scheme 38), to give 4-iodoimidazole in 32% overall 
yield. 
Imidazoles are chlorinated with sodium hypochlorite 270 or N~chloroimides 
271 to produce predominantly 4,5-dichloroimidazole. Chlorine itself is ineffective, 
giving rise to very poor yields and contamination by oxidised by-products 270. 
Unlike bromination and iodination, chlorination of imidazole does not easily 
proceed through to the trichlorinated compound, presumably as a consequence of 
the greater deactivating power of the chloro substituent; 2,4,5-trichloroimidazole 
was obtained in 2.3% yield by the action of sodium hypochlorite on imidazole 270. 
Syntheses of 4-chloroimidazole have been reported. Imbach and co-workers, 
experimenting with N-chlorophthalimide, found that 2-methyl- and 
unsubstituted imidazole produced the 4-chloro species in 19 and 13% yields in 
addition to the 4,5-dichlorinated product (16 and 25% respectively) 271 . A 
relatively simple and fair-yielding procedure requiring the formation and later 
reduction of 4-bromo-5-chloroimidazole has been published 270. While 4,5-
dichloroimidazole is resistant to sulfite reduction, the above is reportedly 
reduced in 10% sodium sulfite solution to give 4-chloroimida~ole as the only 
product. 
In an effort to reproduce this synthesis, 4-bromo-5-chloroimidazole was prepared 
by reacting 4-bromoimidazole with alkaline sodium hypochlorite solution at 0-
50C. This was then subjected to the same reductive conditions used to generate 4-
bromo- and 4-iodoimidazole (Scheme 38); no starting material was 
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evident after four hours at reflux temperature. Identical workup (ether 
extraction) yielded, unexpectedly, a mixture containing 4-chloro- and 4-
bromoimidazole in a 3.7 : 1 ratio. Reducing the concentration of the sulfite 
solution progressively from 20% to 2.5% saw a gradual increase in the proportion 
of 4-chloroimidazole, the ratio reaching ca. 5: 1. Use of the workup procedure 
described by the authors, ie. precipitation from acidic solution, increased this ratio 
still further; the highest ratio of 7.5 : 1 was obtained by refluxing in 2.5% sodium 
sulfite solution. 
All attempts, however, at separating the two products were unsuccessful. 
Recrystallisation served only to enrich the mixture in 4-bromoimidazole. 
Chromatography, using silica, reverse phase and alumina supports, was 
ineffectual in all the solvent systems devised; separation bands of both the 
products and their N-methyl derivatives were observed to be coincident. Picrates 
of the two compounds were prepared from the mixtures, though these also 
proved intractable to separation. 
An alternative reductive procedure utilising metal-halogen exchange (refer 
section 2.3 below) was attempted. 5-Bromo-4-chloroimidazole, dissolved in THF, 
was reacted with n-BuLi at -78°C for 4 hours. The reaction was quenched with 
water to again produce a mixture containing 4-chloro- and 4-bromoimidazole in 
26% combined yield (8: 1 ratio) Traces of imidazole were also evident in the lH 
nmr of the crude mixture (Scheme 40). 
J[N 
i) n-Buli (2.3 eq), 
Cl 
THF, -78°C e.1 + _![N (1 Br N)} Br N)} + ii) ~o N N 
H H H H 
iii) rt 
23% 3%. (trace: 
Scheme 40. 
At this point a different approach was undertaken. From the calculated basic 
pKa values for 4-bromo- and 4-iodoimidazole (3.59 and 4.59 respectively, refer 
chapter 3, s. 3.3.3.1), it was apparent that the difference in acidity between the 4-
chloro- and 4-iodoimidazolium species would be at least one pKa unit. Hence 4-
chloro-5-iodoimidazole was synthesised analogously from 4-iodoimidazole with 
the expectation that reduction would produce less of the contaminant, 4-
iodoimidazole, and any such formed could be separated on the basis of pKa 
disparity. 
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This indeed proved to be the case. The dihaloimidazole was reduced in 5% 
sodium sulfite solution, and the product precipitated from acidic solution with 
the careful addition of sodium carbonate. 4-Chloroimidazole, with purity greater 
than 95% (ratio >30 : 1, 4-chloro-: 4-iodo-), was obtained in 52% overall yield 
from 4-iodoimidazole (Scheme 41). Analytical purity was achieved through large 


















In the course of this preparation a synthesis of 4-chloroimidazole was reported 
by Rowan-Gordon and co-workers 272. Imidazole, present as the 
bis(ethylenediamine)(imidazolato)chlorocobalt(III) complex was nitrated under 
mild conditions and the resultant 4-nitroimidazole complex eluted on a 
Sephadex C-25 ion-exchange column with aqueous sodium chloride. Complexed 
4-chloroimidazole was retrieved, the product of nucleophilic displacement of the 
nitro group by chloride. Halodenitrations of this sort are known to occur with 
relative ease only when polynitroimidazoles are reacted with phosphoryl halides 
or hydrohalic acids 273, 274. The Co(en)iC12+ moiety thus appears not only to 
activate coordinated imidazoles to elctrophilic attack, but also to activate 
mononitroimidazoles to nucleophilic attack. 
Despite certain experimental inconsistencies, this method was attempted to 
investigate its practicability as a means of "large'' scale production of 4-chloro-
and indeed 4-haloimidazoles. The precursor imidazole complex, cis-
[Co(en2)(ImH)Cl]2+, was prepared 275 as its perchlorate salt and exposed to a mild 
nitrating mixture (1.1 equivalents of nitronium tetrafluoroborate in sulfolane) as 
described by the authors. Contrary to procedure, however, the reaction mixture 
was stirred at room temperature for several hours and not 0°C as stated 
(sulfolane m. pt. 27°C). Elution through a Sephadex column with 0.2 mol dm3 
aqueous sodium chloride resolved the mixture into three bands which were 
collected and electrochemically reduced. Subsequent removal of Co(II) from the 
solution and precipitation of the imidazole species from acidic solution, 
produced compounds consistent with lH nmr data known for imidazole (64%), 4-
nitroimidazole (12%) and 4-chloroimidazole (9%). Clearly, under the conditions 
employed, this preparation is far from efficient. 
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4-Nitro- and 5-Halo-4-nitro-imidazoles 
Nitration of imidazoles in mixed acids (nitric and sulfuric) occurs exclusively 
at the 4- or 5-position. In general, if these positions are blocked or if a deactivating 
carboxyl group is present, nitration will fail 276, 277. In accordance with a reduced 
susceptibilty to electrophilic attack at C-2, and possibly less resonance stabilisation 
of the transition state leading to a Wheland-type intermediate 255, 2-
nitroimidazoles are inaccessible by this route; they can be approached through the 
corresponding 2-amino derivatives by nitrolysis of the diazonium salts or 
alternatively by nitration of 2-lithioimidazoles 277. The kinetics and mechanism 
of nitration of imidazole in mixed acids have been studied 278. Austin and co-
workers found that the yield of 4-nitroimidazole was dependent on the acidity of 
the reaction medium, though it was clear, from the comparison of nitration and 
encounter rates, that imidazole was being nitrated in its protonated form. The 
kinetics of nitration, though complicated by this dependency, were observed to 
follow second order form. 
Following the method of Fargher and Pyman 279, 4-nitroimidazole was thus 
obtained as the only product of nitration in fuming nitric and concentrated 
sulfuric acids in 65% yield. 
5-Bromo-4-nitroimidazole was prepared similarly through the nitration of 4-












f. HN03, c. ~S04 
Scheme 42. 
Classically, Balaban and Pyman effected nitration of the nitrate salt in hot 
concentrated sulfuric acid 263. In the mixed acid medium used, temperature 
control was found to be of paramount importance in maximisi_ng the yield of 
nitrated product. Heating the reaction mixture on a steam bath, even when 
stoichiometric quantities of nitric acid were used,resulted in poor yields of the 
nitro compound and negligible recovery of starting material, confirming the 
presenFe of competitive ring-opening 278. At room temperature, however, 5-
bromo-4-nitroimidazole was obtained in 82% yield after recrystallisation from 
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aqueous dimethylformamide. An alternative synthesis, not attempted, reports 
that this product was prepared in 53% yield by bromodeiodination involving 
reaction of 5-iodo-4-nitroimidazole with hydrobromic acid at elevated 
temperatures 274. 
As previously intimated, nitration is unsuccessful for those substrates bearing 
substituents in the 4- and 5-positions. Thus 4,5-dimethyl- 279 and 4,5-
dibromoimidazole 263 fail to form any nitrated product when exposed to mixed 
acid. An exception to this generality is the observed nitrodehalogenation of 4,5-
diiodoimidazole to give 5-iodo-4-nitroimidazole in high yield 268 . While this 
compound had been earlier synthesised in this fashion by Hoffer and co-workers 
280, it was not until recently that the structure of the product was unequivocally 
assigned as the above and not 2-iodo-4-nitroimidazole as previously maintained 
268. Ipso-nitrations of this type are normally favoured by activated aromatics 281; 
hence the observation that 4,5-diodoimidazole can be nitrated while 4,5-
dibromoimidazole cannot. 
Using methodology similar to that above, 5-iodo-4-nitroimidazole was 
prepared in 74% yield by nitrating 4,5-diiodoimidazole in mixed acid at room 
temperature (Scheme 42). 
4-Hydroxymethylimidazole 
There are many examples of direct electrophilic hydroxymethylation of 
substituted imidazoles by formaldehyde. In general, 1-substituted and 1,5-
disubstituted compounds form their respective 2-hydroxymethyl derivatives 
while 4-substituents appear to direct hydroxymethylation to the 5-position. Ring 
deactivated nitroimidazoles, however, are inert to substitution 282. 
4-Hydroxymethylimidazole cannot unfortunately be obtained in this way. 
Originally synthesised by Pyman, by the oxidative action of nitric acid on 4-
aminomethyl-2-(3H)-imidazolethione 283 (Scheme 43), it is formed in fair yield by 
Weidenhagen condensation of ammonia, D-fructose and formaldehyde in the 
































Following the method described by Darby and co-workers 284, 4-
hydroxymethylimidazole picrate was produced in 52% yield by a process similar 
to that.adopted for the preparation of 2,4-dimethylimidazole above (Scheme 44). 
Hydroxypyruvaldehyde, formed in situ by the alkaline hydrolysis of D-
fructose and subsequent oxidation of the 1,3-dihydroxyketone fragment, 
undergoes cyclocondensation with ammonia and formaldehyde to form the 
product as an insoluble copper (I) salt. The picrate obtained following 
decomposition of the salt with hydrogen sulfide, was itself decomposed by the 
method of Turner et al 286 to yield upon workup, 4-hydroxymethylimidazole as 
the free base in 36% overall yield (based on D-fructose). 
Imidazole-4-carbaldehyde, -4-carboxamide and methyl -4-carboxylate 
Imidazole-4-carbaldehyde and -4-carboxylic acid are readily obtainable by 
concentrated nitric acid oxidation of 4-hydroxymethylimidazole 287. It is difficult 
to control the extent of oxidation, however, in as far as the isolation of the 
aldehyde is concerned. Yields are only fair, no doubt the result of accompanying 
ring degradation. 
Schubert and Rudorf achieved the oxidation of 2-hydroxymethyl- and 1-
benzyl-2-hydroxymethylimidazole to the corresponding aldehydes only, in good 
yield, using a six-fold excess of activated manganese dioxide. Essentially this 
method was chosen in the present study to prepare imidazole-4-carbaldehyde. 
Freshly prepared activated manganese dioxide 288 was added in 11-fold excess 
to 4-hydroxymethylimidazole dissolved in anhydrous acetone, to afford almost 
quantitative conversion to the aldehyde (Scheme 45). 
Formation of methyl imidazole-4-carboxylate may be accomplished either 
through simple esterification of imidazole-4-carboxylic acid 287 or more 
complicated synthesis and desulfurisation of methyl 2-(3H)-imidazolethione-4-
carboxylate 289. As mentioned earlier, imidazole-4-carboxylic acid is easily 
obtained by reaction of excess concentrated nitric acid with 4-
hydroxymethylimidazole 287. A second route involving the 
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100°C, 48 h 
Scheme 47. 
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In order to avoid the subsumption of previously prepared starting materials, 
the latter synthesis of the methyl ester, above, was essentially repeated. 
A versatile method for the preparation of 4-substituted or 4,5-disubstituted 
imidazoles involves, initially, interaction of an a-aminoketone with thiocyanic 
acid to produce the respective 4-substituted or 4,5-disubstituted-2-(3H)-
imidazolethiones 290• The thiones (mercaptans) are then desulfurised, typically 
oxidatively, using dilute nitric acid (the Wohl-Marckwald method 283, 291) which 
forms and subsequently hydrolyses the corresponding 2-imidazolesulfinic acids. 
Jones, adopting similar methodology, condensed a-amino-~-ketoesters with 
thiocyanic acid in his synthesis of imidazole-4-, 1-alkyl- and 1-aryl-imidazole-5-
carboxylates from glycine and N-substituted glycine derivatives 289• Following his 
work, it was originally intended to generate ethyl imidazole-4-carboxylate by 
cyclocondensation of the sodium enolate salt of N-formyl-glycine ethyl ester with 
potassium thiocyanate in the presence of HCL However, the substitution of 
methyl formate for ethyl formate in the enolate salt preparation resulted in a 
transesterification process producing sodium methyl N-formyl-C-
hydroxymethyleneglycinate instead of the desired ethyl glycinate (Scheme 46); the 
addition of a catalytic quantity of MeOH to the reaction mixture was found to 
hasten the rate of the Claisen condensation. Subsequent cyclocondensation with 
potassium thiocyanate in acid medium served to form methyl 2-(3H)-
imidazolethione-4-car boxy late (methy 1 2-mercaptoimidazole-4-carboxyla te) in 
substantially lower yield than reported (19% cf. 50% 289). In this author's hands, 
use of the modified Wohl-Marckwald method of oxidative desulfurisation as 
described, failed to produce the methyl ester in yields greater than 50%. An 
alternative, reportedly higher-yielding, reductive desulfurisation using Raney 
Nickel has been used for this purpose 292, though in this instance, it too gave 
only a 53% maximum yield. 
Imidazole carboxylic acids form conventional acid derivatives. Imidazole-4-
carboxamides can hence be obtained by simply heating the methyl ester in the 
presence of ammonia or primary amines 293. Imidazole-4-carboxamide was 
prepared in 79% yield by heating a solution of methyl imidazole-4-carboxylate in 
concentrated ammonium hydroxide for two days in a sealed tube at 100°C 
(Scheme 47). No starting material was recovered upon workup of the reaction 
mixture, indicating that a degree of ring opening had occurred. 
Methyl- and phenyl-nitroimidazole sulfides, methylnitroimidazole sulfoxide 
and sulfone 
The electron-withdrawing effect of a nitro substituent is well known to greatly 
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294• Mercaptonitroimidazoles have been synthesised in this way by the 
displacement of halogen from halonitroimidazoles by hydrogen and alkali metal 
sulfides and hydrosulfides 295-298 (Scheme 48). Nitroimidazole sulfides are 
obtainable in high yield by alkylation of the corresponding salts of 
nitromercaptoimidazoles; alkylations using equimolar base and 5-10% excesss 
alkyl halide were observed exclusively at exocyclic sulfur 297 (Scheme 49). 
Alternatively, 1-methyl-4-nitroimidazole sulfides have been prepared directly 
from 5-chloro-1-methyl-4-nitroimidazole by reaction with mercaptans in 
ammoniacal EtOH 297. 
While the former method was used in this work to synthesise· 5-methylthio-4-
nitroimidazole, the latter was found to be far more efficient at generating 4-nitro-
5-phen yl thioimidazole. 
Thus, 5-iodo-4-nitroimidazole was converted into the ammonium salt of 5-
mercapto-4-nitroimidazole by bubbling hydrogen sulfide, for a short period, 
through a warmed aqueous ammonium hydroxide solution. A colour change 
(yellow to orange) marked the formation of the salt, which separated on cooling 
as orange needles in 59% yield. Care was taken to ensure the solution was not 
saturated with hydrogen sulfide; prolonged exposure to hydrogen sulfide resulted 
in a darkening of the solution and considerable loss of product. Careful analysis 
of the crude product mixture revealed that a competitive reductive process was 
operating, thereby accounting for the presence of an isolable by-product (ca. 10%) 
spectrally consistent with 4-nitroimidazole. This side reaction appears to be 
restricted to iodonitroimidazoles; Bhagwhat and Pyman, using identical reaction 
conditions, produced 2-methyl-5-mercapto-4-nitroimidazole from 5-bromo-4-
nitroimidazole in an almost quantitative conversion. 
Methylation of the nitroimidazole mercaptan was achieved by simple reflux of 
the ammonium salt in methanolic sodium methoxide with equirnolar 
iodomethane. 5-Methylthio-4-nitroimidazole was obtained in 80% yield 
following recrystallisation from aqueous EtOH (Scheme 50). No N-methylated 
products were observed. 
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5-Phenylthio-4-nitroimidazole was prepared in 69% yield by direct 
thioalkylation of 5-iodo-4-nitroimidazole. While 5-bromo-4-nitroimidazole is 
resistant to nucleophilic displacement by mercaptans 297, the iodonitro 
compound underwent smooth thiophenylation with potassium thiophenoxide 










In both of the nucleophilic substitutions described there exists the possibility, 
however remote, of 2-substitution. Van der Plas and co-workers found that 
reaction of 5-bromo-1-methyl- and 5-chloro-1-methylimidazole with lithium 
piperidide and piperidine in boiling ether, produced 1-methyl-2-
piperidinoimidazole in association with the. expected products of halogen 
displacement 299• An addition-elimination mechanism has been proposed to 
account for the position of substitution and the observed displacement of the 5-
halogeno group (Scheme 52). 
In light of spectral evidence and the fact that a single product was isolated in 
each case, 2-substitution has been discounted. Carbon resonances at 136.5 and 
137.0 ppm, respectively for the methythio- and phenylthio-nitro compounds, 
exhibit one-bond coupling in the lH-coupled carbon spectra (lJcH = 217 Hz), 
indicating 2-unsubstitution. The magnitude of the coupling constant is in accord 
with the presence of a nitro substituent (see Chapter 5). 
Imidazole sulfides are readily convertible to their corresponding sulfones with 
normal oxidising agents 300. Bennett, Jr. and Baker have prepared nitroimidazole 
sulfones in excellent yields by reacting the sulfides with excess hydrogen peroxide 
in warm glacial acetic acid 297. 4-Nitro- and 1-methyl-4-nitro-imidazole-5-
sulfones were among the compouds synthesised in this way. Kochergin and 
Bashkir, using very similar methodology, have prepared several 1-methyl-4-
nitroimidazole-5-sulfones by peroxide oxidation of their respective sulfoxides 301. 
These sulfoxide intermediates were reportedly obtained in quantitative yields 
using equimolar hydrogen peroxide in glacial acetic acid (Scheme 53). 
Intermediate sulfoxide formation has also been reported by Fisher and co-
workers 302 who isolated 5-carboxymethylsulfinyl-4-nitroimidazole from the 
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vigorous conditions were apparently necessary to effect further oxidation to the 
sulfone. 
For the present study, it was desired to prepare both 5-methylsulfinyl- and 5-
methylsulfonyl-4-nitroimidazole as starting materials for subsequent alkylation 
experitnen ts. 
The sulfone was prepared according to the method of Bennett, Jr. and Baker 297 











Contrary to reports 301, however, all attempts at isolating the sulfoxide in 
satisfactory yields using equimolar hydrogen peroxide were unsuccessful, in that 
a large degree of sulfone contamination was apparent (30-40%). The sulfoxide 
signals were clearly distinct from those of the sulfone in the lH nmr spectrum of 
the crude mixture; as expected, the methyl resonance of the sulfoxide was shifted 
substantially upfield (0.5 ppm) from that of the sulfone. 
Bordwell and Boutan similarly witnessed the formation of appreciable 
amounts of sulfones from oxidations of arylmethylsulfides utilising one mole of 
hydrogen peroxide 303. They discovered, in very general terms, that conjugative 
(with the sulfoxide) electron-withdrawal decreased the propensity of the 
sulfoxide to undergo competitive oxidation, while the converse held for electron-
donation. This idea fits in nicely with the apparent resistance of 5-
carboxymethylsulfinyl-4-nitroimidazole towards further oxidation 302 compared 
to 5-methylsulfinyl-4-nitroimidazole. Temperature, too, was seen to exert a 
strong influence on the amount of sulfone formed; lower temperatures typically 
favoured sulfinylation. 
Repeats of the peroxide oxidation in glacial acetic acid at reduced temperatures 
and with correspondingly extended reaction times, were thus attempted. 
However, though sulfone contamination was reduced, even at 0°C (48 h), ca. 
10% of the isolated product (40% overall yield) was sulfone material. The 
conjugative electron-withdrawal of the nitro substituent appears thus to be 
insufficient, even in conjunction with temperature control, to selectively 
produce the sulfoxide under hydrogen peroxide/ glacial acetic acid conditions. 
Nitric acid oxidation was found to be successful in selectively creating 
arylmethylsulfoxides 297. It was proposed that under the reaction conditions, a 
sulfonium salt was formed and that such a species would be inherently less 
susceptible to oxidation. In this laboratory, however, these conditions failed to 
afford either the sulfoxide or the sulfone. 
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A sulfoxide preparation was published that utilised a bromine complex of 1,4-
diazabicyclo[2,2,2]octane (DABCO) as the oxidising agent. Dialkyl-,· aryl-alkyl-, 
benzyl-alkyl-, benzyl-aryl- and diarylsulfides reportedly underwent rapid and 
selective oxidation with the above complex in 75% aqueous acetic acid to give 
high yields (70-95%) of the respective sulfoxides 304; oxidation presumably 
transpires through hydrolysis of a bromine-sulfide addition complex. 
To test its efficacy on nitroimidazole sulfide systems, this reagent was 
synthesised as reported, by stirring equimolar bromine with the diamine in 
benzene at room temperature. The crystalline complex was added in half molar 
quantity to a solution of 5-methylthio-4-nitroimidazole in 70% aqueous acetic 
acid, and the reaction monitored by tlc. While the sulfoxide appeared to be the 
only product, yields were very poor, irrespective of heating. 
Magnesium monoperoxyphthalate (MMPP) has also been used for this 
purpose 305, and was the last reagent tested. Finally, under specific conditions, 
MMPP gave acceptable yields of the sulfoxide sufficiently free of the sulfone to 
afford the pure product by recrystallisation. The ideal reaction conditions 
comprised addition of a half molar equivalent of MMPP to the substrate 
dissolved in glacial acetic acid. Gentle warming was used to effect solution, 
whereupon the mixture was immediately quenched with ice-water. Workup 
gave 5-methylsulfinyl-4-nitroimidazole in 67% yield (Scheme 55). While acidic 
medium and low temperatures favoured repression of the sulfone, reaction time 
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2.3 Metalation Work 
It is clearly apparent from the above discussion that there is no single ring-
synthetic method of general application for substituted imidazoles. In recent 
years, however, access to a wide range of substituted azoles has been achieved 
through adherence to common metallation regimes. In particular, the synthetic 
utility of such as they apply to imidazoles has been the subject of progressive 
review 306, 307. 
With this in mind, it was hoped that a relatively simple and high yielding 
preparation of 4-cyanoimidazole could be devised to circumvent the rather 
tortuous existing syntheses : 4-cyanoimidazoles have been prepared from 
imidazole-4-carboxylic acids and derivatives (through the corresponding amides) 
308 or -4-carbaldehyde oximes 309 by reaction with a suitable dehydrating agent. 
Alternatively, ultra-violet irradiation of aminomethylenemalononitrile is 
reported to produce 4-cyanoimidazole, though the yield was not quoted 3o9 
(Scheme 56). 
Clearly, to effect the synthesis of 4-cyanoimidazole or indeed any 4-substituted 
imidazole using an organometallic approach, metallation must perforce proceed 
at C-4 or C-5. Unfortunately, however, the general order of site reactivity in N-
substituted imidazoles is C-2 > C-5 > C-4 307; the reticence towards metallation at 
C-4 can be alleviated somewhat by the use of sterically demanding N-protecting 
groups, eg. trityl 310. Metallation of N-unsubstituted imidazoles occurs at the 
imino group. 
There are two general strategies available to direct metallation to the 4(5)-
position of imidazole. The first involves a multistep sequence whereby N-1 and 
C-2 are successively blocked allowing metallation to occur at the 5-position. 
Addition of an appropriate electrophile and subsequent deprotection generates 
the 4(5)-substituted imidazole (Scheme 57). A second method, requiring fewer 
steps, utilises metal-halogen exchange. In this case suitable 4(5)-halogeno- or N-
protected 4- or 5-halogeno-imidazoles are dehalometallated, quenched and if 
necessary, deprotected in turn to yield the desired product (Scheme 58). 
In the present work both pathways were examined as a means to ultimately 
creating 4-cyanoimidazole. 
2.3.1 Metal-Halogen Exchange 
Metal-halogen exchange reactions of 1-substituted imidazoles occur with 
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nature of the organometal, the N-substituent, the halogen and the electrophile, 
and the same site reactivity observed for metallation, ie. 2-X > 5-X > 4-X, X = 
halogen. 307. N-protected 2,4,5-tribromo- 311, 312 and 2,4,5-triiodoimidazole 313 
undergo polysubstitution in this order when subjected to sequential treatment 
with an organometal. Although chlorine exchange is known, the softer halogens, 
bromine and iodine, are more effectively displaced. The relative inertness of the 
chloro group to exchange is exemplified by the observation that 5-bromo-4-
chloroimidazole produced the product of bromine exchange only 314. Similarly in 
this laboratory, 5-bromo-4-chloroimidazole was treated with BuLi and quenched 
with water to produce a mixture of 4-chloro- and 4-bromoimidazole in a ratio 8: 
1 (section 2.2). 
Lithium-bromine exchange at C-4 is less facile than those at C-2 and C-5 
irrespective of the organolithium reagent used 312. In their isotope exchange 
studies, Kirk et al suggested that the observed lack of reactivity at C-4 may be 
attributed to a destabilising repulsive interaction between the C-4 carbanion and 
the adjacent lone pair at N-3 (the "ALP effect") 315. Further, where the imidazole 
is unsubstituted at C-2, exchange at C-4 may be accompanied or superseded by 
transmetallation to C-2. A case in point, 1-ethoxymethyl-4,5-diodoimidazole 
generated the products of 2- (74%) and 2,5-metallation (16%) when treated with 
one equivalent of BuLi and quenched with diphenyl disulfide 266. Exchange was 
held to occur at C-5, followed by equilibration as depicted in the proposed 
mechanism (Scheme 59). These results and those of Groziak 316 demonstrate that 
reaction time for carbanion generation is a key determinant in product 
orientation and attest the rapidity of metal-halogen exchange : 1-
benzyloxymethyl-4,5-diodoimidazole underwent substitution solely at C-5 when 
treated with BuLi at -78°C for 10 minutes (DMF quench), while 45 minutes at this 
temperature saw substitution occur almost entirely at C-2. 
Exchange of 1-substituted-4(or 5)-halogenoimidazoles occurs with varied 
success. 4-Bromo- 310, 317, 5-bromo- 310 and 4-chloro-1-methyl-imidazole 317 and 
N-protected 4- and 5-bromoimidazoles 48 fail to exchange with BuLi, and often 
give instead products resulting from C-2 lithiation. On the other hand, N-
substituted 4-iodoimidazole gave products of exchange in good yield with 
butylithium 318 and ethylmagnesium bromide 319 using a range of N-protecting 
groups and electrophiles. 
Metal-halogen exchange reactions of N-unsubstituted imidazoles require two 
or more mol equivalents of metallating reagent as a consequence of initial N-
lithiation and are typically lower yielding than those of their N-protected 
counterparts. Nevertheless, this route to 4(5)-substitution was initially chosen in 
the present work for its simplicity and to further examine its generality. 
Esse~tially repeating the procedure of Katritzky and co-workers 310, 4-
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bromoimidazole was dilithiated with 2.3 mol equivalents of BuLi in THF at ca. -
78°C. Before quenching with two equivalents of methyl iodide, the reaction 
mixture was allowed to warm to 10-15°C for 1.5 hours. The products of exchange, 
however, were obtained in poor yield. Together with the expected products, 1,4-
dimethyl- and 1,5-dimethylimidazole (17%), isomeric N-methylated 4- and 5-
bromoimidazole were obtained in greatest yield (62%) (Scheme 60). In a similar 
reaction, Iddon and Lim observed no products of dilithiation when 4-
bromoimidazole was metallated with two equivalents of BuLi in ether at -70°C 
and quenched with dimethyl sulfate. Again, only N-methylated starting material 
was isolated 266. Use of carbonyl electrophiles, however, reportedly results in 
moderate to good yields of imidazol-4-yl carbinols (or ketones); naphthyllithium 
320, n-butyl- and t-butyl-lithium 310 have been used to this effect. As a validity 
check, in this laboratory, 4-bromoimidazole was treated with 2.3 mol equivalents 
of BuLi under the same conditions stated above and quenched with two 
equivalents of benzophenone. While the yield of the exchange product, 
[imidazol-4-yl]diphenylmethanol in this case, was greater than that observed 
using methyl iodide, it was only half as much as the reported value (24% cf. 47% 
310). Notwithstanding, it is apparent that the nature of the electrophile, inter alia, 
is significant to reaction success. Other influential factors determined by Katritzky 
et al. include the time allotted to dilithiation, the nature of the organometal, and 
the quantity of electrophilic reagent used 310. Further, a comparison of metal-
halogen exchange reactions of 4-bromo- and 4-iodoimidazole clearly indicates 
that the halogen exerts an effect on product yield : 4-iodoimidazole was 
metallated analogously and quenched with benzophenone to produce [imidazol-
4-yl]diphenylmethanol in 37% yield. To observe the effect of time and 
temperature on carbanion formation, two experiments were conducted, using 
naphthyllithium and BuLi respectively, whereby samples were removed at 
intervals and quenched with water to determine the extent of dilithiation. Under 
conditions identical to those used above, BuLi (2.3 mol equivalents) was added to 
4-bromoimidazole in THF at ca. -78°C. The reaction mixture was allowed to 
warm slowly over a 12 hour period to 10-15°C and then maintained at this 
temperature for a further 14 hours. Sample analysis revealed a gradual increase 
in the amount of exchange product (imidazole) with time and temperature to a 
maximum reached at ca. 1-2 hours at 10-15°C (17% conversion). Following the 
lithiation procedure of Tertov et al., naphthyllithium was added to 4-
bromoimidazole in THF at -10- -15°C and the mixture kept at this temperature 
for 4 hours. Again a maximum was observed to occur at ca. 30-60 minutes at -10-
-150C (14% conversion). Similar results were obtained for benzophenone quench 
of dilithiated 4-bromo- and 4-iodoimidazoles. Overnight generation of the 
carpanion had little effect on reaction yield. 
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It is apparent from the results of this study and those observed in the 
literature, that metal-halogen exchange reactions should be regarded as acid-base 
equilibria, the positions of which (well to the left in this instance) are hence very 
dependent on the nature of the organolithium, the electrophile and the 
halogenoimidazole (Scheme 61). The poor reaction yields relative to N-
substituted halogenoimidazoles may well be a consequence of a dual ALP effect 
imposed by electron pairs at N-3 and lithiated N-1. 
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Expanding the acid-base interpretation of metal-halogen exchange further to 
incorporate HSAB theory enables tighter definition of these dependencies. The 
application of this theory to organometallic reactions has recently been 
comprehensively discussed 321 . According to Pearson's Hard and Soft Acids and 
Bases Principle 322, "hard acids bind strongly to hard bases and soft acids bind 
strongly to soft bases". Organolithiums, while quite basic, are relatively soft 
species (following the order (softness), t-BuLi > sec-BuLi > n-BuLi » MeLi > ArLi) 
and hence prefer coordination with soft acids. Metal-halogen exchange reactions 
involve a soft-soft interaction, thus the ease of exchange is dependent on the 
softness disparity between the organometal and the organic halide; organic 
halides follow the order (softness), RI > RBr > RCl » RF. Reaction with an 
organometal should therefore be most favoured by organic iodides and bromides 
since the heavier halogens are more able electron acceptors. Upon cursory 
examination, results appear to be consistent with HSAB theory. In this laboratory, 
4-iodoimidazole was observed to produce the greatest yield of exchange product 
([imidazol-4-yl]diphenylmethanol) when treated with BuLi, an organolithium of 
intermediate softness (37% cf. 24% (4-Brim)). On the other hand, the use of a 
Grignard reagent in iodine-exchange reactions of N-protected 4-iodoimidazole 
has produced some of the best yields of carbinols yet reported for 4(or 5)-
monohalogenoimidazoles 319; Grignards are softer metallating reagents than 
organolithiums. Within the organolithium class, replacement of BuLi with tert-
BuLi was shown to double the yield of [imidazol-4yl]diphenylmethanol formed 
from the dilithiation and quench of 4-bromoimidazole with benzophenone (64% 
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cf. 33%) 310. Conversely, use of the harder reagent, naphthyllithium, in this work 
gave a slightly lower yield of imidazole upon quenching with water (14% cf. 18% 
(BuLi)). 
Extending this argument further to cover the reaction of the electrophile with 
the imidazole carbanion, it follows that the hard/ soft character of the electrophile 
can contribute to the overall product yield. Metal-halogen exchange generally 
leads to a harder organolithium (aryl > alkyl) and this intermediate will therefore 
exhibit preference for electrophiles of similar hardness. The electrophilic reagents 
used in this work can be ranked in order of decreasing hardness, H20 » Ph2CO > 
Mel, and on the basis that this interaction is hard-hard relative to halogen 
exchange, yields are predicted to decrease in the same order. In fact, best yields 
were recorded using (moderately hard) benzophenone and poorest yields using 
the softer reagent, methyl iodide. A very high yield (98%) of imidazole has been 
reported using methanol, an electrophile of similar hardness to water, though 5 
mol equivalents of BuLi were necessary to effect such a large degree of dilthiation 
323. A 0.3 mol excess only was used in this work to enable literature comparison. 
As a potential electrophilic reagent for the production of 4-cyanoimidazole, 
cyanogen bromide (CNBr) was investigated. Polarisation and ionisation studies 
on the cyanogen halides 324, 325 have determined that ionisation to CN+ and x- is 
less, equivalent, and more endothermic than the alternative ionisation to CN-
and x+, for the chloride, bromide and iodide respectively (Scheme 62). Cyanogen 

















Owing to the unavailability of cyanogen chloride at the time of this research, 
cyanogen bromide was utilised despite its small dipole moment, in the hope that 
the imidazol-4-yl lithium species would seek the harder acid, CN+, over Br+. 
Reaction was thus attempted using 4-bromoimidazole as the substrate and 
butyllitium as the metallating agent. The general metallation procedure described 
above was followed, though unsuccessfully; 4-bromoimidazole was almost 
completely recovered. Subsequent metallation experiments, involving 1,2-
diprotected imidazole (section 2.3.2) have revealed, however, that under the 
conditions of reaction the e~ectrophilic species is in fact Br+ (see below), and 
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hence the product from such substitution would in this case be indistinguishable 
from starting material. Analogous a.-bromination of enamines is observed with 
cyanogen bromide 326, while a.-cyanation is seen to take place with the chloride 
327. Cyanogen chloride thus appears to be the reagent of choice; a cyano group 
was also introduced into the 2-position of 1-protected imidazole by reacting the 2-
lithio intermediate with cyanogen chloride in acetonitrile 52. 
At this point, misunderstanding the failure of metal-halogen exchange to yield 
4-cyanoimidazole, a different route was undertaken (section 2.3.2). 
In terms of synthetic utility, metal-halogen exchange (particularly of N-
unsubstituted imidazoles) appears somewhat limited and care needs to be taken 
in choosing the appropriate substrate and metallating agent as discussed. 
~2 Lithiation of N-Protected Imidazole 
As intimated, to functionalise the 4-position of imidazole it is necessary to first 
block the N-1 and C-2 positions, since the lability of ring protons in the presence 
of organometals follows the order N-1 > C-2 > C-5 (> C-4 if N-substituted). A large 
number of groups are available as potential N-protectors and these display 
considerable variation in effectiveness so far as stability and ease of 
introduction/ removal are concerned. Alkyl and functionalised alkyl protecting 
groups are listed in an approximate order of versatility in section 1.1; these and 
others including sulfonamido and trialkylsilyl groups are evaluated in the 
literature 41, 42,307. 
The N,N-dimethylaminomethyl group, first used for this purpose by Katritzky 
and co-workers 41 , was chosen for N-protection in this reaction sequence 
primarily because it is simple to prepare and undergoes facile hydrolysis under 
acid workup conditions. It has been shown to allow smooth, regioselective 
lithiation at C-2 using BuLi in ether at -70°C and the resulting 2-lithio 
intermediate reacts readily with a range of carbonyl and primary alkyl halide 
electrophiles to give good to excellent yields of 1-protected 2-derivatised products 
41 . The propensity to promote lateral metallation in 2-alkyl derivatives 41, 54 and 
the inactivity of the 2-lithio intermediate towards sterically hindered 
electrophiles (secondary alkyl halides 41 and 2-arylethyl halides 54) constitute the 
reported disadvantages of N,N-dimethylaminomethyl as a protecting group. 
The Mannich base, 1-(N,N-dimethylaminomethyl)imidazole, was thus 
prepared, according to the reported method 41, in 68% yield by reaction of 
imidazole with dimethylammonium chloride and formaldehyde under mild 
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A variety of 2-protecting groups are known 307. Phenylthio 48, 328 and 
triethylsilyl 329 groups have been used successfully in conjunction with N-
protection to enable selective metallation at C-5. While the 2-phenylthio 
derivatives are sufficiently stable to allow their isolation and purification, 2-
triethylsilyl groups are labile under workup conditions and must therefore be 
introduced immediately prior to in situ metallation. Since substantial C-S 
cleavage is reported to accompany metallation of alkylthioimidazoles with 
butyllithiums 48, 328, the triethylsilyl group was incorporated at the 2-position 
according to the procedure described by Carpenter and Chadwick 329 (Scheme 63). 
The regioselectivity of metallation could not be determined due to the extreme 
!ability of the silyl group; however, test quenching with benzophenone produced 
[imidazol-2-yl]diphenylmethanol only according to lH nmr analysis of the crude 
product mixture. 
Carpenter and Chadwick found that the triethylsilyl group allowed 
regioselective lithiation at C-5 using both LDA and sec-BuLi in THF at -78°C. The 
2-trimethylsilyl group on the other hand gave rise to products of 2- and 5-
substitution upon LDA treatment and deuteromethanol quench (up to 35% 
deuteration at C-2). The appearance of 2-deuterated product is attributed to 
competitive nucleophilic attack at silicon by the metallating agent as a 
consequence of reduced steric resistance 329. Whereas the authors used the 
dimethylsulfonamido group for N-protection, the effect of the 
dimethylaminomethyl group on specificity of metallation at C-5 was determined 
by quenching the in situ generated lithio intermediate with benzophenone. In 
accordance with their findings, LDA gave high (though not total) regiospecificity, 
producing the 5- and 2-carbinols in 64% and 8% yields respectively. In contrast, n-
BuLi gave a low overall yield with the 2-carbinol comprising nearly 40% of the 
product mixture (30% and 18% respectively) (Scheme 63). These results are 
consistent with the increased nucleophilicity of n-BuLi. The use of sec-BuLi, 
though not attempted, is predicted to exhibit similar or higher regioselectivity to 
that of LDA on the basis of its greater steric bulk. 
The in situ cyanation of 1-(N,N-dimethylaminomethyl)-2-
triethylsilylimidazole was attempted using cyanogen bromide as the potential 
source of electrophilic CN+ and LDA as metallating agent (Scheme 64). The only 
isolable product, however, was inconsistent with literature data on 4-
cyanoimidazole and was in fact concluded to be 4-bromoimidazole (19%) after 
spectral comparison with an authentic sample. Thus, cyanogen bromide in the 
presence of heteroaryllithiums evidently constitutes a (relatively poor) source of 
Br+. As speculated previously (section 2.3.1) cyanogen chloride appears a better 
choice of reagent. Others including tosyl cyanide 330 and 1-cyano-1,2,3-





· Though 4-cyanoimidazole was not obtained using metal-halogen exchange or 
selective lithiation methods, their failure lies in lhe poor choice of electrophile; 








2.4 General Experimental 
Melting Points 
Melting points were determined on a Gallenkamp capillary melting point 
apparatus; they are expressed in degrees Celsius (°C) and are uncorrected. 
Infrared Spectra 
IR spectra were run on a Bio-Rad FTS-7 spectrophotometer. Samples were 
examined as KBr discs . 
Elemental Analyses 
Performed by the Campbell Microanalytical Laboratory, c/- Chemistry 
Department, University of Otago, PO Box 56, Dunedin, New Zealand. 
Nuclear Magnetic Resonance Spectroscopy 
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1H nmr Spectra were obtained on Varian VXR-300 or Gemini 200 
spectrophotometers operating near the Larmor precession frequencies 300 and 
200 MHz respectively. Spectra were recorded in 5 mm NMR tubes and were 
locked to a deuterium resonance of the deuterated solvent indicated. Chemical 
shifts are referenced to either an internal standard (TMS) or the residual solvent 
protons 332. Chemical shifts, in ppm downfield from TMS, are reported as follows 
: chemical shift (number of protons, multiplicity (coupling constant, J), 
assignment). Multiplicites are reported ass (singlet), br s (broad singlet), d 
(doublet), t (triplet), q (quartet), and m (multiplet). Assignments are made on the 
basis of chemical shift, HETCOR, and lH coupled carbon spectra. Where 
HETCOR assisted assignments were made, (HETC) preceeds the proton 
assignment. For those imidazoles bearing aromatic substituents, the aromatic 
protons are labelled as depicted in the diagrams below. 
13C nmr Spectra were obtained as above, on Varian VXR-300 and Gemini 200 
spectrophotometers operating near the Larmor precession frequencies 75 and 50 
MHz respectively. Chemical shifts, in ppm, are referenced to solvent resonances. 
Small, broad signals have the designation (sm br). Multiplicities were determined 







quoted where possible. Multiplets with large coupling constants (ie. lJcH), are 
quoted with uppercase letters, while those with small coupling constants are 
given lowercase letters (eg. Dd refers to a large doublet of small doublets etc. ). 
Assignments were made with the aid of HETCOR (HETC), long-range HETCOR 
(LRHETC), 1 H coupled carbon, and 1 H decoupled carbon spectra in conjunction 
with chemical shift consideration. Aromatic carbons are labelled using the same 
convention described above. 
One aromatic substituent 
Chromatography 
(a) Thin Layer Chromatography (tlc) 
4' 3' 
~ 
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Two aromatic substituents 
Thin layer chromatography was performed using Merck tlc aluminium backed 
silica gel 60 F254 and Merck tlc aluminium backed aluminium oxide 60 F254 
neutral (type E) .The components were detected under UV light (254 nm) if 
appropriate, then by iodine vapour. For imidazoles which are N-unsubstituted 
and do not possess a carboxyalkyl substituent, diazotized sulphanilic acid 
(modified Pauly reagent) could be used as an alternative. 
Pauly Reagent 
The following reagents are added in order: 
Sulphanilic acid (10 gin 100 cm3 cone. HCl and 1 dm3 water) - 1 part 
Sodium nitrite (5% in water) - 1 part 
Sodium carbonate (10% in water) - 2 parts 
Commonly, silica tlc was used to separate and identify N-unsubstituted 
imidazoles, while alumina tlc was better suited to N-alkylated products. Typical 








Often a small quantity of ethyl acetate was incorporated as an aid to reduce 
tailing. 
(b) Column Chromatography 
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Column chromatography was performed using either silica gel (Merck #9385) 
or Spence H alumina of appropriate activity. The ratio, by mass, of adsorbent to 
crude product varied between 30:1 and 60:1 depending on degree of separation of 
the products obtained under the elution system used. 
(c) Radial Chromatography 
Radial chromatography was performed using a Harrison Research 
Chromatotron 7924 preparative centrifugal thin layer chromatograph. Silica gel 
60 PF254 plates were prepared of 1, 2 and 4 mm thicknesses for recommended 
maximum loadings of 250, 750 and 1500 mg respectively. The eluting solvent was 
delivered by gravity feed. Eluting solvents were chosen such that an Rf of ca. 0.3 
was obtained under tlc conditions. The bands, where possible, were observed 
with a Rayonet photochemical UV lamp . 
Solvents 
Solvents and commercially available reagents were used as supplied unless 
otherwise stated. If necessary, solvents and reagents were purified and/ or dried 
according to the procedures outlined in Purification of Laboratory Chemicals by 








~ Preparation of Starting Materials 
The following intermediates were prepared by literature methods: 2,4,5-
tribromoimidazole (47%) m. pt. 218°C (lit. m. pt. 221 °C 263); 4.5-diodoimidazole 
(70%) m. pt 196°C (lit. m. pt. 197-8°C 267); 5-bromo-4-chloroimidazole (60%) m. pt. 
195-7°C (lit. m. pt. 195-6°C 270, nmr 6tt (DMK) 7.78 (s, H-2); be (DMK) 102.3 (d 
(Jc(5)C(2)H = 7.1 Hz), C-5(4)), 125.3 (d 0C(4)C(2)H = 10.5 Hz), C-4(5)), 137.0 (D (1JcH = 
214 Hz), C-2)); phenacyl bromide (65%) m. pt. 47-49°C (lit. m. pt. 48-51 °C 252). 
4-Phenylimidazole 
Freshly prepared phenacyl bromide (20.0 g, 0.10 mol) was added to formamide 
(100 cm3) with continued stirring. The temperature was raised to 150-160°C and 
maintained for 2 hours. After cooling, the solution was boiled for 15 min with 
cone. HCl (200 cm3) containing a small quantity of activated charcoal. The hot 
solution was cooled, filtered through celite, and basified with aqueous ammonia. 
The product precipitated immediately, was filtered, washed repeatedly with 
water, and recrystallised from same to yield 3.6 g of analytically pure 4-
phenylimidazole as colourless plates (25% yield). M. pt. 129-130°C (lit. m. pt. 128°C 
250). 
Anal. Found C, 74.8; H, 5.5; N, 19.2%. C9HsN2 requires C, 75.0; H, 5.6; N, 
19.4%. Nmr 8tt (CDCl3) 7.18-7.27 (lH, m, H-4'), 7.30-7.40 (3H, m, (HETC) H-3',5'; 
(7.35, d (JH(5)H(2) = 1.1 Hz), H-5)), 7.68 (lH, d <JH(2)H(5) = 1.1 Hz), H:-2), 7.68-7.75 
(2H, m, (HETC) H-2',6'); be (CDCl3) 115.9 (Dd (1JcH = 189 Hz, JC(5)C(2)H = 5.8 Hz), 
C-5), 125.0 (Dt (1JcH = 160 Hz, 3JcH = 6.8 Hz), C-2',6'), 127.0 (Dt (lJcH = 161 Hz, 3JcH 
= 7.6 Hz), C-4'), 128.8 (Dd (lJcH = 161 Hz, 3JcH = 7.5 Hz), C-3',5'), 132.9 (t (3JcH = 7.5 
Hz), C-1'), 135.8 (Dd lJcH = 206 Hz, JC(2)C(5)H = 9.0 Hz), C-2), 138.5 (m, C-4). 
4-(4 '-MethoxyphenyDimidazole 
Freshly prepared p- methoxyphenacyl bromide (variant of phenacyl bromide 
synthesis above (72% crude yield)), (25.0 g, 0.109 mol) was added to formamide 
(100 cm3) with continued stirring. The temperature was raised to 150-160°C and 








subsequent recrystallisation from water gave 4-(4'-methoxyphenyl)imidazole as 
pale pink plates in 22% yield (4.2 g). M. pt. 135-6°C (lit. m. pt. 137.5-138°C 335). 
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Anal. Found C, 68.9; H, 5.7; N, 16.3%. C10H1oN20 requires C, 68.9; H, 5.8; N, 
16.1 %. Nmr OH (CDCl3) 3.80 (3H, s, OCfu), 6.86-6.94 (2H, m, (HETC) H-3',5'), 7.23 
(1H, d (JH(5)H(2) = 1.0 Hz), H-5), 7.59-7.67 (3H, m, (HETC) H-2',6'; (7.63, d CJH(2)H(5) 
= 1.0 Hz), H-2)); oC (CDCh) 55.3 (Q (lJCH = 143 Hz), OCH3), 114.2 (Dd (lJcH = 159 
Hz, 3JcH = 4.7 Hz), C-3',5'), 114.7 (Dd (lJCH = 188 Hz, Jc(5)C(2)H = 4.8 Hz), C-5), 125.7 
(m, C-1'), 126.3 (Dd (lJcH = 158 Hz, 3JcH = 7.5 Hz), c~2',6'), 135.4 (Dd (lJcH = 206 
Hz, JC{2)C(5)H = 8.8 Hz), C-2), 138.3 (m, C-4(5)), 158.8 (m, C-4'). 
4-( 4'-ChlorophenyDimidazole 
Freshly prepared p- chlorophenacyl bromide (variant of phenacyl bromide 
synthesis above (73% crude yield)), (25.0 g, 0.107 mol) was added to formamide 
(100 cm3) with continued stirring. The temperature was raised to 150-160°C and 
maintained for 3 hours. Work-up as above for 4-phenylimidazole and 
subsequent recrystallisation from water gave 4-(4'-chlorophenyl)imidazole as 
pale pink needles in 18% yield (3.4 g). M. pt. 144-145°C (lit. m. pt. 146-147°C 335). 
Anal. Found C, 60.4; H, 3.8; N, 15.7%. C9H7N2Cl requires C, 60.5; H, 4.0; N, 
15.7%. Nmr OH (CDCl3) 7.31-7.37 (3H, m, (HETC) H-3',5'; (7.33, s, H-5)), 7.64-7.69 
(2H, m, (HETC) H-2',6'), 7.71 (lH, s, H-2); 8c (CDCI3) 114.3 (Dd (lJcH = 189 Hz, 
JC(5)C(2)H = 4.7 Hz), C-5), 126.3 (Dd (1JcH = 159 Hz, 3JcH = 7.1 Hz), C-2',6'), 128.9 
(Dd (lJcH = 163 Hz, 3JcH = 5.2 Hz), C-3',5'), 131.7 (t (3JcH = 7.5 Hz), (LRHETC) C-1'), 
132.7 (tt (Ji= 10.5 Hz, fa= 3.6 Hz), C-4'), 135.7 (Dd (1JcH = 208 Hz, JC(2)C(5)H = 8.7 
Hz), C-2), 138.7 (m, C-4). 
4-(4'-NitrophenyDimidazole 
Freshly prepared p- nitrophenacyl bromide (variant of phenacyl bromide 
synthesis above (65% crude yield)), (25.0 g, 0.102 mol) was added to formamide 
(250 cm3) with continued stirring. The temperature was raised to 150°C and 
maintained for 2.5 hours. Work-up as above for 4-phenylimidazole and two 
subsequent successive recrystallisations from water gave 4-(4'-
nitrophenyl)imidazole as yellow needles in 23% yield (4.4 g). M. pt. 223-5°C (dee) 








Anal. Found C, 57.1; Hl 3.7; N, 22.4%. C9H7N302 requires C, 57.1; H, 3.7; N, 
22.2%. Nmr OH (DMK) 7.82 (1H, s, (HETC) H-2), 7.88 (1H, s, (HETC) H-5), 8.07-
8.15 (2H, m, (HETC) H-2',6'), 8.20-8.28 (2H, m (HETC) H-3',5'); OH (DMSO) 7.83 
(1H, s, (HETC) H-2), 7.91 (1H, s, (HETC) H-5), 7.98-8.05 (2H, m, (HETC) H-2',6'), 
8.17-8.24 (2H, m, (HETC) H-3',5'); oc (DMSO) 117.2 (br) (br Dm (lJcH = 190 Hz), C-
S), 124.1 (Dd (lJcH = 168 Hz, 3JcH = 4.4 Hz), C-3',5'), 124.7 (Dd (1JcH = 165 Hz, 3JcH = 
6.8 Hz), C-2',6'), 137.2 (Dd (lJcH = 207 Hz, JC(2)C(S)H = 8.6 Hz), C-2), 137.5 (br) (m, C-
4), 141.3 (t (3JcH = 7.8 Hz), C-1'), 145.2 (m, C-4'). 
4-Methylimidazole 
Commercially available 4-methylimidazole (Aldrich Chemical Company) was 
purified by vacuum distillation. M. pt. 56-57°C, b. pt. 112°C (2 mmHg) (lit. m. pt. 
56oc 267, b. pt. 264oc 339). 
Nmr OH (CDCl3) 2.27 (3H, s, 4-Cfu), 6.78 (1H, s, H-5), 7.57 (1H, s, H-2); oc 
(CDCl3) 11.5 (Q (lJcH = 126 Hz), 4-CH3), 118.4 (Ddq (lJcH = 185 Hz), C-5), 131.5 
(ddq, C-4), 134.3 (Dd (lJcH = 203 Hz, JC(2)C(S)H = 9.5 Hz), C-2) . 
2,4-Dimethylimidazole 
Acetoxy acetone 337 (prepared from bromoacetone 338 and ethyl acetate) (10.0 g, 
0.086 mol) was added to a solution of copper (II) acetate (34.3 g, 0.172 mol) in 200 
cm3 of 25% ammonium hydroxide containing acetaldehyde (5.3 g, 0.120 mol). 
Upon heating the solution at 100°C for 20 min, a grey-blue precipitate formed 
which was then isolated. Gaseous hydrogen sulfide was bubbled through a hot 
aqueous suspension (250 cm3 of water) of this product for 20 min and the 
resulting copper sulfide precipitate removed by filtration through celite. The 
precipitate was washed several times with water and the filtrate, after cooling, 
was extracted with CH2Cb (3 x 50 cm3). The extracts were combined, dried 
(MgS04), and evaporated under reduced pressure. The crude 2,4-
dimethylimidazole was distilled under vacuum to give 3.7 g of analytically pure 
product (45% yield based on acetoxy acetone). M. pt. 91-92°C (lit. m. pt. 92-93°C 
261), b. pt. 167°C/0.8 mm Hg (lit. b. pt. 120°C/0.02 mm Hg 261). 
Anal. Found C, 62.2; H, 8.3; N, 29.3%. C5H3N2 requires C, 62.5; H, 8.4; N, 








(CDC!J) 11.2 (Q (lJcH = 127 Hz), (HETC) 4-CH3), 13.1 (Q (lJcH = 128 Hz), (HETC) 2-
CH3), 116.5 (Dq (lJcH = 181 Hz), C-5), 130.8 (dq (Jc(4)C(S)H"" 11.6 Hz, JC(4)CH3 ""6.7 
Hz), C-4), 143.5 (dq, <Jc(2)CH3 ""JC(2)C(S)H"" 7.3 Hz), C-2). 
4-Brotnoitnidazole 
A suspension of crude 2,4,5-tribromoimidazole (100 g) in 20% sodium sulfite 
solution (2.5 m. eq., 500cm3) was boiled under reflux for 4 hours, cooled and 
extracted repeatedly with ether. Extracts were checked by silica tlc (CHCl3:MeOH, 9 
: 1). The extracts were combined and the solvent removed under reduced 
pressure. 4-Bromoimidazole was recrystallised from chloroform as colourless 
needles in 68% yield (32.7 g). M.pt. 131 °C (lit. m.pt. 130-131 °C 263, 130-131 °C 267). 
Anal. Found C, 24.4; H, 2.2; N, 19.0%. C3H3N2Br requires C, 24.5; H, 2.1; N, 
19.1 %. Nmr 8H (CDCl3) 7.08 (lH, d <JH(S)H(2) = 1.2 Hz), H-5), 7.61 (lH. d (JH(2)H(S) 
= 1.2 Hz), H-2); 8H (DMK) 7.20 (lH, d <JH(S)H(2) = 1.3 Hz), H-5), 7.65 (lH, s, H-2); 8c 
(DMK) 115.6 (dd <Jc(4)C(S)H = 14.3 Hz, JC(4)C(2)H = 8.3 Hz), C-4), 117.2 (br D (lJcH = 
195 Hz), C-5), 137.1 (Dd (lJcH = 210 Hz, JC(2)C(S)H = 7.9 Hz), C-2) . 
4-Iodoitnidazole 
4,5-Diiodoimidazole (100 g, 0.31 mol) in 20% sodium sulfite solution (2.5 m. 
eq., 500 cm3) was boiled under reflux for 15 hours. On cooling colourless needles 
separated. After filtration, the mother liquor was extracted repeatedly with ether. 
Extracts were checked by silica tlc (CHCl3:MeOH, 9: 1). The extracts were 
combined and the solvent removed under reduced pressure to give further 
product. 4-Iodoimidazole was recrystallised from chloroform as colourless 
needles in 45% yield (27.1 g). M. pt. 136°C (Lit. m. pt. 137-8°C 267). 
Anal. Found C, 18.4; H, 1.5; N, 14.5%. C3H3N2I requires C, 18.6; H, 1.6; N, 
14.4%. Nmr 8H (CDCl3) 7.17 (lH, d <JH(S)H(2) = 1.2 Hz), H-5), 7.62 (lH. s, H-2); 8H 
(DMK) 7.31 (lH, d <JH(S)H(2) = 1.1 Hz), H-5), 7.70 (lH, s, H-2); 8c (DMK) 81.2 (dd 
(Jc(4)C(S)H ""JC(4)C(2)H"" 11 Hz), C-4), 124.4 (Dd (1JcH = 196 Hz, Jc(S)C(2)H = 3.8 Hz), 











4-Iodoimidazole (4.00 g, 0.021 mol) was dissolved in water (20 cm3) containing 
NaOH (0.92 g, 0.023 mol) cooled to 0-5°C in an ice-bath. Freshly prepared sodium 
hypochlorite solution 334 (0.60 M, 38.3 cm3, 0.023 mol) was added portionwise 
with continuous stirring so that the temperature did not exceed 5°C. After 
complete addition, the solution was allowed to warm to room temperature and 
stirring was continued for a further hour. Following decolourisation by 
treatment with activated charcoal, the pH of the solution was adjusted to ca. 3 
with cone. HCL The solid which precipitated was filtered, washed and 
recystallised from water to give 3.21 g of 4-chloro-5-iodoimidazole (67% yield). M. 
pt. 163-4°C 
Anal. Found C, 15.7; H, 0.9; N, 12.1%. C3H2N2Cll requires C, 15.8; H, 0.9; N, 
12.3%. Nmr OH (DMK) 7.83 (s, H-2); 8c (DMK) 135.1 (C-5), 139.9 (C-2), 142.9 (C-4). 
4(5)-Chloroimidazole 
4-Chloro-5-iodoimidazole (2.00 g, 8.76xl0-3 mol) was heated under reflux in 70 
cm3 of 5% sodium sulfite solution for 4 hours. Upon cooling, the pH of the 
solution was adjusted to ca. 2 with cone. HCl a:nd then evaporated to dryness 
under reduced pressure. The solid residue was extracted with boiling EtOH (4 x 
100 cm3), the extracts combined and then evaporated to dryness. The residue was 
redissolved in a small quantity of water and sodium carbonate was added until 
precipitation occurred. After filtration the product was recystallised from water to 
give 4-chloroimidazole (with greater than 95% purity) as colourless needles in 
78% yield (0.70 g). Large scale vacuum sublimation produced analytically pure 
compound. M. pt. 115-6°C (lit. m. pt. 117-8°C 270). 
Anal. Found C, 34.8; H, 2.9; N, 27.4%. C3H3N2Cl requires C, 35.1; H, 3.0; N, 
27.3%. Nmr OH (CDCh) 7.00 (lH, d <JH(S)H(2) = 1.3 Hz), H-5), 7.57 (lH, d <JH(2)H(5) 
= 1.3 Hz), H-2); OH (DMK) 7.11 (lH, d (JH(S)H(2) = 1.4 Hz), H-5), 7.60 (lH, s, H-2); 
Be (DMK) 113.6 (br D (lJCH = 196 Hz), C-5), 129.9 (m, C-4), 136.0 ~Dd (lJcH = 210 Hz, 






Imidazole (15.0 g, 0.22 mol) was added slowly to cone. HN03 (30 cm3, d 1.42) 
maintained at 0-5°C in an ice-bath. Cone. H2S04 (25 cm3) was added portionwise 
to the solution with continuous stirring. The nitrating mixture was then heated 
under reflux for 2 hours. After cooling, the solution was poured into ice water, at 
which time a white solid immediately precipitated. The solid was filtered and 
washed water until the filtrate was non-acidic. Drying and subsequent 
recrystallisation from EtOH gave 4-nitroimidazole in 65% yield (16.2 g). M. pt. 
307-8°C (lit. m. pt. 309°C 89) 
Nmr BH (DMSO) 7.88 (lH, s, H-2), 8.33 (lH, s, H-5(4)); Be (DMSO) 119.1 (Dd, 
(lJeH = 200 Hz, Je(S)e(2)H = 3.6 Hz), C-5), 135.9 (Dd, (1JeH = 214 Hz, Je(2)e(S)H = 9.2 
Hz), C-2), 147.6 (m, C-4). 
5-Bromo-4-nitroimidazole 
4-Bromoimidazole (5.00 g, 34.0 mmol) was added portionwise over 30 
minutes, to a stirred solution of fuming HN03 (d 1.5, 30 cm3) cooled to, and 
maintained at 0-5°C in an ice-bath. Cone. H2S04 (30 cm3) was then added 
dropwise over a similar period, with continued stirring and cooling. The reaction 
mixture was then allowed to warm to room temperature, and stirring continued 
for 2 hours. The solution was poured onto crushed ice (150 g) at which time a 
colourless solid separated. Following filtration and subsequent washings with 
water, the solid was recrystallised from 50% aqueous dimethylformamide (DMF) 
as colourless plates in 82% yield (5.35 g). M. pt. 280-2°C (lit. m. pt. 279°C 263). 
Anal. Found C, 18.9; H, 0.8; N, 22.0%. C3H2N302Br requires C, 18.8; H, 1.0; N, 
21.9%. Nmr BH (DMSO) 7.94 (s, H-2); Be (DMSO) 105.8 (sm br) (br (m?), C-5), 
136.7 (D lJeH = 218 Hz), C-2), 142.7 (sm br) (br (m?), C-4). 
5-Iodo-4-nitroimidazole 
4,5-Diiodoimidazole (20 g, 62.5 mmol) was added portionwise to a stirred 
nitrating mixture, consisting of fuming nitric (d 1.5, 50 cm3) an_d cone. sulfuric (50 
cm3) acids, maintained at -5 to -10°C. The reaction mixture was then allowed to 
warm to room temperature, and stirring continued for 12 hours. The solution 
was poured onto crushed ice (300 g) and the resulting precipitate filtered, washed 







nitroimidazole was recrystallised from DMF in 74% yield (11.1 g) as pale yellow 
plates. M. pt. 284°C (lit. m. pt. 281 °C 280). 
Anal. Found C, 15.3; H, 0.6; N, 17.8%. C3H2N302I requires C, 15.1; H, 0.8; N, 
17.6%. Nmr 8H (DMSO) 7.97 (s, H-2); 8c (DMSO) 74.7 (br) (br (m?), C-5), 139.3 (D 
(lJcH = 217 Hz), C-2), 149.2 (d (Jc(4)C(2)H = 13 Hz), C-4). 
4-Hydroxymethylimidazole 
4-Hydroxymethylimidazole picrate was prepared as described by Totter and 
Darby 284, 285 in 52% yield (based on fructose). The product was recrystallised from 
water. M. pt. 205-206°C (lit. m. pt. 203.5-206°C 284, 285). 
The picrate (80 g, 0.245 mol) was added to a mixture of cone. HCl (100 cm3), 
water (250 cm3), and benzene (500 cm3) and then heated on a water bath 
maintained at ca. 80°C. Once the picrate had completely dissolved, the benzene 
layer was decanted, and the aqueous solution further extracted with benzene (4 x 
300 cm3). Following treatment with activated charcoal, the solution was filtered 
through celite, and the pale yellow filtrate neutralised with the addition of 
sodium carbonate. Evaporation of the solution to dryness under reduced pressure 
left a syrupy residue which was twice extracted with anhydrous EtOH (2 x 50 cm3) 
and filtered. Concentration of the extracts in vacuo . and subsequent elution 
through a short silica filtration column (eluent: MeOH) yielded, after 
recrystallisation from DMK, 16.8 g of 4-hydroxymethylimidazole (70% yield based 
on 4-hydroxymethylimidazole picrate). M. pt. 92°C (lit. m. pt. 91-92°C 284, 91 °C 
286). 
Anal. Found C, 49.1; H, 6.1; N, 28.4%. C4H~20 requires C, 49.0; H, 6.2; N, 
28.6%. Nmr 8H (D20) 4.56 (2H, s 4-CfuOH), 7.10 (lH, s, H-5), 7.70 (lH, s, H-2); 8H 
(DMSO) 4.40 (2H, s, 4-CfuOH), 6.89 (lH, s, H-5), 7.56 (lH, s, H-2); 8c (DMSO) 56.1 
(T (lJcH = 140 Hz), 4-CH20H), 118.0 (br) (Dm <1JcH = 183 Hz), C-5), 135.0 (Dd (lJcH 
= 205 Hz, JC(2)C(5)H = 9.2 Hz), C-2), 137.3 (br) (m, C-4). 
Imidazole-4-carbaldehyde 
Active manganese dioxide (Mn02) (50 g), prepared as described by 
Attenburrow et al 288, was added to 40 cm3 of anhydrous DMK and the mixture 
shaken vigorously to ensure complete wetting of the Mn02. 4-
Hydroxymethylimidazole (5 g, 0.051 mol) was then added to the reaction vessel, 







Mn02 suspended for 12 hours. The solid was then filtered and washed with 
anhydrous DMK. The filtrate and washings were combined and evaporated to 
dryness under reduced pressure, leaving imidazole-4-carbaldehyde, which was 
recrystallised from aqueous MeOH as colourless crystals in 92% yield (4.5 g). M. pt. 
173°C (lit. m. pt. 173-174.5°C 286, 172-173°C 284). 
Anal. Found C, 50.2; H, 4.1; N, 29.0%. C4H,iN20 requires C, 50.0; H, 4.2; N, 
29.2% .. Nmr 6H (DMSO) 7.94 (lH, s, (HETC) H-2), 8.00 (lH, d <JH(5)H(2) = 1.0 Hz), 
(HETC) H-5), 9.76 (lH, s, 4-CHO); 6c (DMSO) 129.7 (Dd (1JcH = 192 Hz, JC(S)C(2)H 
= 4.9 Hz), C-5), 129.7 (ddd (dt), (Jc(4)CHO = 27 Hz, JC(4)C(S)H = }C(4)C(2)H = 10.0 Hz), 
C-4), 139.0 (Dd, (lJcH = 210 Hz, Jc(2)C(S)H = 9.7 Hz), C-2), 183.8 (D (lJcH = 174 Hz), 4-
CHO). 
Methyl Imidazole-4-carboxylate 
Methyl 2-mercaptoimidazole-4-carboxylate · 
Glycine ethyl ester hydrochloride (75.0 g, 0.54 mol) was dissolved by warming 
in 150 cm3 of 90% formic acid. To this solution was added a hot solution of 
sodium formate (45.0 g, 0.66 mol) in 100 cm3 of 90% formic acid. After standing 
for 1 hour, the precipitated sodium chloride was removed by filtration, and 250 
cm3 of acetic anhydride added in portions. When the vigorous reaction had 
subsided, the mixture was heated on a steam-bath for 30 min and then 
evaporated under reduced pressure to remove the formic and acetic acids. The 
residual liquid was taken up into 500 cm3 of DMK whereupon a further quantity 
of sodium chloride separated. The solution was filtered, the DMK evaporated, 
and the crude product distilled under vacuum to give N-formyl glycine ethyl 
ester in 85% yield (59.5 g). B. pt. 127°C/2.0 mm Hg (lit. b. pt. 110°C/1.0 mm Hg 289). 
Dry methyl formate (78.0 g, 1.30 mol), and a catalytic quantity of MeOH was 
added to N-formyl glycine ethyl ester (57 g, 0.43 mol) dissolved in 200 cm3 dry 
benzene and the mixture cooled in an ice-bath. With continuous stirring, freshly 
prepared sodium methoxide (27.0 g, 0.50 mol) suspended in 50 cm3 dry benzene 
was added in portions at a rate that ensured the reaction temperature never 
exceeded 15°C. Stirring was continued for 2 hours and the mi~ture chilled 
overnight in a freezer. 
The crude enola te salt was filtered and washed several times with dry 
benzerie.The salt was completely dissolved in a minimum quantity of water and 
the solution then cooled in an ice-bath while cone. HCl (85 cm3 (12 M), 1.0 mol) 








and the solution warmed to 50-70°C on a steam-bath for 2 hours. The solution 
was allowed to cool in a refrigerator overnight. The crystalline methyl 2-
mercaptoimidazole-4-carboxylate was collected by filtration, washed with a small 
quantity of water and finally air dried. Recrystallisation from water gave 12.9 g, 
19% yield based on N-formyl glycine ethyl ester. M. pt. 189°C (dee) (lit. m. pt. 190-
191 °C (dee) 289). 
Anal. Found C, 38.0; H, 3.8; N, 17.7; S, 20.3%. CsH6N202S requires C, 38.0; H, 
4.0; N, 17.9; S, 20.2%. Nmr 8H (DMSO) 3.80 (3H, s, 4-COOCfu), 7.70 (1H, s, H-5); 
8H (EtOH-d6) 3.79 (3H, s, 4-COOCH3), 7.40 (1H, s, H-5). 
Methyl imidazole-4-carboxylate 
To methyl 2-mercaptoimidazole-4-carboxylate (3.0 g, 0.019 mol) in EtOH (20 
cm3) was added a wet suspension of freshly prepared Raney Nickel in EtOH 340 
(ca. 5 g). The mixture was heated under reflux and monitored by silica tlc (EtOAc). 
Upon completion of the desulfurisation reaction (ca. 1 hour), the suspension was 
treated with activated charcoal and filtered through celite. The solid was washed 
with a little EtOH and the filtrate evaporated under reduced pressure to yield, 
after recrystallisation from aqueous EtOH, 1.27 g methyl imidazole-4-carboxylate 
(53% yield). M. pt. 149°C (lit. m.pt. 154-6°C 341 ). 
Anal. Found C, 47.9; H, 5.0; N, 22.2%. CsH6N202 requires C, 47.6; H, 4.8; N, 
22.2%. Nmr 8H (DMSO) 3.74 (3H, s, 4-COOCH3), 7.82 (2H, br s, H-2, H-5); 8c 
(DMSO) 51.0 (Q (lJcH = 147 Hz), 4-COOCH3), 125.9 (br) (Dm(lJcH"" 191 Hz), C-5), 
129.8 (br) (m, C-4), 137.6 (Dd (lJcH = 210 Hz, Jc(2)C(5)H = 8.8 Hz), C-2), 162.4 (m, 4-
COOCH3). 
Imidazole-4-carboxamide 
A solution of methyl imidazole-4-carboxylate (5 g, 0.04 mol) and cone. 
ammonia (25 cm3) was heated at 100°C in a sealed tube for 2 days. The solution 
was then evaporated to dryness under reduced pressure and the residue extracted 
twice with anhydrous EtOH (2 x 50 cm3). Removal of the EtOH and 
recystallisation of the solid product from water gave imidazole-4-carboxamide in 
79% yield (3.5 g). M. pt. 211-212°C (lit. m. pt. 215°C 342). 
Anal. Found C, 43.3; H, 4.3; N, 37.7%. C4H5N30 requires C, 43.2; H, 4.5; N, 







7.64 (lH, s, (HETC) H-5), 7.72 (1H, s, (HETC) H-2); 6c (DMSO) 121.3 (br) (Dm (lJcH 
= 187 Hz), C-5), 134.8 (sm, br) (m, C-4), 136.1 (Dd (lJcH = 208 Hz, JC(2)C(S)H = 9.0 
Hz), c~2), 164.1 (s, 4-CONH2). 
5-Methylthio-4-nitroimidazole 
Ammonium salt of 5-mercapto-4-nitroimidazole 
Hydrogen sulfide was bubbled through a solution of 5-iodo-4-nitroimidazole 
(5.00 g, 20.9 mmol) dissolved in ammonium hydroxide (5 mol dm-3, 40 cm3) for 5 
minutes with continuous stirring at 50-60°C The solution underwent a marked 
colour change and orange needles separated from the orange-red solution. The 
solid was filtered, washed with a little EtOH, and recrystallised as bright orange 
needles from MeOH to yield 2.0 g of the ammonium salt of 5-mercapto-4- · 
nitroimidazole (59%). M. pt. >300°C (lit. m. pt. >300°C 297). 
Nmr OH (D20) 7.52 (H-2). 
5-Methylthio-4-nitroimidazole 
The ammonium salt of 5-mercapto-4-nitroimidazole (0.250 g, 1.54 mmol), was 
dissolved in methanolic sodium methoxide (1.54 mmol, 0.035 g-atoms Na metal 
in 25 cm3 MeOH). Iodomethane (0.328 g, 2.31 mmol) was added and the solution 
heated under reflux for 2 hours. The solution was observed to change colour 
from orange to yellow over this period. The solvent was then removed under 
reduced pressure, and a small quantity of water added to the solid residue. The 
insoluble solid was filtered, washed with a little water and recrystallised from 
50% aqueous EtOH as pale yellow needles in 80% yield (0.196 g). M. pt. 187-8°C (lit. 
m. pt. 187-9°C 297). 
Anal. Found C, 30.4; H, 3.2; N, 26.7; S, 19.9%. C4H5N302S requires C, 30.2; H, 
3.2; N, 26.4; S, 20.1%. Nmr OH (DMSO) 2.61 (3H, s, 5-SCfu), 7.90 (1H, s, H-2); 6c 
(DMSO) 14.6 (Q (lJcH = 141 Hz), S-SCH3), 119.0 (sm, br) (C-5), 136.5 (br) (Dm (lJcH 
= 217 Hz), C-2), 141.6 (sm br) (br (m?), C-4). 
4-N itro-5-phenylthioimidazole 
Potassium hydroxide (1.40 g, 25.0 mmol) was dissolved in EtOH (75 cm) 







nitroimidazole (5.00 g, 20.9 mmol) was added and the mixture heated under 
reflux for 4 hours. Upon cooling, the reaction mixture was poured over ice-water 
(200 cm3) and neutralised with 10% HCl, at which time a yellow solid separated. 
The product was collected by filtration, washed several times with cold water and 
finally recrystallised from EtOH as very pale yellow needles in 69% yield (3.20g). 
M. pt. 205-6°C (lit. m. pt. 207-8°C 295). 
Anal. Found C, 48.9; H, 3.0; N, 19.0; S, 14.8%. C9H7N302S requires C, 48.8; H, 
3.2; N, 19.0; S, 14.5%. Nmr OH (DMSO) 7.87 (1H, s, H-2), 7.44-7.54 (SH, m, H-2',6', 
H-3',5', H-4'); Be (DMSO) 128.3 (sm, br) (C-5), 129.2 (Dt (lJeH = 162 Hz, 3JeH = 7.2 
Hz), C-4'), 129.9 (C-1'), 130.1 (D(d?) (lJeH = 164 Hz), C-3',5'), 132.1 (Dm (lJeH = 164 
Hz), C-2',6'), 137.0 (br D (lJeH = 217 Hz), C-2), 144.0 (sm, br) (C-4). 
5-Methylsulfinyl-4-nitroimidazole 
5-Methylthio-4-nitroimidazole (0.250 g, 1.57 mmol) was dissolved with slight 
warming in 50 cm3 of glacial acetic acid. Magnesium monoperoxyphthalate 
hexahydrate (80%) (0.5 mol equivalent, 0.98 mmol, 0.485 g) was then added and 
the reaction mixture warmed to ca. 50°C and stirred to effect solution. 
Immediately the mixture was poured onto ice water (50 cm3), and concentrated 
under reduced pressure until a solid was observed to separate. After chilling for 
several hours, the solid was filtered, washed with water, and recrystallised from 
EtOH to yield 0.185 g (67%) 5-methylsulfinyl-4-nitroimidazole as colourless cubes. 
M. pt. 228-30°C (dee). 
Anal. Found C, 27.7; H, 2.9; N, 23.8; S, 18.3%. Cale. for C4HsN303S C, 27.4; H, 
2.9; N, 24.0; S, 18.3%. Nmr OH (DMSO) 3.02 (3H, s, 5-SOCfu), 8.06 (1H, s, H-2); Be 
(DMSO) 41.0 (Q (lJeH = 141 Hz), 5-SOCH3), 136.2 (sm) (m, C-5), 138.9 (D (lJeH = 
218 Hz), C-2), 143.0 (d (Je(4)e(2)H = 12.3 Hz), C-4); u max: 1535, 1480, 1355, 1070, 
1040 cm-1. 
5-Methylsulfonyl-4-nitroimidazole 
5-Methylthio-4-nitroimidazole (0.500 g, 3.14 mmol) was dissolved in acetic acid 
(5 cm3) warmed to 50-60°C on a steam bath. Hydrogen peroxide (30%, 5 cm3) was 
added dropwise over a period of 30 minutes with continuous stirring. Heating 
was subsequently resumed and the temperature increased to 90°C for 1 hour. 








washed with water and recrystallised from 50% aqueous EtOH in 89% yield (0.535 
g). M. pt. 277-8°C (lit. m. pt. 276-7°C 297). 
Anal. Found. C, 25.3; H, 2.6; N, 22.1; S, 16.7%. C4H5N304S requires C, 25.1; H, 
2.6; N, 22.0; S, 16.8%. Nmr OH (DMSO) 3.54 (3H, s, S-S02Cfu), 8.08 (1H, s, H-2); Be 
(DMSO) 43.1 (Q (lJcH = 140 Hz), 5-50&H3), 128.2 (sm) (m, C-5), 136.2 (D (lJcH = 
218 Hz), C-2), 144.1 (d (Jc(4)C(2)H = 11.2 Hz), C-4). 
2.5.2 Metallation Work 
All reactions were carried out in flame-dried apparatus under a slight positive 
pressure of argon. Tetrahydrofuran (THF) solvent was dried by distillation from 
sodium benzophenone ketyl. Transferring operations were performed using 
syringe and cannula techniques. Concentration of n-BuLi in hexanes was 
determined for each experiment by the Gilman back-titration procedure 343. 
Temperatures are those of the cooling baths; reagents were cooled to bath 
temperature prior to slow dropwise addition. · 
2.5.2.1 Metal-Halogen Exchange 
Methyl Iodide Quench (General Procedure) 
To a solution of 4-bromoimidazole (2.0 g, 13.6 mmol) in THF (20 cm3) cooled 
to -78°C, n-BuLi (1.6M in hexane, 31.3 mmol, 19.6 cm3) in THF (10 cm3), similarly 
cooled, was added dropwise over a period of 10 min with continuous stirring. 
The solution was slowly warmed to 10-15°C and maintained at this temperature 
for 1.5 hours. The reaction mixture was then cooled to -78°C at which time a 
solution of the electrophile, iodomethane (3.86 g, 27.2 mmol), in THF (10 cm3) 
was added. The mixture was allowed to warm to 15°C overnight. Saturated 
ammonium chloride solution (15 cm3) was then added and the solution extracted 
with THF (4 x 30 cm3). The combined extracts were washed with water, dried over 
anhydrous MgS04 and evaporated under reduced pressure to produce an oil 
which was separated by flash chromatography (alumina, eluent: 1 % 
EtOAC/CH2Cli) into 2 isomeric mixtures: 4-bromo-1-methyl- and 5-bromo-1-
methylimidazole (62%, 0.680 g); 1,4-dimethyl- and 1,5-dimethylimidazole (17%, 
0.110 g) (refer Chapter 3 for analytical/spectral data). 
Isomer ratios: 1 : 1 (4-bromo-1-methyl-: 5-bromo-1-methylimidazole); 1 : 2.3 








A The procedure for carbanion generation of 4-bromoimidazole described 
above was repeated. Upon addition of the n-BuLi, the solution was allowed to 
warm slowly with continuous stirring (over 10 hours) to 10°C, and maintained at 
10-15°C for a further 14 hours. Periodically, 1 cm3 samples were removed and 
quenched with water (1 cm3). Tlc and 1 H nmr analysis of the neutralised samples 
revealed the first appearance of imidazole at 4 hrs (T = -68°C), 17% conversion 
after 1.5 hours at 10-15°C, and 18% conversion after 14 hours at 10-15°C. 
B A solution of 4-bromoimidazole (1.0 g, 6.8 mmol) in 10 cm3 of THF was 
added dropwise over 10 min with stirring to naphthyllithium (obtained 
previously from reaction of 1-bromonaphthalene and n-BuLi) in THF (20 cm3) 
cooled to -10- -15°C. Stirring was continued at this temperature for 4 hours. 1 cm3 
Samples were taken periodically, and quenched with water (1 cm3). Tlc and lH 
nmr analysis revealed the first appearance of imidazole at 10 min, 14% 
conversion after 1 hour and 12% conversion after 4 hours at -10- -15°C. 
Benzophenone Quench 
4-Bromoimidazole (1.0 g, 6.8 mmol) was subjected to treatment with n-BuLi 
(1.52M in hexanes, 15.6 mmol, 10.3 cm3) and subsequently with benzophenone 
(2.5 g, 13.6 mmol), in THF as described. Workup and purification by column 
chromatography (alumina, eluent: 2% MeOH/18% Et0Ac/CH2Cl2) gave 0.41 g 
[imidazol-4-yl]diphenylmethanol (24%). 
[Imidazol-4-yl]diphenylmethanol 
M. pt. 167-8°C (lit. m. pt 170-172°C 310). Nmr 8H (DMK) 6.62 (1H, s, H-5), 7.20-
7.42 (10H, m, Ar H), 7.66 (lH, s, H-2). 
The above experiment was repeated with carbanion generation prolonged : 
overnight warming to 10-15°C. [Imidazol-4-yl]diphenylmethanol was obtained in 
26% yield (0.44 g). 
4-Iodoimidazole (1.0 g, 5.2 mmol) was subjected to treatment with n-BuLi 
(1.51M in hexanes, 11.9 mmol, 7.9 cm3) and subsequently with benzophenone (1.9 
g, 10.4 mmol), in THF as described. Workup and purification as for 4-









g). Prolonged carbanion generation as above afforded the same in 31 % yield (0.40 
g). 
2.5.2.2 Lithiation of N-protected Imidazole 
N-Protection 
1-(N ,N-dimeth ylaminometh yl)imidazole was prepared according to the 
procedure of Katritzky et al by reaction of imidazole with dimethylammonium 
chloride and formaldehyde 41. (68%, b. pt. 101-103°C (1.5 mmHg) (lit. b. pt. 100-102 
(2 mmHg) 41). 
Nmr 8H (CDC!J) 2.26 (6H, s, l-CH2N(Cfu)i), 4.65 (2H, s, l-CfuN(CH3)i), 6.95 
(lH, d <JH(S)H(4) = 1.1 Hz), H-5), 7.04 (lH, d (JH(4)H(S) = 0.9 Hz), H-4), 7.49 (lH, s, H-
2). 
2-Lithiation and Protection with Triethylsilyl chloride (TESCl); 5-Lithiation 
and Benzophenone quench; N- and 2-Deprotection 
To 1-(N,N-dimethylaminomethyl)imidazole (1.0 g, 7.8 mmol) in THF (30 cm3) 
at -78°C was added a solution of n-BuLi (1.5M in hexanes, 8.8 mmol, 5.9 cm3) in 
THF (10 cm3) over 10 min with stirring and the mixture maintained at this 
temperature for an additional 30 min. A solution of TESCl (2.35 g, 15.6 mmol) in 
THF (10 cm3) was then added dropwise, and the mixture allowed to warm to 
room temperature overnight. The solvent and excess volatile reagent were 
removed by evaporation with gentle warming under vacuum. Once again under 
an argon atmosphere, the residual oil was redissolved in THF (30 cm3) and 
cooled to -78°C. n-BuLi (1.SM in hexanes, 15.6 mmol, 10.4 cm3) in THF (10 cm3) 
was added over 10 min with stirring and the mixture kept at this temperature for 
1 hour. Benzophenone (4.26 g, 23.4 mmol) in THF (10 cm3) was then added 
slowly and the mixture was again allowed to warm to room temperature 
overnight. 
The THF was removed under reduced pressure and 50 cm3 of 10% HCl 
solution added. After stirring for 15 minutes, the acidic solution was extracted 
with ether (3 x 30 cm3), neutralised with potassium carbonate and re-extracted 
with CH2Cli (4 x 30 cm3). The combined CH2Cl2 extracts were dried (MgS04), and 
evaporated under reduced pressure to leave an oily residue. Flash 







both [imidazol-4-yl]diphenylmethanol (30%, 0.58 g) and [imidazol-2-
yl]diphenylmethanol (18%, 0.36 g). 
[Imidazol-2-yl]diphenylmethanol 
M. pt. 186-8°C (lit. m. pt. 187-9°C 41). Nmr OH (DMK) 6.96 (2H, s, H-4, H-5), 
7.23-7.30 (6H, m, Ar H), 7.40-7.46 (4H, m, Ar H). 
90 
The above experiment was repeated using lithium diisopropylamide (LDA) 
(15.6 mmol) to accomplish lithiation of 1-(N,N-dimethylaminomethyl)-2-
triethylsilylimidazole. LDA was freshly prepared by reaction of diisopropylamine 
with n-BuLi in THF. [Imidazol-4-yl]- and [Imidazol-2-yl]diphenylmethanol were 
obtained in 64% (1.25 g) and 8% (0.16 g) yields respectively. 
Attempted Cyanation of 1-(N,N-dimethylaminomethyl)-2-triethylsilylimidazole 
with cyanogen bromide 
To 1-(N,N-dimethylaminomethyl)-2-triethylsilylimidazole formed in situ 
above, LDA (15.6 mmol) in THF (10 cm3) was added over 10 min at -78°C. After 
stirring for 1 hour, cynanogen bromide (1.65 g, 15.6 mmol) in THF (10 cm3) was 
added dropwise and the reaction mixture was allowed to warm to room 
temperature overnight. Workup and deprotection as above yielded, after radial 
chromatography (eluent, 2.5% MeOH/EtOAc), 4-bromoimidazole as the only 














































() ·HCI HCI 
I 
R 




















N-ALKYLATION OF IMIDAZOLES 
3.1 Introduction 
While N-alkylimidazoles can be obtained through cyclocondensation and ring 
modification protocols, the most common route to these compounds involves 
the direct alkylation of preformed imidazoles either as the free base or as the 
conjugate ambident anion. The numerous alternative syntheses available are 
beyond the scope of the present work except perhaps as an aid to unambiguous 
identification of the products of N-alkylation. As such, two syntheses of wide 
application deserve mention: these afford access to a variety of 1-alkyl-4- or -5-
functionalised alkylimidazoles. Jones, as previously described (section 2.2), 
converted sodium enolate salts of N-alkyl-N-formyl-C-formylglycine ethyl esters 
into corresponding 1-alkyl-2-imidazolethione-5-carboxylates by 
cyclocondensation with sodium thiocyanate under acid conditions (Scheme 65, 
see also Scheme 46). Oxidative (or reductive) desulfurisation of the resultant 
imidazolethione derivatives affords the 1-alkylimidazole-5-carboxylate in fair 
overall yield 289 . The second synthesis, reported by Matthews et al 344, provides 
entry to the isomeric 1-alkylimidazole-4-carboxylates by creating and 
subsequently dehydrogenating the appropriate 1-alkyl-2-imidazoline-4-
carboxylate; the imidazoline intermediate, 1-methyl-2-imidazoline-4-carboxylate, 
is obtained in 81 % yield by the action of triethylorthoformate (TEOF) on a-
amino-~-methylaminopropionic acid hydrochloride with a hydrogen chloride 
catalyst (Scheme 66, R=CH3). Other, less versatile, methods are reviewed in the 
literature 345. 
Already discussed in detail in Chapter 1, the course of N-alkylation of 
imidazoles is dependent on numerous factors. Most significant of these is the 
nature of the reaction mechanism. A function of the reaction medium, 
electrophilic substitution occurs through an SE2cB process (Schemes 10, 11) when 
the substrate is present as the deprotonated imidazole anion, while an SE2' 
mechanism operates (Scheme 8) when the reacting species is the (less reactive) 
free base. N-alkylation reactions are thus amenable to broad classification under 
the headings "basic" and "neutral" alkylations. The orientation of reaction 
products of unsymmetrically substituted imidazoles is further controlled by 
substrate substituent effects, medium effects (including solvent and base effects), 
the nature of the alkylating reagent, and the tautomeric disposition of the free 
base in "neutral" alkylations. Added complications may potentially arise in the 
form of product isomerisation through base catalytic or quaternisation-
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dequaternisation processes (Schemes 15, 16). The purpose of the present research 
was to investigate in some detail, some of the key determinants of product 
control (namely mechanism, substrate, reagent, and to a lesser degree, medium 
effects) in the hope of gauging the form of their control and their relative 
significances. 
To this end, 4-substituted and 4,5-disubstituted imidazoles (prepared as 
described in Chapter 2) were subjected to alkylation by dimethyl sulfate, diethyl 
sulfate and benzyl chloride under two different sets of reaction conditions; "basic" 
and "neutral" alkylations utilised aqueous sodium hydroxide and refluxing 
ethanol respectively. The product distributions were determined by nmr 
spectroscopy and the isomer ratios are discussed with reference to the 
aforementioned determinants. To assist in the interpretation of substituent 
effects on positional selectivity, atomic charge densities and solvent accessible 
surface areas were determined using MNDO (v. 6), CHARGE3 346 .and 
Macroinodel (v. 2) software. It was hoped that these calculations would enable 
elucidation of the relative contributions of the electronic and steric constituents. 
It is convenient to divide the alkylation reactions studied into the above 
"basic" and "neutral" categories (sections 3.2.3.1 and 3.2.3.2 respectively). 
A subsequent series of experiments was conducted in an effort to gain further 
insight into the seemingly anomalous product distributions observed when 
imidazoles are methylated by diazomethane (section 3.2.3.3) . 
3.2 N-Alkylation of Imidazoles 
3.2.1 Reactants and Reaction Conditions 
Alkylation of 13 monosubstituted (Ia-m) and 7 disubstituted (In, IVa-f) 
imidazoles was studied under "basic" (Scheme 67) and "neutral" (Scheme 68) 
reaction conditions. These compounds were chosen to cover a range of 
substituent steric and electronic properties, and with the exception of 5-
methylsulfinyl-4-nitroimidazole (IV d), all had been previously synthesised. 
Basic alkylation conditions were selected so that the predominant reacting 
imidazole species in solution was the imidazole. anion. From ~he synthetic 
discussion of N-alkylation (section 1.3), it is evident that a wide variety of 
reaction conditions are available that satisfy this criterion. Several of these, 
including heterogeneous and two step (anion salt isolation) alkylation 
procedures, are synthetically superior to the historically common set of 







development of efficient methods for regiospecific alkylation, endeavours to 
provide some further understanding of the processes which direct the reactions. 
Series I Series IV 
X (Y=H) X 
(a) Cl (i) N02 (a) I 
(b) Br (j) Ph (b) Br 
(c) I (k) p-OCH3C6H4 (c) SCH3 
(d) CH3 (1) p-ClC6l{4 (d) SOCH3 
(e) CH20H (m) p-N02C6lf4 (e) S02CH3 
(f) CHO (f) SPh 
(g) C02CB3 (Y=CH3) 
(h) CONH2 (n) CHJ 
Accordingly, reaction conditions were chosen with a view to comparing our 
results with those of earlier workers. Thus, alkylation in "basic medium" utilises 
10% aqueous sodium hydroxide with the alkylating reagents dimethyl sulfate, 
diethyl sulfate, and benzyl chloride. The general procedure for basic alkylation, 
described in section 3.3.2, involved the addition of the imidazole substrate to 10% 
aqueous sodium hydroxide solution with continuous stirring to effect complete 
dissolution. Reaction was achieved by the addition of 1.1 stoichiometric 
equivalents of alkylating agent with subsequent stirring of the heterogeneous 
reaction mixture for 2 hours at room temperature. 
The products were isolated by CH2Cl2 extraction (detailed in section 3.3.2) and 
the isomer ratios determined by lH nmr analysis of the unpurified product 
mixture (see section 3.2.2 below). Unreacted starting material was recovered, 
generally by (i) neutralisation of the remaining aqueous solution, evaporation to 
dryness, and hot alcohol extraction of the residue~ or (ii) acidification and 
filtration. The yields obtained range from poor to moderate, a consequence in 
part of the hydroxylic nature of the reaction medium. Recovered starting 
material was observed to account for the bulk of the difference although 
discrepancies in the region of 5-15% were common. Possible explanations for this 
observation include {i) quaternisation of one or both of the N-;;ilkylated products 
to form water soluble 1,3-dialkylimidazolium salts, (ii) displacement of a product 
or substrate substituent (halogeno, mesyl) by hydroxyl to form water soluble 
sodium salts of hydroxyimidazoles and (iii) ring opening. 
All three of these possibilities introduce an added complication to the 
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towards further electrophilic or nucleophilic attack. Examples of nucleophilic 
substitution of halo groups by hydroxide and alkoxide are documented for nitro 
activated N-substituted and N-unsubstituted halonitroimidazoles 280, 347,348. 
Halogen displacement was seen to occur in moderate to good yield when the 
substrates were treated with aqueous hydroxide or alcoholic alkoxide at reflux 
temperatures. Conflicting results are apparent, however, when comparing the 
researches of two independent groups : Sanjic et al reported their failure to 
replace a bromo group in the 5-position of 5-bromo-1-methyl-4-nitroimidazole by 
alkoxide action 348, while Kochergin and co-workers claimed successful 
displacement of the same 347. Ring decomposition was observed also, particularly 
of the 5-nitro isomers, after prolonged heating under the same conditions 348. 
Under the mild conditions utilised in the present alkylation series, the extent to 
which substrate and products undergo nucleophilic substitution and/ or ring 
fission is likely to be much diminished. 
Control experiments designed to test the stability of two, potentially more 
susceptible, classes of substrates (4-halo- and 5-halo-4-nitro-) to alkali treatment 
were performed. 4-Bromoimidazole (lb) and 5-bromo-4-nitroimidazole (IVb) and 
their respective N-methyl isomers (Ilb, Illb, Vb, Vlb) were individually subjected 
to base treatment (section 3.3.1). Recovery of unchanged material was in the 
range 91-96%, indicating that very little substitution or ring opening is occurring 
under these conditions. Nothing conclusive regarding the nature of the 
remaining few percent of material was found upon lH nmr analysis of the water 
soluble residue. 
To avoid, as much as possible, competitive quaternisation (Scheme 5), the 
amount of alkylating reagent was restricted to 1.1 molar equivalents; the use of 
excess methylating agent was shown to affect product disposition markedly 
(section 3.3.1). A product ratio of 3.9: 1 (Ilb: lllb, R = CH3) was obtained when lb 
was reacted with a 5 molar excess of dimethyl sulfate in basic medium (cf. 2.6 : 1 
from 1.1 molar equivalents). The disparity, inexplicable in terms of experimental 
error (see section 3.2.2 below), is probably the result of quaternising alkylation of 
the mono-N-methylated products. This is evidenced by the lower yield of Ilb and 
Illb isolated (35% cf. 45% (section 3.3.2)), the comparatively small yield of 
unchanged lb (ca. 18% cf. ca. 42%), and the presence of a water soluble product 
bearing a pair of substantially deshielded (relative to the methyl signals of Ilb and 
Illb) three proton singlets in the crude 1 H nmr spectrum of th~ neutralised 
aqueous residue: B (D20) 4.12 and 4.19 cf. singlets at B (D20) 3.80 and 3.88 for 
methyl signals of 4-bromo-1,3-dimethylimidazolium tosylate obtained from 
reaction of Ilb with methyl toluene-p-sulfonate 349. The increase in the 
proportion of Ilb (relative to Illb) in the product mixture is understandable when 







methylation. Clearly, in this instance, the more riucleophilic and hence reactive 
base, would be lllb which possesses a tertiary nitrogen remote from the steric and 
electronic deactivation of the bromo group. 
Reaction of lb with a 10% stoichiometric equivalent of dimethyl sulfate under 
I 
identical conditions gave rise to a 2.4 : 1 isomer distribution (llb : lllb, cf. 2.6 : 1 
from 1.1 equivalents). This seemingly indicates that only a very small proportion 
(less than 8% in this case and within experimental error (section 3.2.2)) of 
isomeric material may be undergoing quaternisation under standard conditions 
(1.1 molar equivalents of alkylating agent). It is reasonable to assume dissimilar 
substrate and product reactivities considering the basicity difference between the 
anionic substrate and the neutral N-alkyl products. Coupled to this argument is 
the fact that dimethyl sulfate is hydrolysed at such a rate that ca. 11 % of the 
reagent is recoverable after 2 hours stirring in 10% aqueous NaOH at room 
temperature (section 3.3.1); kinetic experiments performed by Ridd and co-
workers showed that the hydroxide ion and the conjugate base of 4-
nitroimidazole (Ii) have almost identical nucleophilic power towards the methyl 
carbons of dimethyl sulfate 93. 
One further complication, however, arises from the heterogeneous nature of 
the reaction mixture. Dimethyl sulfate, diethyl sulfate and benzyl chloride are 
only very slightly soluble in water, and constitute an organic phase within which 
the products of mono-N-alkylation are expected to exhibit greater solubility. This 
would explain why quaternary salt formation is apparent using excess dimethyl 
sulfate while at the same time unreacted anionic starting material is present. An 
experiment was conducted, primarily to determine whether isomerisation is 
operating under these conditions, utilising homogeneous alkaline conditions 
(section 3.3.1). lb was dissolved in a solution comprising methanol (25%) and 10% 
aqueous NaOH (75%) and 1.1 equivalents of dimethyl sulfate was added; 
methanol was added in this instance to solubilise the products in the reaction 
medium. Samples were removed periodically and worked up for ratio 
determination: a constant ratio of 2.2: 1 (Ilb: lllb) was observed. Whether the 
difference is purely due to quaternisation (lack thereof in this case) or whether it 
is in part or primarily attributable to a solvent effect is uncertain. A final 
experiment designed to gauge the significance of the effect of quaternisation on 
the ratios obtained involved placing an isomeric mixture of predetermined ratio 
(Ilb : Illb = 1.9: 1) under standard conditions with 1 equivalent of dimethyl 
sulfate (section 3.3.1). The ratio found on workup, 2.1 : 1, indicates ca. 10% 
variance in favour of the less reactive isomer; a loss of 18% mass was observed. 
Finally, before any detailed analysis of substrate (substituent) and reagent 
effects on isomer ratios could be carried out, it was necessary to confirm that 







equilibration to a thermodynamic mixture. Thus experiments were performed 
whereby purified isomers lib and llib were individually subjected to standard . . 
96 
basic conditions in the presence of 1 and 2 molar equivalents of dimethyl sulfate 
(section 3.3.1). No isomerisation products were observed. Substrate recoveries 
indicate that while some quaternisation may be occurring (83% lib and 78% Illb 
were recovered using 1 equivalent of dimethyl sulfate), no isomerisation via base 
catalysed or thermolytic dequaternisation is operating (see section 1.2.2.1). 
Further, the aforementioned homogeneous alkylation experiment shows that 
isomer_ ratios are constant throughout the course of the reaction, ·confirming that 
alkylation proceeds under kinetic control. 
It is clear from the results of the above experiments that heterogeneous 
alkaline conditions are less than ideal in that quaternisation may be a significant 
complication. The ratios thus obtained will reflect an unnatural bias towards the 
less reactive mono-N-alkylimidazole (Scheme 69); where the substrate 
substituent is electron-withdrawing, for example~ the isomer III is expected to be 
more reactive towards competitive alkylation and the ratio will hence favour II 
by an amount likewise. dependent on the nature of the substituent. In 
consequence, while the ratios determined may not absolutely describe individual 
regioselectivities, they are still relevant to detailed analysis of substituent and 
reagent effects. This conclusion assumes proportionate conversion of isomeric 
products throughout the series of alkylations (ie. proportion of quaternised to 
unquaternised material), since the relative propensities of the mono-N-alkylated 
products to undergo quaternisation are dependent (analogously to mono-
alkylation) on the steric and electronic properties of the substituent(s); ie. k3 oc k2 
and ki oc k1 (Scheme 69). 
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A second set of "basic" alkylation conditions was necessary for the aryl 
substituted substrates lj-m, since these were not sufficiently soluble in aqueous 
alkaline media (Scheme 67). Ethanol was selected as solvent, for both ease of 
workup and to enable tighter comparison with the neutral alkylations of this sub-
series. 1.2 Molar equivalents of sodium ethoxide (NaOEt) was used to effect 
deprotonation of the arylimidazoles prior to the addition of alkylating agent; this 
base was chosen for its high basicity and solubility, and as a source of the same 
counterion present in the aqueous alkaline reactions. All alkylations were 
similarly stirred for 2 hours at room temperature in the presence of 1.1 molar 
equivalents of alkylating reagent. 
Several other substrates, le, lg, and lh, were alkylated under ethanolic sodium 
ethoxide conditions, in addition to aqueous alkaline conditions, when reaction in 
the latter failed to yield appreciable product. 
Though not experimentally confirmed, these modified reaction conditions 
were not expected to complicate isomer distribution as described above. The 
conditions are homogeneous and the markedly disparate substrate and product 
basicities should preclude competitive quaternisation. 
"Neutral" or free base alkylations were performed in refluxing ethanol 
(Scheme 68) using the same alkylating agents in the same stoichiometric 
proportions. Workup (detailed in section 3.3.3) produced the products of N-
alkylation in low to moderate yields. The susceptibility of dimethyl sulfate to 
solvolysis under the reaction conditions was measured by nmr analysis of a 
sample of the reagent dissolved in deuterated ethanol heated to 70-80°C for 2 
hours. 45% of the reagent was destroyed in this period and the expected product 
of solvolysis, ethyl methyl ether, was observed. Interestingly, the appearance of a 
small amount of what appears to be ethyl methyl sulfate (a transesterification 
product) was also noted. No N-ethylated species, however, were observable in the 
methylation reactions studied. The in situ generated acid (see section 1.2.2.1) may 
also contribute to the generally poor yields obtained, particularly with the more 
basic (reactive) substrates. 
Recovered unchanged starting material made up the bulk of the deficit, with a 
small mass percentage (typically less than 10%) unaccounted for. Control 
experiments using lb have shown that substrate and products are relatively inert 
to the solvent under the conditions employed: lb, Ilb, and lllb were dissolved in 
ethanol and refluxed for 2 hours according to the standard procedure. Recovery 
yields were 98, 98 and 96% respectively. 
Some quaternisation appears to be operating, though to an even lesser degree 
than observed in the basic (Na OH) alkylations. An experiment, analogous to the 
one conducted under basic conditions, was carried out to determine whether 









Ilb and Illb with known ratio was exposed to 1 equivalent of dimethyl sulfate in 
refluxing ethanol. Again, approximately 10% variance between initial and final 
isomer ratios was observed (1.7: 1 and 1.9: 1 (lib: Illb) respectively) together with 
a mass loss of 13%. Experiments carried out to discover whether the elevated 
temperatures used in these reactions may facilitate isomerisation (via 
dequatemisation), revealed no trace of isomerised product and substrate 
recoveries of 98 (lib) and 93% (Illb) were observed. To ensure that isomer ratios 
are the product of kinetic control under "neutral" conditions, several reactions 
were examined for ratio constancy over the duration of the experiment. Owing to 
the homogeneous nature of these conditions, two experiments were able to be 
performed in nmr tubes: accurately known quantities of lb and Id were separately 
placed in nmr tubes and to each was added a solution comprising 1.1 
stoichiometric equivalents of dimethyl sulfate dissolved in deuterated ethanol. 
Periodic acquisition delay experiments were initiated whereby lH.nmr spectra 
were recorded at preset time intervals. The duration of measurement was 
extended to 5 hours in compensation for the fact that the nmr experiments were 
carried out at 298K and not reflux temperature; the intensity of the dimethyl 
sulfate signal had fallen to ca. 5% of its original value by this stage. Analysis of 
the spectra using a constant integral scale enabled the calculation of the 
percentage of conversion of substrate and associated product ratios as a function 
of time. In both cases the ratios were observed to remain constant over the course 
of the experiments. The ratios obtained for the methylation of lb after few percent 
conversion (8-17%) were slightly higher than subsequent measurements but this 
can be rationalised by the fact that for the scale used, the degree of inaccuracy 
inherent in the integral ratios is largest for signals just emerging from the 
baseline. A conventional experiment on the same substrate confirmed this : 
ratios obtained after 16% and 58% conversion were (lib : Illb) 1 : 11.8 and 1: 11.6 
respectively. 
3.2.2 Isomer Ratio Determination and Verification of Structures 
As briefly described in the previous section, upon workup of the alkylation 
reactions, the unpurified product mixtures were analysed by lH nmr. In each case 
the spectrum of these mixtures exhibited paired resonances for the N-alkyl 
groups, the ring proton(s) (H-5 and/ or H-2) and for the substituents where 
appropriate. To determine isomer ratios, integrations of the paired signals (of II 
and III or V and VI) were obtained by the nmr software and compared. To 
improve the accuracy of the integral ratios, the paired resonances were 
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these determinations were invariably those corresponding to N-alkyl (N-Cfu, N-
CfuCH3, N-CfuPh) resonances since these typically displayed better lineshape 
and narrower linewidths; ring proton resonances, particularly those of 1-alkyl-5-
substituted imidazoles were often observed to possess linewidths of the order of 
20-30 Hz. For the methylation series, the ratios quoted in sections 3.3.2 and 3.3.3 
are the mean of at least two reactions while those quoted for ethylation (diethyl 
sulfate) and benzylation (benzyl chloride) reactions generally result from single 
experiments. The methylation ratios obtained through utilisation of standard 
basic and neutral reaction conditions are estimated to be reproducible to within 
±10%. Those ratios exceeding 15: 1 in favour one or other of the reaction 
products should be considered less reliable due to the increased inaccuracy of 
integration ratios derived from low threshold signals. 
· G.l.c. has also been used to define isomer ratios quantitatively. The ratios of N-
methylation of unsymmetrical pyrazoles were determined earlier in this 
laboratory using both nmr and g.l.c. analysis 134; generally good agreement was 
observed between the two analytical methods. For g.1.c. to be effective as such a 
tool, resolution and peak shape must be optimal. To achieve maximum 
resolution and uniformity of peak shape it is essential to utilise a liquid phase 
compatible with the chemical properties of the components of the sample 
mixtures. Previous work by Begg 350 and Lim 351 demonstrated the liquid phase 
of choice, for resolving mixtures of 1-substituted imidazoles and pyrazoles, to be a 
5-12% coating of OV-17. Though outside the intended limits of this investigation, 
a cursory attempt was made to compare nmr and g.l.c derived alkylation ratios. 
The unavailability of a pre-packed OV-17, or closely related column, led to the 
trial use of the widely used SE-30 silicone liquid phase. However, the SE-30 
column, installed in a Varian Gas Chromatograph Model 3400 equipped with a 
flame ionisation detector, was found to be unsatisfactory as a separation medium 
irrespective of isothermal or temperature programmed (PTGC) operation. 
Resolution of the alkylation products for a number of reaction mixtures was 
poor, caused mainly by excessive tailing. Contrary to a report by Dou and Lynch 
352, 1-methyl-4- (Ilj) and 1-methyl-5-phenylimidazole (Illj) (and the 
corresponding ethylated products) were resolved using this liquid phase under 
the operating conditions chosen : nitrogen carrier flow rate was ca. 20 cm3 min-1 
through a 0.53mm x 12m column; detector and injector temperatures were 250 
and 200°C respectively; PTGC used initial and final column temperature settings 
of 60 and 250°C and an increment of 20°C min-1; sample concentrations were ca. 
10-20 mg cm-3 (in dry THF) and an injection volume of 0.4-0.7µ1 was used. 
Retention times of 1.02 and 0.91, relative to hexadecane (C16), were observed for 










considerable variation from one sample injection to another, and consequently 
comparative g.l.c analysis was abandoned. 
The structures for the isomeric pairs, 11/111 and V /VI, produced in the 
methylation series were elucidated by various means including nmr spectroscopy 
and alternative synthesis. Existing physical data was also of considerable use in 
the determination of product identity. The methylation products were 
characterised by microanalysis, lH and 13C nmr, while ethylation and benzylation 
products were characterised only by lH nmr and were assigned for the most part 
on the basis of lH nmr comparison with the corresponding N-methyl isomers. 
The identities of the N-methyl products, 11/111 and V /VI (R = CH3) were 
determined as outlined below. 
The difficulties encountered when attempting to differentiate unequivocally 
isomeric 1,4- and 1,5-disubstituted imidazoles are well known. Literature 
assignments of isomer structure have used alternative synthesis, conversion to 
known compounds, spectroscopic evidence, analogy to similar reactions and 
steric arguments. Matthews and Rapoport have explored the generality of isomer 
differentiation on the basis of physical characteristics 353. Infrared and mass 
spectroscopy were found to be inadequate, while ultraviolet spectroscopy 
appeared to hold a somewhat limited diagnostic value for those isomer pairs 
bearing a conjugating substituent. However, no absolute difference was 
observable which would allow the identification of a single compound. Chemical 
shifts were examined for a series of isomer pairs, and although several 
generalisations could be made, nothing definitive was established. One such 
generalisation pertained to the relative chemical shifts of the ring protons : it was 
noted that the H-2 and H-5 resonances of 1,4-disubstituted imidazoles appeared 
slightly upfield of the isomeric H-2 and H-4 resonances. 
. One spectroscopic characteristic did emerge from the study 353 with absolute 
consistency throughout the range of substrates. tested. Long-range (4 bond) 
coupling between H-2 and H-4 or -5 was observed, and the magnitude of this 
coupling was indicative of the form of disubstitution. Coupling between H-2 and 
H-5 and between H-2 and H-4 invariably produced coupling constants (referred to 
in the paper as "cross-ring" coupling constants) in the ranges, JH(S)H(2) = 1.1-1.5 
Hz and JH(4)H(2) = 0.9-1.0 Hz respectively. The spectral data obtained in the 
present study for the isomeric alkylation products are consistent with this 
assertion. However, the resolution of the lH nmr spectra was generally 
insufficient to observe couplings of less than 1.0 Hz and hence H-2/H-4 coupling 
was seen in only one instance (for 1-ethyl-5-methylimidazole, JH(4)H(2) = 1.0 Hz). 
Line broadening of the H-2 and H-4 resonances, as mentioned above, was 
common amongst the 1,5-disubstituted species. Coupling constants in the range 











































































resolution permitted. For the majority of cases where such coupling was evident, 
only the H-5 resonances were distinguishable as a one proton doublet; H-2 
splitting information was obscured due to line broadening. Interestingly, while J 
values for the 1-methyl-4- and 1-ethyl-4-substituted products were similar, the 
corresponding values for 1-benzylated compounds were noticeably smaller. 
Cross-ring coupling constants could not therefore be used to assign structure 
unequivocally, and were useful only as confirmatory evidence. 
In conjunction with published physical data on the methylation products of Ia, 
lb, le, Id and In, NOE difference spectra of the isomeric pairs were found 
adequate for unambiguous assignment. Homonuclear NOE difference 
spectroscopy has recently been applied to the problem of isomer differentiation in 
N-1 substituted azoles. In particular, Holzer has successfully discriminated 
between H-3 and H-5 resonances of 1-substituted-1,2,4-triazoles 354 and -pyrazoles 
355, H-4 and H-5 resonances of 1-substituted-1,2,3-triazoles 356, and between 1- and 
2-substituted tetrazoles 357 (Scheme 70). 
These investigations involved the selective irradiation of N-alkyl resonances 
and the observation of an enhancement of adjacent ring proton signals by means 
of spectral difference. This mode of spectroscopy indicates the presence of nuclear 
relaxation by a through-space dipolar interaction between proximate nuclei. Thus 
for the pyrazoles and triazoles depicted in the scheme, the H-5 resonance was 
predicted and found to show enhancement upon irradiation of N-alkyl protons 
due to an NOE. 
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While imidazoles were excluded from this collective study, the principle 
applied to isomer differentiation is equally applicable to the compounds presently 
under discussion. Clearly irradiation of N-alkyl resonances should result in 
observable enhancement of adjacent proton signals; enhancement of H-5 and H-2 
signals is expected for 1,4-disubstituted imidazoles (II), while enhancement of H-2 
only is predicted for the isomeric 1,5-disubstituted species (III) (Scheme 71). 
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Table 8. lH nmr data (8, ppm, CDCl3) and NOE data for alkylation products of Ia, lb, le, Id and In .. 
Compound Rl R2 R4 R5 Irrad. Reson. NOE on A 
Ilb 3.68 (CH3) 7.32 - 6.87 Cfu H-2 (4.4%), H-5 (6.5%) 
5.05 (CfuPh) 7.40 - 6.84 Cfu H-2 (0.6%), H-5 (1.8%), Ph 
Ila 3.66 (CH3) 7.27 - 6.79 Clli H-2 (4.0%), H-5 (6.0%) 
Ile 3.69 (CH3) 7.33 - 6.97 Cfu H-2 (3.6%), H-5 (6.4%) 
Ild 3.61 (CH3) 7.30 2.20 6.59 Cfu H-2 (3.4%), H-5 (6.5%) 
5.05 (CfuPh) 7.47 2.22 6.61 Cfu H-2 (0.5%), H-5 (2.4%), Ph 
Iln 3.49 (CH3) 2.32 2.14 6.48 Clli 2-CH3 (1.0%), H-5 (4.6%) 
IIIb 3.62 (CH3) 7.53 7.00 - Cfu B 
5.11 (CfuPh) 7.57 7.07 - Cfu H-2 (0.4%), Ph 
Illa 3.59 (CH3) 7.45 6.92 - Clli B 
IIIc 3.61 (CH3) 7.63 7.13 - Cfu B 
IIId 3.53 (CH3) 7.36 6.76 2.18 Cfu 5-Cfu (0.7%) 
5.07 (CfuPh) 7.51 6.86 2.12 Cfu Ph 
Illn 3.41 (CH3) 2.34 6.62 2.16 Cfu 2-CH3 (1.3%), 4-CH3 (1.4%) 
A NOE ~.nhancement determined by NOE difference spectroscopy. Fi.gures in parentheses represent the enhancement as a percentage of the 
conventional 1 H signal. 
B No signal enhancement was observed. 
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The data obtained from NOE difference experiments carried out on the N-
methyl products (and N-benzyl in several cases) of substrates Ia-d and In are 
presented in Table 8 together with lH chemical shifts. Several representative 
conventional and difference spectra are shown in Figure 3. Quite clearly NOE 
difference spectroscopy is a very simple (lD lH experiment) and effective method 
for determining isomer structure. 1-Alkyl-4-substituted imidazoles, Ila-d and 1-
alkyl-2,4-dimethylimidazole, Iln, all displayed positive NOE enhancement of the 
proximate ring proton resonance(s) as predicted when the N-alkyl (methyl or 
methylene) singlets were irradiated. These enhancements were uniformly small, 
varying in the ranges 2.4-6.5% and 0.5-4.4% for H-5 and H-2 resonances 
respectively. While the intensities of the observed enhancements cannot be 
directly compared between compounds, a smaller enhancement was consistently 
noted for H-2 resonances than with H-5 in each case. In all but one case, the 
regioisomeric 1-alkyl-5-substituted imidazoles, Illa-d, failed to show the expected 
NOE for the neighbouring H-2 proton; a small enhancement (0.4%) was observed 
for the H-2 resonance of 1-benzyl-5-bromoimiq.azole (Illb, R=benzyl) upon 
irradiation of the benzyl methylene. This could be attributed to the typically broad 
ring proton signals observed for these isomers. As one might also anticipate, 
observed NOE's extended to adjacent protic substituents; the methyl group(s) 
close in space to the site of irradiation displayed enhanced resonances in the 
spectra of Iln, Hin, and Hid. 
The assignment of structure to ethyl and undetermined benzyl derivatives of 
Ia-d,n was accomplished by direct comparison of their lH nmr data, particularly 
of the ring protons, with those of the appropriate methyl compounds. True to the 
generalisation proffered by Matthews and Rapoport, the ring proton chemical 
shifts of the 1,4-disubstituted compounds, II, were invariably located upfield of 
their isomeric relatives in the 1,5 disubstituted species, III. 
It is apparent upon examination of the lH nmr data given in Table 8 that 
structural assignment of the N-methyl derivatives by chemical shift alone is 
inconclusive. In the halogeno series, Ia-c, one might expect on the basis of a 
substituent negative inductive effect, that the N-methyl protons of 1-methyl-5-
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NOE difference spectra for (a) 4-bromo-1-methyl-, (b) 5-bromo-1-methyl-, and (c) 1-benzyl-4-bromo-
imidazole in CDCl3. 











halogenoimidazoles, Illa-c, would be deshielded with respect to the N-methyl 
protons of Ila-c. In fact the converse is observed probably indicating that 
resonance donation offsets inductive withdrawal in the 1-alkyl-5-
halogenoimidazoles, Illa-c. 
The N-methyl derivatives of le exhibited nearly identical polarities, producing 
overlapping separation bands regardless of the chromatographic support and 
solvent system used. In conjunction with the expected products of methylation, 
Ile and Ille, alkylation by-products 4- and 5-methoxymethyl-1-methylimidazole 
were produced in comparable yield. These isomers too proved inseparable. To 
determine structural identity, methyl 1-methylimidazole-5-carboxylate, Illg (see 
belowt was reduced by LAH essentially according to the procedure described by 
Jones and McLaughlin 358 (Scheme 72) and the crude product, 5-hydroxymethyl-
1-methylimidazole (IIIet was used to spike a CDCl3 solution of Ile and Ille. 
Chemical shift enhancement of one set of the paired resonances allowed isomer 
differ en tia tion. 
MeOOC R 
LiAIH4 (1.3 eq), Et20 
HOH2C ,R 
ti t~ 
Reflux 2 hr N N 
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Scheme 72. 
Methyl 1-methylimidazole-4- and -5-carboxylate, Ilg and Illg, were originally 
synthesised by Hubball and Pyman by heating methyl imidazole-4-carboxylate, lg, 
with neat dimethyl sulfate 359. The authors assigned the structure of the isomer 
Illg by the comparison of its hydrolysis product with the acid formed by the 
oxidation of 1-methylimidazole-5-carbaldehyde, Ill( which in turn was identified 
by its reduction to 1,5-dimethylimidazole, Illd. Since then more definitive 
assignments have made. Jones synthesised IIIg by cyclocondensation of sodium 
enolate salts of N-alkyl-N-formyl-C-formylglycine ethyl esters and subsequent 
desulfurisation (see also section 3.1) 289. In a related paper these authors 
contrived the conversion of Illg into the corresponding 
carboxybenzenesulfonhydrazide and thence into Illf by base decomposition 358. 
Matthews and Rapoport prepared the 1A-disubstituted regioisomer, Ilg, by ring 
synthesis of 1-methyl-2-imidazoline-4-carboxylate and subsequent oxidation 344 
(see also section 3.1). Again simple derivatisation (LAH reduction to Ile followed 
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were prepared by selective monodecarboxylation of 1-methylimidazole-4,5-
dicarboxylic acid and subsequent esterification, and characterised by 1H and 13C 
nmr 360; heating in acetic anhydride produced 1-methylimidazole-5-carboxylic 
acid only while heating in N,N-dimethylacetamide gave only its isomer. The 
physical data, including 1H cross ring coupling constants for Ilg and IIIg, reported 
in these publications have allowed the unequivocal assignment of structure to 
Ilg, IIIg, llf, and III£ in this work by simple comparison. 
1-Methylimidazole-4- and-5-carboxamide, llh and Illh, are known. Russian 
workers recently examined the regiochemistry of N-alkylation of imidazole-4-
carboxamide, Ih, and a number of N'-substituted derivatives (4-CONHR, R=H, 
CH3, C6Hs) 91. Alkylations by dimethyl sulfate and methyl, ethyl and propyl 
iodides in basic medium were reported to yield only 1-alkylimidazole-4-
carboxamides. The physical data of Ilh thus obtained is consistent with the major 
product isolated in this study. Isomeric IIIh was produced in an insufficient 
quantity to allow full characterisation; however, a crude melting point was 
similar to a literature value obtained for IIIh synthesised by diazotisation and 
hydration of 4-amino-1-methylimidazole-5-carbonitrile 361 . Chemical shifts are 
also reconcilable. Following the same trend exhibited by isomeric pairs Ilf/Illf and 
Ilg/Illg, the N-methyl protons of Uh are ca. 0.2 ppm upfield of those in IIIh which 
are adjacent to the site of carboxy substitution. 
The isomeric N-methyl nitroimidazoles, Iii and 11Ii, are readily differentiated. 
Due to their clinical importance, the literature is replete with spectral studies of 
these and related nitroimidazoles (see section 1.1). Two such, in particular, 
examine the usefulness of 13C nmr in structure assignment 362, 363. Nagarajan 
and co-workers found that isomeric nitroimidazoles could be differentiated on 
the basis of the relative chemical shifts of C-4 in 1-substituted-5-nitro- (type III) 
and C-5 in 1-substituted-4-nitro-imidazoles (type II). For the entire series of 
mononitroimidazoles tested (ca. 25 isomeric pairs), the chemical shifts of C-4 in 
series III fell within a narrow range of 130-133 ppm, and those of C-5 in series II 
within the range 120-124 ppm. Further, additional diagnostic information was 
found in the observation of extra multiplicity (1 H coupled spectra) of C-5 signals 
in series II due to three-bond coupling with N-alkyl protons; such multiplicity is 
absent for C-4 in series III. While lH chemical shifts on their own could not 
elucidate the structure of a single compound, solvent induced chemical shift 
differences, ~8 (DMS0-d6 - CDCb) were considered an aid: ~8 values for H-5 in 
series II are generally above 0.45 ppm, while values for H-4 in series III are 
typically less than 0.3 ppm. 
Bearing the above in the mind, Iii and 11Ii were identified from their 13C nmr 
spectra: C-5 of Iii and C-4 of 11Ii exhibited chemical shifts at 120.4 ppm (with extra 




















































The isomeric pairs Ilj /Illj and Ilm/Illm were synthesised by Pyman et al. as far 
back as 1924 364. Such syntheses involved methylation in neat dimethyl sulfate 
and also in the case of Ilm/Illm, by nitration of Ilj/Illj. Structural assignment was 
loosely based on identification of derivatised products. More recently, van Leusen 
and co-workers devised a preparation (albeit often poor yielding) of 1,5-dialkyl-, -
diaryl-, and 1-alkyl-5-aryl-imidazoles involving the base induced cycloaddition of 
the synthon, tosylmethyl isocyanide (TosMIC), to appropriately substituted 
aldimines (Scheme 73) 365. In this way Illj and Illm were synthesised in 10 and 
14% yields respectively; melting point data obtained for these compounds 
matched those reported by Hazeldine and Pyman 364. lH 366 and Be 367 nmr 
studies have been carried out on various phenyl substituted azoles. 
Generalisations arising from these studies include (i) for reasons which include 
ring anisotropy and interannular electron delocalisation, an upfield shift of meta 
I para, and a downfield shift of ortho phenyl protons is observed when the site of 
phenyl substitution is "( to an N-methyl group (cf. the phenyl protons appear as a 
singlet (or nearly so) when phenyl substitution is ~ to an N-methyl group) 366, 
and (ii) in C-phenylazoles where interannular conjugation is extensive,13C 
chemical shifts of ortho carbons are upfield relative to those in C-phenylazoles 
where conjugation is impeded 367. The lack or diminution of interannular 
conjugation and anisotropic effects in phenylimidazoles of type III has been 
ascribed to a steric induced loss of coplanarity between the rings 366. Consistent 
with these observations, the major isomer produced in this study by both the 
basic and neutral methylation of Ij, exhibits an upfield shift of its meta and para 
protons and a downfield shift of its ortho protons. To allow full characterisation 
of the minor isomer, more material was synthesised by an alternative method 
involving successively, (modified) Schotten-Baumann benzoylation, 
quaternisation and debenzoylation (Scheme 74, X = H) as described by Olofson 
and Kendall 368 (section 3.3.2.3). The N-benzoyl product was isolated and 
characterised; its lH nmr spectrum displayed similarly deshielded ortho phenyl 
protons and is assigned to the thermodynamically more stable 1-acyl-4-
substituted configuration. Quaternisation was achieved in good yield by the 
action of the powerful methylating agent, trimethyloxonium tetrafluoroborate, 
and subsequent base hydrolysis gave a product consistent with the minor N-
methyl isomer. In accordance with a reduced ring interaction, the phenyl protons 
of this product (assigned the structure Illj) appeared in the lH spectrum as a 
multiplet spanning only 0.1 ppm. Comparison of the lH and 13C spectra of the 
major isomers, obtained from the methylations of Ik-m, with those of the minor 
isomers, prepared analogously to Illj above (Scheme 74, X=CH30, Cl, N02), 
revealed trends in agreement with the above generalisations : the ortho phenyl 
protons and carbons of the major isomers, Ilk-m, were deshielded (0.2-0.4 ppm) 
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and shielded (3.4-4.0 ppm) respectively with respect to their counterparts in Illk-
m. The meta protons of Ilk-m were consistently shielded (< 0.1 ppm) with respect 
to the meta protons of lllk-m. Compounds Illk and III 1 have not been reported 
previously. 
4-Iodo-1-methyl-5-nitro- (Via) and 5-iodo-1-methyl-4-nitroimidazole (Va) were 
originally prepared and incorrectly assigned as 2-iodo-1-methyl-5-nitro- and 2-
iodo-1-methyl-4-nitro-imidazole respectively by Hoffer and co-workers 280. These 
preparations involved free base (Via) and basic (Va) methylations of 5-iodo-4-
nitroimidazole (IVa) with dimethyl sulfate. The error in the structural 
assignment of these iodonitroimidazoles, determined and corrected by Dickens et 
al. 268, stemmed from mistakenly believing that diiodination of imidazole 
occurred at the 2,4- rather than 4,5-positions. 
Hazeldine and Pyman similarly prepared the N-methyl derivative Vlb of 5-
bromo-4-nitroimidazole (IVb), as the only product of methylation of the latter in 
hot neat dimethyl sulfate 364. Isomeric 5-Bromo-1-methyl-4-nitroimidazole (Vb) 
was synthesised analogously to Va (above) by Dickens and co-workers 268. 
The nmr spectral properties of these nitroimidazole derivatives are closely 
related to those exhibited by 1-substituted 4- and 5-nitroimidazoles and discussed 
above for Iii and llli. lH chemical shifts of the N-methyl protons in Via and Vlb 
are similarly deshielded (ca. 0.2 ppm) with respect to those in Va and Vb, thereby 
consistent with a proximate nitro substituent. Whereas the 13C chemical shifts of 
C-5 in Va,b and C-4 in Vla,b do not fall within the ranges stipulated for the 
corresponding carbons in 1-substituted 4- and 5-nitroimidazoles (C-5 120-124 
ppm; C-4 130-133 ppm 362), the respective separations of C-5 and C-4 for the 
isomeric pairs Va/Via and Vb /Vlb are consistent with their analogues (ca. 11 
ppm cf. 8-13 ppm 362). 
Compounds V c,e,f were originally reported by Bennett and Baker as 
intermediates in the preparation of 4-amino-5-imidazole sulfones 297. 5-Chloro-1-
methyl-4-nitroimidazole was converted into 5-alkylthio-1-methyl-4-
nitroimidazoles, either directly, by reaction with a variety of mercaptans in 
ammoniacal ethanol, or via alkylation of the intermediate ammonium salt of 5-
mercapto-1-methyl-4-nitroimidazole (see also section 2.2). The corresponding 
sulfones were generated from the sulfides by hydrogen peroxide oxidation in 
glacial acetic acid. In each of the methylations of IV c and IVe, a single isomer was 
isolated irrespective of the reaction conditions. To verify their structure, the 
above methodology was applied to 5-iodo-1-methyl-4-nitroimidazole, Va, (s. 
3.3.2.3) to unambiguously generate Ve and Ve (Scheme 75). The methylation 
products were not consistent with these compounds and were accordingly 
assigned the structures Vic and Vie, in agreement with published physical data 
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nucleophilic displacement of an iodo group by methylthiolate. However, when 
Va was reacted with freshly prepared sodium methylthiolate 369 in ethanol, the 
major product isolated (64%) was not Ve as anticipated, but gave spectral data 
consistent with 1-methyl-4-nitroimidazole, Iii (Scheme 76). 
0 2N 
NaSCH3 
0 2N 0 2N 
IJc)\ CH3S):)\ /[)\ + N EtOH N 
I I I 
CHs CH3 CH3 
Va ( <5%) Iii ( 64%) 
Scheme 76. 
As observed in the formation of the ammonium salt of 5-mercapto-4-
nitroimidazole by gaseous hydrogen sulfide action on IVa (section 2.2), a 
reductive pathway (favourable in this instance) appears to operate in competition 
with nucleophilic dispacement; only a very small amount of the desired product, 
Ve, was detected (<5%). Carrying out the reaction in dry acetone served to reduce 
the amount of reduction product (31 %) and concomitantly to increase the 
proportion of Ve produced (ca. 9%); due to the hygroscopic nature of sodium 
methylthiolate, some water may still have been present in the reaction mixture. 
The structures of the isomer pair Vf/Vlf were distinguished on the basis of the 
physical data reported by Bennett (Vf) 297 and Kulkarni (Vf and Vlf) 295• 
Previously unreported 1-methyl-5-methylsulfinyl-4-nitroimidazole, Vd, was 
synthesised from V c for comparison with the single methylation product 
obtained under ethanolic conditions. V c was oxidised to the sulfoxide by brief 
treatment with half an equivalent of MMPP in glacial acetic acid (Scheme 75). 
Spectral comparison revealed that the products were in fact isomeric; the product 
of free base methylation was thereby assigned the structure Vld. Insufficient 
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3.2.3 Isomer Ratios 
3.2.3.1 "Basic" Alkylation 
Substituent Effects 
The SE2cB mechanism of N-alkylation of imidazoles under alkaline 
conditions (pH> pKa) involves nucleophilic attack of the ambident deprotonated 
substrate on the alkylating agent in a second order process 89, 93, 94 (sections 1.2.1 
and 1.2.2.1). Other factors being approximately equal across the alkylation series 
(alkylating agent, medium, quaternisation (s. 3.2.1)), the orientation of N-
alkylation in basic medium is defined by substituent effect alone and the 
interpretation of isomer ratios is uncomplicated by consideration.of in situ 
prototropic equilibria. 
However, in a general sense the natures of these equilibria serve to 
quantitatively aid the analysis of observed product orientation and enable coarse 
prediction of such. This is reasonab_le since the relative positions of tautomeric 
equilibria of substituted imidazole free bases are also substituent dependent; the 
tautomer ratio is a measure of the relative basicity of the nitrogen atoms and 
hence, to a large degree, of their relative nucleophilicity. Ridd and co-workers 
studied this relationship in some detail 89, 93, 94• Upon examination of relative 
rate data and product distribution for N-methylation of 4(5)-nitroimidazole (Ii) 
under SE2cB (aq NaOH) and 5E2' (formic acid)conditions (Figure 1, s. 1.2.2.1), rate 
coefficients were calculated for the annular nitrogens in each medium, 
demonstrating relationships to their previously determined relative basicities. In 
fact a linear free energy relationship, k oc K-a (a=0.3), was proposed where k and K 
represent the rate coefficient and the equilibrium constant for protonation (KBH+, 
N-methyl derivative) of the same nitrogen 93• Further, where O<a<l, a 
mechanistic transition from 5E2cB to 5E2' is predicted to change the main 
product of substitution. The application of this mechanistic and tautomeric 
analysis to a very limited number of literature results for the N-methylation of 
unsymmetrical imidazoles and benzimidazoles was successful only in explaining 
the general features of the observed isomer distributions 94• Inconsistencies were 
attributed to the approximations inherent in the relationship between 
nucleophilicity and basicity of the nitrogen atoms, the presence of steric factors, 
and the ambiguous methods of determining product ratios. 
Substituent effects, in this case on the relative nucleophilicities of the 
imidazole ring nitrogen atoms, are a composite of component field, inductive, 
mesomeric, steric and solvent effects. The complex interplay of all or some of 
these effects in any particular reaction system is thus exceedingly difficult to 
Table 9. Classical isomer ratios A formed on N-methylation of substituted 
imidazoles 
Imidazole Me2S04 Me2S04/0H- CH2N2 Ref 
4-Me 2.2 : 1 B 373 
4-Ph 4.8 1 2 : 1 364,374 
4-Ph-2-Me 2.7 : 1 375 
4-p-N02Ph 1 : 10.8 364 
4-Br 1 34 364 
4-Br-5-Me C 1 1.5 D 374 
4-N02 1 : 350 3 1E 1 : 45 364,374,376 
4-N02-5-Br F 364 
4-N02-2-Me 1 50 296 
4-N02-5-p-N02Ph G 364 
4-CN 2.9 1 373,377 
4-CHO H 359 
4-C02Me H 359 
I 
A 1,4-Isomer : 1,5-isomer; B Methylation with methyl iodide in benzene; C 5-Br-l,4-Me2 
only; D 4-Br-l,5-Me2 : 5-Br-1,4-Me2; E Ridd and co-workers obatined a ratio 8.1 : 1 using 
homogeneous conditions (10% EtOH) (ref 93); F 4-Br-1-Me-5-N02 only; G 1-Me-5-N02-4-
p-C6H1N02 only; H 1,5-Isomer only. 
Table 10. Isomer ratios formed on N-alkylation of 2,4(5)-disubstituted 















8.1 : 1 
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6.7 : 1 
3.5 : 1 
A Alkylation with RX under NaH/THF + DMF conditions : RT /2 h. 
B 1,2,4-Isomer : 1,2,5-isomer. 













interpret with certainty, since their relative contributions not only vary between 
reaction systems but also between substituents within these. 
Ridd proposed that inductive interactions (comprising both field and cr 
polarisation) were the dominant effects in N-substitution reactions of imidazoles, 
whereby the electrons directly involved in proton transfer and hence 
nucleophilic attack reside in cr orbitals, free from conjugative influence. Evidence 
for this conclusion was two-fold : (i) the substituent effect on the pKBH+ values of 
the N-methyl derivatives of the 5(6)-substituted benzimidazoles studied was 
negligible (indicating a tautomer ratio of near unity), consistent with the 
approximation that inductive effects are transmitted about equally to both the 
meta and para positions 370, and (ii) on the basis of resonance contributions, 
tautomer stability is predicted to favour the linearly conjugated 5-substituted 
tautomer (III, R=H) over the branched conjugated system of the 4-substituted 
tautomer (II, R=H). In fact the latter species was shown to predominate in a 
solution of 4(5)-phenylimidazole (Ij) 94. 







Consequently estimation of expected product orientation followed from 
consideration of substituent inductive power only. -I Substituents would render 
the remote nitrogen atom more basic and hence lead to a predominance of 
tautomer II (R=H) in solution. Thus N-alkylation via an 5E2cB mechanism 
should proceed with greatest facility at the remote nitrogen to form the 4-
substituted isomer (II) as the major product. Conversely, +I substituents should 
lead to a predominance of the 5-substituted isomer (III). 
A variety of literature alkylation data are presented in Tables 9-11. It is clear 
upon examination of the tabulated alkylation ratios that this rationale of 
inductive control is effective only in the broadest sense. Using literature cr1 values 
(listed in Table Al.l except where indicated), the imidazole substituents present 
in these literature alkylations can be ranked in approximate order of decreasing 
inductive power (withdrawal) as follows : 
N02 > CN 371 > Cl > Br °"' C2Fs 372 > I > C02Et > CHO > Ph> CH20H > Me 
Table 11. Isomer ratios A formed on N-alkylation of 2,4,5-trisubstituted 
imidazoles with 2-(2-triphenylmethyl)tetrazol-5-yl)-4'-
(bromomethyl)-1,1 '-biphenyl 378. 
Imidazole 5E2cB B 5E2'C 
R2 R4 RS 
Propyl H CH20H 1 6.1 1 : 9 
Propyl I CH20H 1.1 1 1 : 3.8 
Propyl I CHO 8.1 1 no reaction 
Propyl I CN 1.4 1 no reaction 
Propyl I CD2Et 1.6 : 1 1 : 3 
Propyl C2Fs CD2Et 99 1 no reaction 
Butyl Cl CH20H 1.5 : 1 1 : 2.7 
B1:!Y_l Cl CHO 13.3 1 no reaction 
A 1,5-Isomer: 1,4-isomer. 
B Alkylation with ArCH2Br under K2C03/DMF conditions: RT /1-3 days. 






















The classical ratios of N-methylation in aqueous sodium hydroxide (Table 9) 
show the predicted predominance of 1,4 substitution, and their magnitudes are 
superficially consistent with the degree of substituent electron withdrawal (N02 > 
CN > Ph). However, the differences between these ratios are too small to fully 
attribute control to inductive effects alone. A number of anomalies are also 
present in the ratios of N-alkyl-2,4,5-trisubstituted imidazoles obtained from 
alkylation with 2-[2-(triphenylmethyl)tetrazol-5-yl)-4'-(bromomethyl)-1,1'-
biphenyl 378 (Table 11). The ability of substituents to direct alkylation toward 1,4-
substituted isomers was shown to follow the order C2F5 ~ Cl > I > H which is 
reasonable, and secondly the order C2F5 > CH20H > CN > C02Et > CHO, which is 
irreconcilable with purely inductive control. Considering the probable severity of 
the steric constraints imposed by the large alkylating agent, these results 
(particularly the inordinately high regioselectivity observed for N-alkylation of 
ethyl 4-iodo-2-propylimidazole-5-carbaldehyde adjacent to the CHO group) are 
suggestive of an electronic exocyclic substituent (carbonyl or nitrile) interaction 
acting to direct substitution to the adjacent nitrogen atom. Such an effect, 
observed also in the alkylation reactions of pyrazoles 143 and 1,2,4-triazoles 153, 
may be analogous to the intramolecular lone-pair co-operativity proposed by 
Deady 144 where non-vicinal lone-pair effects enhance the nucleophilicity of the 
proximate nitrogen atom (s. 1.2.2.2), or it may perhaps involve weak 
complexation of the substituent with the orthogonal 1t system of the incoming 
electrophile. The significance of steric induced destabilisation of the transition 
state for substitution at the nitrogen atom adjacent to the substituent, is 
exemplified by the ratios obtained for the basic alkylations of various 2,4(5)-
disubstituted imidazoles in THF /DMF 261 (Table 10). Clearly, the ratios are 
dependent on both the size of the subsituent and the alkylating agent. Thus, steric 
effects augment -I and offset +I electronic effects. It is also interesting to note the 
effect of 2-substitution on regioselectivity. The presence of a symmetrically 
disposed substituent at C-2 might be expected to hinder alkylation equally at N-1 
and N-3 and hence reduce reactivity in the same ratio observed for alkylation of 
the 2-unsubstituted compound. However, methylation of 2-methyl-4-tert-
butylimidazole with methyl iodide (cf. 4-tert-butylimidazole) proceeded with 
greater facility than expected at N-1 (6.7: 1 cf. 3.5: 1 (1,2,4-: 1,2,5-)) indicating that 
steric effects are not additive in these instances. 
The Hammett linear free energy relationship, though initially proposed for 
simple aromatic systems, has been applied in somewhat modified form to azole 
systems for the purpose of quantifying substituent electronic effects 125. 
The influence of substituents on the acid-base properties of imidazoles and 
benzimidazoles has been examined 95, 96. Charton showed that pKBH+ values of 









substituted imidazoles, for ionisation in water at 25°C, gave better correlation 
with Gm and GI constants than with Gp constants 95. In all cases Gm constants gave 
best correlation; correlation coefficients, R, in the range 0.995 - 0.999 (n=3-6) were 
observed for the substituted imidazole sets. More recently, acid pKa values of 2-
methyl-, 2-phenyl, 4,5-dibromo-2-phenyl-, and 2,4,5-tribromoimidazole in DMSO 
at 25°C were found to be linearly related to the sum of the Gm constants for the 
ring stibstituents irrespective of their position 379: 
pKa = 18.9 - 9.5 I: Gm; R = 0.9991, n = 5. 
The generality of such a condition is questionable, however. The acid pKa values 
of 2-substituted benzimidazoles also exhibit a better correlation using Gm than 
with GI constants 380. 
Much effort has been expended trying to separate substituent electronic effects 
into their component polar (field and inductive) and mesomeric (resonance) 
contributions, and much controversy has arisen as a result. A dual parameter 
equation of the form 
& = 11.cr1 + O<fR 
is used to allow for a variation in the relative contributions of inductive and 
resonance effects from one reaction system to another 371, 381,382. ~p represents 
any property, including log (K/Ko) and log (k/k0 ), where a systematic variation 
with substituent is observed, GI and GR are the polar and mesomeric substituent 
constants, A and o are coefficients indicating the different contributions of each 
effect in the reaction system. A number of sets of polar (eg. GI 381, 383, G
1 384, 385, G* 
386, 387
1 
F & F' 388
1 
F 389) and resonance (eg. GoR 382, 390
1 
M & M' 388
1 
R 389) 
substituent constants have been determined, but considerable debate exists as to 
the purity (of separation) inherent in these constants. It is agreed however, that 
crm constants are a hybrid of polar and resonance effects such that meta 
substituents exert a total electronic effect described by 
ctr = A.GI + OCfR 
where A= 1 for a meta substituent and 6/A (e 391) represents the ratio of meta to 
para resonance effects which is dependent on the reaction series under 
X 
t1 k\m 0(Ill) 










[ II ] X · = concentration of 1,4-isomer, 
[ III ] X = concentration of 1,5-isomer and 
N 
m 
[I] X = concentration of substituted (X = substituent) imidazole anion, 
Then 
d[II]X - kX) [I]X ' 
dt - (II 
d [ III] X - kX [I] X 
dt - (ill) 
and 
d [ II ] X / dt X X 
d [ III ] X / dt = k(II) / k(III) = ( k*) X 
where 
k* = k(n) / k(III) = partial isomeric rate factor 
Thus 
[II] X 
[ III ]X = ( k* )X 
The Hammett (LFER) equation : 
log (K / Ko) = log (k / k0 ) = cr p 
Application to N-alkylation : 
log ( k* )X = cr* p * or log ( k* )X = A crr + o O"R 












investigation. It has been estimated by Taft and co-workers to lie in the range 0.1-
0.33 381 . Under the Swain-Lupton approach, the percentage contribution of 
resonance effects to CTm constants was calculated to be in the order of 22% 389. The 
presence of a resonance component of a meta substituent effect is considered the 
result of indirect inductive transmission of charge to the reaction site from ortho 
and para positions (relative to the reaction site) as a consequence of a direct 
resonance interaction of the meta substituent with these positions. 
Thus, while the above substituted imidazole and benzimidazole pK values are 
dominated by inductive substituent effects, conjugative interactions cannot be 
entirely ignored. Charton has applied a dual parameter equation of the above 
form to the pKBH+ values of 4- and 5-substituted 1-methylimidazoles and pKa 
values of 4(5)-substituted imidazoles 96. While the regression parameters were 
not significantly improved over those derived from single parameter (CTm) 
correlations (above, 95), the coefficient ratios E (8/'A,) obtained (0.36, 0.51 and 0.41 
respectively) indicate a substantial resonance contribution and an order of 
relative significance: 5-X-1-Me > 4(5)-X > 4-X-1-Me. It is apparent from these 
values that the resonance contribution (to the basicity of N-3) is more significant 
from the 5-position than the 4-position. 
For the purposes of this alkylation study, CTI values were chosen as an indicator 
of polar effects (Table Al.1), while CTxR values 382 were chosen as an indicator of 
resonance effects. "Normal" CTR values (CTOR) are predicted to be more suitable for 
application to the imidazole ring system (cf. CT+R, CT-R) on the assumption that 
imidazole mimics the pyridine system somewhat in that the nucleus is less 
polarisable than benzene and is hence more reluctant to accept electronic charge 
by resonance 370. It should also be noted that the CTR constants are calculated (CTp -
CTI) using the approximation that polar effects are equal at the meta and para 
positions. 
The Hammett relationship can be applied to imidazole substitution reactions 
by considering the product ratios as described in Figure 4. 
The alkylation data obtained for reaction under basic conditions is 
summarised in Table 12. Using the ratio data for the N-methylation of 4-
substituted (Table Al.1) and 4,5-disubstituted imidazoles (Table Al.3), single 
parameter correlations were attempted utilising CTI, CTp, and CTm substituent 
constants. The resultant Hammett plots (log ([ II ] / [ III ]) vs. CTx) for N-
methylation of 4-substituted imidazoles are shown in Figures A2.1-A2.3 
respectively, and those for N-methylation of 4,5-disubstituted imidazoles are 
shown in Figures A2.4-A2.5. 
It is immediately apparent from the scattering of points in these plots that 
electronic influences cannot quantitatively be separated from steric and other 
effects. This is understandable if one considers the difference in steric 
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A Ratios are II: III for substrates I, and V: VI for substrates IV. 
B NaOEt/EtOH conditions. 
C II isomer plus trace quantities of III. 
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requirements between the ionisation reactions considered above and the SN type 
N-alkylations of this study. However, from a qualitative perspective it appears 
that resonance electronic effects in general play a subsidiary role to those of polar 
(inductive and field) origin, in accordance with Ridd's proposal (above). Thus log 
([II] / [III]) appears to correlate best (though so poorly as to defeat a significant 
regression) with CTm or crr than with O'p substituent constants (Figures A2.1-A2.3). 
The methylation ratios of the 4-nitro-5-substituted imidazoles studied, appear to 
be less dependent on electronic interactions than those of the monosubstituted 
substrates; while correlation lines can be drawn with crr and O'm constants (Figures 
A2.4-A2.5), their slopes reflect an increase in 1,4-methylation (w.r. t. N02) with 
increasing crr (of the 5-substituent), contrary to expectation. 
That the importance of a resonance contribution cannot be ignored is 
particularly evident from the behaviour of the highly conjugated para-
substituted phenylimidazoles (Figure A2.2 and expanded in Figure A2.6). 
Contrary to Ridd's argument that conjugative effects could be ignored on the 
grounds that 1t electron displacement is transmitted approximately equally to the 
two nitrogen atoms 94, methylation ratios for the series Ij-m are observed to 
correlate excellently with the O'p constants of 4'-substituted phenyl substituents 
derived by Berliner and Liu (from the ionisation constants and alkaline ester 
hydrolyses of ethyl p-biphenylcarboxylates in 88.7% aqueous ethanol (25°C) 392) : 
[ II] 
log [ III] (j-m) = 0.85 + 1.70 O'p(aryl) ; R2 = 0.990, n = 4 
A good correlation is also observed for the O'p constants of the para-substituents 
proper (Table Al.2, Figure A2.7) : 
[ II] 
log [ III] (j-m) = 0.84 + 0.52 O'p ; R2 = 0.988, n = 4 
Clearly, the degree of resonance transmission to/from the 4- and 5-positions is 
unequal. 
Such correlations are explicable if one considers that across this series other 
variables, including solvent dependent and particularly steric factors, are 
reasonably constant. Quite clearly, the p values (1.70 and 0.52) indicate that SE2cB 
methylation is facilitated at the remote nitrogen atom, N-1 (cf. N-3t by electron 







sensitivity of the regioselectivity to substituent electronic effects is relatively 
small compared to ionisation reactions; p values of -10.5, -7.27 and -6.86 were 
obtained from pKBH+ vs. O'm correlations for 1-methyl-4- and 1-methyl-5-
substituted imidazoles 95, and a pKa vs. O'm correlation for 4-substituted 
imidazoles respectively (the latter p value was obtained from a Hammett plot 
using the acid pKa values tabulated in ref. 96 (Figure A2.8). Further, the solvent 
in which these methylations were performed differed necessarily from the 
standard aqueous medium because of solubility problems, and the calculated p 
values may in fact be inflated somewhat (cf. reaction in aqueous medium) as a 
consequence of diminished charge stabilisation by solvation in ethanol. 
Analogous findings have been reported by Butler and co-workers in their 
investigation of substituent effects on the N-methylation of para-substituted 5-
aryltetrazole anions in aqueous ethanol 200. A good correlation of log (k2/k1) with 
O'p constants was found for para-substituents (R2 = 0.981, n=7, p = 0.32) requiring 
cr0 p for the MeO and cr-p for the N02 substituent, where k2/k1 is the ratio of the 
rate constants (and is hence equal to the product ratio) for the formation of the N-
2- (k2) and N-1-methyl (k1) isomers. It is apparent that the ratio sensitivity of 
tetrazolate methylations to electronic effects is slightly less than that observed for 
the imidazolate reactions. This difference is probably largely due to the use of 
dissimilar reaction conditions; charge stabilisation by salvation is greater in 
aqueous ethanol. In this case it also appears that extent of resonance withdrawal 
(ie. the difference in resonance withdrawal (from the azole nucleus) between the 
reactant and transition states) is greater for the tetrazole series. The reason for this 
behaviour is uncertain. The implication is that the degree of through 
conjugation (withdrawal) present in the reactant and transition states, is 
significantly different. Perhaps this is a consequence of the greater intrinsic 
stability of the tetrazole anion, evidenced by the pronounced increase in acidity 
observed upon moving from 4-phenylimidazole to 5-phenyltetrazole (pKa = 
13.42 and 4.38 393 respectively). Reliance on substituent electron-withdrawal to 
stabilise the azole anion in solution is therefore expected to be substantially less 
in the case of tetrazole. 
In an attempt to obtain a better correlation of product ratios with electronic 
substituent constants, the ratio data were subjected to a dual parameter equation 
with the added hope of determining the relative contribution of resonance and 
polar effects. However, correlation of the type 
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using three different sets of resonance parameters (<JOR, <:rR, and o+R 382) served 
no better than the single parameter correlations to accurately define electronic 
control. 
In the furtherance of this goal, atomic charge density calculations were 
performed using two different programs: the semi-empirical MNDO method 
within the MOPAC (v. 6) 394 MO program, and the CHARGE3 program kindly 
lent to this laboratory by Abraham and co-workers 346, 395. While semi-empirical 
(CNDO) MO methods have been used to facilitate discussion on the 
regioselectivity of N-alkylation in 1,2,3-triazoles 175 and 5-substituted tetrazoles 
199, no similar studies pertaining to imidazole alkylation have been found in the 
literature. 
The substrates Ia-n and IVa-f, separately as both the anion and as the free base, 
were initially individually subjected to a conformational search and concurrent 
geometry optimization using Macromodel v. 2 software 396 (refer to keys to Tables 
A3.1-A3.2) to determine lowest energy (global minimum) conformations for the 
conjugate species. Due to shortcomings in the modelling software, the 
heteroaromatic anions were built as tautomeric analogues consisting of an sp2 
hybridised (pyridine-like) N-3 and a charged divalent N-1. The geometries of 
these minimised structures were saved as the appropriately formatted Z-matrix 
data files which were subsequently submitted to the MOP AC and CHARGE3 
programs for atomic charge density determination. The resultant charge 
information (including atomic charge, Pz charge and total electron density) is 
expressed in tabular form for the tautomeric anion analogues (Table A4.1) and 
free bases (Table A4.2) and illustrated pictorially in the atomic charge density 
diagrams displayed in Appendix 4. 
The atomic charge densities for the annular nitrogens of the 4-substituted and 
4,5-disubstituted imidazole anions are given in Tables Al.4 and Al.5 respectively 
and were determined by averaging the densities obtained for the corresponding 
nitrogen atoms in the 4- and 5-substituted anion analogues. Pi densities were 
similarly calculated using the Pz charges obtained from the electron density 
matrices generated by the MNDO program. On the basis of these (MNDO derived) 
values two new substituent parameters, crc and crpz were created for the anionic 
imidazole system, and were defined as the ratio of nitrogen atomic charge and Pz 
densities (N-1/N-3) respectively, minus a value of one to produce a scale similar 
to the Hammett derived substituent constants. Charge densitie_s produced by the 
CHARGE3 program were not amenable to such-manipulation due to an inherent 
deficiency in the program to account for aromatic charge delocalisation: 
molecular charge was by necessity localised on N-1 of the anion analogues 
(incorporation of charge handling into the basic methodology is restricted to the 







It is apparent from Table Al.4 that all such parameters obtained for the 
monosubstituted substrates are greater than or equal to zero. Thus according to 
the MNDO semi-empirical MO method, the net electronic effect of all the 
substituents under investigation in this study (including the methyl substituent) 
is a withdrawal of electron density from the proximate nitrogen atom. The crc 
values were correlated with various sets of Hammett constants to observe the 
nature of the electronic substituent effects. Figures A2.9 and A2.10 show that 
although correlation is poor, there is a significant resonance contribution to the 
overall atomic charges on the annular nitrogens. Moreover, a correlation exists 
between crc and the crpz parameters calculated from the ratio of Pz charges (R2 = 
0.874) (Figure A2.11), indicating that the (MO derived) overall charge is a linear 
function of atomic pi density ie. a function of resonance. 
However, these new parameters bring us no closer to quantifying the 
regioselectivity of N-methylation on the basis of electronic effects alone. 
Correlation of relative atomic charge with log ([II]/[ III]) is again so poor as to 
defeat analysis (Figures A2.12-A2.13). The validity of this MO method as an 
indicator of substituent effect is questionable, however, as evidenced by the 
correlations observed for the aryl substituted series, Ij-m, where steric (and other) 
effects are approximately constant (Figures A2.14-A2.15). While the correlations 
are excellent in themselves, the order of crc (crpz} values for the para-substituted 
phenyl substitutents is the reverse of that expected, ie. according to the MO 
method, the substituent effect is felt most strongly at the remote nitrogen, in 
direct contradiction with the product ratios. The expected trend is observed if the 
N-3 atomic charges are considered separately. 
Despite the fact that an empiricism cannot be established which relates 
regioselectivity to electronic substituent effect, the various substituent parameters 
discussed can be useful in qualitatively interpreting the isomer ratios obtained in 
the methylation reactions (Table 12). 
If the halogeno substituted substrates, Ia-c, are treated in isolation, it is 
apparent from Figure A2.16 that correlations can be effectively found with cr1 
(best), crp constants and the crc parameter, in spite of the predicted disparity in 
steric effects across the halogen series (Table Al.6). In accordance with Ridd's 
assertion of inductive direction, methylation is favoured at the least deactivated 
(ie. remote) nitrogen, giving rise to a predominance of isomers IIa-c in the 
reaction mixture. It is well known that halogens attached to b1:nzene systems 
exert a -I, +M effect where inductive withdrawal outweighs resonance donation 
(exemplified by crr > crp), and yet the MNDO derived atomic charges reflect the 
reverse trend as shown by the negative slope in the log ([II]/[ III]) vs. crc 
correlation (Figure A2.16). The validity of the crc parameters is again called into 
question. Whether this is a true depiction of charge distribution or perhaps a 
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consequence of inadequate parameterisation and/ or a deficiency in the anion 
analogue structure approximation is uncertain; CHARGE3 (N-3) atomic charges, 
derived from parametised atomic electronegativities and polarisabilities, display 
the expected trend and hence give weight to the latter explanations. 
While the methylation ratio obtained for the 4-nitroimidazole anion,li, (8.6 : 1 
cf. 8.1 :.1 93) is very much in favour of the 1,4-isomer (Iii) as predicted on the basis 
of the strong electron-withdrawing ability (-I, -M) of the nitro group (largest crc 
and Hammett values for the substituents examined), those obtained for 
substrates Id-hare not so easily rationalised in terms of electronic effects. 
Inductive direction would result in ratios progressively favouring 1,4-
substitution in the order 
CH3 < CH20H <<CHO= CONH2 < C02CH3, 
while the observed order was 
CHO< CH3 = CH20H < C02CH3 <<CONH2. 
Even considering the cumulative effect of carbonyl resonance withdrawal, this 
trend is inexplicable in terms of electronic control alone; with the exception of a 
depressed value for CONH2, the crc parameters parallel O'I constants and are thus 
similarly unsupportive of such control. 
It must be pointed out here that the ratios obtained for substrates le, lg and Ih 
are of questionable accuracy. Yields were so poor (<10%, and zero for le) that the 
reactions were repeated in ethanolic sodium ethoxide medium in order to raise 
them to a level comparable to those achieved by the remainder of the substrates, 
I. This had very limited beneficial effect, however, and in fact served to 
complicate ratio interpretation further in the cases of le and Ih by introducing 
competitive substituent side-reactions : methylation of Ih in NaOEt/EtOH 
medium produced the side-products of esterification (CONH2 ~ C02CH3), while 
le under the same conditions produced a small amount of isomeric N-
methylated methoxymethyl substituted imidazoles (Scheme 77). Thus, for the 
purposes of correlation and discussion, the methylation ratios _utilised for lg and 
Ih were those originally acquired under aqueous alkaline conditions. However, 
since le failed to react with dimethyl sulfate under these conditions, by necessity 
the reaction described above was used. The ratio 1.2 : 1 (Ile : Ille) is complicated by 
the co-production of methoxymethyl derivatives (Scheme 77) and is in fact 








methoxymethyl derivative, as intimated by the ratio (1 : 1.5; 1,4 : 1,5) of 
derivatives observed in the reaction mixture. There is no evidence for the dotted 
pathway drawn in Scheme 77; no trace of 4-methoxymethylimidazole was found 
in the recovered starting material. 
While the methylation ratios of the series of 4-para-substituted 
phenylimidazoles, Ij-m, have been shown above to reflect electronic control, this 
can no longer be said when they are taken in context with the entire substrate 
range. For example, the overall electronic effects of phenyl and substituted 
phenyl groups are in some cases almost an order of magnitude removed from 
the strong (withdrawing) effect exerted by the nitro substituent (cr constants, Table 
A1.1) and yet the range of their methylation ratios encompasses that of 4-
nitroimidazole, Ii. Clearly, steric and/ or medium effects are paramount in this 
series. 
Further evidence for the importance of steric effects in controlling 
regioselectivity lies in the comparison between methylation ratios obtained for 4-
methyl- (Id) and 2,4-dimethyl-imidazole (In). As previously noted above in the 
analysis of the alkylation of 2,4(5)-disubstituted imidazoles (Table 10), the 
addition of a symmetrically disposed (with respect to N-1 and N-3) substituent at 
C-2 results in a bias towards alkylation at the nitrogen remote from the 4-
substituent, ie. N-1 (1.2: 1 (Ild: Illd) cf. 1.4: 1 (Iln: Illn)). 
With regard to the 4,5-disubstituted substrat_es, two points worth noting upon 
examination of the atomic charges in Table A1.5 for the 4-nitro-5-substituted 
imidazoles (IVa-f) are (i) the relative ratios (N-l/N-3), and hence the substituent 
parameters, crc, appear to be approximately additive : 
crc (Ii) - crc (le).,. crc (IVa) (± 10%) 
crc (Ii) - crc (lb).,. crc (IVb) (± 2%) 
and (ii) the electronic effect of the nitro substituent is dominant in all of the 
substrates, IV, studied. These observations are consistent with the observed 
additivity of Hammett substituent constants in the absence of steric effects 398 and 
the preeminence of the nitro group as an (uncharged) electron-withdrawing 
substituent (exemplified by the magnitude of the Hammett cr (N02) constants 371) 
respectively. Thus, assuming electronic control of regioselectivity, the following 
orders of alkylation ratios (progressively favouring 1,4-substitution with respect 







S02CH3 < SOCH3 < Br < I < SPh < SCHJ ( crm, cri:) 
Br < S02CH3 < SPh < SCHJ < I < S0CH3 (crc ) 
Again, the observed order 
S02CH3 < SCH3 << SPh < Br = I 
is very different indeed. In fact, as previously intimated, the correlation of log ([ V 
]/[VI]) vs. cr1 shown in Figure A2.4 (excluding substrates IVd and IVe) describes 
the reverse trend. This, in conjunction with the observation that the ratios 
obtained for IVc and IVe are substantially less than one, indicates that steric 
and/ or other factors are dominant in this series. 
In order to get a better picture of substituent steric effects and their role in the 
control of regioselectivity of N-alkylation, a new steric parameter was devised, 
based upon the relative accessibility of the nucleophilic nitrogen atoms to the 
solvent and hence to the alkylating agent. Solvent accessible surface areas (SASA) 
(hydration surfaces) were calculated within Macromodel for each of the 
molecular conformations found for the 4-substituted and 5-nitro-4-substituted 
anion analogues (using the systematic Monte-Carlo style search method as 
described in the key to Table A3.2) using a standard water probe radius of 1.4 A. 
Conformational populations were calculated as a (Boltzmann) function of their 
relative potential energies and these populations then used to calculate the 
SASA's of N-1 and N-3 as a weighted average of the conformational SASA's (the 
raw conformational and SASA data is presented in Table A3.2. As a consequence 
both of the error implicit in the method of area calculation, and the fact that the 
quoted conformational energies are those determined for minimised unsolvated 
structures at OK, the resultant surface areas are only very approximate. However, 
if observed relatively, these SASA's should allow effective comparison of steric 
effects across the substituent range. Thus, a steric parameter, crs, was established, 
defined as the ratio of nitrogen SASA's: (N-1/N-3)-1 (Tables Al.6-Al.7); positive 
values hence reflect greater steric interference at N-3 while the opposite is true 
for negative values. Several other sets of steric parameters have been reported in 
the literature, most notably Taft's Es 386, 387 and Charton's u 39_9 parameters. The 
Es parameters were developed using the expression : 
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where Ecs is an electronic substituent constant and k/ko is the relative rate of acid-
catalysed hydrolysis for any substituent of an aliphatic ester reaction series. Taft 
assumed here that the susceptibility of an acid-catalysed reaction to polar effects 
was negligible (ie. p = 0) 386• Charton, on the other hand, was critical of this 
assumption and believed that Es was in fact a hybrid parameter with contributing 
electronic factors. Accordingly, he developed the u parameter which was derived 
from correlations between van der Waals radii and the rates of acid-catalysed 
esterifications and hydrolyses of aliphatic acids and esters : 
log kx = \jf Ux + h and Ux = rvx - rvH 
where rvx and rvH are the van der Waals radii of the X group and the hydrogen 
atom respectively 399. 
Notwithstanding the approximate nature of the crs parameters, the 
significance of these values as a measure of the relative (steric) accessibility of the 
imidazole alkylation sites is apparent upon correlation with adjusted Taft 
parameters, Es , (adjusted to set Es for hydrogen rather than methyl at zero) 
depicted in Figure A2.17. Interestingly, a poorer correlation was obtained with 
Charton's parameters, despite the similarity of approach (Figure A2.18). 
While the methylation ratios correlate poorly with crs steric parameters as 
expected (Figure A2.19), the latter are useful in explaining some of the gross 
anomalies apparent in the log ([II]/[ III ])vs. cr1 plot (Figure A2.1). The phenyl 
(and para-substituted phenyl) and carboxamide substituents exhihit the largest 
deviation from the trend predicted on the basis of inductive control; the 
correlation with cr1 is much better when these points are excluded from the data 
set as shown in Figure A2.20. The crs values calculated for these groups are the 
largest by far of all the substituents studied indicating substantial occlusion of the 
proximate nitrogen atom. For the aryl substrates, Ij-m, the minimum energy 
structures (depicted in Appendix 4) arrived at by the geometry optimisation 
procedures are those exhibiting ring coplanarity. Such conformations are 
considerably more sterically demanding than those bearing an orthogonally 
disposed aryl system, and the exaggerated preponderance of 1,4-substitution 
observed for these compounds (4.7-17: 1, llj-m: lllj-m) clearly _gives credence to 
the existence of ring coplanarity in aqueous solution at moderate temperatures. 
Further evidence for coplanarity in solution is seen in the isomer ratio 
dependence on interannular conjugation (discussed above). The carboxamide 
group is similarly predicted to be coplanar with the imidazole nucleus. The 








hydrogen bond term not included in Allinger's original force field 400. As a 
result, a (stabilising) intramolecular hydrogen-bonding interaction was theorised 
to occur between the neighbouring nitrogen atom (N-3) and an amide hydrogen 
(Table A3.2, and depicted in Appendix 4). Partial or complete hydrogen bond 
formation of this type would clearly place the transition state of the SN alkylation 
at N-3 under considerable steric constraint; such a feature is consistent with the 
methylation ratio obtained (6.5: 1, Ilh: IIIh). At the same time, one might expect 
the steric induced regioselectivity to be enhanced to a degree by the movement of 
electron density from N-3 to the substituent through the hydrogen bond (Scheme 
78); such movement would reduce the electron-donating capacity of N-3 and 
thereby direct alkylation to N-1. The behaviour of imidazole-4-carbaldehyde, If, is 
also anomalous by the fact that the isomer ratio recorded was smaller than 
expected on the basis of electronic effect (-1, -M). The comparatively small steric 
effects imposed by the aldehyde group (from crs comparison, Table Al.6) are not 
entirely able to rationalise the absence of regioselectivity in this case. It is likely 
that other factors are present which are directing alkylation to the proximate 
nitrogen. As previously discussed, Pierce and co-workers very recently observed 
identical behaviour in the alkylation of 2,4-disubstituted imidazole-5-
carbaldehydes with 2-[2-(triphenylmethyl)tetrazol-5-yl)-4'-(bromomethyl)-l,l'-
biphenyl 378 (Table 11). The subsequent proposal of an intramolecular lone-pair 
co-operative effect 144 directing alkylation to N-3, is corroborated by the present 
result: 






The order of methylation ratios described by the 4-nitro-5-substituted series, 
IV, begins to make sense when the crs parameters (Table Al.7) are viewed 
together. On steric grounds, the N-1 sites of the substrates bearing sulfur 
substituents are expected to be more hindered than those of the corresponding 
halogeno substrates and hence smaller ratios (V : VI) should result. While this is 
observed, the ordering within this group of compounds (IV c-f) is harder to 
define. The product mixture of 4-nitro-5-phenylthioimidazole, IV£, is predicted to 
contain more of the 1-methyl-5-nitro- isomer (Vlf) than that of 5-methylthio-4-
nitroimidazole, IVc (crs values of 0.700 and 0.583 respectively). However, 
experiments show a complete reversal of the expected trend (1.7: 1 (Vf: Vlf) and 
1: 30 (Ve: Vic)). Conformational analysis of IV£ produced a large number of 
A log ([II]/[ III]) = A crc + 8 crs + constant; n = 12, R2 = 58.0%, s = 0.29 
Std. Dev. t-ratio p 
Coe£., A 0.39 1.38 0.28 0.782 
Coef., 8 1.02 0.28 3.62 0.005 
Constant -0.04 0.26 -0.14 0.893 
B log ([II]/[ III]) = A crc + 8 Es + constant; n = 6, R2 = 81.9%, s = 0.19 
Std. Dev. t-ratio p 
Coe£., A 0.78 1.42 0.55 0.621 
Coef., 8 0.13 0.04 2.86 0.064 
Constant 0.37 0.16 2.33 0.102 
C log ([II]/[ III]) = Acri+ 8 crs + constant; n = 9, R2 = 84.4%, s = 0.16 
Std. Dev. t-ratio p 
Coe£., A 1.08 0.30 3.62 0.011 
Coef., 8 1.22 0.23 5.31 0.002 
Constant -0.37 0.16 -2.35 0.057 
D log ([II]/[ III]) = Acri+ 8 Es + constant; n = 6, R2 = 94.5%, s = 0.11 
Std. Dev. t-ratio p 
Coe£., A 0.53 0.19 2.82 0.067 
Coe£., 8 0.14 0.02 6.60 0.007 
Constant 0.27 0.08 3.57 0.037 
Figure 5. Dual parameter correlations : log ([ II ]/ [ III ]) vs. crc, as (A); crc, Es 
(B); cr1, crs (C); cr1, Es (D). Minitab statistical parameters : n = number 
of data points, R2 = coefficient of determination, s =residual· 
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structures, all of which exhibited non-coplanarity of the aromatic rings as 
exemplified by the lowest energy conformation depicted in Appendix 4. It is 
possible that the pi system of the nearby, twisted phenyl ring is increasing the 
nucleophilicity of N-1 through an interaction analagous to the proposed lone-
pair cooperative effect. Alternatively, the true solvated structure may differ 
markedly from the model. 
The reason(s) underlying the observed inactivity of 5-methylsulfinyl-4-
nitroimidazole, IV d, towards dimethyl sulfate under aqueous alkaline conditions 
is uncertain. The crc parameters do, however, show IVd to be the most electron-
deficient and hence least reactive substrate. 
Since steric and electronic effects are demonstrably so intimately entwined, a 
final attempt to derive an empirical relationship quantitatively relating 
substituent effect to N-alkylation ratios required the use of a dual parameter 
equation incorporating both an electronic and a steric parameter. This was tested 
for correlation initially using the crc and crs parameter sets proposed for this 
study. Unfortunately, the results (A in Figure 5) are not particularly helpful in 
this respect. They indicate that while a correlation appears to exist, it is 
insufficiently reliable to enable accurate prediction of substituent effect purely on 
the basis of these parameters. Similar correlations using combinations of O'J, crc, 
O'S and Es parameters were more successful; O'J vs. Es gave best correlation (Din 
Figure 5), though it is importantto note that a dual correlation using crs across 
the whole data base significantly improves the result (cf. single parameter 
correlation). It is apparent from the confidence data that crc parameters as a whole 
cannot accurately represent the electronic disposition of the ring nitrogens and 
hence are of only limited use in the analysis of regioselectivity. 
Effect of Alkylating Agent and Reaction Medium 
The ratios of isomeric N-alkyl imidazoles obtained for reaction with diethyl 
sulfate and benzyl chloride under aqueous alkaline conditions were presented 
alongside methylation ratios in Table 12 (in the preceding sub-section). It is 
apparent from the ethylation ratios that the increased steric bulk of the 
electrophile has intensified reaction dependence on substituent steric effects and 
concomitantly decreased dependence on substituent electronic effects. This is 
exemplified by the behaviour of the aryl substituted substrates, Ij-m, under 
ethanolic sodium ethoxide conditions. Figures A2.21 shows a Hammett plot of 
log ([ II ] / [ III ]) (R = ethyl) vs. O'p(aryl) for this series. The O'p(aryl) constants again 
show excellent correlation 
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and the computed p value (1.27) is smaller than the corresponding value found 
for the analogous methylation reactions (1.70, Figure A2.6) indicating diminished 
ratio dependence on electronic effects. 
It is interesting to note that the trends in isomer ratios observed in the 
methylation reactions are reproduced to a remarkable degree in the ethylation 
series. This is obvious when the ethylation ratios are correlated with cr1 (compare 
Figure A2.22 and Figure A2.1) and more importantly with the methylation ratios, 
shown in Figure A2.23. In spite of the general non-additivity of steric effects 387, it 
appears that the replacement of a hydrogen for a methyl group at the electrophilic 
carbons of the dialkyl sulfate, produces a near uniform increase in steric 
constraint across the substrate range. The same cannot be said for benzylation 
reactions, however; analogous correlation with methylation ratios is poor (Figure 
A2.24). This is reasonable when one considers that benzyl chloride differs 
markedly from the dialkyl sulfates in structure and electrophilic properties. 
The ratios obtained from reaction with benzyl chloride do not lend themselves 
to simple analysis. For the majority of substrates, Ic-g,i-1,n, the ratios are larger 
(reflecting greater 1,4-substitution) than the corresponding ethylation ratios, 
indicating more pronounced steric control. Four notable exceptions, however, are 
oberved with substrates la,b,h,m, which produce ratios smaller than those 
obtained for the corresponding methylation reactions. 
Whereas the transition states of N-methylation and N-ethylation are expected 
to be very similar in structure, and possibly associative in nature given that the 
electrophilic carbon is primary, the transition state (TS) of N-benzylation is likely 
to be 'loose' in comparison, reflecting a greater degree of carbenium character at 
the benzylic carbon atom. In other words, the phenyl nucleus is better able than 
alkyl to stabilise the build up of slight positive charge on the benzylic carbon 
atom in a dissociative SN2 reaction. Represented diagramatically, the TS 
structures may resemble the following: 
8- H,,,,.8/H 8-
1 mN- --- ------- -·c --- ------- --Cl 
H (8-) H 8-
8- · ,,,, .. / ---0 
lmN------·C--- 'so OCH2R 
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R= H, CH 3 







Further, if the benzylic system adopted a planar conformation and the steric 
effect of the phenyl ring was comparable to that of the methyl group in the 
ethylating agent, these conditions should facilitate benzylation at N-3 (cf. 
ethylation at N-3) as a consequence of greater steric relief imparted by a 
dissociative TS, ie. II : III (R=benzyl) < II : III (R=ethyl). 
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As already indicated, however, this is not generally observed. Benzylation TS 
structure appears to vary considerably more with the substrate as a function of 
substituent effects (cf. ethylation) to the extent that the effective strain introduced 
by the phenyl group is larger than methyl for certain substrates and smaller than 
methyl for others. The reasons for this are obscure. 
Without the aid of further TS studies, little more can be offered to rationalise 
the spread of benzylation ratios in relation to methylation and ethylation ratios. 
As an example, it should be possible to check the validity of the comparatively 
'loose' TS proposed above for benzylation by carrying out rate determinations for 
N-benzylation reactions on deprotonated imidazole using a range of meta- and 
para- substituted benzyl chlorides (including unsubstituted benzyl chloride) 
under the same conditions. In an analysis of the appropriate Hammett plot, the 
sign(s) and magnitude(s) of the reaction constant(s) (two correlation lines may be 
apparent if a TS change occurs across the range of benzyl substituents) will 
convey whether the reaction of unsubstituted benzyl chloride with imidazole 
anion is facilitated by electron-releasing (negative p, indicative of carbenium 
character at benzylic carbon) or -withdrawing substituents (positive p, indicative 
of a 'tight' associative SN2 T.S.) or neither (p = 0, indicating that bond formation 
is concomitant with bond breaking). Strictly speaking, however, since TS 
structure is sensitive to the nature of the nucleophile, it would be necessary to 
perform the above experiments on a number of the imidazole substrates 
concerned in order to make an accurate assessment. 
Alternatively, a truer comparison of methylation, ethylation and benzylation 
TS structure may be made by carrying out kinetic isotope studies. Normal a.-
deuterium secondary kinetic isotope effects are expected if a dissociative 
mechanism is operating (kH/ko > 1, reflecting relief of steric strain in the TS), 
while inverse secondary KIE's are expected if the mechanism is associative 
(kH/ko < 1, reflecting increase of steric strain in TS). Lee et al have performed 
these studies on the reactions of benzyl- and alkyl-benzenesulfonates with 
substitued anilines. In accordance with the TS structures prop<?sed above, they 
observed normal and inverse secondary KIE's for the benzyl and alkyl substrates 
respectively 401. 
Methylation of 4-bromoimidazole was carried out using methyl iodide under 
identical reaction conditions (s. 3.3.5) to observe the effect of leaving group ability 









1.5: 1 (Ilb: Illb) compared to the ratio, 2.6: 1, obtained using dimethyl sulfate. 
Experimental evidence indicates that a better leaving group results in an earlier 
TS in an associative mechanism 401 , in agreement with Thornton's proposal 113, 
discussed previously (s. 1.2.2.1). Thus, in the same way that 2-substituted 
pyridines are less subject to steric effects in reaction with methyl fluorosulfonate 
compared with methyl iodide, substituted imidazole anions should exhibit a 
slower rate of methylation at N-3 with methyl iodide compared with dimethyl 
sulfate, ie. they should produce larger isomer ratios (II: III) with the former 
reagent. This is contrary to the experimental result obtained. While no 
conclusions can be reliably made on the basis of one such result, the ratio 
disparity is probably a consequence of differing reagent solubility in the 
heterogeneous medium rather than an indicator of a dissociative type process. 
A number of experiments were conducted using 4-bromoimidazole to observe 
the effect of medium on "basic" alkyation ratios (s. 3.3.5). The SN2 solvation rule, 
· proposed by Westaway 118, allows that SN2 reactions can be categorised into two 
types according to the charge characteristics of the nucleophile and the leaving 
group. It states that a change in solvent will only lead to a change in TS structure 
if the charges on the nucleophile and leaving group are dissimilar in the TS. It 
follows then that in terms of TS structure, the rates of N-1- and N-3-alkylation 
reactions involving imidazole anions and alkyl halide or sulfate reagents should 
be relatively independent of solvent since the nucleophile and leaving group are 
similarly charged in the TS : 
8- H,,,,. /H 8-
lmN-- ----:c ---- --X 
I 
R 
However, the important consideration as far as ratios are concerned, is how 
the rate of alkylation at N-1 is affected in relation to alkylation at N-3. The degree 
of charge stabilisation of the ambident nucleophile by solvation is very likely to 
affect the relative nucleophilicities of the nitrogen atoms : solvation in a polar 
protic solvent is expected to significantly reduce nucleophilicity (cf. solvation in 
a non-polar, aprotic medium) by exacerbating the energy requirements for 
successful reaction. It is very difficult, however, with the information at hand, to 
comment on the relative salvation characteristics of the nucleophilic nitrogen 
atoms. Thus, it is inappropriate to speculate as to the effect of solvent variation 







A further consideration which needs to be addressed is the influence of 
solvent on the electronic properties of ring substituents. Taft et al have observed 
the effect of solvent on the 19p chemical shift of fluorine in meta-substituted 
fluorobenzenes and have correlated these shifts with O"J constants 402. It was 
shown that Ol, particularly for substituents possessing ionic resonance structures, 
increases as the solvent becomes more protic, illustrating the effect of hydrogen-
bonding on the electron-withdrawing properties of solvated substitutents. Lewis 
basic (eg. hydroxylic) solvents were also seen to reduce electron-withdrawal by 
Lewis acidic (protic) substituents. 
It is extremely difficult to separate solvent effects from base effects in the few 
reactions studied due to the ambident nature of the imidazole anions. A 
significant difference in product ratios is apparent upon moving from aqueous 
NaOH to ethanolic NaOEt or KOH (2.6: 1 cf. 1.7: 1 and 1.6: 1 (llb: lllb) 
respectively). This is consistent with reduced salvation of the imidazole anion, 
assuming a proportionately greater reduction in salvation at N-3, but the 
difference may just as well be attributable to a change in mixture homogeneity 
and/ or ion-association effects. 
As described in s.1.2.2.1, ion association can exert a marked effect on 
regioselectivity in non-aqueous solvents of low polarity. As the cation-solvating 
ability of the solvent decreases, increased ion association at the more nucleophilic 
nitrogen will direct alkylation to the less hindered and previously less 
nucleophilic nitrogen. A clear example of this effect is apparent from the product 
ratios obtained using triethylamine (a base commonly used to deprotonate azoles 
in non-aqueous solvents) in EtOH, dioxane and DMF : 1 : 7.2-7.6, Ilb : lllb. 
Assuming substantial deprotonation of the substrate, lb, association of the 
triethylammonium cation at N-1 is extensive enough to completely reverse the 
regioselectivity of methylation. 
A high yielding method of azole N-alkylation, reviewed ins. 1.3, involves a 
two step process whereby a salt of the anion is generated, isolated and finally 
reacted with the alkylating agent in a second, non-aqueous, non-protic solvent. 
Following this methodology, the triethylammonium salt of 4-bromoimidazole 
was generated by dissolving lb in triethylamine and removing the excess under 
reduced pressure. The salt was redissolved in CH2c1i·and subsequently reacted 
with dimethyl sulfate. The methylation ratio, 1 : 16 (lib: Illb), is consistent with 
enhanced cation association at N-1 in comparison with the ab~ve solvents. A 
second reaction using the tetrabutylammonium salt (synthesised according to the 
procedure reported by Searcey et al 237) produced a ratio of 1 : 4.5 (lib: lllb), which 
again reflects cation association at N-1, though to a lesser degree. The exact nature 
of the association of these alkylammonium ions with the imidazole anion is 










Et3NH+ ion, the ratios suggest greater hindrance to alkylation at N-1 by the latter. 
This is reasonable considering the proportionately reduced accessibility of the 
electrophilic nitrogen atom (and a-carbons?) of the Bll4N+ ion to electrostatic 
interaction. Coupled to this argument is the possiblity that steric interference may 
be enhanced by partial or complete proton transfer which might occur between 
the imidazole and Et3NH+ ions : 
Et Br 
\ 3+ 3- __/ 




Complete transfer would result in the generation of the imidazole free base 
with subsequent alkylation falling under tautomeric control (see following 
section 3.2.3.2) to yield predominantly the 1,5-disubstituted product, IIIb. Charge 
stabilising interactions of this type are likely to be much more important in non-
polar, aprotic, solvents where charge dispersal by salvation is substantially 
reduced. 
Begtrup and Larsen performed similar alkylation experiments using pre-
isolated sodium salts in various solvents 238. The sodium salt of lb was alkylated 
with stoichiometric methyl iodide in CH2Cl2, over 3 days at room temperature, to 
produce llb and IIIb in 96% yield and in the ratio 2.9 : 1 respectively. Identical· 
reaction in MeOH gave a 94% yield and the ratio 1.2 : 1. Since it is doubtful that 
isomerisation is responsible for the increase in proportion of Ilb upon moving 
from MeOH to CH2Cl2, a solvent induced TS change may account for the 
disparity : a tighter TS with increased steric congestion might well result from a 
lack of charge stabilisation by salvation in CH2Cl2. Another possibility may exist 
in the form of preferred cation association at N-3. It is accepted in the literature 
that substituent chelation stabilises ortho-lithio imidazoles in ethereal solvents 
316, and it may be that an analogous interaction (lone-pair cooperative effect) is 
operating in the present example, with small cations and in solvents of low 
solvating power : 
•• • ......-Na+ 
•.Br. t_ 
/fN :\ I,_; 
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B 6% Phase transfer catalyst (tetrabutylammonium bromide). 






















Thus, this effect may also explain the ratio 3.8: 1 (lib: Illb) observed in the 
alkylation of lb with dimethyl sulfate in acetone using powdered KOH as the base 
(s. 3.3.5). This hypothesis could be tested by repeating this experiment using 
hydroxylic bases with progressively larger counterions and/ or various substrates 
bearing substituents capable or incapable of such interaction. 
Liquid-liquid phase-transfer catalysis (PTC) is another commonly used, 
relatively high yielding, alkylation method that involves the imidazole anion. 
Some representative ratios for PTC methylation of lb and ethylation of Ii, using 
Bu4NBr catalyst, are given in Table 13 (from s. 3.3.5). These ratios are smaller 
than those obtained under standard conditions, though not reversed as observed 
for the reaction of the Bu4N+ salt of lb in CH2Cl2. It is also apparent that the 
amount of catalyst present in the reaction mixture affects product distribution. 
Perhaps, under these conditions, the molecular ratio of catalyst to nucleophile is 
greater during the transportation of the anionic substrate into the organic phase; 
more cation association at N-3 (cf. N-1) would account for the observed trend. 
Summary 
Alkylation of substituted imidazole anions has been shown to be dependent 
on substituent electronic and steric effects, the nature of the alkylating agent, and 
the nature of the reaction medium. Steric effects appear to dominate 
regioselectivity (particularly in the disubstituted substrates), though electronic 
effects are important where steric effects are minor; electronic control appears to 
be predominantly inductive in origin, although resonance effects are important 
where inductive effects are small. Two new substituent parameters were 
established for the purpose of quantifying regioselectivity, namely crc and crs. 
While the crs parameters correlate well with literature Es values, the validity of 
the crc parameters as a collective set is questionable; crc values correlate poorly 
with Hammett substituent constants and they do not correlate well with the 
product ratios in a dual parameter equation. A good correlation was observed, 
however, with cr1 and Taft's Es constants; this should permit an approximate 
prediction of isomer ratios obtained using dimethyl sulfate under standard (aq. 
Na OH) conditions : 
log ([II]/[ III]) = 0.53 cr1 + 0.14 Es + 0.27; n = 6, R2 = 0.945 
As the size of the incoming electrophile increases, ratio dependence on steric 
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from the ethylation reactions are enriched in the 1,4-isomer; ethylation ratio 
dependence parallels methylation. Substrate behaviour with benzyl chloride is 
ambiguous at this stage. 
The effect of reaction medium on regioselectivity is considerable, particularly 
in as far as the role of the counterion in non-hydroxylic, aprotic solvents is 
concerned. 
3.2.3.2 "Neutral" Alkylation 
Substituent Effects 
Alkylation of free base imidazoles occurs via an SE2' pathway, again in a 
second order process 89, 93, 94 (refer sections 1.2.1 and 1.2.2.1). Under these 
conditions, product composition is dependent to a very large extent on the course 
of in situ prototropic equilibria. As previously discussed in section 1.2.1, N-
unsubstituted imidazoles in solution exhibit rapid proton exchange in an 
intermolecular process : (protic) solvent-free base and/ or free base-free base. The 
relationship between tautomerism and alkylation ratios is defined in Figure 6; 
the isomer ratios are a function of both the alkylation rate constants (kn, km) and 
the tautomeric composition. For the purposes of this discussion the tautomeric 
equilibrium constant, hereafter referred to as KT, is defined as the ratio of [ 11-H ]/[ 
III-H ]. 
The positions of tautomeric equilibria in usymmetrically substituted 
imidazoles (ie. values of KT) are clearly dependent on phase, the solvent and 
substrate concentration in solution, the temperature, and the nature of the ring 
substituent(s). The other factors being approximately equal in this investigation, 
substituent dependence is preeminent here, and is dominated by electronic effects 
since the incoming/ outgoing electrophile is small. This is evidenced by the 
excellent correlation of pKBH+ values (of 1-methyl-4- and 1-methyl-5-substituted 
imidazoles) with O'm substituent constants 95, 96. 
Methods used to determine KT for heteraromatics are numerous and varied; 
literature work prior to 1976 has been extensively reviewed by Elguero et al 97. 
The physical methods best suited to examining such equilibria are those utilising 
basicity measurements, nmr (particularly lH and 13C) or UV spectroscopy, all of 
which require the use of fixed model compounds : normally N-methyl 
derivatives. A more recent paper usefully exemplifies use of the former in the 
tautomerk analysis of NU-acetyl-4-nitrohistidine 403. Spectroscopically 
determined pKBH+ values of the above and its N-methyl compounds enabled a 
quantitative estimate of KT, while comparison of the changes in 13C chemical 
Table 14. KT Determination for substrates Ia-d from pKBH+ data (H20, 25°C) presented in Appendix 5. 
Acid Dissociation Constants, KBH+ / mol dm-3 
(pKBH+) KT * 
Substrate Free Base 1-Methyl-4-substituted 1-Methyl-5-substituted 
4-Iodoimidazole (2.6±0.1)x10-s ( 6.3 ± 0.6 ) X 10-5 (3.4 ± 0.2 ) X 10-6 19±3 
(le) ( 4.59 ± 0.02 ) ( 4.20 ± 0.04 ) ( 5.47 ± 0.03 ) 
4-Bromoimidazole ( 2.6 ± 0.1 ) X 10-4 ( 4.3 ± 0.3) X 10-4 ( 9.1 ± 0.8) X 10-6 47±7 
(lb) ( 3.59 ± 0.03 ) ( 3.37 ± 0.03 ) ( 5.04 ± 0.04 ) 
4-Chloroimidazole (3.4±0.2)x10-4 (7.4±0.2)x1Q-4 (8.3±0.S)xJ0-6 90 ± 10 
(Ia) ( 3.47 ± 0.03 ) ( 3.13 ± 0.01 ) ( 5.08 ± 0.04 ) 
4-Methylimidazole ( 3.5 ± 0.4 ) X 10-8 ( 3.1 ± 0.3) X 10-8 ( 2.8 ± 0.3) X 10-8 1.1 ± 0.2 
(Id) ( 7.46 ± 0.05 ) ( 7.51 ± 0.04 ) ( 7.56 ± 0.05 ) 
* Tautomeric Equilibrium Constant, KT= KBH+(4-X-1-Me) / KBH+(5-X-1-Me) 








shifts (between neutral and protonated forms) of the parent with those of the 
methyl derivatives provided qualitative evidence for the position of equilibrium. 
Theoretical treatments have gained popularity in recent years. Commonly 
involving the determination of intrinsic basicity (from theoretical protonation 
enthalpies, eg. 72), these calculations are extremely basis-set dependent and have 
dubious applicability to prototropic equilibria in solution. 
To effectively analyse product ratio dependence for alkylation in "neutral" 
medium, it was necessary to calculate, either experimentally or theoretically, the 
KT values for the series of imidazoles studied. Basicity measurements were 
chosen for this purpose due both to the relative simplicity of the method and also 
to the existence of literature ionisation data for a number of the substrates. It was 
hoped that pKBH+ values experimentally determined for a small number of N-
methyl derivatives, II and III, would correlate sufficiently well with Hammett 
substituent constants that approximate predictions (of KT) could be made for the 
remainder of the substrates. Thus, pKBH+ values were determined for the N-
methyl derivatives of Ia-d by potentiometric titration of the corresponding free 
bases with 0.100 mol dm-3 HCl in water at 25°C (refers. 3.3.3.1 and Appendix 5); 
these substrates were selected because they are water soluble in the concentration 
range utilised for pK measurement (0.010-0.025 mol dm-3). The resultant values 
are given in Table 14. Correlation of these ionisation constants with Hammett 
substituent constants was most successful with am in accordance with Charton's 
findings 95, 96. The Hammett plots of pKBH+ vs. am are displayed in Figure A2.25 
and the corresponding correlation equations are given below Table 15. 
KT values for the 4-substituted imidazoles were calculated as follows : 
f 1. K1-Me 
KT = f 3 . K3-Me 
where K1-Me and K3-Me are the ionisation constants of the protonated forms of II 
and III respectively (II and III represent fixed models of the tautomers II-Hand III-
H (Figure 6)), and f 1 andf 3 are the ratio between the acidity of each protonated 
tautomer and the corresponding methyl derivative. If the assumption is made 
that the effect of N-methylation on acidity is the same for both protonated 
models, ie. f 1 = f 3, the above equation is simplified to 
K1-Me 
KT = K3-Me 
. KBH+ (4-X-1-Me) 
ze. = K + 
BH (5-X-1-Me) 
Table 15. Approximate KT values for Ie-h and Ij, calculated from pKBH+ vs. 
Gm correlation equations below (refer correlation plots in Figure 
A2.25) and from log KT vs. Gm correlation plot in Figure A2.26. 
Predicted pKBH+ values 
X 4-X-1-Me 5-X-1-Me KTA 
Ph 5.78 B 6.93 14 (2) 
CH20H 6.94 7.33 2 (1) 
CHO 3.47 5.02 36 (30) 
C02CH3 3.77 5.22 28 (22) 
CONH2 4.17 5.48 20 (15) 
N02 -0.53 C 2.13 C 457 (960) I 
2,4,-(CH3)2 8.33D 8.25D 0.8 (0.3) 
A Tautomeric equilibrium constant, KT= KBH+(4-X-1-Me) / KBH+(s-X-1-Me). 
Numbers in parentheses refer to KT values calculated from log KT vs. crm correlation 
plot (log KT= 4.2 crm) in Figme A2.26. 
B Literature value used for pKBH+ (Ilj) in above correlation equation 94, 393. 
C Literature values used in above correlation equations 89; see Table Al.10. 
D I, Gm used in place of crm. 
pKBtt+ vs. Gm Correlations 
4-X-1-Me pKBH+ = 6.94 - 9.91 Gm ; n = 7, R2 = 0.973 
5-X-1-Me pKBH+ = 7.33 - 6.60 CTm ;· n=6, R2 = 0.963 














KT's for Ia-d were calculated using the experimentally determined pKBH+ 
values and are given in Table 14, while values for Ie-h and Ij were predicted 
using the pKaH+ correlation equations and are given in Table 15. An alternative 
method for predicting KT values, based on Charton's Hammett treatment 95, was 
attempted. The KT'S of Ia-d were further correlated with crm (as log KT), and this 
plot (Figure A2.26) was then used to determine KT for the remainder of the 
substrates on the basis of the substituent crm constants. The resulting correlation 
equation: 
log KT = 4.2 <J'm (cf. 3.2 <J'm 95) 
gave KT values (shown in parentheses in Table 15 and with the exception of Ii 
and Ij) close to those obtained using the former method notwithstanding the 
larger inherent error introduced by the additional correlation. 
It is apparent from these determinations that electron withdrawal (primarily 
inductive) by the substituent destabilises III-H with respect to 11-H. This finding is 
consistent with the generalisation that the less basic tautomer predominates in 
solution 75 . 
The results for neutral alkylation of the imidazole substrates are tabulated in 
Table 16 (located in experimental section 3.3.3). It is clear from the product ratios 
obtained in this investigation and the historical ratios shown in Table 9, that 
ratio reversal is frequently observed when "neutral" alkylations are compared 
with the corresponding anion reactions. Thus, it appears that the predominant 
tautomer in solution, rather than the more nucleophilic species, controls 
regioselectivity, ie. the ratios approach 1/KT rather than kn/km. 
As intimated above and in Figure 6, alkylation ratios are related to KT: [II]/[ 
III] oc 1/KT. This relationship was tested using the KT values experimentally 
obtained for Ia-d (Table 14) and a KT value for Ii based on literature pKBH+ data 89. 
Depicted in Figure A2.27, log ([II]/[ III]) was found to linearly correlate with log 
(1/KT) with remarkable precision, 
[IT] 1 
2 log [ ID] = 0.18 + 0.71 log KT ; n=5, R = 0.998, 
indicating that steric imposition is not significantly different for the methylation 
and protonation reactions of these particular substrates. Once the predicted KT 
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values ,for Ie-h,J,n are superimposed on this plot, substantial deviations are 
immediately apparent for If,h and Ij, as might be expected from their behaviour 
in aqueous alkali (s. 3.2.3.1). 
Sterk parameters, cr's, for the imidazole free bases were calculated analogously 
to the crs parameters from the ratio of SASA's (of the unprotonated nitrogens) 
for the tautomeric forms: N-1 (111-H)/N-3 (11-H) -1. These parameters, listed in 
Table Al.13 and derived from the raw data in Table A3.1, appear consistent with 
the deviations of Ih and Ij; cr's values for these substrates exceed an apparent 
threshold value in the range 0.5-0.9. In validation of the method, these 
parameters correlated well with adjusted Es constants (Figure A2.28) 
It is interesting to note that the conformational potential energies obtained for 
the tautomer pairs (Table A3.1) conversely suggest that KT < 1 when <Jm > 0. 
Similar trends have been observed for theoretical gas phase KT studies in the 
literature 72, 404, highlighting the dependence of KT on phase. As a corollary of 
this, it should also be noted that since the acidity determinations were performed 
in water, the actual KT values in ethanolic medium will be different as a 
consequence of altered solvation characteristics. However, these values are still 
applicable in the present analysis because the solvation effect should be 
approximately proportional across the substrate range. 
While 11-H is predicted to be the predominant tautomer in solution for the 
imidazoles, If,h and lj (predicted Kr's are 36, 20 and 14 respectively), the 
correlation plot indicates that methylation is not occurring with the degree of bias 
expected towards substitution of this species. Indeed no regioselectivity is 
apparent for Ih, while opposite regioselectivity is noted for Ij. Whereas the latter 
is explicable in terms of a steric effect (km is smaller than expected on the basis of 
electronic behaviour), the former is more difficult to rationalise. Complicating 
factors are present in the fact that substituent side-reactions were concomitant 
with N-methylation. As detailed in s.3.3.3, aside from the products of 
carboxamide N-methylation,, both methyl and ethyl esterification products were 
formed under the reaction conditions, ie. methyl and ethyl 1-me~hylimidazole-
4(and 5)-carboxylates, in isomeric ratios of 1 : 2.7 and 1 : 1.6 respectively. Thus, the 
observed ratio 1 : 1 (Uh: Illh) is almost certainly not an accurate reflection of 
kn/km.KT (Scheme 79). The carboxamide group is again theorised, by the 
modelling program, to engage in hydrogen bonding with N-3 in the 11-H 
tautomer (Table A3.l and illustrated in Appendix 4). Since sta~ilisation by 
intramolecular (and intermolecular) hydrogen bonding is more important in 
ethanolic medium than aqueous, KT for Ih in ethanol is presumably affected 
more than KT for the other substrates; intramolecular hydrogen bonding through 
the carbonyl oxygen in the 111-H tautomer is not theorised. Further, such an effect 
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tautomer (ie. a reduced km), and this may well contribute to the deviation 
observed. 
The smaller discrepancy noted for If implies an actual ethanolic KT less than 
predicted, since no steric argument pertains in this case (smallest cr's value noted 
for the carbaldehyde group (Table Al.13)). Two possible explanations present 
themselves (Scheme 80). Either the 111-H tautomer is further stabilised in 
ethanolic (cf. aqueous) medium, perhaps through solvent mediated hydrogen-
bonding, or reversible modification of the carbaldehyde group is occurring under 
the reaction conditions. Taft et al noted in their 19p nmr studies of solvent effects 
on cr1, that the effective electron-withdrawing capacity of the aldehyde group of 
meta-fluorobenzaldehyde was considerably weaker in methanol (smaller cr1) than 
in a range of non-alcoholic solvents 402. This observation was put down to the 
reversible formation of a carbonyl addition compound. Hemiacetal formation in 
the acidic ethanolic medium of the present study would thus reduce the effective 
KT, thereby increasing the product ratio as observed. It should be possible to 
determine the relevance of the latter by observing reaction progress with nmr. 
It has been shown that KT for substrates bearing sterically less significant 
substituents, is dependent primarily on substituent inductive effects. Further, 
through correlation with product ratios, these values have proved valuable as a 
means of quantifying regioselectivity under these reaction conditions. It stands to 
reason therefore that the ratios should bear a direct relationship with either 
Hammett crm or cri substituent constants. This is indeed the case; log ([II]/[ III]) 
vs. cr1 correlation plots are displayed in Figures A2.29 and A2.30. While 
correlation with crm was acceptable, cr1 values gave the best result, 
[Il] 
log [ ID] = 0.08-2.64 cr1 ; n = 7, R2 = 0.954 
if the ratios for Ij-m and Ih were excluded. As anticipated, the reaction constant, 
p, is negative, indicating the reaction at N-1 is accelerated by electron-donating 
substituents. This is reasonabie considering that electron-donation will stabilise 
the 111-H tautomer in solution, and it is the reaction of this species which 
enriches the proportion of II in the reaction mixture. Comparing Figures A2.30 
and A2.20, it appears that "neutral" (cf. basic) alkylation ratios-exhibit a truer 
dependence on cr1. Whether this is truly the case or the difference,merely a 
consequence of appreciable cr1 variation in aqueous sodium hydroxide (Lewis-
basic, hydroxylic solvent) 402, is uncertain. The relative magnitudes of the 








































slightly greater in ethanol than in alkali. This may not necessarily reflect greater 
charge disparity between reactant and transition states in the former of the two 
mechanisms, since the degree of charge stabilisation by solvation in ethanol 
(smaller dielectric constant) is less than in aqueous medium. 
Ratio dependence on conjugative interaction with the substituent appears less 
than in alkali, particularly when the substituent is -M .. The product ratios for the 
sub-series Ij-m were again correlated with O'p(aryl) constants (shown in Figure 
A2.31). Interpretation of the resultant plot is made difficult by the fact that no 
experimental KT data is known for these substrates; the plot is no_n-linear and 
although more points are needed to accurately define the two regions (three if the 
changeover region is included), probably comprises two correlation lines as 
shown. Two possible explanations are apparent: (i) if KT for these substrates is 
approximately a linear function of O'p(aryl), the plot may represent a transition 
state change as the electronic effect of the para-substituent changes from electron-
release to -withdrawal, and (ii) KT is not a linearly related to O'p(aryl); either para 
electron-donating substituents stabilise the 111-H tautomer to a larger degree than 
electron-withdrawing groups destabilise the same, or the converse is true. The 
first possibility is graphically illustrated in Scheme 81. Increased reaction 
sensitivity to electon-donating substituents follows if the degree of positive 
charge development at the nucleophilic nitrogen is greater (signified by o++) in 
the transition state for these methylations. Perhaps deprotonation is not 
concerted, or proceeds to a lesser extent in the TS, if the imidazole substituent is 
electron-releasing. Further experimentation is required before positive 
statements can be made regarding the verity of the two rationales. 
Electronic substituent parameters, a'c and 0"
1
pz, were determined for the free 
base substrates, for comparative correlation with product ratios. Atomic charge 
densities for the 11-H and 111-H tautomers were obtained using MNDO and 
CHARGE3 395 software (raw data tabulated in Table A4.2 and illustrated in 
Appendix 4) and the parameters defined as the ratio (N-1 (111-H) / N-3 (11-H)) of 
MNDO atomic and Pz charges minus one (refer .previous section for further 
details). The nitrogen atomic charge densities and corresponding electronic 
parameters for series I and series IV are given in Tables Al.11 and Al.12 
respectively. 
Although a'c and 0"
1
pz values were again found to correlate poorly with 
Hammett substituent constants, correlation with product ratio~ was considerably 
more successful than the analogous correlation (ac and O'pz) in alkali, perhaps 
fortuitously since no steric related anomalies are present. Slightly better 
correlation was found using the a'c parameters (depicted in Figure A2.32), 
though according to the MO calculations these are predominantly of pi origin 
(Figure A2.33), as noted for ac in the previous section. It was necessary to exclude 
Table 17. Approximate KT values for 4-nitro-5-substituted imidazoles, IVa-
e, calculated from pKBH+ vs. LO'rn correlation equations (refer 
Table15). 
4-N02-5-X Predicted pKBH+ values A I 
X 1-Me-4-N02-5-X 1-Me-5-N02-4-X KTB 
I 3.37 4.95 38 
Br 3.77 5.22 28 
SCH3. 1.39 3.63 170 
S0CH3 5.06 6.08 10 
S02CH3 5.85 6.60 6 
SPh - - 50-120 C -
A LO'rn = O'rn(N02) - O'rn(X). 
B Tautorneric equilibrium constant, KT= KBH+(l-Me-4-N02-5-X) I KBH+(l-Me-5-
N02-4-X). 














the a'c values for substrates Ia-c from the correlation; it is again apparent from 
Table Al.11 and Figure A2.32 (cf. Figure A2.16) that the MO calculations 
overestimate the +M component of the halogeno substituent effect. That the cr'c 
parameters hold some value is further evidenced by correlation with product 
ratios for the aryl substituted imidazoles, Ij-k. Figure A2.34 (cf. Figure A2.31) 
displays the same trend found using the CTp(aryl) constants, discussed above. 
CHARGE3 atomic densities were not amenable to similar treatment; little 
consistency with Hammett constants or methylation ratios was observed. 
In the previous section it was noted that steric factors were found to feature 
more prominantly in the N-alkylation of disubstituted imidazole anions. The 
same is true for free base alkylation in ethanol. Approximate KT values for the 4-
nitro-5-substituted imidazoles, IVa-f, were determined using the pKBH+ vs. CTm 
correlation equations (given in Table 15), modified for 4,5-disubstituted substrates 
: LCTm replaces CTm, ie. crm(N02) - crm(X). These values are shown in Table 17. Plots 
of log ([ V ]/[VI]) vs. log (1/KT) and crr for the three data points available (IVa-c), 
again demonstrate product ratio dependence on tautomer distribution and 
inductive rather than conjugative substituent effects (Figures A2.35 and A2.36 
respectively) : 
[V] - _!_ . - 2 -log [VI] - 1.66 + 1.51 log KT , n-3, R - 0.973 
[V] 
log [ VI ] = -3.07 + 5.88 cr1 ; n=3, R2 = 0.992 
Ratios for IV d-f, however, do not satisfy these correlations. On the basis of 
predicted KT, the order of methylation ratios (progressively favouring 1,4-
substitution with respect to the nitro substituent) should resemble 
SCH3 < SPh < I < Br < SOCH3 < S02CH3. 
The observed order is 
S02CH3 ""' SOCH3 ""' SPh < SCH3 < I < Br 
where IVd-f are seen to produce the 1-methyl-5-nitro-4-substituted isomer only. 







consistent with these deviations. An apparent a's threshold value in the range 
0.2-0.7 is exceeded for these species (Table Al.14). The extremely poor yields 
obtained for the nitrosulfinyl and nitrosulfonyl imidazoles (<10%) are reasonable 
considering the large degree of ring deactivation towards electrophilic 
substitution. 
Effect of Alkylating Agent and Reaction Medium 
The alkylation ratios for the ethylation and benzylation reactions are presented 
alongside the methylation ratios in Table 16 (s. 3.3.3). A cursory inspection of 
these results reveals that under the reaction conditions, product mixtures are 
progressively enriched in the 1,4-isomer as the alkylating agent is changed from 
dimethyl sulfate to diethyl sulfate and then to benzyl chloride. Clearly, steric 
congestion in the transition state progressively worsens as the alkylating reagent 
is varied in the above order. Thus, product ratios for ethylation and benzylation 
reactions resemble 1/KT less and at the same time approach kn/km. 
It is no surprise that methylation ratio trends are mimicked by the ethylation 
reactions. As noted for the basic alkylations, the methylation and ethylation 
transition states are similar enough that ratio trends are reproduced in response 
to a near uniform steric effect across the substrate range. This is obvious when 
plots of log ([II]/[ III]) (R = Ethyl)vs. log (1/KT), ar and CJp(aryl) (Figures A2.37, 
A2.38 and A2.39) are compared with their methylation counterparts (Figures 
A2.27, A2.29-30 and A2.31); the high degree to which ethylation parallels 
methylation is exemplified by the remarkable ratio correlation shown in Figure 
A2.40. 
It is interesting to note that contrary to observation in basic medium, free base 
benzylation behaves similarly. A significant correlation with methylation ratios 
is also apparent in Figure A2.40. Further, the benzylation ratios invariably reflect 
greater steric control of regioselectivity. This is reasonable if transition state 
structure for benzylation differs markedly in the two media. In theory, since 
charge stabilisation by solvation is reduced in ethanol, the transition state is 
probably significantly less dissociative in nature, than the TS in aqueous alkali, in 
order to reduce charge development on the benzylic carbon and on the leaving 
group. Thus, steric congestion in the TS of N-benzylation is expected to be greater 
in ethanol than in alkali, the latter being able to support a "loose" TS as described 
in the previous section. 
As intimated above, as the size of the electrophile increases, ratio dependence 
on steric effects increases at the expense of electronic control. Ratio sensitivity to 







is clearly shown in an overlayed plots of alkylation ratios against 1/KT (Figure 
A2.41); the slope of the correlation lines (ie. sensitivity) decreases in the order Me 
> Et > Bz. However, the ethylation ratios obtained for the para-substituted phenyl 
imidazoles, Ij-m, tell a different story. While the ratio trend observed is 
consistent with the methylation results, a comparison of Figures A2.39 and A2.31 
seemingly reveals that electronic control is enhanced for these substrates. Again, 
a more in depth study of the alkylation of these and other m,p-substituted 
phenylimidazoles is required to explain this apparent inconsistency; it must be 
pointed out that the ethylation ratios are determined from a single experiment 
only. 
Several methylation reactions were carried out on 4-bromoimidazole, lb, using 
a range of other solvents (DMF, p-dioxane, THF, Et20, CH2Cl2 and benzene) to 
cursorily examine the nature of the solvent effect, if any, on the regioselectivity 
of "neutral" alkylation. These experiments are described in section 3.3.5. 
Unfortunately, nothing conclusive was found beyond the fact that the choice of 
solvent does effect product distribution. According to Westaway's SN2 solvation 
rule 118 the effect of solvent change (on the TS) is maximal when the developing 
charges on the nucleophilic atom and the leaving group are dissimilar in the TS 
(as they are in free base alkylation), since the solvation mechanisms for unlike 
charges are likewise dissimilar. At the same time, according to the solvation 
characterisitics of the medium, varying the solvent will change the 
nucleophilicity of the reacting tautomers and, importantly, the distribution of 
such. Thus, the exact nature of the observed solvent effect is very difficult to pin 
down, particularly on the basis of these few experiments, and in view of the fact 
that methylation was performed at variable (solvent reflux) temperature. 
However, some interesting observations were forthcoming. The dielectric 
constant, E, is a convenient measure of a solvent's ability to stabilise charge by 
solvation. Ignoring temperature effects, a correlation appears to exist between l9g 
([ llb ]/[ lllb]) and E2s (the dielectric constant of the solvent measured at 25°C 405), 
with notable exceptions for the cyclic ethers THF and p-dioxane (Figure A2.42). In 
general, it appears that as the dielectric constant of the solvent decreases, the 
proportion of lllb in the product mixture concomitantly increases. If such a 
relationship is obeyed, the net effect of such a solvent change is an increase in KT 
and/ or a decrease in the relative rate of methylation, kn/km. Intuitatively, the 
former explanation is the most probable; recall that alkylation _ ratios more closely 
resemble 1/KT than kn/km. However, as solvent polarity is decreased, the more 
polar tautomer (which is preferentially stabilised in media with high dielectric 
constants) would be destabilised with respect to its isomer, thereby reducing KT. 
Perhaps this contrariness of experiment and theory is explicable in terms of 






media of low polarity 406, though the effect of such on alkylation ratios is difficult 
to define beyond a substantial effect on KT, 
The variations from the discussed trend, observed for the cyclic ethers, p-
dioxane and THF, are possibly the result of a change in identity of the alkylating 
agent. Lund and Lund found that the behaviour of methyl iodide in the 
quaternisation of pyridazines differed in ethereal solvents 119; it was proposed 
that methyloxonium species were generated in situ. 
Summary 
"Neutral" product ratios were found to resemble 1/KT, the inverse of the 
tautoni.eric equilibrium constant, more than the relative rates of alkylation, 
kn/km, ie. the predominant tautomer in solution, rather than the more reactive, 
controlled regioselectivity. To quantify ratio dependency on KT, basicity 
measurements were made on N-methyl, "fixed model" derivatives of substrates 
Ia-d and approximate KT (aqueous) values calculated. Correlation of pKBH+ with 
Hammett crm constants enabled prediction of KT for the remainder of the 
substrates in the investigation. Correlation of KT with product ratios afforded 
expressions useful in predicting regioselectivity in neutral medium on the basis 
of aqueous KT values : 
[ II] - J__ . 2 
log [ID] - 0.18 + 0.71 log KT , n=5, R = 0.998, 
[ V] 1 
log [VI] = 1.66 + 1.51 log KT ; n=3, R2 = 0.973. 
A steric restriction was observed and quantified using cr's parameters 
determined through molecular modelling and SASA calculations : substituents 
exceeding a threshold value of cr's 0.5-0.9 (monosubstituted imidazoles, I) and 
0.2-0.7 (disubstituted imidazoles, IV) failed to obey these relationships. 
Electronic control of product ratios is primarily inductive. Good correlation 
was observed with cr1 constants, if the same steric restrictions are imposed : 
[ II] 








log [VI] = -3.07 + 5.88 cri ; n=3, R2 = 0.992 
Ratio dependence on conjugative interaction appears less than in alkali, 
particularly when the substituent is -M. The nature of this dependence is 
uncertain. cr'c values were again determined from MO charge calculations; 
correlation with ratios is better than in alkali, though still inferior to correlation 
with Hammett constants. 
Ratio dependence on steric effects intensifies as the size of the incoming 
electrophile increases; product mixtures from the ethylation and benzylation 
reactions are enriched in the 1,4-isomer, ie. sensitivity to KT is observed to 
diminish . 
The effect of solvent on the regioselectivity of lb methylation was cursorily 
examined. A ratio dependency on dielectric constant is apparent, the nature of 
which is unknown : 1,5-substitution appears to increase as the dielectric constant 
of the solvent decreases. 
3.2.3.3 Diazomethane Methylation 
The product ratios obtained for diazomethane reactions are presented in Table 
18 (located in experimental section 3.3.4) and in the correlation Table Al.15. It is 
well documented that diazomethane alkylation of unsymmetrical, tautomeric 
azole substrates produces isomer ratios uniquely dissimilar to those from typical 
free base and anionic methylation methods. The results from this investigation 
are consistent with scattered literature data (eg. Table 9) in that product 
distribution generally resembles SE2' more than SE2cB alkylation mixtures 
(compare Tables 12, 16 and 18 ), ie. predominant formation of the 1,5-
methylation product is observed when the substituent is electron-withdrawing. 
Further, only substrates with pKa values less than""' 13 underwent reaction; 4-
methyl-, 2,4-dimethyl-, 4-hydroxymethyl-, 4-phenyl- and 4-(4'-methoxyphenyl)-
imidazole methylations failed. Beyond these broad generalisations little can be 
said with any degree of certainty. 
The uniqueness of diazomethane as a methylating agent is evidenced by very 
poor ratio correlation with "neutral" and basic alkylation data. An unfortunate 
corollary of this fact is the presence of ambiguity in any subsequent analysis of 
substituent effect, particularly in light of the fact that the mechanism for 
diazomethane alkylation has yet to be satisfactorily elucidated. In reconciliation 
of literature results, two schools of thought have developed concerning its nature 
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: Arndt's classical "direct methylation" theory 102, 103 and the more contemporary 
"oriented ion-pair" SN postulate 101 . These have been discussed in some detail in 
the introductory chapter (s. 1.2.2.1 and Scheme 13). In brief, the first requires that 
an acidic hydrogen is directly replaced by a methyl group via a hydrogen bonded 
complex, while the second holds that, depending on the reaction, a diazonium or 
methyl cation is produced which subsequently reacts with the resultant 
nucleophile in an SN2 or SN1 pathway respectively. 
Applying the classical interpretation to tautomeric imidazoles (Scheme 82), it 
is apparent that the more acidic tautomer (111-H if X is electron-withdrawing) 
would preferentially react with diazomethane to produce isomer mixtures 
comprising a greater proportion of III than that of 111-H in the initial tautomeric 
equilibrium. Thus, depending on the relative acidities of 11-H and 111-H, the 
product ratios would be expected to resemble 1 /KT; the greater the difference in 
acidity, the more the resemblance. At the same time, however, the predominant 
(less acidic) tautomer may control regioselectivity as it does in "neutral" 
methylation. If this is the case, product ratios should resemble KT, It is important 
to consider here that the diazomethane alkylations are typically performed in 
ethereal solvent (as they are in this investigation) and KT is therefore likely to be 
substantially different (and possibly not linearly related) to aqueous KT values. 
The ion-pair postulate, on the other hand, involves the deprotonated 
imidazole anion, wherefore the product ratios are accordingly dependent on the 
relative nucleophilicity or basicity of the repective nitrogen atoms (Scheme 83). If 
the rate-determining step is the formation of ions rather than bond formation, ie. 
SN1 rather than SN2 process, reaction at the more basic (electron dense) nitrogen 
will be favoured over the more nucleophilic nitrogen (if they are not the same), 
since the former will give rise to a stronger electrostatic interaction. Conversely, 
an SN2 pathway will favour reaction at the more nucleophilic site due to the 
existence of a pentavalent transition state. 
If the "direct methylation" theory is used in explanation of the present results, 
it would appear that more acidic tautomer, rather than the predominant 
tautomer, controls regioselectivity since the product ratios tend to reflect 1/KT. 
Indeed, a correlation is seen to exist between ratios and 1/KT, though it is 
significantly weaker than the corresponding correlation using "neutral" product 
ratios (Figure A2.43). Considering the preponderance of tautomer 11-H in 
solutions of imidazoles bearing electron-withdrawing groups, and methylation 
behaviour in ethanol, this seems a most unlikely rationale. The alternative 
theory, as it stands now, seems even less appropriate. If the imidazole substituent 
is electron-withdrawing, methylation should be directed to the remote nitrogen 
irrespective of the order of substitution; this site is both more nucleophilic and 
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1H nmr spectrum of 4-bromo-1-methylimidazole and deuterated analogue(s) in CDCl3, isolated from.the 
reaction of N-2H enriched 4-bromoimidazole with diazomethane. 







shown. Perhaps, in ethereal solvent, the electron dense withdrawing groups are 
important participants in the stabilisation of the charged species in solution. 
In further examination of regioselectivity, diazomethane product ratios were 
correlated with Hammett substituent constants and the crc parameter sets devised 
in the preceding sections. Figures A2.44 and A2.45 represent the best correlations 
obtainable with the data at hand; O'p constants were found to give best results for 
both the monosubstituted (I) and disubstituted (IV) imidazole reactions. Thus, 
contrary to observation in basic and "neutral" media, it appears that substituent 
electronic control in diazomethane methylation has a substantial resonance 
component. The net effect is an increase in 1,5-methylation as the electron-
withdrawing ability of the substituent increases. Deviations are again noted for 
the bulky substituents, para-chlorophenyl and para-nitrophenyl. Phenylthio and 
methylsulfinyl groups also produce ratios (V: VI) which sit above the respective 
correlation lines, ie. exhibit increased 1-methyl-4-nitro-5-substituted product. 
These deviations are inexplicable, however, in terms of a substituent steric effect. 
Several additional experiments were performed in an attempt to shed a little 
more light on the process of diazomethane methylation as it relates to ambident 
imidazole substrates. The results are ambiguous at best. 
It is clear that for methylation to proceed via either of the proposed 
mechanisms, a proton source must be present. Indeed, reaction of the sodium salt 
of 4-nitroimidazole with ethereal diazomethane was unsuccessful. The observed 
reaction dependence on substrate pKa and the results of a deuterium 
incorporation experiment are consistent with both theories, ie. proton 
abstraction to form associated imidazolate and diazonium ions, and methylene 
insertion. The deuterium incorporation experiment entailed the formation of a 
percentage of the N-deuterated free base of 4-bromoimidazole through solvent 
assisted prototropic exchange in D20. Subsequent drying and reaction with 
ethereal diazomethane produced both N-methyl derivatives, Ilb and Illb, which 
were separated and revealed by nmr to be isotopic mixtures. The lH nmr 
spectrum of the Ilb (isolated by column chromatography as a single band) is 
shown. in Figure 7; the integral of the methyl signal and the appearance of three 
upfield low intensity peaks with 2 Hz separation are indicative of the presence of 
deuterated product. The multiplicity of the deutero signal(s) is difficult to define 
due to the proximity of the dominant methyl singlet of non-deuterated Ilb in the 
spectrum; it probably corresponds to monodeuterated product. However, 
complex multiplicity was observed for the methyl carbon in the proton-
decoupled 13C nmr spectrum of Ilb, which could suggest polydeuteration. 
Absolute confirmation of the species formed in this experiment would require 
mass spectrometric analysis. As stated, incorporation of a single deuterium could 
satisfy either an acid-base equilibrium or a methylene insertion pathway, as 
or 
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shown in Scheme 84. Polydeuteration, on the other hand, would point 
unequivocally to the former : 
Im- + CH2D-N2+ Im-H + CHD-N2 
Im-D + CHD-N2 1m- + CHD2-N2+ etc. 
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All the diazomethane methylations described thus far have utilised 1.1 
stoichiometric equivalents of diazomethane in diethyl ether. When reactions 
were repeated on lb and Ii using excess reagent (usual methodology), the 
methylation ratios altered slightly in favour of the 1,4-substitution product. The 
use of excess lb (ie. 10% equivalent CH2N2), however, caused a much more 
drastic change in product distribution: the ratio Ilb: Illb decreased markedly (1 : 
20 cf. 1 : 2.6 ). In should be noted that in the performance of this experiment it was 
necessary to ensure a homogeneous reaction mixture, and to this end ethanol 
was used to solubilise the substrate. The change in product ratio c.annot be 
attributed solely to solvent variation as subsequent experiments using similar 
reaction media (Et20/EtOH), 1.1 equivalents diazomethane and the substrates, lb 
and Ii, resulted in product ratios nearly identical to those obtained under 
heterogeneous diethyl ether conditions. This behaviour may lend credence to the 
ion-pair theory; if under these conditions the nature of the ion-pairing is such 
that substrate/solvent access to the diazonium ion is appreciable, the observed 
increase in 1,5-methylation could be achieved through significant SN attack of 
unreacted (predominant) tautomer, 11-H, on the diazonium species in 
competition with the imidazole anion. 
Irrespective of the reaction mechanism, the facts remain that (i) substitution is 
predominantly adjacent to an electron-withdrawing group, (ii) ratios appear to 
correlate with O'p substituent constants and to a lesser extent with 1/KT, and (iii) 
product yield is dependent on substrate acidity : imidazoles must have an acid 







3.3.1 Kinetic vs. Thermodynamic Control of N-Alkylation 
All methylated substrates used in the following experiments were prepared 
and purified according to the alkylation experiments described in section 3.3.2. 
Isomer purity was confirmed by lH nmr analysis. 
Usual Workup refer to Usual Workup for alkylation reactions under the 
appropriate conditions (sections 3.3.2 and 3.3.3). 
lsomerisation Experiments 
(i) 'Neutral' conditions 
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4-Bromo-1-methylimidazole (0.100 g, 0.62 mmol) was dissolved in 10 cm3 of 
ethanol. Two equivalents of dimethyl sulfate (0.156 g, 1.24 mmol) were added and 
the mixture was heated under reflux for 2 hours. Usual workup recovered 0.098 g 
(98%) of the substrate. lH nmr analysis showed no trace of isomerised product. 
5-Bromo-1-methylimidazole (0.150 g, 0.99 mniol) was dissolved in 10 cm3 of 
ethanol. Two equivalents of dimethyl sulfate (0.250 g, 1.98 mmol) were added and 
the mixture was heated under reflux for 2 hours. Usual workup recovered 0.126 g 
(84%) of the substrate. lH nmr analysis showed no trace of isomerised product. 
The above experiment was repeated using one equivalent of dimethyl sulfate. 
Substrate recovery was raised to 93%. 
Control 
4-Bromo-, 4-bromo-1-methyl- and 5-bromo-1-methyl-imidazole were 
individually dissolved in ethanol and heated under reflux for 2 hours. Recovery 








A mixture containing 5-bromo-1-methyl- and 4-bromo-1-methyl-imidazole 
(0.138 g, 0.86 mmol) in known ratio, was dissolved in 10 cm3 ethanql. One 
equivalent of dimethyl sulfate (0.108 g, 0.86 mmol) was added and the solution 
was heated under reflux for 2 hours. Upon usual workup, 0.119 g (87%) of an 
isomeric mixture was recovered. 
Isomer ratios (4-bromo-1-methyl- : 5-bromo-1-methyl-imidazole) 
Initial mixture: 1.7: 1 
Recovered mixture: 1.9: 1. 
(ii) Basic conditions 
4-Bromo-1-methylimidazole (0.084 g, 0.52 mmol) was added to a stirred 
solution of 10% aqueous sodium hydroxide. Two equivalents of dimethyl sulfate 
(0.132 g, 1.04 mmol) were added and the heterogeneous mixture was stirred at 
room temperature for 2 hours. Usual workup recovered 0.050 g (60%) of the 
substrate. lH nmr analysis showed no trace of isomerised product. 
The above experiment was repeated using one equivalent of dimethyl sulfate. 
Substrate recovery was raised to 83%. 
5-Bromo-1-methylimidazole (0.090 g, 0.56 mmol) was added to a stirred 
solution of 10% aqueous sodium hydroxide. Two equivalents of dimethyl sulfate 
(0.141 g, 1.12 mmol) were added and the heterogeneous mixture stirred at room 
temperature for 2 hours. Usual workup recovered 0.050 g (56%) of the substrate. 
lH nmr analysis showed no trace of isomerised product. 
The above experiment was repeated using one equivalent of dimethyl sulfate. 
Substrate recovery was raised to 78%. 
Control 
4-Bromo-, 4-bromo-1-methyl-, 5-bromo-l-methyl-, 5-bromo-4-nitro-, 5-bromo-
1-methyl-4-nitro- and 4-bromo-1-methyl-4-nitro-imidazole were individually 
subjected to 2 hours stirring at room temperature in 10 cm3 of 10% sodium 










A mixture containing 5-bromo-1-methyl- and 4-bromo-1-methyl-imidazole 
(0.071 g, 0.44 mmol) in known ratio, was added to 10 cm3 of 10% aqueous sodium 
hydroxide solution. One equivalent of dimethyl sulfate (0.056 g, 0.44 mmol) was 
added and the heterogeneous mixture stirred at room temperature for 2 hours. 
Upon usual workup, 0.058 g (82%) of an isomeric mixture was recovered. 
Isomer ratios (4-bromo-1-methyl- : 5-bromo-1-methylimidazole) 
Initial mixture : 1.9 : 1 
Recovered mixture : 2.1 : 1. 
Reagent susceptibility to solvolysis 
"Neutral" Conditions 
Dimethyl sulfate (0.040 g), D6-ethanol (100 µ1) and CDCl3 (600 µ1) were placed in 
a 5 mm nmr tube. The tube was sealed and heated at 70-80°C for 2 hours. Detailed 
nmr analysis (lH, 13C, COSY, HETCOR) revealed that 45% of the reagent was 
destroyed in this period and the following by-products were produced : 
Ethyl methyl ether 
Nmr OH 1.20 (3H, t, CfuCH20CH3), 3.34 (3H, s, CH3CH20Cfu), 3.46 (2H, q, 
CH3CfuOCH3); 8c 14.7 ~H3CH20CH3), 57.9 (CH3CH20CH3), 67.9 
(CH3CH20CH3) . 
Ethyl methyl sulfate 
Nmr OH 1.33 (3H, t, CfuCH20S020CH3), 3.45 (3H, s, CH3CH20S020Cfu), 4.15 
(2H, q, CH3CfuOS020CH3); oc 14.6 ~H3CH20S020CH3), 49.7 
(CH3CH20S020CH3), 64.8 (CH3CH20S020CH3). 
Basic Conditions 
Dimethyl sulfate (0.250 g) was added to 10 cm3 of 10% aqueous sodium 
hydroxide solution and the heterogeneous mixture was stirred at room 
temperature for 2 hours. After the addition of 50 cm3 of water the mixture was 







dried over anhydrous magnesium sulfate, and evaporated under reduced 
pressure to yield 0.028 g (11%) of unchanged reagent. 
Ratio Determination after Few Percent Conversion. 
"Neutral" Conditions 
A 4-Bromoimidazole (0.500 g, 3.40 mmol) was dissolved in 20 cm3 of 
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ethanol. Dimethyl sulfate (1.1 equivalents, 0.472 g, 3.74 mmol) was added and the 
solution brought to reflux temperature. At this point, 10 cm3 of the solution was 
removed and worked up as usual for ratio determination (0.044 g; 16% 
conversion). The remainder of the solution was heated under reflux for 2 hours 
and worked up subsequently to yield 0.159 g (58% conversion) of an isomeric 
mixture. 
Isomer ratios (4-bromo-1-methyl- : 5-bromo-1-methylimidazole) 
16 percent conversion : 1 : 11.8 
2 hours reflux : 1 : 11.6 
B 4-Bromoimidazole (0.020 g, 0.14 mmol), D6-ethanol (750 µ1) and 
dimethyl sulfate (1.1 equivalents, 0.019 g, 0.15 mmol) were added to a 5 mm nmr 
tube. A periodic aquisition delay experiment was set up whereby lH nmr spectra 
were recorded at 5 min intervals for 1 hour, and 15 min intervals for a further 4 
hours. The sample was maintained at 298 K throughout the experiment. 
Time interval Percent Conversion Isomer Ratio B 
/min (%) 
30A 8 1: 12.5 
60 17 1: 12.1 
90 23 1: 11.2 
120 25 1: 11.3 
180 29 1: 11.5 
240 33 1: 11.2 
300C 38 1: 11.4 
A During the time interval 0-30 min, ratios could not be determined since-the nmr signal of the 
minor isomer was not above threshold. 
B 4-Bromo-1-methyl- : 5-bromo-1-methylimidazole. 







C 4-Methylimidazole (0.020 g, 0.24 mmol), D6-ethanol (750 µ1) and 
dimethyl sulfate (1.1 equivalents, 0.031 g, 0.27 mmol) were added to a 5 mm nmr 
tube. A periodic aquisition delay experiment was set up whereby lH nmr spectra 
were recorded at 5 min intervals for 1 hour, and 15 min intervals for a further 4 
hours. The sample was maintained at 298 K throughout the experiment. 
Time interval Percent Conversion Isomer Ratio A 
/min (%) 
5 7 1.4: 1 
10 15 1.4:1 
15 17 1.4: 1 
20 20 1.4: 1 
30 30 1.4:1 
60 34 1.4: 1 
120 38 1.4: 1 
180 39 1.4: 1 
300 B 40 1.4: 1 
A 1,4-Dimethyl- : 1,5-dimethylimidazole. 
B Dimethyl sulfate signal intensity less than 5% of original. 
Basic Conditions 
4-Bromoimidazole (0.250 g, 1.70 mmol) was dissolved in a solution comprising 
15 cm3 of 10% aqueous sodium hydroxide and 5 cm3 methanol. Methanol was 
added in this instance to solubilise the products in the reaction medium. 
Dimethyl sulfate (1.1 equivalents, 0.236 g, 1.87 mmol) was added and the mixture 
was stirred at room temperature for the requisite 2 hour period. 4 cm3 samples 
were taken at various time intervals and worked up as usual for ratio 
determination. 
Time interval Percent Conversion Isomer Ratio A 
/min (%) 
5 12 2.2: 1 
10 22 2.2: 1 
15 39 2.2: 1 
30 44 2.2: 1 
120 52 2.3: 1 








Excess Dimethyl Sulfate 
4-Bromoimidazole (0.200 g, 1.36 mmol) was dissolved in 10 cm3 of 10% 
aqueous sodium hydroxide solution. 5 Equivalents of dimethyl sulfate (0.858 g, 
6.80 mmol) were added and the heterogeneous mixture stirred 2 hours. Usual 
workup produced an isomeric mixture in 35% yield (0.060 g). Unchanged starting 
material was recovered by neutralising (with cone. HCl) and subsequently 
evaporating the aqueous solution to dryness under reduced pressure. Extraction 
of the residue with ethanol (3 x 50 cm3), gave, after drying and solvent removal, 
ca. 18% unchanged 4-bromoimidazole. 
Isomer ratio : 3.9: 1 (4-bromo-1-methyl-: 5-bromo-1-methylimidazole). 
1 H nmr analysis of the remaining aqueous residue revealed the presence of an 
imidazole product, likely in the form of a 4-bromo-1,3-dimethylimidazolium salt : 
8H (D20) 4.12 (3H, s, NCH3), 4.19 (3H, s, NCH3), 7.89 (1H, s, H-5), 8.85 (lH, br s, 
H-2). 
4- 4-bromo-1,3-dimethylimidazolium tosylate 349 
8H (D20) 3.80 (3H, s, NCH3), 3.88 (3H, s, NCH3), 7.58 (1H, d 0-H(S)H(2) = 1.9 Hz), 
H-5), 8.82 (1H, br s, H-2). 
10% Dimethyl Sulfate 
4-Bromoimidazole (2.00 g, 13.6 mmol) was dissolved in 20 cm3 of 10% aqueous 
s,odium hydroxide solution. 10% Equivalent of dimethyl sulfate (0.172 g, 1.36 
mmol) was added and the heterogeneous mixture stirred 2 hours. Usual workup 
produced an isomeric mixture in 6% yield (0.060 g). 
Isomer ratio: 2.4: 1 (4-bromo-1-methyl- :-5-bromo-1-methylimidazole). 
3.3.2 N-Alkylation in Basic Medium 
General Procedure for Alkylation of Unsymmetrical Imidazoles under Basic 
Conditions 
149 
To a solution of an appropriate 4-substituted or 4,5-disubstituted imidazole 
(0.250 g) in 10% NaOH (10 cm3), was added 1.1 stoichiometric equivalents of 
freshly distilled alkylating agent (dimethyl sulfate, diethyl sulfate, or benzyl 
chloride). The heterogeneous mixture was then stirred at ambient temperature 
for 2 hours. 
4(5)-Phenyl- and para- substituted phenylimidazoles 
Alkylations of 4(5)-phenylimidazole and related para - substituted 
phenylimidazoles were performed in ethanolic sodium ethoxide medium since 
these substrates are only slightly soluble in aqueous NaOH. 1.2 Molar equivalents 
of base (NaOEt in 10 cm3 EtOH) were used throughout and the reaction mixture 
was similarly stirred 2 hours at ambient temperature. 
Usual Workup 
The reaction mixture was acidified by the addition of 10% HCl (50cm3) and 
then extracted with diethyl ether (3 x 30 cm3) to remove unreacted alkylating 
reagent. The aqueous solution was then basified by the addition of solid sodium 
carbonate, and finally extracted with CH2Cl2 (4 x 30 cm3). The combined CH2Ch 
extracts were washed with water (30 cm3) before being dried over anhydrous 
MgS04. Solvent removal by evaporation under reduced pressure yielded a 
mixture of isomeric N-alkylated products which was analysed by lH NMR 
spectroscopy. The yields quoted are of unpurified material unless otherwise 
stated. 
4(5)-Phenyl- and para- substituted phenyl-imidazoles 
The reaction mixture was concentrated under reduced pressure and acidified 
by the addition of 10% HCl (100 cm3). Work up continued as above. 
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Isomer Ratio Determinations / Yields 
Isomer ratios were determined by analysis of the isomeric peak integrations as 
described in section 3.2.2. The ratios quoted for methylations are the mean of at 
least two reactions. The yields also, are given as averages for the crude alkylation 
mixtures. Full characterisation of the methylation products was achieved where 
possible. Ethylation and benzylation products were characterised by 1 H nmr only. 
3.3.2.1 4(5)-Substituted Imidazoles (I) 
4(5)-Chloroimidazole (Ia) 
Methylation 
Usual workup produced an oil containing the isomers, 4-chloro-1-methyl- and 
5-chloro-1-methylimidazole in 58% yield. 
Isomer Ratio : 3.0 : 1 (4-chloro-1-methyl-: 5-chloro-1-methylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 2% EtOAc/CH2Cl2), and purified by vacuum distillation. 
4-Chloro-1-methy limidazole 
Anal. Found C, 40.9; H, 4.2; N, 23.7%. C4H5N2Cl requires C, 41.2; H, 4.3; N, 
.. 
24.0%. Nmr CH (CDCl3) 3.66 (3H, s, 1-Cfu), 6.79 (1H, d <JHCS)H(2) = 1.5 Hz), H-5), 
7.27 (1H, d <JH(2)H(5) = 1.5 Hz), H-2); CC (CDCl3) 33.9 (Q (lJcH = 141 Hz), 1-CH3), 
115.9 (br Dm (1JcH"'" 194 Hz), C-5), 129.3 (dd (Jc(4)C(S)H = 14.1 Hz, JC(4)C(2)H = 7.1 
Hz), C-4), 136.1 (br Dm (lJcH"'" 213 Hz), C-2). 
5-Chloro-1-meth ylimidazole 
Anal. Found C, 41.0; H, 4.3; N, 23.8%. C4H5N2Cl requires C, 41.2; H, 4.3; N, 
24.0%. Nmr CH (CDCl3) 3.59 (3H, s, 1-Cfu), 6.92 (1H, br s, H-4), 7.45 (1H, br s, H-2); 
cc (CDCl3) 31.5 (Q (lJcH = 142 Hz), 1-CH3), 118.3 (br) (br m, C-5), 126.0 (br) (br Dm 













Usual workup produced an oil containing the isomers, 4-chloro-1-ethyl- and 5-
chloro-1-ethylimidazole in 57% yield. 
Isomer Ratio: 3.2: 1 (4-chloro-1-ethyl-: 5-chloro-1-ethylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 2% Et0Ac/CH2Cb). 
4-Chloro-1-ethylimidazole 
Nmr 8H (CDCl3) 1.45 (3H, t (J = 7.3 Hz), l-CH2Cfu), 3.95 (2H, q (J = 7.5 Hz), l-
CfuCH3), 6.84 (lH, s, H-5), 7.34 (lH, s, H-2). 
5-Chloro-1-ethylimidazole 
Nmr 8H (CDCl3) 1.43 (3H, t (J = 7.2 Hz), l-CH2Cfu), 3.98 (2H, q (J = 7.2 Hz), l-
CfuCH3), 6.97 (lH, br s, H-4), 7.55 (lH, br s, H-2). 
Benzylation 
Usual workup produced an oil containing the isomers, 1-benzyl-4-chloro- and 
1-benzyl-5-chloroimidazole in 48% yield. 
Isomer Ratio : 2.4 : 1 (1-benzyl-4-chloro-: l-benzyl-5-chloroimidazole). 
The isomers were separated as colourless solids by radial chromatography 
(eluent: 1% MeOH/4% Et0Ac/CH2Cb). 
1-Benzyl-4-chloroimidazole 
Nmr 8H (CDCl3) 5.06 (2H, s, 1-CfuPh), 6.79 (lH, d (Jc(5)C(2)H = 1.4 Hz), H-5), 
7.15-7.21 (2H, m, H-2',6'), 7.35-7.43 (4H, m, H-3',5', H-4'; (7.41, d (Jc(2)C(5)H = 1.4 
Hz), H-2)). 
1-Benzyl-5-chloroimidazole 
M. pt. 58-59°C. Nmr 8H (CDC!J) 5.09 (2H, s, 1-CfuPh), 6.99 (lH, br s, H-4), 7.12-














Usual workup produced an oil containing the isomers, 4-bromo-1-methyl- and 
5-bromo-1-methylimidazole in 45% yield. Approximately 42% starting material 
was recovered. 
Isomer Ratio : 2.6: 1 (4-bromo-1-methyl-: 5-bromo-1-methylimidazole). 
The isomers were separated by column chromatography (alumina, eluent : 2% 
EtOAc/CH2Cl2), and purified by vacuum distillation. 
4-Bromo-1-meth ylimidazole 
Oil. Anal. Found C, 29.7; H, 3.2; N, 17.3%. C4H5N2Br requires C, 29.8; H, 3.1; 
N, 17.4%. Nmr OH (CDCl3) 3.68 (3H, s, 1-Cfu), 6.87 (lH, s, H-5), 7.32 (1H, s, H-2); 
oc (CDCl3) 33.9 (Q (lJcH = 140 Hz), l-CH3), 115.0 (m, C-4), 119.4 (br D (lJcH = 197 
Hz), C-5), 137.4 (br D (lJcH = 210 Hz), C-2). 
5-Bromo-1-methylimidazole 
M. pt. 42°C (lit m. pt. 45-46°C 407). Anal. Found C, 29.6; H, 3.0; N, 17.2%. 
C4H5N2Br requires C, 29.8; H, 3.1; N, 17.4%. Nmr OH (CDCl3) 3.62 (3H, s, l-CH3), 
7.00 (lH, s, H-4), 7.53 (lH, s, H-2); oc (CDCl3) 32.6 (Q (lJcH = 149 Hz), l-CH3), 103.7 
(br m, C-5), 129.5 (Dd (lJcH = 196 Hz, JC(4)C(2)H = 9.6 Hz), C-4), 138.3 (Dm (lJcH = 
210 Hz), C-2). 
Ethylation 
Usual workup produced an oil containing the isomers, 4-bromo-1-ethyl- and 5-
bromo-1-ethylimidazole in 42 % yield. 
Isomer Ratio : 3.2: 1 (4-bromo-1-ethyl-: 5-bromo-1-ethylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 1 % Et0Ac/CH2Cl2). 
4-Bromo-1-eth ylimidazole 
Nmr OH (CDCl3) 1.44 (3H, t (J = 7.5 Hz), l-CH2Cfu), 3.97 (2H, q (J = 7.5 Hz), l-












Nmr 8H (CDCl3) 1.43 (3H, t (J = 7.2 Hz), l-CH2Cfu), 3.99 (2H, q (J = 7.2 Hz), l-
CfuCH3), 7.01 (lH, br s, H-4), 7.59 (lH, br s, H-2). 
Benzylation 
Usual workup produced an oil containing the isomers, 1-benzyl-4-bromo- and 
1-benzyl-5-bromoimidazole in 44% yield. 
Isomer Ratio : 1.6 : 1 (1-benzyl-4-bromo-: 1-benzyl-5-bromoimidazole). 
The isomers were separated by radial chromatography (eluent : 1 % MeOH/ 4% 
EtOAc/ CH2Cb). 
1-Benzyl-4-bromoimidazole 
Colourless needles. M. pt. 88-89°C (lit. m. pt. 91-93°C 238). Nmr 8H (CDCl3) 
5.05 (2H, s, 1-CfuPh), 6.84 (lH, d CJH(S)H(2) = 1.4 Hz), H-5), 7.14-7.18 (2H, m, (HETC) 
H-2',6'), 7.31-7.38 (3H, m, (HETC) H-3',5', H-4'), 7.40 (lH, d <JH(2)H(5) = 1.5 Hz), H-
2); 8c (CDCl3) 51.3 (Tdd (1JcH = 140 Hz, JCH2C(2)H"" JCH2C(S)H) ""4.6 Hz), l-
CH2Ph), 115.4 (dd CJCC4)C(S)H = 14.1 Hz, Jc(4)C(2)H = 7.5 Hz), C-4), 118.4 (Ddt (1JcH = 
196 Hz, Jc(S)C(2)H ""JC(S)CH2"" 3.2 Hz)), C-5), 127.5 (Dm (1JcH = 159 Hz), C-2',6'), 
128.5 (Dt (lJcH = 161 Hz, 3JcH = 7.3 Hz), C-4'), 129.0 (Dd <1JcH = 160 Hz, 3JcH = 7.2 
Hz), C-3',5'), 135.1 (m, C-1'), 136.8 (Ddt (lJcH = 210 Hz, JC(2)C(5)H"" 7.2 Hz, JC(2)CH2 
""3.6 Hz), C-2). 
1-Benzyl-5-bromoimidazole 
Colourless solid. M. pt. 72°C (lit. m. pt. 74-75°C 238) Nmr 8H (CDCl3) 5.11 (2H, 
s, 1-CfuPh), 7.07 (lH, br s, H-4), 7.12-7.15 (2H, m, (HETC) H-2',6'), 7.29-7.40 (3H, m, 
(HETC) H-3',5', H-4'), 7.57 (lH, br s, H-2); 8c (CDCl3) 49.5 (T (lJcH = 141 Hz), l-
CH2Ph), 103.5 (br) (m, C-5), 127.1 (Dm (lJcH = 159 Hz), C-2',6') 128.3 (Dt (lJcH = 160 
Hz, 3JcH = 6.9 Hz), C-4'), 129.0 (Dd (lJcH = 160 Hz, 3JcH = 7.0 Hz), C-3',5'), 129.9 (Dd 















Usual workup produced an oil containing the isomers, 4-iodo-1-methyl- and 5-
iodo-1-methylimidazole in 52% yield. 
Isomer Ratio: 1.4: 1 (4-iodo-1-methyl-: 5-iodo-1-methylimidazole). 
The isomers were separated by column chromatography (alumina, eluent: 2% 
EtOAc/CH2Cl2). 4-Iodo-1-methylimidazole was purified by vacuum distillation; 
5-iodo-1-methylimidazole was purified by vacuum sublimation. 
4-lodo-1-methylimidazole 
Anal. Found C, 22.9; H, 2.3; N, 13.2%. C4H5N 2I requires C, 23.1; H, 2.4; N, 
13.5%. Nmr OH (CDCl3) 3.69 (3H, s, 1-Cfu), 6.97 (1H, d <JH(S)H(2) = 1.3 Hz), H-5), 
7.33 (1H, br s, H-2); oc (CDCb) 33.5 (Q (1JcH = 139 Hz), 1-CH3), 81.2 (dd <Jc(4)C(S)H 
= 13.8 Hz, JC(4)C(2)H = 8.8 Hz), C-4), 125.5 (Dm (1 JcH = 194 Hz), C-5), 139.2 (Dm 
(lJcH = 208 Hz), C-2). 
5-Iodo-1-methylimidazole 
M. pt. 103°C (lit. m. pt. 102-103°C 266). Anal. Found C, 23.1; H, 2.3; N, 13.3% . 
C4H5N2I requires C, 23.1; H, 2.4; N, 13.5%. Nmr OH (CDCl3) 3.61 (3H, s, 1-Cfu), 
7.13 (1H, br s, H-4), 7.63 (1H, br s, H-2); oc (CDCl3) 34.8 (Q (lJcH = 141 Hz), l-CH3), 
70.7 (br) (br m, C-5), 137.0 (br) (Dd (lJcH = 197 Hz, JC(4)C(2)H = 10.0 Hz), C-4), 140.0 
(br) (br Dm <1JcH ~ 208 Hz), C-2) . 
Ethylation 
Usual workup produced an oil containing the isomers, 1-ethyl-4-iodo- and 1-
ethyl-5-iodoimidazole in 52% yield. 
Isomer Ratio : 1.7: 1 (1-ethyl-4-iodo-: 1-ethyl-5-iodoimidazole). 
The isomers were separated by column chromatography (alumina, eluent : 2% 
EtOAc/CH2Cli), 1-ethyl-4-iodoimidazole as an oil, 1-ethyl-5-iodoimidazole as a 















Nmr 8H (CDCl3) 1.46 (3H, t (J = 7.3 Hz), l-CH2Cfu), 3.99 (2H, q (J = 7.3 Hz), l-
CfuCH3), 7.02 (lH, d (Jc(S)C(2)H = 1.4 Hz), H-5), 7.41 (lH, br s, H-2). 
1-Ethyl-5-iodoimidazole 
Nmr 8H (CDCl3) 1.45 (3H, t (J = 7.2 Hz), 1-CH2Cfu), 4.01 (2H, q (J = 7.3 Hz), 1-
CfuCH3), 7.20 (lH, br s, H-4), 7.92 (1H, br s, H-2). 
Benzylation 
Usual workup produced an solid residue containing the isomers, 1-benzyl-4-
iodo- and 1-benzyl-5-iodoimidazole in 45% yield. 
Isomer Ratio: 2.0 : 1 (1-benzyl-4-iodo-: 1-benzyl-5-iodoimidazole). 
The isomers were separated as colourless solids by radial chromatography 
(eluent: 1 % MeOH/ 4% Et0Ac/CH2Cb). 
1-Benzyl-4-iodoimidazole 
M. pt. 101-102.5°C. Nmr 8H (CDCl3) 5.09 (2H, s, 1-CfuPh), 6.98 (1H, d 
(Jc(5)C(2)H = 1.2 Hz), H-5), 7.14-7.20 (2H, m, H-2',6'), 7.32-7.41 (3H, m, H-3',5', H-4'), 
7.52 (1H, d (JC(2)C(5)H = 1.2 Hz), H-2). 
1-Benzyl-5-iodoimidazole 
M. pt. 94-95.5°C. Nmr 8H (CDCl3) 5.11 (2H, s, 1-CfuPh), 7.08-7.15 (2H, m, H-
2',6'), 7.17 (1H, br s, H-4), 7.29-7.39 (3H, m, H-3',5', H-4'), 7.65 (lH, br s, H-2). 
4(5)-Methylimidazole (Id) 
Methylation 
Usual workup produced an oil containing the isomers, 1,4-dimethyl- and 1,5-
dimethylimidazole in 58% yield. 
Isomer Ratio : 1.2 : 1 (1,4-dimethyl- : 1,5-dimethylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 2% MeOH/8% EtOAc/10% CH2Cl2/Hexane), or radial chromatography 












Anal. Found C, 62.2; H, 8.6; N, 28.7%. C5HsN2 requires C,62.5; H, 8.4; N, 29.1 %. 
Nmr 8H (CDCl3) 2.20 (3H, s, 4-Cfu), 3.61 (3H, s, 1-Cfu), 6.59 (lH, d (JH(S)H(2) = 1.3 
Hz), (HETC) H-5), 7.30 (lH, br s, (HETC) H-2); 8c (CDCl3) 13.4 (Q (lJcH = 127 Hz), 
4-CH3), 33.1 (Q (lJcH = 140 Hz), l-CH3), 116.6 (Dm (lJcH = 186 Hz), C-5), 136.8 (Dm 
(lJcH""' 204 Hz), C-2), 138.2 (m, C-4). 
1,5-Dimethylimidazole 
Anal. Found C, 62.3; H, 8.6; N, 28.8%. C5HsN2 requires C,62.5; H, 8.4; N, 29.1 %. 
Nmr 8H (CDCl3) 2.18 (3H, s, 5-Cfu), 3.53 (3H, s, l-CH3), 6.76 (lH, br s, H-4), 7.36 
(lH, br s, H-2); 8c (CDCl3) 8.9 (Q (lJcH = 128 Hz), 5-CH3), 31.0 (Q <1JcH = 137 Hz), 
l-CH3), 126.5 (br Dm (lJcH""' 186 Hz), C-4), 127.5 (br) (m, C-5), 137.2 (br) (br Dm 
(lJcH > 200 Hz), C-2). 
Ethylation 
Usual workup produced an oil containing the isomers, 1-ethyl-4-methyl- and 
1-ethyl-5-methylimidazole in 52% yield. 
Isomer Ratio : 1.3 : 1 (1-ethyl-4-methyl- : 1-ethyl-5-methylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 2% MeOH/8% EtOAc/10% CH2Cli/Hexane). 
1-Ethyl-4-methylimidazole 
Nmr 8H (CDCl3) 1.41 (3H, t (J = 7.4 Hz), l-CH2Cfu), 2.21 (3H, d (J = 1.0 Hz), 4-
Cfu), 3.90 (2H, q (J = 7.4 Hz), l-CfuCH3), 6.63 (lH, d (J = 1.3 Hz), H-5), 7.35 (lH, br s, 
H-2). 
1-Ethyl-5-methylimidazole 
Nmr 8H (CDCl3) 1.38 (3H, t (J = 7.4 Hz), l-CH2Cfu), 2.19 (3H, d (J = 1.0 Hz), 5-
Cfu), 3.87 (2H, q (J = 7.4 Hz), l-CfuCH3), 6.75 (lH, d (J = 1.0 Hz), H-4), 7.41 (lH, br s, 
H-2). 
Benzylation 
Usual workup produced an oil containing the isomers, 1-benzyl-4-methyl- and 









Isomer Ratio : 1.7: 1 (1-benzyl-4-methyl-: 1-benzyl-5-methylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 2% MeOH/8% EtOAc/10% CH2Ch/Hexane). 
1-Benzyl-4-methylimidazole 
Nmr 8H (CDCl3) 2.22 (3H, s, 4-CH3), 5.05 (2H, s, 1-CfuPh), 6.61 (lH, s, H-5), 
7.14-7.18 (2H, m, H-2',6't 7.28-7.38 (3H, m, H-3',5', H-4'), 7.47 (lH, s, H-2). 
1-Benzyl-5-methylimidazole 
157 
Nmr 8H (CDCl3) 2.12 (3H, s, 5-CH3), 5.07 (2H, s, 1-CfuPh), 6.86 (lH, br s, H-4t 
7.04-7.06 (2H, m, H-2\6'), 7.27-7.37 (3H, m, H-3\5\ H-4t 7.51 (lH, br s, H-2). 
4(5)-Hydroxymethylimidazole (le) 
Methylation 
4(5)-Hydroxymethylimidazole (0.250 g, 2.55 mmol) was dissolved in ethanolic 
NaOEt (3.06 mmol, 0.070 g-atoms Na metal in 10 cm3 EtOH). Me2S04 (0.354 g, 2.80 
mmol) was added and the solution stirred at room temperature for 2 hours. 
Workup proceeded as for the phenylimidazoles. In the final extraction step, the 
basified aqueous solution was presaturated with sodium chloride. An oil was 
produced containing the isomers, 4-hydroxymethyl-1-methyl- and 5-
hydroxymethyl-1-methylimidazole (8%) in conjunction with the by-products of 
exocyclic alkylation, 4-methoxymethyl-1-methyl- and 5-methoxymethyl-1-
methylimidazole (4%) in 13% overall yield. The ratio of isomeric products to 
isomeric by-products, as determined by Nmr, was approximately 2: 1. (Recovered 
starting material showed no evidence of 4(5)-methoxymethylimidazole). 
Isomer Ratios: 1.2: 1 (4-hydroxymethyl-1-methyl-: 5-hydroxymethyl-1-
methylimidazole); 1 : 1.5 (4-methoxymethyl-1-methyl- : 5-methoxymethyl-1-
methylimidazole). 
Both the isomeric hydroxymethyl products and methoxymethyl by-products 
were observed to have identical Rf values irrespective of the solvent system and 
support (silica or alumina) used. Thus the N-methylated hydroxymethyl and 
methoxymethyl isomeric pairs were isolated as oily mixtures by radial 









Nmr OH (CDCl3) 3.65 (3H, s, 1-Cfu), 4.54 (2H, s, 4-CfuOH), 6.83 (1H, s, H-5), 
7.35 (1H, s, H-2). 
5-Hydroxymethyl-1-methylimidazole 
Nmr OH (CDCl3) 3.69 (3H, s, 1-Cfu), 4.60 (2H, s, 5-CfuOH), 6.87 (1H, s, H-4), 
7.38 (1H, s, H-2). 
4-Methoxymethyl-1-methylimidazole 
Nmr OH (CDCl3) 3.41 (3H, s, 4-CH20CH3), 3.66 (3H, s, l-CH3), 4.40 (2H, s, 4-
CfuOCH3), 6.87 (lH, s, H-5), 7.39 (lH, s, H-2). 
5-Methoxymethyl-1-methylimidazole 
Nmr OH (CDCl3) 3.31 (3H, s, S-CH20CH3), 3.66 (3H, s, l-CH3), 4.42 (2H, s, 4-
CfuOCH3), 7.02 (1H, s, H-4), 7.47 (lH, s, H-2). 
Ethylation 
158 
4(5)-Hydroxymethylimidazole (0.250 g, 2.55 mmol) was dissolved in ethanolic 
NaOEt (3.06 mmol, 0.070 g-atoms Na metal in 10 cm3 EtOH). Et2S04 (0.432 g, 2.80 
mmol) was added and the solution stirred at room temperature for 2 hours. 
Workup proceeded as for the phenylimidazoles. In the final extraction step, the 
basified aqueous solution was presaturated with sodium chloride. An oil was 
produced containing the isomers, 1-ethyl-4-hydroxymethyl-and 1-ethyl-5-
hydroxymethylimidazole (6%) in conjunction with the by-products of exocyclic 
alkylation, 4-ethoxymethyl-1-ethyl- and 5-ethoxymethyl-1-ethylimidazole (6%) in 
12% overall yield. The ratio of isomeric products to isomeric by-products, as 
determined by nmr, was approximately 1: 1. 
Isomer Ratios : 1.7: 1 (1-ethyl-4-hydroxymethyl-: 1-ethyl-5-
hydroxymethylimidazole); 1 : 1 (4-ethoxymethyl-1-ethyl- : 5-ethoxymethyl-1-
ethylimidazole). 
Analogously to the products of methylation above, the isomeric 
hydroxymethyl products and ethoxymethyl by-products were separated as oily 
mixtures of isomeric pairs by radial chromatography (eluent : 5% MeOH/5% 












Nmr OH (CDCl3) 1.44 (3H, t (J = 7.3 Hz), l-CH2Cfu), 3.94 (2H, q (J = 7.4 Hz), l-
CfuCH3), 4.55 (2H, s, 4-CfuOH), 6.88 (lH, s, H-5), 7.40 (lH, s, H-2). 
1-Ethyl-5-hydroxymethylimidazole 
Nmr OH (CDCl3) 1.45 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.06 (2H, q (J = 7.3 Hz), l-
CfuCH3), 4.60 (2H, s, 5-CfuOH), 6.85 (lH, s, H-4), 7.44 (lH, s, H-2). 
4-Ethoxymethyl-1-ethylimidazole 
Nmr OH (CDCl3) 1.24 (3H, t (J = 7.0 Hz), O-CH2CH3), 1.44 (3H, t (J = 7.3 Hz), l-
CH2Cfu), 3.60 (2H, q (J = 7.0 Hz), O-CfuCH3), 3.95 (2H, q (J = 7.3 Hz), l-CfuCH3), 
4.44 (2H, s, 4-CfuOEt), 6.92 (lH, s, H-5), 7.43 (lH, s, H-2). 
5-Ethoxymethyl-1-ethylimidazole 
Nmr OH (CDCl3) 1.20 (3H, t (J = 7.0 Hz), O-CH2CH3), 1.45 (3H, t (J = 7.3 Hz), l-
CH2Cfu), 3.47 (2H, q (J = 7.0 Hz), O-CfuCH3), 4.02 (2H, q (J = 7.3 Hz), l-CfuCH3), 
4.46 (2H, s, 4-CfuOEt), 6.98 (lH, s, H-5), 7.51 (lH, s, H-2). 
Benzylation 
4(5)-Hydroxymethylimidazole (0.250 g, 2.55 mmol) was dissolved in ethanolic 
NaOEt (3.06 mmol, 0.070 g-atoms Na metal in 10 cm3 EtOH). PhCH2Cl (0.355 g, 
2.80 mmol) was added and the solution stirred at room temperature for 2 hours. 
Workup proceeded as for the phenylimidazoles. In the final extraction step, the 
basified aqueous solution was presaturated with sodium chloride. An oil was 
produced containing the isomers, 1-benzyl-4-hydroxymethyl- and 1-benzyl-5-
hydroxymethylimidazole in 8% combined yield. 
Isomer Ratios: 2.1: 1 (1-benzyl-4-hydroxymethyl-: 1-benzyl-5-
hydroxymethylimidazole). 
The isomers, indistinguishable by tlc, were isolated together as an oily mixture 
by radial chromatography (5% MeOH/ 5% EtOAc/ CH2Ch). 
1-Benzyl-4-hydroxymethylimidazole 
Nmr OH (CDCl3) 4.52 (2H, s, 4-CfuOH), 4.97 (2H, s, 1-CfuPh), 6.80 (lH, s, H-5), 











Nmr OH (CDCl3) 4.44 (2H, s, 5-CfuOH), 5.15 (2H, s, 1-CfuPh), 6.85 (lH, s, H-4), 
7.34 (lH, s, H-2). 
Imidazole-4(5}-carbaldehyde (If) 
Methylation 
Usual workup produced an oil containing the isomers, 1-methylimidazole-4-
and 1-methylimidazole-5-carbaldehyde in 24% combined yield. 
Isomer Ratio : 1 : 1 (1-methylimidazole-4- : 1-methylimidazole-5-
carbaldehyde). 
The isomers were separated as colourless crystalline materials by radial 
chromatography (eluent: 4% MeOH/CH2Cl2). Purification was achieved by 
vacuum sublimation. 
1-Methylimidazole-4-carbaldehyde 
M.pt. 64-65°C (lit. m. pt. 65-66.5°C 344). Anal. Found C, 54.5; H, 5.4; N, 25.6%. 
C5H~20 requires C, 54.5; H, 5.5; N, 25.4%. Nmr OH (CDCl3) 3.79 (3H, s, 1-Cfu), 
7.55 (lH, br s, (HETC) H-2), 7.62 (lH, d CJH(5)H(2) = 1.1 Hz), (HETC) H-St 9.86 (lH, s, 
4-CHO); oc (CDCl3) 34.0 (Q (lJcH = 141 Hz), l-CH3), 125.6 (Dm (lJcH = 191 Hz), C-
S), 139.5 (Dm (lJcH = 209 Hz), C-2), 142.5 (m, C-4), 186.1 (D (lJcH = 176 Hz), 4-CHO). 
1-Methylimidazole-5-carbaldehyde 
M.pt. 54-55°C (lit. m. pt. 53-54°C 358). Anal. Found C, 54.3; H, 5.4; N, 25.6%. 
C5H~20 requires C, 54.5; H, 5.5; N, 25.4%. Nmr OH (CDCl3) 3.96 (3H, s, 1-Cfu), 
7.65 (lH, br s, (HETC) H-2), 7.79 (lH, br s, (HETC) H-4), 9.78 (lH, d (0.9 Hz), 5-CHO); 
oc (CDCl3) 34.2 (Q (lJcH = 143 Hz), l-CH3), 131.7 (m, C-5), 143.3 (Dd (lJcH = 191 Hz, 
JC(4)C(2)H = 10.1 Hz), C-4t 144.2 (Dm (1JcH"" 210 Hz), C-2), 179.5 (D (lJcH = 178 Hz), 
5-CHO). 
Ethylation 
Usual workup produced an oil containing the isomers, 1-ethylimidazole-4-








Isomer Ratio: 1.1 : 1 (1-ethylimidazole-4-: 1-ethylimidazole-5-carbaldehyde). 
The isomers were separated as colourless solids by radial chromatography 
(eluent: 3% MeOH/CH2Cb). 
1-Ethylimidazole-4-carbaldehyde 
Nmr OH (CDCl3) 1.52 (3H, t (J = 7.2 Hzt l-CH2Cfut 4.08 (2H, q (J = 7.2 Hzt l-
CfuCH3t 7.60 (lH, s, H-2t 7.67 (lH, s, H-St 9.87 (lH, s, 4-CHO). 
1-Ethylimidazole-5-carbaldehyde 
Nmr OH (CDCl3) 1.45 (3H, t (J = 7.2 Hz), l-CH2Cfu), 4.35 (2H, q (J = 7.2 Hz), l-
CfuCH3t 7.72 (lH, s, H-2t 7.81 (lH, s, H-4t 9.76 (lH, s, 5-CHO). 
Benzylation 
Usual workup produced an oil containing the isomers, 1-benzylimidazole-4-
and 1-benzylimidazole-5-carbaldehyde in 34% combined yield. 
Isomer Ratio : 1.1 : 1 (1-benzylimidazole-4- : 1-benzylimidazole-5-
carbaldehyde). 
The isomers were separated as colourless crystalline materials by radial 
chromatography (eluent: 1 % MeOH/ 4% Et0Ac/CH2Cl2). 
1-Benzylimidazole-4-carbaldehyde 
Low melting solid. Nmr OH (CDCl3) 5.16 (2H, s, 1-CfuPht 7.18-7.40 (SH, m, H-
2\6\ H-3',5\ H-4t 7.61 (lH, s, H-2 or H-4), 7.62 (lH, s, H-4 or H-2). 
1-Benzylimidazole-5-carbaldehyde 
M. pt. 50-51 °C (lit. m. pt. 53-55°C 408). Nmr OH (CDCIJ) 5.51 (2H, s, 1-CfuPht 
7.18-7.24 (2H, m, H-2\6't 7.28-7.38 (3H, m, H-3\5\ H-4t 7.68 (lH, s, H-2t 7.81 (lH, 
s, H-St 9.75 (lH, s, 4-CHO). 
Methyl imidazole-4(5)-carboxylate (lg) 
Methylation 
(A) Methyl imidazole-4(5)-carboxylate (0.250 g, 1.98 mmol) was dissolved in 
10 cm3 of 10% NaOH solution Me2S04 (0.275 g, 2.18 mmol) was added and the 







workup produced an oil containing the isomers, methyl 1-methylimidazole-4-
and methyl 1-methylimidazole-5-carboxylate in 8% yield. 
Isomer Ratio : 1.5 : 1 (methyl 1-methylimidazole-4- : methyl 1-
methylimidazole-5-carboxylate). 
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(B) Methyl imidazole-4(5)-carboxylate (0.250 g, 1.98 mmol) was dissolved in 
ethanolic NaOEt (2.38 mmol, 0.055 g-atoms Na metal in 10 cm3 EtOH). Me2S04 
(0.275 g, 2.18 mmol) was added and the solution stirred at room temperature for 2 
hours. Workup as for the phenylimidazoles produced an oil containing the 
isomers, methyl 1-methylimidazole-4- and methyl 1-methylimidazole-5-
carboxylate in 54% yield. Small quantities of possible trans-esterification products 
were also observed by lH nmr. 
Isomer Ratio: 1.1: 1 (methyl 1-methylimidazole-4-: methyl 1-
methylimidazole-5-carboxylate). 
The isomers were separated as oils by radial chromatography (eluent: 2% 
MeOH/2% Et0Ac/CH2Cl2) and triturated from CH2Cb/hexane to give colourless 
crystalline materials. 
Methyl 1-methylimidazole-4-carboxylate 
M.pt. 96-97°C (lit. m. pt. 97-98°C 344, 98-101 °C 360). Anal. Found C, 51.3; H, 5.7; 
N, 20.0%. C6HsN202 requires C, 51.4; H, 5.8; N, 20.0%. Nmr 8H (CDCl3) 3.76 (3H, 
s, (HETC) l-CH3), 3.88 (3H, s, (HETC) 4-COOCfu), 7.47 (lH, s, (HETC) H-2), 7.59 
(lH, s, (HETC) H-5); 8c (CDCl3) 33.7 (Q (lJcH = 141 Hz), l-CH3), 51.5 (Q lJcH = 147 
Hz), 4-COOCH3), 126.1 (Dm (lJcH = 193 Hz), C-5), 133.8 (dd (Jc(4)C(S)H = 11 Hz, 
JC(4)C(2)H = 8.1 Hz), C-4), 138.5 (Dm (lJcH = 209 Hz), C-2), 163.l (m, 4-COOCH3). 
Methyl 1-methylimidazole-5-carboxylate 
M.pt. 54-55°C (lit. m. pt. 56-57°C 289, 56-57°C 360). Anal. Found C, 51.3; H, 6.0; 
N, 20.0%. C6HsN202 requires C, 51.4; H, 5.8; N, 20.0%. Nmr 8H (CDCl3) 3.85 (3H, 
s, (HETC) 5-COOCfu), 3.91 (3H, s, (HETC) 1-Cfu), 7.57 (lH, s, (HETC) H-2), 7.72 
(lH, s, (HETC) H-4); 8c (CDCl3) 33.8 (Q (lJcH = 142 Hz), l-CH3), 51.2 (Q lJcH = 147 
Hz), 4-COOCH3), 122.7 (m, C-5), 137.3 (Dd (lJcH = 193 Hz, JC(4)C(2)H = 10.3 Hz), C-













Methyl imidazole-4(5)-carboxylate (0.250 g, 1.98 mmol) was dissolved in 
ethanolic NaOEt (2.38 mmol, 0.055 g-atoms Na metal in 10 cm3 EtOH). Et2S04 
(0.336 g, 2.18 mmol) was added and the solution stirred at room temperature for 2 
hours. Workup as for the phenylimidazoles produced an oil containing the 
isomers, methyl 1-ethylimidazole-4- and methyl 1-ethylimidazole-5-carboxylate 
(19%) in conjunction with trans-esterification products, ethyl 1-ethylimidazole-4-
and ethyl 1-ethylimidazole-5-carboxylate (28%) in 47% overall yield. The ratio of 
isomeric products to isomeric by-products, as determined by nmr, was 
approximately 1: 1.5. A trace amount of ethyl imidazole-4(5)-carboxylate was 
observed upon nmr analysis of recovered starting material. 
Isomer Ratios : 1.7: 1 (methyl 1-ethylimidazole-4- : methyl 1-ethylimidazole-5-
carboxylate); ca. 1.3 : 1 (ethyl 1-ethylimidazole-4- : ethyl 1-ethylimidazole-5-
carboxyla te). 
Methyl 1-ethylimidazole-4- and ethyl 1-ethylimidazole-4-carboxylate and the 
corresponding 5-carboxylates were observed to have overlapping Rt ranges 
irrespective of the solvent system and support (silica or alumina) used. Thus the 
N-ethylated methyl and ethyl 4-carboxylates and the N-ethylated methyl and 
ethyl 5-carboxylates were isolated as oily mixtures by radial chromatography 
(eluent: 2% MeOH/2% Et0Ac/CH2Cb). 
Methyl 1-ethylimidazole-4-carboxylate 
Nrnr 8H (CDCl3) 1.49 (3H, t (J = 7.4 Hz), l-CH2Cfu), 3.88 (3H, s, 4-COOCH3), 
4.06 (2H, q (J = 7.4 Hz), l-CfuCH3), 7.55 (lH, s, H-2), 7.65 (lH, s, H-5). 
Ethyl 1-ethylimidazole-4-carboxylate 
Nmr 8H (CDCl3) 1.38 (3H, t (J = 7.1 Hz), 4-COOCH2Cfu), 1.49 (3H, t (J = 7.4 Hz), 
l-CH2Cfu), 4.06 (2H, q (J = 7.4 Hz), l-CfuCH3), 4.36 (2H, q (J = 7.1 Hz), 4-
COOCfuCH3), 7.55 (lH, s, H-2), 7.65 (lH, s, H-5). 
Methyl 1-ethyiimidazoie-5-carboxyiate 
Nrnr 8H (CDCl3) 1.45 (3H, t (J = 7.4 Hz), l-CH2Cfu), 3.86 (3H, s, 5-COOCH3), 
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Ethyl 1-ethylimidazole-5-carboxylate 
Nmr OH (CDCl3) 1.37 (3H, t (J = 7.1 Hz), 5-COOCH2Cfu), 1.45 (3H, t (J = 7.4 Hz), 
1-CH2Cfu), 4.33 (2H, q (J = 7.1 Hz), 5-COOCfuCH3), 4.35 (2H, q (J = 7.3 Hz), 1-
CfuCH3), 7.62 (1H, s, H-2), 7.74 (1H, s, H-4). 
Ethyl imidazole-4(5)-carboxylate 
Nmr OH (CDCl3) 1.36 (3H, t (J = 7.1 Hz), 4(5)-COOCH2Cfu), 4.36 (2H, q (J = 7.1 
Hz), 4(5)-COOCfuCH3), 7.79 (1H, s, H-?), 7.82 (1H, s, H-?). 
Benzylation 
Methyl imidazole-4(5)-carboxylate (0.250 g, 1.98 mmol) was dissolved in 
ethanolic NaOEt (2.38 mmol, 0.055 g-atoms Na metal in 10 cm3 EtOH). PhCH2Cl 
(0.276 g, 2.18 mmol) was added and the solution stirred at room temperature for 2 
hours. Workup as for the phenylimidazoles produced an oil containing the 
isomers, methyl 1-benzylimidazole-4- and methyl 1-benzylimidazole-5-
carboxylate in 12% yield. Small quantities of possible trans-esterification products 
were also observed by lH nmr. 
Isomer Ratio : 2.1 : 1 (methyl 1-benzylimidazole-4-: methyl 1-
benzylimidazole-5-carboxyla te). 
The isomers were separated (with trace impurity) as oils by radial 
chromatography (eluent: 2% MeOH/2% Et0Ac/CH2Cli). Methyl 1-
benzylimidazole-5-carboxylate was triturated from CH2Cl2/hexane as a colourless 
solid for literature melting point comparison . 
Methyl 1-benzylimidazole-4-carboxylate 
Nmr OH (CDCb) 3.86 (3H, s, 4COOCfu), 5.12 (2H, s, 1-CfuPh), 7.15-7.21 (2H, m, 
H-2',6'), 7.34-7.41 (3H, m, H-3',5', H-4'), 7.57 (1H, s, H-2 or H-5), 7.58 (1H, s, H-5 or 
H-2). 
Methyl 1-benzylimidazole-5-carboxylate 
M. pt. 60-61 °C (lit. m. pt 63-64°C 289). Nmr OH (CDCl3) 3.74 (3H, s, 5-COOCfu), 
5.51 (2H, s, 1-CfuPh), 7.15-7.20 (2H, m, H-2',6'), 7.29-7.38 (3H, m, H-3',5', H-4'), 7.64 














(A) Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 
cm3 of 10% NaOH solution Me2S04 (0.250 g, 1.98 mmol) was added and the 
heterogeneous mixture was stirred at room temperature for 2 hours. Workup 
proceeded as usual. In the final extraction step, the basified aqueous solution was 
presaturated with sodium chloride. A residue was produced containing the 
isomers, 1-methylimidazole-4- and 1-methylimidazole-5-carboxamide in 6% 
yield. 
Isomer Ratio : 6.5 : 1 (1-methylimidazole-4- : 1-methylimidazole-5-
carboxamide). 
(B) Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 
ethanolic NaOEt (2.16 mmol, 0.050 g-atoms Na metal in 10 cm3 EtOH). Me2S04 
(0.250 g, 1.98 mmol) was added and the solution stirred at room temperature for 2 
hours. Workup proceeded as for the phenylimidazoles. In the final extraction 
step, the basified aqueous solution was presaturated with sodium chloride. An oil 
was produced containing the isomers, 1-methylimidazole-4- and 1-
methylimidazole-5-carboxamide (7%) in conjunction with the products of 
esterification, methyl 1-methylimidazole-4- and methyl 1-methylimidazole-5-
carboxylate (7%) in 14% overall yield. The ratio of amide products to methyl ester 
by-products, as determined by nmr, was approximately 1: 1. 
Isomer Ratios : 2.3 : 1 (1-methylimidazole-4- : 1-methylimidazole-5-
carboxamide); 1.8: 1 (methyl 1-methylimidazole-4- : methyl 1-methylimidazole-5-
carboxylate). 
The N-methylated amide and ester products were separated as colourless 
crystalline materials by radial chromatography (eluent : 5% MeOH/5% 
EtOAc/CH2Cl2). lH nmr analysis of the methyl ester products was consistent with 
the spectral information obtained for the basic (NaOEt/EtOH) methylation of 
methyl imidazole-4(5)-carboxylate above. 
1-Methylimidazole-4-carboxamide 
M. pt. 203-204°C (lit. m. pt. 209-211 °C 91 ). Anal. Found C, 47.8; H, 5.3; N, 33.5%. 
C5H7N30 requires C, 48.0; H, 5.6; N, 33.6%. Nmr 8H (CDCl3) 3.74 (3H, s, 1-Cfu), 
5.41 (lH, v br s, 4-CONfu), 6.94 (lH, v br s, 4-CONfu), 7.39 (lH, br s, H-5), 7.55 (lH, 











s, 4-CONfu), 7.60 (lH, br s, H-5), 7.66 (lH, br s, H-2); 8c (DMSO) 33.3 (Q (1JcH = 
140 Hz), l-CH3), 123.2 (Dm (1JcH"" 191 Hz), C-5), 136.3 (m, C-4), 137.8 (Dq (1JcH""' 
207 Hz), C-2), 163.8 (s, 4-CONH2). 
1-Methylimidazole-5-carboxamide 
Insufficient material for full characterisation. Nmr 8H (CDCl3) 3.94 (3H, s, l-
CH3), 5.63 (2H, v br s, 5-CONfu), 7.50 (lH, s, H-4), 7.53 (lH, s, H-2). 
Ethylation 
(A) Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 
cm3 of 10% NaOH solution Et2S04 (0.278 g, 1.98 mmol) was added and the 
heterogeneous mixture was stirred at room temperature for 2 hours. Workup 
proceeded as usual. In the final extraction step, the basified aqueous solution was 
presaturated with sodium chloride. A solid residue was produced containing the 
isomers, 1-ethylimidazole-4- and 1-ethylimidazole-5-carboxamide in 7% 
combined yield. 
Isomer Ratio : 15 : 1 (1-ethylimidazole-4- : 1-ethylimidazole-5-carboxamide). 
The isomers were isolated as a colourless solids by radial chromatography (eluent 
: 5% MeOH/5% Et0Ac/CH2Cli). 
(B) Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 
ethanolic NaOEt (2.16 mmol, 0.050 g-atoms Na metal in 10 cm3 EtOH). Et2S04 
(0.278 g, 1.98 mmol) was added and the solution stirred at room temperature for 2 
hours. Workup proceeded as for the phenylimidazoles. In the final extraction 
step, the basified aqueous solution was presaturated with sodium chloride. An oil 
was produced containing the isomers, 1-ethylimidazole-4- and 1-ethylimidazole-
5-carboxamide (12%) in conjunction with the products of esterification, ethyl 1-
ethylimidazole-4- and ethyl 1-ethylimidazole-5-carboxylate (3%) in 15% overall 
yield. The ratio of amide product to ethyl ester by-products, as determined by 
nmr, was approximately 4: 1. 
Isomer Ratios: 5.6 : 1 (1-ethylimidazole-4- : 1-ethylimidazole-5-carboxamide). 
The isomer was separated as a colourless solid by radial chromatography 
(eluent: 10% MeOH/10% EtOAc/CH2Cl2). 1H nmr analysis of the by-products was 
consistent with that of the by-products obtained for the basic (NaOEt/EtOH) 












M. pt. 135-6°C (lit. m. pt. 138-141 °C 91 ). Nmr 8H (CDCl3) 1.48 (3H, t (J = 7.4 Hz), 
l-CH2CH3), 4.03 (2H, q (J = 7.4 Hz), l-CfuCH3), 5.92 (lH, v br s, 4-CONH2), 7.04 (lH, 
v br s, 4-CONfu), 7.43 (lH, br s, H-5), 7.62 (lH, br s, H-2). 
1-Ethylimidazole-5-carboxamide 
Nmr 8H (CDCl3) 1.46 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.40 (2H, q (J = 7.3 Hz), l-
CfuCH3), 5.70 (2H, v br s, 4-CONfu), 7.54 (lH, br s, H-4), 7.63 (lH, br s, H-2). 
Benzylation 
Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 cm3 of 
10% NaOH solution PhCH2Cl (0.251 g, 1.98 mmol) was added and the 
heterogeneous mixture was stirred at room temperature for 2 hours. Workup 
proceeded as usual. In the final extraction step, the basified aqueous solution was 
presaturated with sodium chloride. A solid residue was produced containing the 
isomers, 1-benzylimidazole-4- and 1-benzylimidazole-5-carboxamide in 8% 
combined yield. 
Isomer Ratio : 3.0 : 1 (1-benzylimidazole-4- : 1-benzylimidazole-5-carboxamide). 
The isomers were isolated as a colourless solids by radial chromatography (eluent 
: 5% MeOH/5% Et0Ac/CH2Cl2). 
1-Benzylimidazole-4-carboxamide 
Nmr bH (CDCl3) 5.13 (2H, s, 1-CfuPh), 5.48 (lH, v br s, 4-CONfu), 6.97 (lH, v 
br s, 4-CONfu), 7.16-7.22 (2H, m, H-2',6'), 7.34-7.41 (3H, m, H-3',5', H-4'), 7.47 (lH, 
br s, H-5), 7.58 (lH, br s, H-2). 
1-Benzylimidazole-5-carboxamide 
Nmr bH (CDCl3) 5.57 (2H, s, 1-CfuPh), 5.66 (2H, v br s, 4-CONfu), 7.16-7.40 












Usual workup, utilising 20% HCl in the acidification step, produced a solid 
residue containing the isomers, 1-methyl-4-nitro- and 1-methyl-5-nitroimidazole 
in 37% yield. 
Isomer Ratio : 8.6 : 1 (1-methyl-4-nitro- : 1-methyl-5-nitroimidazole). 
The isomers were separated as off-white crystalline solids by column 
chromatography (alumina, eluent: 1 % MeOH/ 40% CH2Cl2/Hexane), and 
triturated from CH2Cli/hexane. 
1-Methyl-4-nitroimidazole 
M. pt. 132-133°C (lit. m. pt. 130-132°C 362). Anal. Found C, 37.7; H, 4.0; N, 
33.0%. C4H5N302 requires C, 37.8; H, 4.0; N, 33.1 %. Nmr CH (CDCl3) 3.81 (3H, s, 
1-Cfu), 7.41 (lH, br s, H-2), 7.77 (lH, d 0H(5)H(2) = 1.5 Hz), H-5); oc (CDCl3) 34.3 (Q 
<1JcH = 141 Hz), l-CH3), 120.4 (Dm (lJcH = 200 Hz), C-5), 136.7 (Ddq (lJcH = 214 Hz, 
JC(2)C(5)H"" 8.8 Hz, JC(2)CH3 "'"4.4 Hz), C-2), 148.1 (br) (m, C-4) . 
1-Methyl-5-nitroimidazole 
M. pt. 54-55°C (lit. m. pt. 56-58°C 362). Anal. Found C, 37.5; H, 3.9; N, 32.9%. 
C4H5N302 requires C, 37.8; H, 4.0; N, 33.1 %. Nmr CH (CDCl3) 4.03 (3H, s, 1-Cfu), 
7.63 (lH, s, H-2), 7.97 (lH, s, H-4); oc (CDCl3) 34.9 (Q (lJcH = 144 Hz), l-CH3), 132.7 
(Dd (lJcH = 201 Hz, JC(4)C(2)H = 9.5 Hz), C-4), 138.8 (br) (m, C-5), 141.6 (Ddq (lJcH = 
212 Hz, JC(2)C(4)H = 12.5 Hz, JC(2)CH3 = 4.1 Hz), C-2) . 
Ethylation 
Usual workup, utilising 20% HCl in the acidification step, produced a solid 
residue containing the isomers, 1-ethyl-4-nitro- and 1-ethyl-5-nitroimidazole in 
34% yield. 
Isomer Ratio : 16 : 1 (1-ethyl-4-nitro- : 1-ethyl-5-nitroimidazole). 
The isomers were separated as off-white crystalline solids by column 









M. pt. 36-38°C (lit. m. pt. 40°C 409). Nmr 8H (CDCl3) 1.48 (3H, t (J = 7.5 Hz), l-
CfuCH3), 4.12 (2H, q (J = 7.5 Hz), l-CfuCH3), 7.43 (lH, br s, H-2), 7.79 (lH, d 
CJH(S)H(2) = 1.5 Hz), H-5). 
1-Ethyl-5-nitroimidazole 
M. pt. 145-146°C (lit. m. pt. 150°C 410). Nmr 8H (CDCl3) 1.52 (3H, t (J = 7.2 Hz), 
l-CH2Cfu), 4.43 (2H, q (J = 7.2 Hz), l-CfuCH3), 7.62 (lH, br s, H-2), 7.85 (lH, br s, H-
4). 
Benzylation 
Usual workup, utilising 20% HCl in the acidification step, produced a solid 
residue from which only the isomer, 1-benzyl-4-nitroimidazole, was 
chromatographically isolated in 19% yield. 
Isomer Ratio : 1-benzyl-4-nitroimidazole plus trace 1-benzyl-5-nitroimidazole. 
1-Benzyl-4-nitroimidazole was separated as an off-white crystalline solid by 
column chromatography (alumina, eluent: 1 % MeOH/CH2Cb/Hexane). 1-
Benzyl-5-nitroimidazole was obtained by similar separation of the product 
mixture arising from benzylation of the free base. 
1-Benzyl-4-nitroimidazole 
M. pt. 73-74°C (lit. m. pt. 76°C 409). Nmr 8H (CDCl3) 5.17 (2H, s, 1-CfuPh), 7.17-
7.42 (SH, m, H-2',6', H-3',5', H-4'), 7.50 (lH, s, H-2), 7.74 (lH, s, H-5). 
1-Benzyl-5-nitroimidazole 
Nmr 8H (CDCl3) 5.55 (2H, s, 1-CfuPh), 7.18-7.23 (2H, m, H-2',6'), 7.36-7.41 (3H, 
m, H-3',5', H-4'), 7.60 (lH, br s, H-2), 8.04 (lH, d (JH(4)H(2) = 1.4 Hz), H-4). 
4(5)-Phenylimidazole (Ij) 
Methylation 
Usual workup produced an oil from which the isomers 1-methyl-4-phenyl-
and 1-methyl-5-phenylimidazole were chromatographically isolated in 47% 








Isomer Ratio : 7.3 : 1 (1-methyl-4-phenylimidazole : 1-methyl-5-
phenylimidazole) 
The isomers were separated by radial chromatography (eluent: 3% 
MeOH/CH2Cl2). The minor isomer was compared with an authentic sample 
synthesised via an alternative route (refer section 3.3.2.3 below). 
1-Methyl-4-Phenylimidazole 
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M. pt. 108-109°C (lit. m. pt. 110-111°C 364 ). Anal. Found C, 75.7; H, 6.6; N, 
17.8%. C10H10N2 requires C, 75.9, H, 6.4; N, 17.7%. Nmr 8H (CDCl3) 3.52 (3H, s, 
l-CH3), 7.05 (lH, d (JH(5)H(2) = 1.3 Hz), H-5), 7.15-7.24 (lH, m, H-4'), 7.29-7.39 (3H, 
m, (HETC) H-3',5'; (7.35, s, H-2)), 7.71-7.77 (2H, m, (HETC) H-2',6'); 8c (CDC13) 33.1 
(Q (lJcH = 140 Hz), l-CH3), 115. 8 (Dq (1JcH = 187 Hz, JC(5)C(2)H ""'Jc(5)CH3""' 3.0 
Hz), C-5), 124.5 (Dm (lJcH = 161 Hz), C-2',6'), 126.4 (Dt (lJcH = 161 Hz, 3JcH = 7.7 
Hz), C-4'), 128.3 (Dd (lJcH = 160 Hz, 3JcH = 7.2 Hz), C-3',5'), 134.1 (t (3JcH = 6.9 Hz), 
C-1'), 137.8 (Ddq ( 1JcH = 206 Hz, Jc(2)C(5)H""' 7.0 Hz, JC(2)CH3""' 3.5 Hz), C-2 ), 141.9 
(m, C-4). 
1-Methyl-5-phenylimidazole (refer section 3.3.2.3 below) 
Nmr 8H (CDCl3) 3.65 (3H, s, 1-Cfu), 7.13 (lH, br s, H-4), 7.35-7.45 (SH, m, H-
2',6', H-3',5', H-4'), 7.67 (lH, br s, H-2); 8c (CDCl3) 32.5 (Q (lJcH = 140 Hz), l-CH3), 
127.2 (br) (br Dd (1JcH = 189 Hz, JC(4)C(2)H = 9.6 Hz), C-4), 127.9 (Dt (lJcH = 161 Hz, 
3JcH = 7.2 Hz), C-4'), 128.4 (Dt (1JcH = 160 Hz, 3JcH = 6.4 Hz), C-2',6'), 128.6 (Dd 
(lJcH = 161 Hz, 3JcH = 6.8 Hz), C-3',5'), 133.4 (br) (m, C-5), 139.0 (br) (br Dm (lJcH""' 
206 Hz), C-2. 
Ethylation 
Usual workup produced an oil from which only the isomer, 1-ethyl-4-
phenylimidazole was chromatographically isolated as a low me~ting solid in 33% 
yield (0.097 g). 
Isomer Ratio : 9.5 : 1 (1-ethyl-4-phenyl-: 1-ethyl-5-phenylimidazole) 
Nmr revealed the presence of both ethylated products. The product mixture 
was separated by radial chromatography (eluent: 3% MeOH/CH2Cl2). The minor 










M. pt. 51-52°C (lit. m. pt 54-55°C 368). Nmr bH (CDCl3) 1.36 (3H, t (J = 7.3 Hz), 1-
CH2Cfu), 3.86 (2H, q (J = 7.3 Hz), 1-CfuCH3), 7.13 (1H, d <JH(S)H(2) = 1.3 Hz), H-5), 
7.14-7.24 (1H, m, H-4'), 7.29-7.38 (2H, m, H-3',5'), 7.43 (lH, br s, H-2), 7.72-7.78 (2H, 
m, H-2',6'); be (CDCl3) 16.1 (Qt (lJcH = 128 Hz, 2JcH = 3.5 Hz), 1-CH~H3), 41.7 
(Tm (lJcH = 139 Hz), 1-CH2CH3), 114.1 (Dm (lJcH = 186 Hz), C-5), 124.5 (Dm (lJcH 
""159 Hz), (HETC) C-2',6'), 126.4 (Dt (lJcH = 161 Hz, 3JcH = 7.5 Hz), (HETC) C-4'), 
128.3 (Dm (lJcH"" 159 Hz), (HETC) C-3',5'), 134.2 (m, C-1'), 136.5 (Ddt (lJcH = 205 
Hz, JC(2)C(S)H"" 7.2 Hz, JC(2)CH2"" 3.6 Hz), C-2), 141.9 (m, C-4). 
1-Ethyl-5-phenylimidazole 
Nmr bH (CDCl3) 1.32 (3H, t (J = 7.3 Hz), 1-CH2Cfu), 4.01 (2H, q (J = 7.3 Hz), l-
CfuCH3), 7.13 (1H, br s, H-4), 7.33-7.50 (SH, m, H-2',6', H-3',5', H-4'), 7.77 (1H, br s, 
H-2). 
Benzylation 
Usual workup produced an oil from which only the isomer, 1-benzyl-4-
phenylimidazole was chromatographically isolated as a low melting solid in 21 % 
yield (0.084 g). 
Isomer Ratio : 1-benzyl-4-phenylimidazole only. (A trace amount of what 
might possibly be the minor isomer was also detected). 
The reaction product, 1-benzyl-4-phenylimidazole was obtained by radial 
chromatography (eluent: 2.5% MeOH/CH2Cl2). 
1-Benzyl-4-phenylimidazole 
M. pt 93-94°C. Nmr bH (CDCl3) 5.10 (2H, s, 1-CfuPh), 7.15-7.40 (9H, m, H-3',5', 
H-4', H-b,f, H-c,e, H-d; (7.16, d <JH(S)H(2) = 1.2 Hz), H-5)), 7.59 (1H, d (JH(2)H(5) = 1.1 
Hz), H-2), 7.71-7.78 (2H, m, H-2',6'); be (CDCl3) 51.0 (Tt (lJcH = 139 Hz, 3JcH = 4.3 
Hz), 1-CH2Ph), 115.1 (Ddt (1 J CH = 188 Hz, J C(S)C(2)H ""J C(S)CH2 "" 3.4 Hz), C-5), 124.8 
(Dm <1JcH = 161 Hz), (HETC) C-2',6'), 126.8 (Dt (lJcH = 161 Hz, 3JcH = 7.5 Hz), C-4'), 
127.3 (Dm (1JcH"" 160 Hz), C-b,f), 128.3 (D(m?) (lJcH"" 160 Hz), C-d), 128.6 (D(m?) 










(3JcH = 7.0 Hz), C-1'), 136.0 (m, C~a), 137.7 (Ddt (1JcH = 209 Hz, JC(2)C(5)H'"" 7.2 Hz, 
Jq2)CH2'"" 3.6 Hz), C-2), 142.5 (m, C-4). 
4(5)-(4'-Methoxyphenyl)imidazole (Ik) 
Methylation 
Usual workup produced a coloured oil from which the isomers 4-(4'-
methoxyphenyl)-1-methyl- and 5-( 4'-methoxyphenyl)-1-methylimidazole were 
chromatographically isolated in 45% combined yield (0.122 g). Decomposition was 
observed on exposure to silica and chlorinated solvent. 
Isomer Ratio: 4.7: 1 (4-(4'-methoxyphenyl)-1-methyl-: 5-(4'-methoxyphenyl)-
1-methylimidazole). 
The isomers were separated as solids by radial chromatography ( eluent : 5% 
MeOH/ CH2C!i). The minor isomer was compared with ari. authentic sample 
synthesised via an alternative route (refer section 3.3.2.3 below). 
4-(4'-Methoxyphenyl)-1-methylimidazole 
M. pt. 135-7°C (dee) Anal. Found C, 70.2; H, 6.2; N, 15.8%. C11H12N20 requires 
C, 70.2, H, 6.4; N, 14.9%. Nmr OH (CDCIJ) 3.68 (3H, s, 1-Cfu), 3.82 (3H, s, 4'-
0Cfu), 6.87-6.95 (2H, m, H-3',5'), 7.05 (lH, d (JH(5)H(2) = 1.2 Hz), H-5), 7.46 (lH, br 
s, H-2), 7.64-7.71 (2H, m, H-2',6'); oc (CDCl3) 33.5 (Q (lJcH = 139 Hz), l-CH3), 55.3 
(Q (lJcH = 143 Hz), 4'-0CH3), 114.0 (Dd (lJcH = 158 Hz, 3JcH = 4.5 Hz, C-3',5'), 114.9 
(br D (lJcH = 187 Hz), C-5), 126.0 (Dd (lJcH = 158 Hz, 3JcH = 7.4 Hz), C-2',6'), 126.9 (t 
(3JcH = 7.5 Hz), C-1'), 137.8 (br D (lJcH = 205 Hz), C-2), 142.1 (m, C-4), 158.7 (m, C-
4'). 
5-(4'-Methoxyphenyl)-1-methylimidazole (refer section 3.3.2.3 below) 
Nmr OH (CDCl3) 3.64 (3H, s, 1-Cfu), 3.85 (3H, s, 4-0Cfu), 6.93-7.01 (2H, m, H-
3',5'), 7.06 (lH, br s, H-4), 7.27-7.34 (2H, m, H-2',6'), 7.67 (lH, br s, H-2); oc (CDCl3) 
32.6 (Qm (lJcH = 138 Hz), l-CH3), 55.3 (Q (lJcH = 143 Hz), 4'0CHJ), 114.2 (Dd (lJcH 
= 161 Hz, 3JCH = 4.6 Hz), C-3',5'), 121.7 (m, C-1'), 126.6 (br) (Dm (1JcH'"" 185 Hz), C-
4), 130.0 (Dd (lJcH = 161 Hz, 3JcH = 7.4 Hz), C-2',6'), 133.4 (br) (m, C-5), 138.5 (br) (br 













Usual workup produced a coloured oil from which only the isomer, 1-ethyl-4-
(4'-methoxyphenyl)imidazole was isolated as a semi-solid in 27%i yield (0.079 g). 
On silica the product was observed to decompose rapidly to give numerous 
intractable, higher Rf, non-imidazole, products. 
Isomer Ratio: 7.9: 1 (1-ethyl-4-(4'-methoxyphenyl)-: 1-ethyl-5-(4'-
methoxyphenyl)imidazole) 
The crude reaction mixture was separated by radial chromatography (eluent: 
3% MeOH/CH2Cb). The major product was observed to have an Rf of ca. 0.3 on 
silica tlc in 5% MeOH/25% EtOAc/CH2Cb. The minor isomer, 1-ethyl-5-(4'-
methoxyphenyl)imidazole, was detected spectroscopically in the crude reaction 
mixture. Sufficient material was isolated from both the basic and neutral 
ethylations, to enable identification by lH nmr . 
1-Ethyl-4-(4'-methoxyphenyl)imidazole 
Nmr DH (CDC]J) 1.49 (3H, t CT= 7.4 Hz), l-CH2Cfu), 3.83 (3H, s, 4'-0Cfu), 4.01 
(2H, q (J = 7.4 Hz), l-CH2CH3), 6.90-6.94 (2H, m, H-3',5'), 7.12 (lH, s, H-5), 7.60 (lH, 
s, H-2), 7.67-7.71 (2H, m, H-2',6'); De (CDCl3) 16.3 (Q (lJcH = 127 Hz), l-CH2CH3), 
42.2 (Tm (lJcH = 144 Hz), l-CH2Cfi3), 55.3 (Q (lJcH = 144 Hz), 4'-0CH3), 113.3 (Dm 
(lJcH = 185 Hz), C-5), 114.1 (Dd (lJcH = 159 Hz, 3JcH = 4.5 Hz), C-3',5'), 126.1 (Dd 
(lJcH = 159 Hz, 3JcH = 7.1 Hz), C-2',6'), 126.6 (t (3JcH = 8.3 Hz), C-1'), 136.5 (Dm 
Gq2)C(S)H = 207 Hz), C-2), 141.7 (m, C-4), 158.8 (m, C-4'). 
1-Ethyl-5-(4'-methoxyphenyl)imidazole 
Nmr DH (CDC]J) 1.37 (3H, t CT = 7.3 Hz), l-CH2Cfu), 3.87 (3H, s, 4'-0Cfu), 4.05 
(2H, q (J = 7.3 Hz), l-CfuCB3), 6.97-7.02 (2H, m, H-3',5'), 7.13 (lH, br s, H-4), 7.27-
7.32 (2H, m, H-2',6'), 8.21 (lH, br s, H-2). 
Benzylation 
Usual workup produced a coloured oil from which only the isomer, 1-benzyl-
4-(4'-methoxyphenyl)imidazole was chromatographically isolated as a semi-solid 
in 17% yield (0.065 g). Substantial decomposition was again observed on silica and 
in chlorinated solvent. 
Isomer Ratio : 1-benzyl-4-(4'-methoxyphenyl)imidazole only. (A trace amount 








The crude reaction mixture was separated by radial chromatography (eluent: 
2.5% MeOH/CH2Cb). The product was observed to have an Rt of ca. 0.5 on silica 
TLC in 10% MeOH/CH2Ch. 
1-Benzyl-4-(4'-methoxyphenyl)imidazole 
Nmr 8H (CDC!J) 3.81 (3H, s, 4'-0Cfu), 5.10 (2H, s, 1-CfuPh), 6.87-6.92 (2H, m, 
H-3',5'), 7.07 (lH, s, H-5), 7.17-7.22 (2H, m, H-b,f), 7.32-7.40 (3H, m, H-c,e, H-d), 7.57 
(lH, s, H-2), 7.64-7.69 (2H, m, H-2',6'); 8c (CDCl3) 51.1 (Tm (lJcH = 136 Hz), l-
CH2Ph), 55.3 (Q (lJcH = 143 Hz), 4'-0Cfi3), 114.0 (Dd (lJcH = 159 Hz, 3JcH = 4.0 Hz), 
C-3',5'), 114.0 (br D (lJcH = 185 Hz), C-5), 126.1 (Dd (lJcH = 159 Hz, 3JcH = 7.7 Hz), 
C-2',6'), 126.7 (m, C-1'), 127.4 (Dm (lJcH = 158 Hz), C-b,f), 128.4 (Dt (lJcH = 161 Hz, 
3JcH = 7.4 Hz), C-d), 129.1 (Dd (lJcH = 159 Hz, 3JcH = 7.2 Hz), C-c,e), 136.0 (m, C-a), 
137.4 (br D (lJcH = 208 Hz), C-2), 142.3 (m, C-4), 158.8 (m, C-4'). 
4(5)-(4'-Chlorophenyl)imidazole (11) 
Methylation 
Usual workup produced a coloured oil containing both methylated products. 
Only 4-(4'-chlorophenyl)-1-methylimidazole was chromatographically isolated as 
a solid in 51 % yield (0.138 g). 
Isomer Ratio: 9.6: 1 (4-(4'-chlorophenyl)-1-methyl-: 5-(4'-chlorophenyl)-1-
methylimidazole) . 
The major isomer was isolated from the crude reaction mixture by radial 
chromatography (eluent: 3% MeOH/CH2Cl2) and recrystallisation from 
CH2Cb/hexane as colourless needles. The minor isomer was isolated 
chromatographically from the reaction mixture obtained from methylation 
under neutral conditions (see section 3.3.3) and compared with an authentic 
sample synthesised via an alternative route (refer section 3.3.2.3 below). Both 
isomers underwent slight decomposition on exposure to silica and chlorinated 
solvent. 
4-(4'-Chlorophenyl)-1-methylimidazole 
M. pt. 140.5-141.5°C. Anal. Found C, 62.3; H, 4.4; N, 14.8%. C10H9N2Cl requires 








:= 1.3 Hz), (HETC) H-5), 7.27-7.34 (2H, m, H-3',5'), 7.41 (lH, br s, (HETC) H-2), 7.63-
7.70 (2H, m, H-2',6'); 8c (CDCl3) 33.4 (Q (lJcH = 139 Hz), l-CH3), 116.1 (Dm (lJcH = 
187 Hz), C-5), 125.9 (br D (lJcH = 163 Hz, 3JcH = 7.4 Hz), (HETC) C-2',6'), 128.6 (Dd 
(lJcH = 167 Hz, 3JcH = 5.1 Hz), (HETC) C-3',5'), 132.0 (tt (3JcH = 10.5 Hz, J = 3.5 Hz), 
C-4'), 132.7 (t (3JcH = 7.5 Hz), C-1 '), 138.0 (Ddq (1JcH = 206 Hz, JC(2)C(S)H"" 7.2 Hz, 
Jc(2)CH3""' 3.6 Hz), C-2), 141.1 (m, C-4). 
5-(4'-Chlorophenyl}-1-methylimidazole (refer section 3.3.2.3 below) 
Nmr 8H (CDCl3) 3.66 (3H, s, 1-Cfu), 7.10 (lH, br s, H-4), 7.30-7.44 (2H, m, H-
3',5'), 7.39-7.44 (2H, m, H-2',6'), 7.57 (lH, br s, H-2); 8c (CDCl3) 32.6 (Q (lJcH = 139 
Hz), l-CH3), 127.7 (m, C-1'), 128.0 (br) (br Dm (lJcH > 180 Hz), C-4), 129.0 (Dd (lJcH 
= 166 Hz, 3JcH = 5.0 Hz), C-3',5'), 129.7 (Dd (lJcH = 161 Hz, 3JcH = 7.3 Hz), C-2',6'), 
132.4 (br) (m, C-5), 134.1 (m, C-4'), 139.3 (br) (br Dm (lJcH > 200 Hz), C-2). 
Ethylation 
Usual workup produced a coloured oil from which only the isomer, 4-(4'-
chlorophenyl)-1-ethylimidazole was chromatographically isolated in 29% yield 
(0.083 g). 
Isomer Ratio: ca. 12: 1 (4-(4'-chlorophenyl)-1-ethyl- : 5-(4'-chlorophenyl)-1-
ethylimidazole). 
The major isomer was isolated by radial chromatography (eluent : 3% 
MeOH/CH2Cl2). Nmr revealed the presence of the minor isomer in the crude 
product mixture. There was insufficient product to enable clean separation. It was 
isolated relatively cleanly, however, from the reaction mixture obtained from 
ethylation under neutral conditions (see section 3.3.3). Slight decomposition was 
apparent for both isomers on exposure to silica and chlorinated solvent. 
4-(4'-Chlorophenyl)-1-ethylimidazole 
Nmr 8H (CDCl3) 1.46 (3H, t (J = 7.5 Hz), l-CH2Cfu), 3.97 (2H, q (J = 7.4 Hz), l-
CfuCH3), 7.14 (lH, s, H-5), 7.27-7.32 (2H, m, H-3',5'), 7.56 (lH, s, H-2), 7.63-7.68 (2H, 
m, H-2',6'); 8c (CDCl3) 16.2 (Qt (lJcH = 127 Hz, 2JcH = 3.5 Hz), l-CH~H3), 42.1 
(Tm (lJCH = 139 Hz), l-CH2CH3), 114.6 (br D (lJcH = 185 Hz), C-5), 126.1 (Dd (lJcH = 








132.2 (m, C-1' or 4'), 132.4 (br) (m, C-4' or 1'), 137.1 (br D (lJcH = 206 Hz), C-2), 1_40.9 
(m, C-4). 
5-( 4 '-Chlorop heny 1)-1-eth y limidazole 
Nmr 8H (CDCl3) 1.50 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.03 (2H, q (J = 7.3 Hz), l-
CfuCH3). 
Benzylation 
Usual workup produced a coloured oil from which only the isomer, 1-benzyl-
4-(4'-chlorophenyl)imidazole was chromatographically isolated in 20% yield 
(0.074 g). 
Isomer Ratio : 1-benzyl-4-(4'-chlorophenyl)imidazole only. (A trace amount of 
what might possibly be the minor isomer was also detected). 
The crude reaction mixture was separated by radial chromatography (eluent: 
2.5% MeOH/CH2Cl2). Marked decomposition was noted on prolonged exposure 
to chlorinated solvent. 
1-Benzyl-4-(4'-chlorophenyl)imidazole 
M. pt. 95-96°C (dee). Nmr 8H (CDCl3) 5.09 (2H, s, 1-CfuPh), 7.13 (lH, d 
(JH(S)H(2) = 1.3 Hz), H-5), 7.15-7.21 (2H, m, H-b,f), 7.25-7.32 (2H, m, H-3',5'), 7.31-
7.38 (3H, m, H-c,e,H-d), 7.57 (lH, br s, H-2), 7.62-7.69 (2H, m, H-2',6'); 8c (CDCl3) 
51.1 (Tt (lJcH = 140 Hz, 3JcH = 4.6 Hz), l-CH2Ph), 115.3 (Ddt (lJcH = 188 Hz, 
Jc(S)C(2)H"'" Jc(S)CH2"'" 3.4 Hz), C-5), 126.1 (Dd (lJcH = 162 Hz, 3JcH = 7.3 Hz), 
(HETC) C-2',6'), 127.4 (Dm (lJcH"'" 159 Hz), (HETC) C-b,f), 128.4 (Dt (lJcH = 161 Hz, 
3JcH = 7.2 Hz), (HETC) C-d), 128.7 (Dd (lJcH = 167 Hz, 3JcH = 4.9 Hz), (HETC) C-
3',5'), 129.1 ( Dd (lJcH = 161 Hz, 3JcH =7.1 Hz), (HETC) C-c,e), 132.3 (m, C-1' or 4'), 
132.6 (br) (m, C-4' or 1'), 135.8 (m, (LRHETC) C-a), 137.8 (Ddt (lJcH = 207 Hz, 












Usual workup produced a solid residue containing both methylated isomers, 
from which only the isomer 1-methyl-4-(4'-nitrophenyl)imidazole was 
chromatographically isolated in 49% yield (0.131 g). 
Isomer Ratio: ca. 17: 1 (1-methyl-4-(4'-nitrophenyl)- : 1-methyl-5-(4'-
ni trophen yl)-imidazole) 
The major isomer was isolated from the crude reaction mixture by radial 
chromatography (eluent: 3% MeOH/CH2Cl2) and triturated from CH2Cl2/hexane 
as pale-yellow needles. The minor isomer was isolated chromatographically from 
the reaction mixture obtained from methylation under neutral conditions (see 
section 3.3.3) and compared with an authentic sample synthesised via an 
alternative route (refer section 3.3.2.3 below). 
1-Methyl-4-(4'-nitrophenyl)imidazole 
M. pt. 191.5-192.5°C (lit. m. pt. 195°C 364). Anal. Found C, 59.2;, H, 4.4; N, 
20.9%. C10H9N302 requires C, 59.1, H, 4.5; N, 20.7%. Nmr bH (CDC!J) 3.77 (3H, s, 
1-Cfut 7.34 (lH, d <JH(S)H(2) = 1.2 Hzt (HETC) H-5), 7.52 (lH, br s, (HETC) H-2t 
7.85-7.91 (2H, m, H-2\6t 8.18-8.24 (2H, m, H-3\5'); 8c (CDCl3) 33.7 (Q (lJcH = 139 
Hzt l-CH3), 118.4 (br D (lJcH = 187 Hzt C-5t 124.2 (Dd (lJcH = 169 Hz, 3JcH = 4.0 
Hzt (HETC) C-3'S), 124.9 (Dd (lJcH = 165 Hz, 3JcH = 6.9 Hzt (HETC) C-2\6't 138.9 
(br D (1JcH = 204 Hzt C-2t 140.3 (m, C-4t 140.7 (m (t?), C-lt 146.2 (m, C-4') . 
1-Methyl-5-(4'-nitrophenyl)imidazole (refer section 3.3.2.3 below) 
Nmr bH (CDCl3) 3.78 (3H, s, l-CH3t 7.29 (lH, br s, (HETC) H-4t 7.57-7.63 (2H, 
m, H-2',6'), 7.66 (lH, br s, (HETC) H-2), 8.27-8.33 (2H, m, H-3',5'); 8c (CDCl3) 33.0 
(Q (1JcH = 140 Hz), l-CH3t 124.1 (Dd (lJcH = 168 Hz, 3JcH = 4.7 Hzt (HETC) C-
3\5t 128.3 (Dd (1JcH = 164 Hz, 3JcH = 7.0 Hzt (HETC) C-2\6't 129.9 (br) (br D 
(1JcH = 190 Hzt C-4), 131.3 (br) (m, C-5t 136.1 (t (lJcH = 8.0 Hzt C-l't 140.7 (br) (br 












Usual workup produced a solid residue from which only the isomer 1-ethyl-4-
(4'-nitrophenyl)imidazole was chromatographically isolated and triturated from 
CH2Cb/hexane as pale-yellow needles in 34% yield (0.097 g). 
Isomer Ratio: ~20 : 1 (1-ethyl-4-(4'-nitrophenyl)- : 1-ethyl-5-(4'-nitrophenyl)-
imidazole). 
The major isomer was isolated from the crude reaction mixture by radial 
chromatography (eluent: 2.5% MeOH/CH2Cb). Though nmr revealed the 
presence of the minor isomer in the crude product mixture, there was 
insufficient product to enable clean separation; it was therefore isolated 
chromatographically from the reaction mixture obtained from ethylation under 
neutral conditions (see section 3.3.3). 
1-Ethyl-4-(4'-nitrophenyl)imidazole 
M. pt. 123-124°C (dee). Anal. Found, C, 60.7; H, 4.8; N, 19.3%. C11H11N302 
requires C, 60.8; H, 5.1; N, 19.3%. Nmr bH (CDCl3) 1.47 (3H, t (J = 7.3 Hz), l-
CH2Cfu), 4.01 (2H, q (J = 7.3 Hz), l-CfuCH3), 7.36 (lH, d (JH(S)H(2) = 1.3 Hz), 
(HETC) H-5), 7.54 (lH, d (J = 1.2 Hz), (HETC) H-2), 7.81-7.88 (2H, m, H-2',6'), 8.12-
8.19 (2H, m, H-3',5'); 8c (CDCl3) 16.2 (Qt (lJcH = 128 Hz, 2JcH = 3.5 Hz), l-
CH~H3), 42.2 (Tm (lJcH = 140 Hz), l-CH2CH3), 116. 9 (br D (lJCI---I = 188 Hz), C-5), 
124.1 (Dd (lJcH = 169 Hz, 3JcH = 4.5 Hz), (HETC) C-3',5'), 124.8 (Dd (lJcH = 165 Hz, 
3JcH = 6.9 Hz), (HETC) C-2',6'), 137.7 (Ddt C1JcH = 207 Hz, JC(2)C(S)H ~ 7.2 Hz, 
JC(2)CH2 ~ 3.6 Hz), C-2), 139.9 (m, C-4), 140.8 (t (3JCH = 7.6 Hz), C-1'), 146.1 (m, C-4') . 
1-Ethyl-5-(4 '-nitrophenyl)imidazole 
Nmr bH (CDCl3) 1.39 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.ll (2H, q (J = 7.3 Hz), l-
CfuCH3), 7.24 (lH, br s, H-4), 7.53-7.60 (2H, m, H-2',6'), 7.70 (lH, br s, H-2), 8.28-8.35 
(2H, m, H-3',5'). 
Benzylation 
Usual workup produced a solid residue from which only the isomer, 1-benzyl-
4-(4'-nitrophenyl)imidazole was chromatographically isolated and triturated 











Isomer Ratio : >15: 1 (1-benzyl-4-(4'-nitrophenyl)-: 1-benzyl-5-(4'-
ni trophen yl)-imidazole. 
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The product was separated from the crude mixture by radial chromatography 
(eluent: 2% MeOH/CH2Cl2). 1-benzyl-5-(4'-nitrophenyl)imidazole was isolated in 
sufficient quantity from the neutral benzylation reaction (refer section 3.3.3) to 
allow spectral identification. 
1-Benzyl-4-(4'-nitrophenyl)imidazole 
M. pt. 128-129°C (dee). Anal. Found C, 68.6; H, 4.4; N, 15.0%. C16H13N302 
requires C, 68.8; H, 4.7; N, 15.0%. Nmr OH (CDCl3) 5.16 (2H, s, 1-CfuPh), 7.18-7.25 
(2H, m, (HETC) H-b,f), 7.33-7.41 (4H, m, (HETC) H-c,e, H-d; (7.35, d (JH(S)H(2) = 1.1 
Hz), (HETC) H-5)), 7.64 (lH, d (JH(2)H(5) = 1.1 Hz), H-2), 7.83-7.91 (2H, m, H-2',6'), 
8.15-8.22 (2H, m, H-3',5'); oc (CDCl3) 51.2 (Tt <1JcH = 140 Hz, 3JcH = 4.6 Hz), l-
CH2Ph), 117.6 (Ddt (1JcH = 188 Hz, Jc(S)C(2)H ""'Jc(S)CH2""' 3.6 Hz), C-5), 124.1 (Dd 
(lJcH = 169 Hz, 3JcH = 4.4 Hz), (HETC) C-3',5'), 124.9 (Dd <1JcH = 165 Hz, 3JcH = 7.1 
Hz), (HETC) C-2',6'), 127 5 (Dm (lJcH"" 160 Hz), C-b,f), 128.6 (Dt (lJcH = 161 Hz, 
3JcH = 7.3 Hz), C-d), 129.2 (Dd (lJcH = 161 Hz, 3JcH = 7.2 Hz), C-c,e), 135.4 (m, C-a), 
138.5 (Ddt (1JcH = 208 Hz, JC(2)C(S)H""' 7.2 Hz, JC(2)CH2""' 3.6 Hz), C-2), 140.4 (m, C-4 
or C-1'), 140.6 (m, C-1' or C-4), 146.2 (m, C-4'). 
1-Benzyl-5-(4'-nitrophenyl)imidazole 
Nmr OH (CDCl3) 5.22 (2H, s, 1-CfuPh), 6.97-7.05 (2H, m, H-b,f?), 7.31-7.40 (4H, 
m, H-c,e?, H-d; (7.36, br s, H-4)), 7.41-7.48 (2H, m, H-2',6'?), 7.72 (lH, br s, H-2), 8.18-
8.25 (2H, m, H-3',5'?). 
2,4(5)-Dimethylimidazole (In) 
Methylation 
Usual workup produced an oil containing the isomers, 1,2,4-trimethyl- and 
1,2,5-trimethylimidazole in 35% yield. 
Isomer Ratio : 1.4: 1 (1,2,4-trimethyl-: 1,2,5-trimethylimidazole). 
The isomers were separated oils by column chromatography (alumina, eluent : 












Nmr OH (CDCb) 2.14 (3H, s, 4-Cfu), 2.32 (3H, s, 2-CH3), 3.49 (3H, s, 1-Cfu), 6.48 
(lH, s, H-5). 
1,2,5-Trimethylimidazole 
Nmr OH (CDCl3) 2.16 (3H, s, 5-Cfut 2.34 (3H, s, 2-CH3), 3.41 (3H, s, 1-Cfut 6.62 
(lH, s, H-4). 
Ethylation 
Usual workup produced an oil containing the isomers, 1-ethyl-4-methyl- and 
1-ethyl-5-methylimidazole in 33% yield. 
Isomer Ratio : 2.1 : 1 (1-ethyl-2,4-dimethyl- : 1-ethyl-2,5-dimethylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent : 1 % MeOH/1 % EtOAc/ 40% CH2Cb/Benzene). 
1-Ethyl-2,4-dimethylimidazole 
Nmr OH (CDCl3) 1.34 (3H, t (J = 7.3 Hzt l-CH2Cfut 2.16 (3H, d (J = 1.1 Hzt 4-
CH3), 2.33 (3H, s, 2-CH3), 3.80 (2H, q (J = 7.3 Hzt l-CfuCH3t 6.52 (lH, s, H-5). 
1-Ethyl-2,5-dimethylimidazole 
Nmr OH (CDCb) 1.27 (3H, t (J = 7.3 Hz), l-CH2Cfu), 2.18 (3H, d (J = 1.0 Hz), 5-
CH3t 2.39 (3H, s, 2-CH3), 3.83 (2H, q (J = 7.3 Hz), l-CfuCH3t 6.64 (lH, s, H-4). 
Benzylation 
Usual workup produced an oil containing the isomers, 1-benzyl-2A-dimethyl-
and 1-benzyl-2,5-dimethylimidazole in 30% yield. 
Isomer Ratio: 3.0: 1 (1-benzyl-2A-dimethyl-: l-benzyl-2,5-dimethylimidazole). 
The isomers were separated as oils by column chromatography (alumina, 
eluent: 0.5% MeOH/0.5% EtOAc/ 40% CH2Cb/Benzene). 
1-Benzyl-2,4-dimethylimidazole 
Nmr OH (CDCl3) 2.21 (3H, d (J = 1.1 Hz), 4-CH3\ 2.36 (3H, s, 2-Cfut 4.99 (2H, s, 










Nmr 8H (CDCl3) 2.11 (3H, d (J = 1.0 Hz), 5-CH3), 2.30 (3H, s, 2-Cfu), 5.03 (2H, s, 
1-CfuPh), 6.75 (lH, s, H-4), 6.91-6.97 (2H, m, H-2',6'), 7.29-7.38 (3H, m, H-3',5', H-
4'). 
3.3.2.2 4-Nitro-5-substituted Imidazoles (IV) 
5( 4)-Iodo-4(5)-nitroimidazole (IV a) 
Methylation 
The solution was filtered, washed with a little 10% NaOH and water to yield 
an off-white solid containing isomeric 5-iodo-1-methyl-4-nitroimidazole and 4-
iodo-1-methyl-5-nitroimidazole. The filtrate was then worked up as usual using 
20% HCl in the acidification step and EtOAc for the final extraction. A second 
crop of isomeric product was obtained and was combined with the first to give a 
total yield of 25% . 
Isomer Ratio: 7.4: 1 (5-iodo-1-methyl-4-nitro-: 4-iodo-1-methyl-5-
ni troimidazole). 
The isomers were separated as pale yellow solids by radial chromatography 
(eluent: 5% MeOH/5% Et0Ac/CH2Cl2). 
5-Iodo-1-methyl-4-nitroimidazole 
M. pt. 237-239°C (lit. m. pt. 240°C 280, 240°C 268). Anal. Found C, 19.3%; H, 
1.3%; N, 16.9%. C4}4N302I requires C, 19.0%; H, 1.6%; N, 16.6%. Nmr 8H 
(CDCl3) 3.75 (3H, s, 1-Cfu), 7.70 (1H, s, H-2); 8H (DMSO) 3.69 (3H, s, l-CH3), 8.10 
(lH, s, H-2); 8c (DMSO) 36.3 (Q (1JcH = 142 Hz), l-CH3), 82.5 (dq (Jc(S)C(2)H ~ 
Jc(S)CH3""' 3.9 Hz), C-5), 140.0 (Dq (1JcH = 222 Hz, JC(2)CH3 = 3.5 Hz), C-2), 149.5 (sm, 
br) (d (JC(4)C(2)H = 12.6 Hz), C-4). 
4-Iodo-1-methyl-5-nitroimidazole 
M. pt. 150°C (lit. m. pt. 150-1 °C 280, 151 °C 268). Anal. Found C, 19.2%; H, 1.3%; 
N, 16.7%. C4B4N302I requires C, 19.0%; H, 1.6%; N, 16.6%. Nmr 8H (CDCl3) 4.03 







(DMSO) 36.7 (Q (1JcH = 144 Hz), l-CH3), 92.7 (d (JC(4)C(2)H = 11.9 Hz), C-4), 140.6 
(sm) (m, C-5), 144.7 (Dq (1JcH = 217 Hz, JC(2)CH3 = 4.3 Hz), C-2). 
Ethylation 
Usual workup, using 20% HCl in the acidification step, gave isomeric 1-ethyl-
5-iodo-4-nitro- and 1-ethyl-4-iodo-5-nitroimidazole in 14% yield . 
Isomer Ratio : 4.5 : 1 (1-ethyl-5-iodo-4-nitro- : 1-ethyl-4-iodo-5-nitroimidazole). 
The isomers were separated as pale yellow solids by radial chromatography 
(eluent: 5% MeOH/5% Et0Ac/CH2Cli). 
1-Ethyl-5-iodo-4-nitroimidazole 
Nmr bH (CDCl3) 1.52 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.14 (2H, q (J = 7.3 Hz), l-
CfuCH3), 7.77 (1H, s, H-2). 
1-E thy 1-4-iodo-5-nitroimidazole 
Nmr 8H (CDCl3) 1.51 (3H, t (J = 7.2 Hz), l-CH2Cfu), 4.47 (2H, q (J = 7.2 Hz), l-
CfuCH3), 7.62 (lH, s, H-2). 
Benzylation 
Usual workup, using 20% HCl in the acidification step, gave isomeric 1-benzyl-
5-iodo-4-nitro- and 1-benzyl-4-iodo-5-nitroimidazole in 4% yield . 
Isomer Ratio : 7.2 : 1 (1-benzyl-5-iodo-4-nitro- : 1-benzyl-4-iodo-5-
nitroimidazole). The isomers were separated as colourless solids by radial 
chromatography (eluent: 3% MeOH/3% Et0Ac/CH2Cli). 
1-Benzyl-5-iodo-4-nitroimidazole 
Nmr 8H (CDCl3) 5.24 (2H, s, 1-CfuPh), 7.18-7.21 (2H, m, H-2',6'), 7.36-7.40 (3H, 
m, H-3',5', H-4'), 7.70 (lH, s, H-2). 
1-B enzyl-4-io do-5-nitroimidazole 
Nmr 8H (CDCl3) 5.56 (2H, s, 1-CfuPh), 7.17-7.22 (2H, m, H-2',6'), 7.37-7.41 (3H, 











The solution was filtered, washed with a little 10% NaOH and water to yield 
an off-white solid containing 'isomeric 5-iodo-1-methyl-4-nitroimidazole and 4-
iodo-1-methyl-5-nitroimidazole. The filtrate was then worked up as usual using 
20% HCl in the acidification step and EtOAc for the final extraction. A small 
second crop of isomeric product was obtained and was combined with the first to 
give a total yield of 22% . 
Isomer Ratio: 6.4: 1 (5-bromo-1-methyl-4-nitro-: 4-bromo-1-methyl-5-
ni troimidazole). 
The isomers were separated as pale yellow ( 4-bromo-1-methyl-5-
nitroimidazole) and colourless plates (5-bromo-1-methyl-4-nitroimidazole) by 
radial chromatography (eluent: 5% MeOH/5% Et0Ac/CH2C!i). 
5-Bromo-1-methyl-4-nitroimidazole 
M. pt. 177-8 °C (lit. m. pt. 279°C 263). Anal. Found C, 23.4%; H, 1.7%; N, 20.5%. 
C4H4N302Br requires C, 23.3%; H, 2.0%; N, 20.4%. Nmr 6H (CDCl3) 3.76 (3H, s, 1-
Cfu), 7.61 (1H, s, H-2); 6H (DMSO) 3.70 (3H, s, 1-Cfu), 8.04 (1H, s, H-2); 6c (DMSO) 
33.9 (Q (1JcH = 143 Hz), 1-CH3), 107.8 (dq <Jc(S)C(2)H ""'Jc(S)CH3 ""'4.0 Hz), C-5), 137.9 
(Dq (1JcH = 220 Hz, Jc(2)CH3 = 3.4 Hz), C-2), 144.2 (d (Jc(4)C(2)H = 12.8 Hz), C-4). 
4-Bromo-1-methyl-5-nitroimidazole 
M. pt. 104°C (lit. m. pt. 105-6°C 411). Anal. Found C, 23.1 %; H, 1.7%; N, 20.4%. 
C4H4N302Br requires C, 23.3%; H, 2.0%; N, 20.4%. Nmr 6H (CDCl3) 4.03 (3H, s, 1-
CH3), 7.54 (1H, s, H-2); 6H (DMSO) 3.92 (3H, s, 1-Cfu), 8.08 (1H, s, H-2); 6c (DMSO) 
36.2 (Qd (lJcH = 144 Hz, J~H3C(2)H = 1.3 Hz), 1-CH3), 119.1 (d (Jc(4)C(2)H = 13 Hz), 
C-4), 141.5 (Dq (1JcH = 219 Hz, Jc(2)CH3 = 4.2 Hz), C-2), C-5 signal unobserved. 
Ethylation 
Usual workup, using 20% HCl in the acidification step and EtOAc for the final 
extraction, gave isomeric 5-bromo-1-ethyl-4-nitro- and 4-bromo-1-ethyl-5-
nitroimidazole in 7% yield . 










The isomers were separated as off-white solids by radial chromatography 
(eluent: 5% MeOH/5% Et0Ac/CH2Cb). 
5-Bromo-1-ethyl-4-nitroimidazole 
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Nmr OH (CDCl3) 1.52 (3H, t (J = 7.4 Hz), l-CH2Cfu), 4.11 (2H, q (J = 7.4 Hz), l-
CfuCH3), 7.59 (lH, s, H-2). 
4-Bromo-1-ethyl-5-nitroimidazole 
Nmr OH (CDCl3) 1.51 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.43 (2H, q (J = 7.3 Hz), l-
CfuCH3), 7.53 (lH, s, H-2). 
Benzylation 
Following usual workup (using 20% HCl in the acidification step), tlc analysis 
of the crude reaction mixture showed only traces of possible benzylated products. 
The mixture was unidentifiable by nmr. 
5(4)-Methylthio-4(5)-nitroimidazole (IV c) 
Methylation 
The solution was filtered, washed with a little 10% NaOH and water to yield a 
yellow solid containing 1-methyl-4-methylthio-5-nitroimidazole plus a trace of 
the 4-nitro- isomer. The filtrate was then worked up as usual using 20% HCl in 
the acidification step. A small second crop of isomeric product was obtained and 
was combined with the first to give a total yield of 68% . 
Isomer Ratio : ca. 1 : 30 (1-methyl-5-methylthio-4-nitro- : 1-methyl-4-
meth y 1 thio-5-ni troimidazole). 
1-Methyl-4-methylthio-5-nitroimidazole was obtained as yellow plates by 
recrystallisation of the above mixture from 70% aqueous EtOH. The structure of 
this major product was confirmed by comparison with an authentic sample of 1-
methyl-5-methylthio-4-nitroimidazole synthesised via an alternative route 
(refer section 3.3.2.3 below). 
1-Methyl-4-methylthio-5-nitroimidazole 
M. pt. 158-9°C (lit. m. pt. 156-157°C 295). Anal. Found C, 34.8; H, 3.8; N, 24.2%. 









SCH3), 4.00 (3H, s, 1-Cfu), 7.52 (lH, s, H-2); 8c (CDCl3) 13.6 (Q (lJcH = 142 Hz), 4-
SCH3), 35.8 (Q (lJcH = 144 Hz), l-CH3), 133.9 (sm br) (m, C-4), 140.9 (Dq (lJcH = 212 
Hz, JC(2)CH3 = 4.1 Hz), C-2), 149.0 (sm br) (m, C-5). 
1-Methyl-5-methylthio-4-nitroimidazole (refer section 3.3.2.3 below) 
Nmr 8H (CDCl3) 2.51 (3H, s, 5-SCfu), 3.81 (3H, s, 1-Cfu), 7.57 (lH, s, H-2); 8c 
(CDCl3) 18.5 (Q <1JcH = 142 Hz), 4-SCH3), 32.9 (Q (lJcH = 141 Hz), l-CH3), 126.9 
(sm br) (m, C-5), 136.5.(Dq (lJcH = 214 Hz, Jc(2)CH3 = 4.4 Hz), C-2), 149.0 (sm br) (m, 
C-4). 
Ethylation 
The product mixture was worked up as usual using concentrated HCl (with 
cooling) in the acidification step to produce an isomeric mixture of 1-ethyl-5-
methylthio-4-nitro- and 1-ethyl-4-methylthio-5-nitroimidazole in 42% . 
Isomer Ratio : 1 : 6.2 (1-ethyl-5-methylthio-4-nitro- : 1-ethyl-4-methylthio-5-
ni troimidazole). 
The isomers were separated as pale-yellow solids by radial chromatography 
(eluent: 5% Hexane/CH2Ch). 
1-Ethyl-5-methylthio-4-nitroimidazole 
Nmr 8H (CDCl3) 1.49 (3H, t (J = 7.4 Hz), l-CH2Cfu), 2.53 (3H, s, 5-SCfu), 4.09 
(2H, q (J = 7.4 Hz), l-CfuCH3), 7.59 (lH, s, H-2). 
1-Ethyl-4-methylthio-5-nitroimidazole 
Nmr 8H (CDCl3) 1.49 (3H, t (J = 7.2 Hz), l-CH2Cfu), 2.62 (3H, s, 4-SCfu), 4.41 
(2H, q (J = 7.2 Hz), l-CfuCH3), 7.55 (lH, s, H-2). 
Benzylation 
The solution was extracted with CH2Cb (4 x 30 cm3), the extracts combined and 
dried over anhydrous MgS04. The mixture was then concentrated under reduced 
pressure at room temperature, and immediately run through a silica filtration 
column (eluent: CH2Cb). An isomeric mixture of 1-benzyl-5-methylthio-4-nitro-
and 1-benzyl-4-methylthio-5-nitroimidazole was obtained in 9% yield . 










The major isomer was separated by radial chromatography (eluent : 10 % 
Hexane/CH2Cb). The minor isomer was isolated in an amount insufficient to 
allow full characterisation by lH nmr. 
1-Benzyl-5-methylthio-4-nitroimidazole 
Nmr OH (CDCIJ) 2.35 (3H, s, 5-SCfu), 5.16 (2H, s, 1-CfuPh). 
1-Benzyl-4-methy I thi o-5-ni troimidazole 
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Nmr OH (CDCl3) 2.62 (3H, s, 4-SCfu), 5.53 (2H, s, 1-CfuPh), 7.18-7.25 (2H, m, H-
2',6'), 7.34-7.41 (3H, m, H-3',5', H-4'), 7.55 (lH, s, H-2). 
5(4)-Methylsulfinyl-4(5)-nitroimidazole (IV d) 
Methylation, Ethylation and Benzylation 
Methylation, ethylation and benzylation reactions on 5(4)-methylsulfinyl-4(5)-
nitroimidazole under alkaline (10% NaOH) conditions were unsuccessful 
irrespective of reaction time. Workup involved CH2Cb extraction and tlc 
analysis. Starting material was nearly completely recovered in each case. An 
authentic sample of 1-methyl-5-methylsulfinyl-4-nitroimidazole was prepared 
via an alternative route (see section 3.3.2.3 below) for comparison with the single 
isomer obtained in the 'neutral' methylation of the substrate (refer Neutral 
Alkylations, s.3.3.3). 
1-Methyl-5-methylsulfinyl-4-nitroimidazole (refer section 3.3.2.3 below) 
Nmr OH (CDCl3) 3.16 (3H, s, 5-SOCfu), 4.11 (3H, s, 1-Cfu), 7.51 (lH, s, H-2); oc 
(CDCl3) 34.9 (Q (lJcH =144 Hz), 1-CHJ), 41.6 (Q (lJcH = 141 Hz), 5-SOCHJ), 130.9 
(sm) (m, C-5), 139.8 (D (lJcH = 216 Hz), C-2), 145.7 (sm br) (C-4). 
1-Methyl-4-methylsulfinyl-5-nitroimidazole 
Insufficient material to characterise. Nmr OH (CDCl3) 3.01 (3H, s, 4-SOCfu), 











The solution was extracted with CH2Cl2 (4 x 30 cm3), the extracts combined and 
dried over anhydrous MgS04. The solvent was concentrated under reduced 
pressure (at room temperature) and immediately run through a silica filtration 
column (eluent : 2% MeOH/CH2Cl2) to give a 9% yield of the methylated 
product, 1-methyl-4-methylsulfonyl-5-nitroimidazole . 
Isomer Ratio : 1-methyl-4-methylsulfonyl-5-nitroimidazole only. 
The product was recrystallised from 50% aqueous EtOH as colourless plates. 
An authentic sample of 1-methyl-5-methylsulfonyl-4-nitroimidazole was 
prepared via an alternative route (see section below) for comparison with the 
single isomer obtained. 
1-Methyl-4-methylsulfonyl-5-nitroimfdazole 
M. pt. 208-9°C (lit. m. pt. 210-212°C 295). Nmr bH (CDCl3) 3.38 (3H, s, 4-
S02CH3), 4.05 (3H, s, 1-Cfu), 7.62 (lH, s, H-2); bH (DMSO) 3.37 (3H, s, 4-S02Cfu), 
3.95 (3H, s, 1-Cfu), 8.18 (lH, s, H-2); 8c (DMSO) 35.5 (Q (lJcH = 145 Hz), l-CH3) 
42.1 (Q ( lJcH = 140 Hz), 4-S0&H3), 135.6 (sm br) (br (m?), C-5), 139.5 (d (Jc(4)C(2)H 
= 10.3 Hz), C-4), 139.6 (Dq (lJcH = 221 Hz, JC(2)CH3 = 4.0 Hz), C-2). 
1-Methyl-5-methylsulfonyl-4-nitroimidazole (refer section 3.3.2.3 below) 
Nmr bH (CDCl3) 3.51 (3H, s, 5-S02Cfu), 4.03 (3H, s, 1-Cfu),7.52 (lH, s, H-2). 
Ethylation and Benzylation 
Ethylation and benzylation reactions on 5(4)-methylsulfonyl-4(5)-
nitroimidazole under alkaline (10% NaOH) conditions were unsuccessful. 
Workup proceeded as for methylation above. Starting material was almost 









4(5)-Nitro-5( 4)-phenylthioimidazole (IV f) 
Methylation 
The solution was filtered, washed with a little 10% NaOH and water to yield a 
yellow solid containing the methylated products, 1-methyl-5-nitro-4-phenylthio-
and l-methyl-4-nitro-5-phenylthioimidazole. The filtrate was then extracted with 
CH2Cl2 (4 x 30 cm3), the extracts combined and dried over anhydrous MgS04. The 
solvent was concentrated under reduced pressure (at room temperature) and 
immediately run through a silica filtration column (eluent : CH2Cb). A small 
second crop of isomeric product was obtained and was combined with the first to 
give a total yield of 72% . 
Isomer Ratio : 1.7: 1 (1-methyl-4-nitro-5-phenylthio- : 1-methyl-5-nitro-4-
phen yl thioimidazole). 
The isomers were separated as pale-yellow solids by radial chromatography 
(eluent: 5% Hexane/CH2Cb). 
1-Methyl-4-nitro-5-phenylthioimidazole 
M. pt. 78°C (lit. m. pt. 77-78°C 297, 77-78°C 295). Anal. Found C, 51.0; H, 4.0; N, 
18.0%. C10H9N302S requires C, 51.1; H, 3.9; N, 17.9% .. Nmr OH (CDCl3) 3.63 (3H, 
s, 1-Cfu), 7.18-7.36 (SH, m, H-2',6', H-3',5', H-4'), 7.61 (lH, s, H-2); oc (CDCl3) 33.1 
(Q (lJcH = 142 Hz), l-CH3), 122.5 (sm br) (C-5), 127.8 (Dt (lJcH = 162 Hz, 3JcH = 7.3 
Hz), C-4'), 128.9 (Dm (lJcH = 162 Hz), C-2',6'), 129.7 (D(d?) (lJcH = 163 Hz), C-3',5'), 
132.5 (t (3JcH = 7.3 Hz), C-1'), 137.4 (Dq <1JcH = 215 Hz, JC(2)CH3 = 3.6 Hz), C-2), 
149.7 (m, C-4). 
1-Methyl-5-nitro-4-phenylthioimidazole 
M. pt. 151-2°C (lit. m. pt. 152-153°C 295). Anal. Found C, 50.9; H, 4.1; N, 17.9%. 
C10H9N302S requires C, 51.1; H, 3.9; N, 17.9% .. Nmr OH (CDCl3) 3.98 (3H, s, l-
CH3), 7.39 (lH, s, H-2), 7.41-7.46 (3H, m, (HETC) H-3',5', H-4'), 7.59-7.65 (2H, m, 
(HETC) H-2',6'); Oc (CDCl3) 35.8 (Q (lJcH = 144 Hz), l-CH3), 128.5 (C-1'), 129.3 
(D(dd?) (lJcH = 162 Hz), C-3',5'), 129.7 (Dt (lJcH = 162 Hz, 3JcH = 7.4 Hz), C-4'), 
133.4 (sm br) (C-4), 135.1 (Dm (lJcH z 164 Hz), C-2',6'), 141.1 (Dq (lJcH = 213 Hz, 












The solution was extracted with CH2Cb (4 x 30 cm3), the extracts combined and 
dried over anhydrous MgS04. The solvent was concentrated under reduced 
pressure (at room temperature) and immediately run through a silica filtration 
column (eluent: CH2Cb) to give a 44% yield of the ethylated products, 1-ethyl-4-
nitro-5-phenylthio- and 1-ethyl-5-nitro-4-phenylthioimidazole . 
Isomer Ratio : 1.8 : 1 (1-ethyl-4-nitro-5-phenylthio- : 1-ethyl-5-nitro-4-
phen ylthioimidazole). 
The isomers were separated by radial chromatography ( eluent : 5% 
Hexane/ CH2Cb). 
1-Ethyl-4-ni tro-5-p henyl thi oimidazol e 
Nmr 8H (CDCb) 1.38 (3H, t (J = 7.3 Hz), l-CH2Cfu), 4.09 (2H, q (J = 7.4 Hz), 1-
CfuCfi3), 7.15-7.32 (SH, m, H-2',6', H-3',5', H-4'), 7.69 (lH, s, H-2). 
1-Ethyl-5-nitro-4-phenylthioimidazole 
Nmr 8H (CDCl3) 1.48 (3H, t (J = 7.2 Hz), l-CH2Cfu), 4.40 (2H, q (J = 7.2 Hz), 1-
CfuCfi3), 7.42-7.47 (4H, m, H-3',5', H-4', (7.46, s, H-2)), 7.61-7.65 (2H, m, H-2',6'). 
Benzylation 
The solution was extracted with CH2Cb (4 x 30 cm3), the extracts combined and 
dried over anhydrous MgS04. Tlc analysis of the concentrated extract showed 
only traces of possible benzylated products. The mixture was unidentifiable by 
nmr. 
A very small quantity of the benzylated material was obtained by ethanolic 
('neutral') alkylation. The minor isomer, 1-benzyl-4-nitro-5-
phenylthioimidazole, could not be fully characterised by ltt nmr, but was 
observed on tlc analysis. 
1-Benzyl-4-nitro-5-phenylthioimidazole 
Nmr 8H (CDCl3) 5.20 (s, 1-CfuPh). 
1-Benzy 1-5-nitro-4-phenylthioimidazole 
Nmr 8H (CDCb) 5.52 (2H, s, 1-CfuPh), 7.19-7.26 (2H, m, H-b,f), 7.34-7.39 (3H, m, 










3.3.2.3 Alternative Synthesis of some Isomeric Products 
1-Methyl-5-phenylimidazole (Illj) 
1-Benzoyl-4-phenylimidazole 368 
4(5)-Phenylimidazole (0.500 g, 3.47 mmol) was dissolved in a cooled solution 
of NaOH (0.17 g, 4.16 mmol) in 15 cm3 aqueous acetone (1:2 acetone/water). With 
continuous stirring, benzoyl chloride (0.58 g, 4.16 mmol) was added and the 
reaction mixture stirred 2 hours at room temperature. A white solid was seen to 
precipitate immediately after the addition. To ensure complete precipitation, a 
further 50 cm3 water was added. The solid was then filtered, washed several 
times with water and air dried. 1-Benzoyl-4-phenylimidazole was obtained as 
colourless plates in 82% yield (0.703 g) after initial purification by radial 
chromatography (eluent: 1 % MeOH/CH2Cl2), and subsequent recrystallisation 
from CH2Cb/hexane. M. pt. 124-5°C (lit. m. pt 124-124.5°C 368). 
Anal. Found C, 77.4; H, 4.7; N, 11.3%. C16H12N20 requires C, 77.4, H, 4.9, N, 
11.3%. Nmr OH (CDCl3) 7.26-7.46 (3H, m, H-4', H-3',5'), 7.51-7.61 (2H, m, H-c,e), 
7.64-7.73 (lH, m, H-d), 7.78-7.87 (SH, m, H-2',6', H-b,f, (HETC) H-5), 8.09 (lH, d 
<JH(2)H(S) = 1.2 Hz), (HETC) H-2); oc (CDCl3) 112.7 (Dd (1JcH = 194 Hz, Jc(S)C(2)H = 
2.5 Hz), C-5), 125.5 (Dm (lJcH ~ 162 Hz), C-2',6'), 128.0 (Dt (lJcH = 161 Hz, 3JcH = 7.6 
Hz), C-4'), 128.7 (Dd (lJcH ~ 160 Hz, 3JcH = 7.5 Hz), (HETC) C-3',5'), 129.0 (Dd <1JcH 
= 164 Hz, 3JcH = 7.4 Hz), (HETC) C-c,e), 129.7 (Dt (lJcH = 163 Hz, 3JcH = 6.7 Hz), C-
b,f), 131.9 (m (t?), C-a), 132.5 (t (3JcH = 6.9 Hz) C-1'), 133.6 (Dt (lJcH = 162 Hz, 3JcH = 
7.4 Hz), (HETC) C-d), 138.4 (Dd (lJcH = 215 Hz, JC(2)C(S)H = 6.4 Hz), C-2), 143.6 (m, 
C-4), 166.0 (m, 1-COPh). 
1-Methyl-5-phenylimidazole (Illj) 
1-Benzoyl-4-phenylimidazole (0.500 g, 2.01 mmol) was dissolved in 10 cm3 dry 
CH2Cl2 and trimethyloxonium tetrafluoroborate (0.327 g, 2.21 mmol) added 
under dry nitrogen. The reaction mixture was stirred at room temperature under 
a dry nitrogen atmosphere for 24 hours. After removal of the solvent, the solid 
residue was dissolved in 30 cm3 water and the acidic solution basified by the 











50 cm3), the combined extracts dried over anhydrous MgS04, and evaporated 
under reduced pressure. 1-Methyl-5-phenylimidazole 
191 
was obtained as colourless plates in 81 % yield (0.258 g) after purification by radial 
chromatography (eluent: 3% MeOH/CH2C!i). M. pt 93-94°C (lit. m. pt. 96-97°C 364, 
94-95°C 365). 
Anal. Found C, 75.6; H, 6.2; N, 17.5%. C10H10N2 requires C, 75.9, H, 6.4; N, 
17.7%. Nmr data presented in previous section. 
5-(4 '-MethoxyphenyD-1-methylimidazole (lllk) 
1-Benzoyl-4-(4'-methoxyphenyl)imidazole 
4(5)-(4'-Methoxyphenyl)imidazole (0.500 g, 2.87 mmol) was dissolved in a 
cooled solution of NaOH (0.14 g, 3.44 mmol) in 15 cm3 aqueous acetone (1:2 
acetone/water). With continuous stirring, benzoyl chloride (0.48 g, 3.44 mmol) 
was added and the reaction mixture stirred 2 hours at room temperature. Work-
up as for 1-benzoyl-4-phenylimidazole produced after chromatographic 
purification (eluent: 1 % MeOH/CH2Cl2) and recrystallisation (CH2Cli/hexane), 
1-benzoyl-4-(4'-methoxyphenyl)imidazole as colourless plates in 78% yield (0.621 
g). M. pt. 114-5°C. 
Anal. Found C, 73.1; H, 4.9; N, 10.2%. C17H14N202 requires C, 73.4; H, 5.1; N, 
10.1 %. Nmr 8H (CDCl3) 3.82 (3H, s, 4'-0Cfu), 6.92-6.96 (2H, m, H-3',5'), 7.52-7.58 
(2H, m, (HETC) H-c,e), 7.64-7.83 (6H, m, H-2',6', H-b,f, H-d; (7.71 d CJH(5)H(2) = 1.2 
Hz),; (HETC) H-5)), 8.06 (lH, d (JH(2)H(5) = 1.2 Hz), H-2); 8c (CDCl3) 55.2 (Q <1JcH = 
144 Hz), 4'-0CH3), 111.4 (br D (1JcH = 194 Hz), C-5), 114.1 (Dd (1JcH = 159 Hz, 3JcH 
= 4.9 Hz), (HETC) C-3',5'), 125.2 (t (3JcH = 7.4 Hz), (LRHETC) C-1'), 126.7 (Dd (1JcH 
= 159 Hz, 3JcH = 7.4 Hz), (HETC) C-2',6'), 129.0 (Dd (1JcH = 162 Hz, 3JcH = 7.6 Hz), 
C-c,e), 129.7 (Dt (1JcH = 164 Hz, 3JcH = 6.7 Hz), C-b,f), 131.9 (t (1JcH = 7.7 Hz), 
(LRHETC) C-a), 133.4 (Dt (1JcH = 163 Hz, 3JcH = 7.5 Hz), C-d), 138.3 (Dd <1JcH = 215 
Hz, Jc(2)C(5)H = 6.1 Hz), C-2), 143.5 (m, C-4), 159.5 (m, C-4'), 165.9 (m, 1-COPh). 
5-(4'-Methoxyphenyl}-1-methylimidazole (lllk) 
1-Benzoyl-4-(4'-methoxyphenyl)imidazole (0.500 g, 1.80 mmol) was dissolved 






mmol) added under dry nitrogen. The reaction mixture was stirred at room 
temperature under a dry nitrogen atmosphere for 24 hours. Work-up as for 1-
methyl-5-phenylimidazole, produced 5-(4'-methoxyphenyl)-1-methylimidazole 
in 72% yield (0.243 g) after purification by radial chromatography (eluent: 5% 
MeOH/CH2Cl2). Rapid decomposition precluded microanalysis. Nmr data is 
presented in previous section. 
5-( 4'-ChlorophenyD-1-methylimidazole (Illl) 
1-Benzoyl-4-(4'-chlorophenyl)imidazole 
4(5)-(4'-Chlorophenyl)imidazole (0.500 g, 2.80 mmol) was dissolved in a cooled 
solution of NaOH (0.13 g, 3.36 mmol) in 15 cm3 aqueous acetone (1:2 
acetone/water). With continuous stirring, benzoyl chloride (0.47 g, 3.36 mmol) 
was added and the reaction mixture stirred 2 hours at room temperature. Work-
up as for 1-benzoyl-4-phenylimidazole produced after chromatographic 
purification (eluent: 1 % MeOH/CH2Cli) and recrystallisation (CH2Cl2/hexane), 
1-benzoyl-4-(4'-chlorophenyl)imidazole as colourless needles in 76% yield (0.600 
g). M. pt. 135-6°C. 
Anal. Found C, 67.7; H, 3.8; N, 9.9%. C16H11N20Cl requires C, 68.0; H, 3.9; N, 
9.9%. Nmr OH (CDCl3) 7.34-7.41 (2H, m, H-3',5'), 7.53-7.63 (2H, m, H-c,e), 7.66-7.86 
(6H, m, H-2',6', H-b,f, H-d; (7.80, d <JH(5)H(2) = 1.3 Hz), (HETC) H-5)), 8.10 (lH, d 
(JH(2)H(5) = 1.2 Hz), (HETC) H-2); 8c (CDCl3) 112.9 (br D (1JcH = 193 Hz), C-5), 
126.8 (Dd <1JcH"'" 162 Hz, 3JcH = 7.4 Hz) (HETC) C-2',6'), 129.0 (D(d?) (lJcH"'" 162 
Hz) (HETC) C-3',5'), 129.1 (D(d?) (lJcH"'" 162 Hz), (HETC) C-c,e), 129.8 (Dm (1JcH"'" 
163 Hz), C-b,f), 131.0 (t (3JcH = 7.6 Hz), (LRHETC) C-1'), 131.8 (m, (LRHETC) C-a), 
133.7 (Dt (lJcH= 163 Hz, 3JcH = 7.5 Hz), C-d), 133.7 (m, C-4'), 138.6 (Dd (lJcH = 214 
Hz, JC(2)C(5)H = 6.5 Hz), C-2), 142.6 (m, C-4), 165.9 (m, 1-COPh). 
5-(4 '-Chlorophenyl}-1-methylimidazole (1111) 
1-Benzoyl-4-(4'-chlorophenyl)imidazole (0.500 g, 1.77 mmol) was dissolved in 
10 cm3 dry CH2Cl2 and trimethyloxonium tetrafluoroborate (0.288 g, 1.95 mmol) 
added under dry nitrogen. The reaction mixture was stirred at room temperature 
under a dry nitrogen atmosphere for 24 hours. Work-up as for 1-methyl-5-










(0.264 g) after purification by radial chromatography (eluent: 5% MeOH/CH2Cl2). 
M. pt. 67-68°C. 
Anal. Found C, 62.2; H, 4.5; N, 14.5%. C10H9N2Cl requires C, 62.4, H, 4.7; N, 
14.5%. Nmr data presented in previous section. 
1-Methyl-5-(4'-nitrophenyDimidazole (Ulm) 
1-Benzoyl-4-(4'-nitrophenyl)imidazole 
4(5)-(4'-Nitrophenyl)imidazole (0.500 g, 2.64 mmol) was dissolved in a cooled 
solution of NaOH (0.13 g, 3.17 mmol) in 15 cm3 aqueous acetone (1:2 
acetone/water). With continuous stirring, benzoyl chloride (0.45 g, 3.17 mmol) 
was added and the reaction mixture stirred 2 hours at room temperature. Work-
up as for 1-benzoyl-4-phenylimidazole produced after chromatographic 
purification (eluent: 1 % MeOH/CH2Cl2) and recrystallisation (CH2Cb/hexane), 
1-benzoyl-4-(4'-nitrophenyl)imidazole as pale yellow needles in 85% yield (0.655 
g). M. pt. 178-9°C (lit. m. pt. 182°C 256). 
Anal. Found C, 65.2; H, 3.7; N, 14.4%. C16H11N303 requires C, 65.5; H, 3.8; N 
14.3%. Nmr 8H (CDCl3) 7.57-7.66 (2H, m, (HETC) H-c,e), 7.71-7.79 (lH, m, H-d), 
7.82-7.89 (2H, m, (HETC) H-b,f), 7.96-8.04 (3H, m, H-2',6'; (7.99, d <JH(2)H(5) = 1.2 
Hz), (HETC) H-5)), 8.15 (lH, d (JH(S)H(2) = 1.2 Hz), (HETC) H-2), 8.24-8.31 (2H, m, 
H-3',5'); 8c (CDCl3) 115.2 (br D (1JcH = 194 Hz), C-5), 124.3 (Dd (lJcH = 169 Hz, 
3JcH = 4.5 Hz), (HETC) C-3',5'), 126.0 (Dd (lJcH = 165 Hz, 3JcH = 6.8 Hz), (HETC) C-
2',6'), 129.2 (Dd <1JcH = 169 Hz, 3JcH = 7.4 Hz), C-c,e), 129.8 (Dt (lJcH = 163 Hz, 3JcH 
= 6.6 Hz), C-b,f), 131.5 ((LRHETC) C-a), 134.0 (Dt (lJcH = 163 Hz, 3JCH = 7.4 Hz), 
(HETC) C-d), 138.9 (Dd <1JcH = 214 Hz, JC(2)C(S)H = 6.5 Hz), C-2), 138.9 (t (3JcH = 7.7 
Hz), C-1'), 141.5 (m, (LRHETC) C-4), 147.2 (m, (LRHETC) C-4'), 165.8 (m (t?), 1-
COPh). 
1-Methyl-5-(4'-nitrophenyl)imidazole (Ulm) 
1-Benzoyl-4-(4'-nitrophenyl)imidazole (0.500 g, 1.71 mmol) was dissolved in 10 
cm3 dry CH2Cb and trimethyloxonium tetrafluoroborate (0.278 g, 1.88 mmol) 










under a dry nitrogen atmosphere for 24 hours. Work-up as for 1-methyl-5-
phenylimidazole, produced 1-methyl-5-(4'-nitrophenyl)imidazole as yellow 
needles in 75% yield (0.264 g) after purification by radial chromatography (eluent: 
5% MeOH/CH2Cb). M. pt. 166-167°C (lit. m. pt. 171-172°C 364, 166-167°C 365). 
Anal. Found C, 59.1; H, 4.2; N, 20.8%. C10H9N302 requires C, 59.1, H, 4.5; N, 
20.7%. Nmr data presented in previous section. 
1-Methyl-5-methylthio-4-nitroimidazole (V c) 
The ammonium salt of 1-methyl-4-nitro-5-thioimidazole was prepared, 
(analogously to the ammonium salt of 5-methylthio-4-nitroimidazole) from 5-
iodo-1-methyl-4-nitroimidazole as bright orange needles (79% yield, m. pt. 196-
70C (lit. m. pt. 197-8°C 297, 194-7°C 298). To this salt (0.200 g, 1.14 mmol) was added 
methanolic sodium methoxide (1.14 mmol, 0.026 g-atoms Na metal in 30 cm3 
MeOH). Iodomethane (0.253 g, 1.78 mmol) was added and the solution heated 
under reflux for 2 hours. The solution was observed to change colour from 
orange to yellow over this period. The solvent was then removed under reduced 
pressure, and a small quantity of water added to the solid residue. The insoluble 
solid was filtered, washed with a little water and recrystallised from 50% aqueous 
EtOH as pale yellow cubes in 58% yield (0.114 g). M. pt. 116-117°C (lit. m. pt. 119-
12ooc 297). 
Anal. Found C, 35.3; H, 4.0; N, 24.4%. C5H7N302S requires C, 34.7, H, 4.1; N, 
24.3%. Nmr data presented in previous section. 
1-Methyl-5-methylsulfinyl-4-nitroimidazole (V d) 
1-Methyl-5-methylthio-4-nitroimidazole (0.040 g, 0.23 mmol) was dissolved 
with slight warming in 15 cm3 of glacial acetic acid. Magnesium 
monoperoxyphthalate hexahydrate (80%) (0.5 mol equivalent, 0.14 mmol, 0.071 g) 
was then added and the reaction mixture stirred no longer than five min at 
ambient temperature. The mixture was poured onto ice water (50 cm3), basified 
with sodium carbonate, and extracted with CH2Ch (4 x 30 cm3). The extracts were 
combined, dried over anhydrous MgS04 and the solvent removed under reduced 
pressure. The crude mixture was then chromatographed (radial, eluent : 2% 











materials. 0.028 g (64%) of 1-methyl-5-methylsulfinyl-4-nitroimidazole was 
obtained as colourless cubes. M. pt. 185-6°C. 
Anal. Found C, 31.7; H, 3.7; N, 21.9%. Cale. for C5H7N303S C, 31.7; H, 3.7; N, 
22.2%; u max: 1530, 1490, 1305, 1280, 1075, 1060 cm-1. Nmr data presented in 
previous section. 
1-Methyl-5-methylsulfonyl-4-nitroimidazole (Ve) 
1-Methyl-5-methylthio-4-nitroimidazole (0.030 g, 0.17 mmol) was dissolved 
with slight warming in 3 cm3 of glacial acetic acid. Hydrogen peroxide (30%, 3 
cm3) was added and the mixture stirred at moderate temperature (30-50°C) for 1 
hour. Following extraction with CH2Cli (4 x 30 cm3), drying and solvent removal, 
the product, 1-methyl-5-methylsulfonyl-4-nitroimidazole was recrystallised from 
50% aqueous EtOH as colourless plates in 66% yield (0.023 g). M. pt. 158-9°C (lit. 
m. pt. 160-161 °C 297). 
Anal. Found C, 29.1; H, 3.3; N, 20.4%. C5H7N304S requires C, 29.3; H, 3.4; N, 








3.3.3 N-Alkylation in "Neutral" Medium 
General Procedure for Alkylation of Unsymmetrical Imidazoles under Neutral 
Conditions 
To a solution of an appropriate 4-substituted or 4,5-disubstituted imidazole 
(0.250 g) in ethanol (10 cm3t was added 1.1 stoichiometric equivalents of freshly 
distilled alkylating agent (dimethyl sulfate, diethyl sulfate, or benzyl chloride). 
The mixture was then heated under reflux for 2 hours. 
Usual Workup 
The solvent was removed by evaporation under reduced pressure and the oily 
residue redissolved in 10% hydrochloric acid (50 cm3). Following extraction with 
diethyl ether (3 x 30 cm3) to remove unreacted alkylating agent, the solution was 
basified by the addition of solid sodium carbonate and re-extracted with 
dichloromethane (4 x 30 cm3). The combined dichloromethane extracts were 
washed with water (30 cm3) and then dried over anhydrous magnesium sulfate. 
The solvent was removed by evaporation under reduced pressure and the crude 
product mixture analysed by lH NMR spectroscopy. 
4(5)-Phenyl- and para- substituted phenylimidazoles 
The reaction mixture was concentrated under reduced pressure and 100 cm3 
10% hydrochloric acid added. Work up continued as above. 
Isomer Ratio Determinations / Yields 
Isomer ratios were determined as described in section 3.2.2. Methylations were 
performed in duplicate; the yields and ratios given are averages for the crude 
mixtures. Analytical data for the isomeric N-alkylation products are presented in 




Table 16. "Neutral" Alkylations of Unsymmetrical Imidazoles 
Substrate Methylation Ethylation Benzylation 
Yield(%) Ratio A Yield(%) Ratio A Yield(%) Ratio A 
Ia 4-Cl 53 1 : 17 58 1 : 14 52 1 : 6.0 
Ib 4-Br 44 1 : 11.5 35 1 : 7.5 49 1 : 5.7 
le 4-I 58 1 : 4.9 54 1 : 3.0 46 1 : 2.3 
Id 4-CH3 49 1.4 : 1 50 1.5 : 1 42 1.9 : 1 
le 4-CH20H 25 1 : 1.6 B 17 1 : 1.7 B 14 1.5 : 1 
If 4-CHO 34 1 : 3.6 32 1 : 2.0 37 1 : 1.7 
lg 4-C02CH3 34 1 : 6.5 C 37 1 : 4.0 C 24 1 : 2.2 
Ih 4-CONH2 D 1 : 1 D D 2.9 : 1 D D 1.9 : 1 D 
Ii 4-N02 41 ,,,, 1 : 50 44 ,,,, 1 : 35 21 1 : 10 
Ij 4-C61-Is 56 4.0 : 1 44 E > 12 : 1 29 E F 
Ik 4-p- CH30C6H4 52 G 5.1 : 1 35 E,G F 36 E,G F 
11 4-p-ClC6H4 49 3.2 : 1 30 7.4 : 1 31 E F 
Im 4-p- N02C6H4 46 2.9 : 1 29 5.0 : 1 26 E F 
In 2,4-(CH3)2 35 1.2 : 1 33 2.3 : 1 35 4.5 : 1 
IVa 5-I-4-N02 12 H 1 : 6.9 3 H 1 : 4.2 H,I 
IVb 5-Br-4-N02 10 H 1 : 2.7 H, I - H, I -
IVc 5-SCH3-4-N02 45 J ,,,, 1 : 50 12 H K 8 L M 
IVd 5-CH3S(0)-4-N02 3 L M L,I - L,I -
IVe 5-CH3S( 02)-4-N02 7 L M L,I - L,I -
IVf 4-N02-5-SPh 51 L M 15 L 1 : 16 7 L 1 : 10 
_\ 
"'- --,, 14 
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A 1-alkyl-4-R-: 1-alkyl-5-R-imidazole; 1-alkyl-5-R-4-nitro- : 1-alkyl-4-R-5-
nitroimidazole. 
198 
B Trace amounts of the N-alkylated alkoxymethyl by-products were observed 
by lH nmr. 
C Trace quantities of possible trans-esterification products (ie. ethyl 1-
alkylimidazole-4- and 5-carboxylates) were also observed by lH nmr. 
D Imidazole-4(5)-carboxamide: 
Methylation 
Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 cm3 of 
ethanol. Dimethyl sulfate (0.250 g, 1.98 mmol) was added and the solution heated 
under reflux for 1 hour. Workup proceeded as usual. In the final extraction step, 
the basified aqueous solution was presaturated with sodium chloride. A residue 
was produced containing the isomers, 1-methylimidazole-4- and 1-
methylimidazole-5-carboxamide (4%) in conjunction with isomeric methyl 1-
methylimidazole-4- and methyl 1-methylimidazole-5-carboxylate (8%) and 
isomeric ethyl 1-methylimidazole-4- and ethyl 1-methylimidazole-5-carboxylate 
(12%) in 24% overall yield. The ratio of N-methylated products (amide : methyl 
ester: ethyl ester), as determined by nmr, was approximately 1:2:3. Of the 
recovered unreacted starting material less than half escaped esterification in the 
refluxing ethanol. Ethyl imidazole-4(5)-carboxylate was a major recovery product. 
Isomer Ratio : 1 : 1 (1-methylimidazole-4- : 1-methylimidazole-5-
carboxamide); 1 : 2.7 (methyl 1-methylimidazole-4-: methyl 1-methylimidazole-5-
carboxylate); 1 : 1.6 (ethyl 1-methylimidazole-4- : ethyl 1-methylimidazole-5-
carboxylate). 
Ethyl 1-methylimidazole-4-carboxylate 
NMR DH (CDCl3) 1.37 (3H, t (J = 7.1 Hz), 4-COOCH2Cfu), 3.76 (3H, s, 1-Cfu), 
4.36 (2H, q (J = 7.1 Hz), 4-COOCfuCH3), 7.49 (1H, s, H-2), 7.58 (1H, s, H-5). 
Ethyl 1-methylimidazole-5-carboxylate 
NMR OH (CDCl3) 1.36 (3H, t (J = 7.1 Hz), 5-COOCH2Cfu), 3.92 (3H, s, 1-Cfu), 










Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 cm3 of 
ethanol. Diethyl sulfate (0.278 g, 1.98 mmol) was added and the solution heated 
under reflux for 1 hour. Workup proceeded as usual. In the final extraction step, 
the basified aqueous solution was presaturated with sodium chloride. A residue 
was produced containing the isomers, 1-ethylimidazole-4- and 1-ethylimidazole-
5-carboxamide (7%) in conjunction with isomeric ethyl 1-ethylimidazole-4- and 
ethyl 1-ethylimidazole-5-carboxylate (11 %) in 18% overall yield. The ratio of N-
ethylated amide products to ethylated ethyl ester by-products, as determined by 
nmr, was approximately 1:2. Ethyl imidazole-4(5)-carboxylate was a major 
recovery product. 
Isomer Ratio: 2.9: 1 (1-ethylimidazole-4-: 1-ethylimidazole-5-carboxamide); 
1.8 : 1 (ethyl 1-ethylimidazole-4- : ethyl 1-ethylimidazole-5-carboxylate). 
Benzylation 
Imidazole-4(5)-carboxamide (0.200 g, 1.80 mmol) was dissolved in 10 cm3 of 
ethanol. Benzyl chloride (0.251 g, 1.98 mmol) was added and the solution heated 
under reflux for 1 hour. Workup proceeded as usual. In the final extraction step, 
the basified aqueous solution was presaturated with sodium chloride. A residue 
was produced containing the isomers, 1-benzylimidazole-4- and 1-
benzylimidazole-5-carboxamide in 10% yield. A small quantity of probable N-
benzylated ethyl ester material was observed by lH nmr, but was not 
characterised. 
Isomer Ratio: 1.9: 1 (1-benzylimidazole-4-: 1-benzylimidazole-5-carboxamide). 
E Only the 1-alkyl-4-R-imidazole isomer was chromatographically isolated. 
F 1-Alkyl-4-R-imidazole only. (A trace amount of (possibly) the minor isomer 
was also detected). 
G Decomposition was observed on long standing to give numerous 
intractable, higher Rf, non-imidazole products. 
H Usual workup, using 20% hydrochloric acid in the acidification step and 
ethyl acetate for the final extraction. 
I Tlc and nmr analysis of the crude product mixture showed no trace of 
alkylated products. Starting material was almost completely recovered in 
each case. 
J Usual workup, using 20% hydrochloric acid in the acidification step. 










L Workup: The solution was concentrated under reduced pressure and 
immediately run through a silica filtration column. 2% MeOH/CH2Cli was 
used as eluent for methylthio, methylsulfinyl and methylsulfonyl 
substrates, CH2Cli for 4-nitro-5-phenylthioimidazole. 
M 1-Alkyl-4-R-5-nitro- isomer only. 
3.3.3.1 Potentiometric Titrations 
4-iodo-, 4-bromo-, 4-chloro-, 4-methylimidazole and their respective N-methyl 
derivatives were prepared for potentiometric titration. All samples were purified 
by chromotography and/ or recrystallisation with subsequent vacuum 
sublimation/ distillation. The microanalytically pure samples were dissolved in 
distilled water (using ultrasonication if necessary) to produce homogeneous 
solutions with concentrations in the range 0.01000M - 0.02500M. 
General Procedure 
10.00 cm3 of 1.049 x 10-2 M 4-Bromo-1-methylimidazole was titrated with 0.10 
cm3 aliquots of 0.100M HCl at 25°C. The pH was recorded after each addition 
upon equilibration. The titration was duplicated and the average pH readings 
used to calculate the acid ionization constant of the base. 
The solution pH was measured using a PHM82 standard pH meter equipped 
with G2020B (glass) and K4040 (calomel) electrodes. Both electrodes were 
standardised using 0.025M Na2HP04 / 0.025M KH2P04 ( pH(25°C) = 6.86 ) and 
either borax ( 0.01M, pH(25°C) = 9.18) or potassium hydrogen phthalate ( 0.05M, 
pH(25°C) = 4.01 ). Considerable care is needed in maintaining constant 
temperature when standardising the potentiometer and during the course of the 
titration. 
The pKBH+ calculations are presented in Appendix 5. It should be pointed out 
that these values are in fact 'mixed' (K~8 +) and not thermodynamic (K~8 +) 
ionisation constants, ie. no activity correction was included in _the calculations. 
Such a correction is relatively small at the ionic concentrations present; 
thermodynamic constants are smaller by a factor of the same order as the 
experimental uncertainties.(0.03-0.05 pK units). 
~ Diazomethane Methylations 
General Procedure for Methylation of Unsymmetrical Imidazoles with 
Diazomethane 
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To the 4-substituted or 4,5-disubstituted imidazole (generally 0.150 g), was 
added 1.2 stoichiometric equivalents of freshly prepared ethereal diazomethane 
(refer diazomethane preparation below) of known concentration in the range 
(0.4-0.6 mol dm-3). The reaction mixture was then stirred at ambient temperature 
until decolourisation or complete evaporation of the ethereal diazomethane had 
occurred. 
Usual Workup 
25 cm3 of 10% aqueous sodium hydroxide was added to the residue and the 
resulting solution was extracted with dichloromethane (4 x 30 cm3) or ethyl 
acetate (4 x 30 cm3) (specified). The combined dichloromethane extracts were 
washed with water (30 cm3) before being dried over anhydrous magnesium 
sulfate. Solvent removal by evaporation under reduced pressure yielded a 
mixture of isomeric N-methylated products which was analysed by lH nmr 
spectroscopy. The yields quoted are of unpurified material unless otherwise 
stated. 
Isomer Ratio Determinations / Yields 
Isomer ratios were determined as for the "basic" (s. 3.3.2) and "neutral" 
alkylation reactions (s. 3.3.3). The diazomethane methylations reactions recorded 
below were performed in duplicate, and the ratios quoted are averages. The yields 
also, are given as averages for the crude alkylation mixtures. 
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Diazomethane Preparation 
Diazomethane was prepared as an ethereal solution by the procedure described 
as Method 1 in Vogel's Textbook of Practical Organic Chemistry, 5th Edition 412. 
An accurate solution concentration was determined by the following procedure : 
5.0 cm3 of the ethereal diazomethane was added to an accurately weighted 
amount of benzoic acid (:c:: 0.5 g) dissolved in 25 cm3 of anhydrous diethyl ether. 
The decolourised solution was diluted with 50 cm3 of water and titrated with 
standard 0.10 mol dm-3 sodium hydoxide solution with phenolphthalein as 
indicator. 
Table 18. Diazomethane methylations of unsymmetrical imidazoles. 
Substrate Yield(%) Isomer Ratio A 
Ia 4-Cl 26 1 : 3.8 
lb 4-Br 21 1 : 2.6 
le 4-I 12 1 : 2.3 
Id 4-CH3 3 1 : 1 
If 4-CHO 12 1 : 4.4 
lg 4-C02CH3 16 1 : 6.0 
Ih 4-CONH2 4 1 : 5.4 
Ii 4-N02 58 1 : 16 
Il 4-p- ClC6B4 3 1 : 1.1 
Im 4-p- N02C6H4 4 1 : 1.4 
IVa 5-I-4-N02 89 B 1 : 6.1 
IVb 5-Br-4-N02 91 B 1 : 3.6 
IVc 5-SCH3-4-N02 93 1 : 17 
IVd 5-S0CH3-4-N02 81 4.5 : 1 
IVe 5-S02CH3-4-N02 90 3.0 : 1 
IVf 5-SPh-4-N02 88 1 : 5.8 
A 1-Methyl-4-substituted : 1-methyl-5-substituted; 1-methyl-4-nitro-5-substituted : 1-
methyl-5-nitro-4-substituted. 
B Ethyl acetate extraction. 
Note: Attempted diazomethane alkylations of 4(5)-phenyl-, 4(5)-(4'-
methoxyphenyl)-, 2,4(5)-dimethyl-, and 4(5)-hydroxymethyl- imidazole substrates 
were unsuccessful. 
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3.3.4.1 Mechanistic Studies 
Attempted methylation of the sodium salt of 4-nitroirnidazole 
To sodium 4-nitroimidazolate (0.250 g, 1.85 mmol) was added 10 
stoichiometric equivalents of ethereal diazomethane (0.46 mol dm-3, 40 cm3) and 
the reaction mixture was stirred at ambient temperature until complete 
evaporation of the ethereal diazomethane had occurred. No sign of any 
methylated product was observed upon usual workup. 
Excess Diazornethane 
4-Brornoimidazole 
To 4-bromoimidazole (0.150 g, 1.02 mmol), was added 20 stoichiometric 
equivalents of freshly prepared ethereal diazomethane (0.55 mol dm-3, 37 cm3). 
The reaction mixture was then stirred at ambient temperature until complete 
evaporation of the ethereal diazomethane had occurred. Usual workup produced 
an isomeric mixture containing 4-bromo-1-methyl- and 5-bromo-1-
methylimidazole (0.042 g, 26%) in a ratio of 1 : 1.7. 
4-Nitroirnidazole 
To 4-nitroimidazole (0.150 g, 1.33 mmol), was added 20 stoichiometric 
equivalents of freshly prepared ethereal diazomethane (0.55 mol dm-3, 48 cm3). 
The reaction mixture was then stirred at ambient temperature until complete 
evaporation of the ethereal diazomethane had occurred. Usual workup produced 
an isomeric mixture containing 1-methyl-4-nitro- and 1-methyl-5-nitroimidazole 
(0.095 g, 56%) in a ratio of 1 : 15. 
Excess Substrate 
4-Brornoimidazole 
To 4-bromoimidazole (0.500 g, 3.40 mmol) dissolved in ethanol (5 cm3), was 
added 0.1 stoichiometric equivalent of freshly prepared ethereal diazomethane 
(0.55 mol dm-3, 0.6 cm3). The reaction mixture was observed to decolourise 
immediately. Usual workup produced an isomeric mixture containing 4-bromo-




To 4-bromoimidazole (0.150 g, 1.02 mmol) dissolved in ethanol (5 cm3), was 
added 1.2 stoichiometric equivalents of freshly prepared ethereal diazomethane 
(0.43 mol dm-3, 2.9 cm3). The reaction mixture was then stirred at ambient 
temperature until complete evaporation of the ethereal diazomethane had 
occurred. Usual workup produced an isomeric mixture containing 4-bromo-1-
methyl- and 5-bromo-1-methylimidazole (0.028 g, 17%) in a ratio of 1: 3.0. 
4-Nitroimidazole 
To 4-nitroimidazole (0.150 g, 1.33 mmol) partially dissolved in ethanol (5 cm3), 
was added 1.2 stoichiometric equivalents of freshly prepared ethereal 
diazomethane (0.43 mol dm-3, 3.7 cm3). The reaction mixture was then stirred at 
ambient temperature until complete evaporation of the ethereal diazomethane 
had occurred. Usual workup produced an isomeric mixture containing 1-methyl-
4-nitro- and 1-methyl-5-nitroimidazole (0.102 g, 60%) in a ratio of 1 : 14. 
Deuterium Incorporation 
4-Bromoimidazole (0.500 g, 3.40 mmol) was completely dissolved in D20 (99.8 
atom% D, 10 cm3), and subsequently evaporated to dryness under reduced 
pressure. 1.2 Equivalents of ethereal diazomethane (0.52 mol dm-3, 7.9 cm3) were 
then added and the mixture stirred at room temperature for 2 hours. Usual 
workup produced an isomeric mixture (18%) from which the deuterium 
enriched products were isolated by column chromatography (alumina, eluent : 
2% Et0Ac/CH2Ch) and subjected to nmr analysis. 
4-Bromo-1-methylimidazole 
Nmr 8H (CDCl3) 3.67 (0.3H), 3.68 (0.3H), 3.68 (0.3H), 3.69 (2.0H), 6.87 (lH, s, H-
5), 7.41 (lH, s, H-2); see Figure 7, s. 3.2.3.3. 
5-Bromo-1-methylimidazole 
Nmr 8H (CDCh) 3.60 (0.3H), 3.61 (0.3H), 3.62 (1.9H), 7.03 (lH, br s, H-5), 7.55 
(1H, br s, H-2). 
~ Alkylation Studies on 4-Bromoimidazole 
Solvent Dependence - "Neutral" Conditions 
4-Bromoimidazole (0.250 g, 1.70 mmol) was dissolved in 10 cm.3 of the 
appropriate solvent. Dimethyl sulfate (1.1 equivalents, 0.236 g, 1.87 mmol) was 
added and the solution heated under reflux for 2 hours. The reaction mixtures 
were worked up as usual for yield and ratio determination. 
Solvent Yield Isomer Ratio A 
(%) 
EtOH 44 1: 11.5 
DMF 58 1: 8.4 
(p-) Dioxane 44 1: 10.0 
THF 61 1: 12.0 
Et20 66 1: 22 
CH2Cli 49 1:18 
Benzene 50 1: 20 
A 4-Bromo-1-methyl- : 5-bromo-1-methylimidazole. 
Solvent and Base Dependence "Basic" Conditions 
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Unless otherwise specified, 4-Bromoimidazole (0.250 g, 1.70 mmol) was 
dissolved in 10 cm3 of the appropriate solvent. 1.2 Equivalents of the appropriate 
base was added followed by dimethyl sulfate (1.1 equivalents, 1.87 mmol, 0.236 g) 
and the mixture stirred at room temperature for 2 hours. The reaction mixtures 








A 4-Bromo-1-methyl- : 5-bromo-1-methylimidazole. 
B Powdered KOH (1.5 equivalents). 
Yield Isomer Ratio A 
(%) 
50 1.7:1 
68 1.6: 1 
38 1: 7.8 
22 1: 7.2 
31 1: 7.6 
75 3.8: 1 
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Phase Transfer Catalysis (PTO 
(i) 4-Bromoimidazole 
4-Bromoimidazole (0.250 g, 1.70 mmol) dissolved in 10 cm3 of 10% sodium 
hydroxide solution. Tetrabutylammonium bromide (6% equivalent, 0.033 g, 0.10 
mmol) was added followed by a solution of dimethyl sulfate (1.1 equivalents, 
0.236 g, 1.87 mmol) dissolved in 20 cm3 of chloroform. The biphasic reaction 
mixture was stirred for 2 hours at room temperature. The mixture was then 
transferred to a separating funnel and the chloroform layer collected. The 
aqueous solution was extracted twice more with chloroform (40 cm3) and the 
extracts combined. The solvent was then removed and the residue dissolved in 
50 cm3 of 10% hydrochloric acid. The aqueous solution was extracted with 
dichloromethane (6 x 50 cm3) and then basified by the addition of solid sodium 
carbonate. Workup then proceeded as usual to produce an isomeric mixture in 
77% yield (0.210 g). 
Isomer ratio : 2.4: 1 (4-bromo-1-methyl- : 5-bromo-1-methylimidazole). 
(ii) 4-Nitroimidazole 
4-Nitroimidazole (0.250 g, 2.21 mmol) was reacted with diethyl sulfate (1.1 
equivalents, 0.375 g, 2.43 mmol) under the above phase transfer conditions. 
Identical workup produced an isomeric mixture in 68% yield (0.212 g). 
Isomer ratio : 3.6 : 1 {1-methyl-4-nitro : 1-methyl-5-nitroimidazole). 
4-Nitroimidazole (0.250 g, 2.21 mmol) was reacted with diethyl sulfate (1.1 
equivalents, 0.375 g, 2.43 mmol) under phase transfer conditions using 12% 
equivalent of the catalyst. Identical workup produced an isomeric mixture in 53% 
yield (0.165 g). 
Isomer ratio : 3.2 : 1 (1-methyl-4-nitro : 1-methyl-5-nitroimidazole). 
Alkylation of 4-bromoimidazolate salt 
(i) Tetrabutylammonium salt 237 
4-Bromoimidazole (0.250 g, 1.70 mmol) was dissolved in 10% sodium 
hydroxide (10 cm3). Tetrabutylammonium bromide (0.548 g, 1.70 mmol) was 
added and the solution evaporated to dryness under reduced pressure. The 
syrupy residue was extracted with dichloromethane (4 x 40 cm3), the extracts were 
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combined and dried over anhydrous magnesium sulfate. After filtration, the 
solvent was removed and the residual oil was dried under vacuum (92% crude 
yield, 0.607 g). 
Nmr bH (CDCl3) 0.99 (12H, t, (CfuCH2CH2CH2)4Nlm), 1.44 (16H, m, 
(CH3CfuCfuCH2)4Nlm), 2.99 (8H, m, (CH3CH2CH2Cfu)4Nlm), 6.75 (lH, d 
(JH(S)H(2) = 1.0 Hz), H-5(4)), 7.25 (lH, d CJH(2)H(5) = 1.0 Hz), H-2). 
The oil was redissolved in dichloromethane (10 cm3) and dimethyl sulfate (1.1 
equivalents, 0.236 g, 1.87 mmol) was added. The solution was stirred at room 
temperature for 2 hours. The solvent was then removed and the residue was 
dissolved in 50 cm3 of 10% hydrochloric acid. The aqueous solution was extracted 
with dichloromethane (6 x 50 cm3) and then basified by the addition of solid 
sodium carbonate. Workup then proceeded as usual to produce an isomeric 
mixture in 74% yield (0.203 g). 
Isomer ratio : 1 : 4.5 (4-bromo-1-methyl-: 5-bromo-1-methylimidazole). 
(ii) Triethylammonium salt 
4-Bromoimidazole (0.250 g, 1.70 mmol) was dissolved in a minimum amount 
of triethylamine. Excess triethylamine was removed under reduced pressure and 
the residue was redissolved in 10 cm3 of dichloromethane. Dimethyl sulfate (1.1 
equivalents, 0.236 g, 1.87 mmol) was added and the solution was stirred at room 
temperature for 2 hours. The solvent was then removed and 50 cm3 water was 
added to the residue. The pH of the mixture was adjusted to ca. 9 and it was then 
extracted with dichloromethane (4 x 40 cm3). The extracts were combined and 
upon removal of the solvent, the residue was dissolved in 50 cm3 of 10% 
hydrochloric acid. The aqueous solution was extracted with dichloromethane (4 x 
30 cm3) and then basified by the addition of solid sodium carbonate. Workup 
then proceeded as usual to produce an isomeric mixture in 68% yield (0.186 g). 
Isomer ratio : 1 : 16 (4-bromo-1-methyl-: 5-bromo-1-methylimidazole). 
Alkylating Agent 
The following alkylations were carried out under the reaction conditions 
specified. 0.250 g of the substrate and 1.1 equivalents of the alkylating agent were 
used in each case. The reaction mixture was stirred at room temperature for 2 
hours and worked up as usual for yield and ratio determination. 
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Reaction Conditions Yield Isomer Ratio A 
Substrate (%) 
4-Bromo 10% NaOH/CH3l 62 1.5: 1 
PTCB/CHJ! 69 2.1: 1 
EtOH/CHJI 34 1: 5.8 
EtOH/ (CH3)30BF4 8 1: 7.6 
(Bu)~+ salt 79 2.1: 1 
/CH2Ch/(CH3)30BF4 C 
4-Nitro PTC B (6%)/C2HsBr 65 3.4: 1 
PTC B (12%)/C2H5Br 59 3.1: 1 
A 1-Alkyl-4substituted : 1-alkyl-5-substituted. 
B Phase transfer catalytic conditions. Refer above for workup procedure. 
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The spectra were run in CDCh or DMS0-d6 as dictated by solubility, and the 
results are recorded in Table 19 (see experimental section 2.4 for further details). 
The chemical shifts of the ring and N-methyl protons only are tabulated; refer 
experimental sections 2.5 and 3.3.2 for substituent chemical shifts and coupling 
information. 
As detailed in section 3.2.2, Matthews and Rapoport discovered that proton 
chemical shifts are insufficient by themselves, to enable identification of a single 
isomeric N-methyl derivative 353. Cross-ring coupling constants on the other 
hand were deemed a suitable criterion on which to base structure elucidation, 
and the nmr results of this investigation appear to bear out this assertion. To see 
if in fact chemical shift information can be used constructively, the changes in 
ring proton chemical shift caused by N-methylation were calculated from the 
data in Table 19 and tabulated in Tables 20-21. 
The conclusions of the above authors are found to hold : identification cannot 
be made from the spectrum of a single isomer, and in general terms the ring 
proton resonances of II appear upfield of the corresponding protons of III. For the 
4-nitro-5-substituted imidazoles, with the exception of IV d and IVe, methylation 
adjacent to the nitro group results in greater shielding of the H-2 proton; the 
substantial electron-withdrawing power of the sulfinyl and sulfonyl groups and 
possible associated anisotropic effects result in the opposite trend. 
The phenyl proton resonances of 4-phenylimidazole, Ij, and its N-methyl 
derivatives, IIj and IIIj, are in close agreement with earlier published data for 
these compounds 366, and are consistent with ring coplanarity in the substrate. 
This structural feature is necessary for conjugative (interannular) interaction and 
accordingly supports the observed methylation dependence on O'p substituent 
constants (s. 3.2.3.1). A comparison of the spectra of aryl N-methylazoles in 
Butler's nmr study revealed that while the phenyl protons of IIIj give a single 
signal (broad multiplet), the ortho proton resonances are shifted downfield and 
the meta/para resonances upfield, in IIj. Disruption of ring coplanarity was cited 
as the leading contributor to this behaviour; N-methylation af the nitrogen 
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Table 19. lH nmr data (8, ppm, CDCl3 (unless otherwise stated)) for the mono-
(I Rl=R2=R5=H) and disubstituted-imidazoles (IV R2=H, R4=N02; In 
R2=CH3) and their N-methyl derivatives (II, III, V, VI Rl=Cfu; II 
R5=H; III R4=H; V R4=N02; VI R5=N02). 
Compound Rl R2 R4 R5 
I a - 7.57 - 7.00 
II a 3.66 7.27 - 6.79 
III a 3.59 7.45 6.92 
I b - 7.61 - 7.08 
II b 3.68 7.32 - 6.87 
III b 3.62 7.53 7.00 
I C - 7.62 - 7.17 
II C 3.69 7.33 - 6.97 
III C 3.61 7.63 7.13 · 
I d - 7.57 - 6.78 
II d 3.61 7.30 - 6.59 
III d 3.53 7.36 6.76 
I e (DMSO) - 7.56 - 6.89 
II e 3.65 7.35 - 6.83 
III e 3.69 7.38 6.87 
I f (DMSO) - 7.94 - 8.00 
II f 3.79 7.55 - 7.62 
III f 3.96 7.65 7.79 
I g (DMSO) - 7.82 - 7.82 
II g 3.76 7.47 .- 7.59 
III g 3.85 7.57 7.72 
I h (DMSO) - 7.72 - 7.64 
II h 3.74 7.55 - 7.39 
III h 3.94 7.53 7.50 
I i (DMSO) - 7.88 - 8.33 
II i 3.81 7.41 - 7.77 
III i 4.03 7.63 7.97 
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· Table 19 contd. 
Compound Rl R2 R4 R5 
I j - 7.68 - 7.35 
II j 3.52 7.35 - 7.05 
III j 3.65 7.67 7.13 
I k - 7.63 - 7.23 
II k 3.68 7.46 - 7.05 
III k 3.64 7.67 7.06 
I 1 - 7.71 - 7.33 
II 1 3.63 7.41 - 7.08 
III 1 3.66 7.57 7.10 
I m (DMSO) - 7.83 - 7.91 
II m 3.77 7.52 - 7.34 
III m 3.78 7.66 7.29 
I n - - - 6.60 
II n 3.49 - - 6.48 
III n 3.41 - 6.62 
IV a (DMSO) - 7.97 
V a 3.75 7.70 
VI a 4.03 7.51 
IV b (DMSO) - 7.94 
V b 3.76 7.61 
VI b 4.03 7.54 
IV c (DMSO) - 7.90 
V C 3.81 7.57 
VI C 4.00 7.52 
IV d (DMSO) - 8.06 
V d 4.11 7.51 
VI d 4.08 7.75 
IV e (DMSO) - 8.08 
V e 4.03 7.52 
VI e 4.05 7.62 
IV f (DMSO) - 7.87 
V f 3.63 7.61 
VI f 3.98 7.39 
Table 20. Ring proton chemical shift differences, 8H (II, III) - 8H (I) for the 
imidazole series, I. 
Compound ~8H-2 ~8 H-4 (5) Compound ~8H-2 ~8 H-4 (5) 
II a -0.30 -0.21 III a -0.12 -0.08 
II b -0.29 -0.21 III b -0.08 -0.08 
II C -0.29 -0.20 III C 0.01 -0.04 
II d -0.27 -0.19 III d -0.21 -0.02 
II e * -0.21 -0.06 III e * -0.18 -0.02 
II f * -0.39 -0.38 III f * -0.29 -0.21 
II g * -0.35 -0.23 III g * -0.25 -0.10 
II h * -0.17 -0.25 III h * -0.19 -0.14 
II i * -0.47 -0.56 III i * -0.25 -0.36 
II j -0.33 -0.30 III j · -0.01 -0.22 
II k -0.17 -0.18 III k 0.04 -0.17 
II 1 -0.30 -0.25 III 1 -0.14 -0.23 
II m * -0.31 -0.57 III m * -0.17 -0.62 
II n - -0.12 III n - 0.02 
* Chemical shifts for the substrate protons used in the difference calculations are in DMS0-
d6 (see Table 19). 
Table 21. Ring proton chemical shift differences, 8H (V, VI)- 8H (IV) for 
the imidazole series, IV. 
Compound ~8H-2 Compound ~8H-2 
V a * -0.27 VI a * -0.46 
Vb* -0.33 VI b * -0.40 
V C * -0.33 VI C * -0.38 
V d* -0.55 VI d * -0.31 
V e * -0.56 VI e * -0.46 
V f * -0.26 VI f * -0.48 
* Chemical shifts for the substrate protons used in the difference calculations are ~n DMS0-
d6 (see Table 19). 
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The spectra of the para-substituted phenylimidazoles, Ik-m, display the 
expected AA'XX' splitting patterns for the H-2',6' and H-3',5' phenyl protons. 
These patterns are most closely reproduced (separation and chemical shift) in the 
spectra of the corresponding N-methylated derivatives, llk-m. Considerable 
deviation is observed for the splitting patterns of isomeric Illk-m, which can 
again be attributed to non-coplanar geometry; the chemical shifts of the (ortho)H-
2',6' multiplets for each of lllk-m are significantly upfield of the isomeric signals 
(0.2-0.3 ppm). 
4.2 13c nmr 
The carbon spectra were similarly run in CDCl3, DMK-d6 or DMS0-d6 as 
dictated by solubility, and the chemical shifts of the ring and N-methyl carbons 
are recorded in Table 22 (see experimental section 2.4 for further details). One-
bond coupling constants (lJcH) obtained from lH-coupled carbon spectra are 
included in the table; where observed, additional coupling information (2JCH, 
3JcH) is included in the experimental sections 2.5 and 3.3.2. 
The relative simplicity of the carbon spectra of substituted imidazoles, has 
enabled the use of non-decoupled acquisition as an effective tool for peak 
assignment. Despite the large run times necessary for these experiments, this 
method has proved particularly useful in distinguishing substituent and 
irnidazole ring carbons. The benefits of retaining coupling information are 
exemplified by the spectrum of imidazole-4-carbaldehyde displayed in Figure 8 (p. 
209a). As can be seen in this case, a problem of overlapping signals is eliminated, 
and at the same time peak assignment is facilitated by consideration of one-bond 
13C-1H coupling constants; the relative magnitudes of these constants for 
protonated C-2 and C-5(4) carbons allows unambiguous assignment. From a 
comparison of these constants for unsubstituted and N-methylated irnidazoles 
alike (Table 22), it is clear that 1JC(2)H > 200 Hz and 1JC(4 (S))H::;; 200 Hz. Further, it 
is appears that vicinal cross-ring coupling constants, 3JC(2)C(5(4))H and 
3JC(5(4))C(2)H, are also diagnostic. Illustrated in Figure 8, cross-ring coupling from 
C-2 to H-5(4) in N-unsubstituted imidazoles is typically larger than coupling from 
C-5(4) to H-2 : for the substrates in this investigation, 3JC(2)C(5(4))H = 7.9-9.7 Hz 
and 3JC(5(4))C(2)H = 3.6-5.8 Hz. Although less data is available for the N-methyl 
derivatives from which to examine these trends, the same generalisation seems 
to hold true. 
R4'{-N 
s-!!.._ ~ 2 R s N R 
I 
R1 
Table 22. 13C nmr data (o, ppm, CDC!J (unless otherwise stated); lJCH, Hz) for 
the mono- (I Rl=R2=R5=H) and disubstituted-imidazoles (IV R2=H, 
R4=N02; In R2=CH3) and their N-methyl derivatives (II, III, V, VI 
Rl=CH3; II R5=H; III R4=H; V R4=N02; VI R5=N02). 
Compound Rl C-2 1JCH C-4 1JCH C-5 1JCH 
I a (DMK) - 136.0 210 129.9 - 113.6 196 
II a 33.9 136.1 213 129.3 - 115.9 194 
III a 31.5 137.4 215 126.0 196 118.3 -
I b (DMK) - 137.1 210 115.6 - 117.2 195 
II b 33.9 137.4 210 115.0 - 119.4 197 
III b 32.6 138.3 210 129.5 196 103.7 -
I c (DMK) - 139.0 210 81.2 - 124.4 196 
II C 33.5 139.2 208 81.2 - 125.5 194 
III C 34.8 140.0 208 137.0 197 70.7 -
I d - 134.3 203 131.5 - 118.4 185 
II d 33.1 136.8 204 138.2 - 116.6 186 
III d 31.0 137.2 > 200 126.5 186 127.5 -
I e (DMSO) - 135.0 205 137.3 - 118.0 183 
II e - - - - - - -
III e - - - - - - -
I f (DMSO) - 139.0 210 129.7 - 129.7 192 
II f 34.0 139.5 209 142.5 - 125.6 191 
III f 34.2 144.2 210 143.3 191 131.7 -
I g (DMSO) - 137.6 210 129.8 - 125.9 191 
II g 33.7 138.5 209 133.8 - 126.1 193 
III g 33.8 142.2 210 137.3 193 122.7 -
I h (DMSO) - 136.1 208 134.8 - 121.3 187 
II h (DMSO) 33.3 137.8 207 136.3 - 123.2 191 
III h - - - - - - -
I i (DMSO) - 135.9 214 147.6 - 119.1 200 
II i 34.3 136.7 214 148.1 - 120.4 200 
Ill i 34.9 141.6 212 132.7 201 138.8 -
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Table 22 contd. 
Compound Rl C-2 1JCH C-4 1JCH C-5 1JCH 
I j - 135.8 206 .138.5 - 115.9 189 
II j 33.1 137.8 206 141.9 - 115.8 187 
III j 32.5 139.0 206 127.2 189 133.4 -
I k - 135.4 206 138.3 - 114.7 188 
II k 33.5 137.8 205 142.1 - 114.9 187 
III k 32.6 138.5 >200 126.6 185 133.4 -
I 1 - 135.7 208 138.7 - 114.3 189 
II 1 33.4 138.0 206 141.1 - 116.1 187 
III 1 32.6 139.3 >200 128.0 > 180 132.4 -
I m (DMSO) - 137.2 207 137.5 - · 117.2 190 
II m 33.7 138.9 204 140.3 - 118.4 187 
III m 33.0 140.7 213 129.9 190 131.3 -
I n - 143.5 - 130.8 - 116.5 181 
IV a (DMSO) - 139.3 217 149.2 - 74.7 -
V a (DMSO) 36.3 140.0 222 149.5 - 82.5 -
VI a (DMSO) 36.7 144.7 217 ·92.7 - 140.6 -
IV b (DMSO) - 136.7 218 142.7 - 105.8 -
V b(DMSO) 33.9 137.9 220 144.2 - 107.8 -
VI b (DMSO) 36.2 141.5 219 119.1 - ? -
IV c (DMSO) - 136.5 217 141.6 - 119.0 -
V C 32.9 136.5 214 149.0 - 126.9 -
VI C 35.8 140.9 212 133.9 - 149.0 -
IV d (DMSO) - 138.9 218 143.0 - 136.2 -
V d 34.9 139.8 216 145.7 - 130.9 -
VI d - - - - - - -
IV e (DMSO) - 136.2 218 144.1 - 128.2 -
V e - - - - - - -
VI e (DMSO) 35.5 139.6 221 139.5 - 135.6 -
IV f (DMSO) - 137.0 217 144.0 - 128.3 -
V f 33.1 137.4 215 149.7 - 122.5 -
VI f 35.8 141.1 213 133.4 - 147.5 -
Table 23. Ring carbon chemical shift differences, oC (II, III) - oC (I) for the 
imidazole series, I. C-4 and C-5 represent the substituted carbons in II 
and III respectively. 
Compd AoC-2 AoC-4 AoC-5 Compd A8C-2 A8C-5 A8C-4 
II a+ 0.1 -0.6 2.3 III a+ 1.4 -11.6 12.4 
II b + 0.3 -0.6 2.2 III b + 1.2 -11.9 12.3 
II Ct 0.2 0.0 1.1 III Ct 1.0 . -10.5 12.6 
II d 2.5 6.7 -1.8 III d 2.9 -4.0 8.1 
II f * 0.5 12.8 -4.1 III f * 5.2 2.0 13.6 
II g * 0.9 4.0 0.2 III g * 4.6 -7.1 11.4 
II h * 1.7 1.5 1.9 III h * - - -
II i * 0.8 0.5 1.3 III i * 5.7 -8.8 13.6 
II j 2.0 3.4 -0.1 III j 3.2 -5.1 11.3 
II k 2.4 3.8 0.2 III k 3.1 -4.9 11.9 
II 1 2.3 2.3 1.8 III 1 3.6 -6.3 13.7 
II m * 1.7. 2.8 1.2 III m * 3.5 -6.2 12.7 
+ * Chemical shifts for the substrate carbons used in the difference calculations are in DMK-
d6 + or DMS0-d6 *(see Table 22). 
Table 24. Ring carbon chemical shift differences, oC (V, VI)- oC (IV) for the 
imidazole series, IV. C-4 and C-5 represent the nitro-substituted 
carbon in V and VI respectively. 
Compd AoC-2 AoC-4 AoC-5 Compd AoC-2 AoC-5 AoC-5 
Va+ 0.7 0.3 7.8 VI a+ 5.4 -8.6 18.0 
Vb+ 1.2 1.5 2.0 VI b+ 4.8 :j: 13.3 
V C * 0.0 7.4 7.9 VI C * 4.4 -7.4 14.9 
V d* 0.9 2.7 -5.3 VI d - - -
V e VI e * 3.4 -8.5 11.3 - - -
V f * 0.4 5.7 -5.8 VI f * 4.1 3.5 5.1 
+ Chemical shifts for compounds IV, V and VI are in DMS0-d6 (see Table 22). 
* Chemical shifts for the substrate carbons used in the difference calculations are in DMS0-
d6 (see Table 22). 
t No signal observed for C-5 of Vlb. 
In the same way that proton chemical shift differences were calculated to 
compare the general effect of 1,5- and 1,4-methylation (s. 4.1), L'.\oC values were 
determined for the N-methyl derivatives, II, III, V, VI, and are presented in 
Tables 23-24. 
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These values appear to reflect the tautomeric bias towards 11-H noted in the 
"neutral" alkylation study (s. 3.2.3.2); ring carbon chemical shifts of the 1,5-
isomers are generally seen to show greatest dissimilarity to those in the 
corresponding N-unsubstituted imidazole. No correlation is apparent however 
between the magnitude of this dissimilarity and KT (determined previously). 
Several trends can be isolated from these tables : (i) N-methylation invariably 
results in the deshielding of C-2, the extent of which is greater for the isomers III 
and VI, (ii) further to the observed tautomeric bias, the substituted (ipso) carbon 
(C-5) in isomers III and VI is substantially shielded (relative to C-4 of I and IV) 
while the adjacent carbon (C-4) is substantially deshielded. 
Carbon peak assignments for the phenyl carbons of the substrates Ij-m and 
their N-methyl derivatives were facilitated again by the use of lH~coupled 13C 
nmr; lJcH""' 160 Hz for phenyl carbons. To aid in the identification of the 
quaternary carbons, C-1' and C-4', and to distinguish between C-2',6' and C-3',5', 
incremental chemical shifts were determined for the imidazol-4(5)-yl, 1-
methylimidazol-4-yl and 1-methylimidazol-5-yl functionalities and these were 
used in conjunction with literature incremental shifts for the para-susbtituents 
413. The former are given in Table 25 below. A consistency of better than 1 ppm 
was typical. 
Table 25. Incremental shifts of the aromatic carbon atoms of imidazolyl 
substituted benzenes (ppm from benzene at 128,5 ppm, 
+ downfield, - upfield; TMS reference) 
Substituent C-1 C-2 C-3 C-4 
(ipso) 
Imidazol-4(5)-yl +4.4 -3.5 +0.3 -1.5 
1-Methylimidazol-4-yl +5.6 -4.0 -0.2 -2.1 




APPENDIXl Correlation Data 
Table Al.1. Data for Hammett correlation (a111 , CTJ, and ap) with basic methylation 
ratios of 4(5)-monosubstituted imidazoles (I). 
Substrate (I) Ratio Log (11/111) (5 m A a I A (5 p A 
(II : III) 
Ia 4-Cl 3.0 1 0.477 0.37 0.46 0.23 
Ib 4-Br 2.6 1 0.415 0.39 0.44 0.23 
le 4-I 1.4 1 0.146 0.35 0.39 0.18 
Id 4-CH3 1.2 1 0.079 -0.07 -0.04 -0.17 
le 4-CH20H 1.2 1 B 0.079 0.00 C - 0.00 C 
If 4-CHO 1 1 0.000 0.35 0.25 D 0.42 
lg 4-C02CH3 1.5 1 0.176 0.32 E 0.30 F 0.45 G 
Ih 4-CONH2 6.5 1 0.813 0.28 E 0.27H 0.36 I 
Ih 2.3 1 B 0.362 
Ii 4-N02 8.6 1 0.935 0.71 0.65 0.78 
Ij 4-Ph 7.3 1 B 0.863 0.06 0.10 -0.01 
Ik 4-p-CH30C6H4 4.7 1 0.672 - - -0.09 J 
Il 4-p-ClC6H4 9.6 1 0.982 - - 0.08 J 
Im 4-p-N02C6H4 17 1 1.231 - - 0.23 J 
A Substituent constants, cr, are taken from a literature compilation by R. A. Y. Jones 371 unless 
otherwise noted; crJ values were devised by statistical analysis of various sets of reactions 
'f' 11 f · d 1 · 371 spec1 1ca y or use ma ua parameter equation . 
B NaOEt/EtOH conditions. 
C P. Zuman, "Substituent Effects in Organic Polarography" 414. 
D R. W. Taft et al. 402; nmr derived cr1 value for CHO. 
E H.H. Jaffe 415. 
F R. W. Taft and I. C. Lewis 381 
G M. Charton and H. Meislich 416. 
H M. Charton 383. 
I M. Charton 417. 
J E. Berliner and L. H. Liu 392. 
Table Al.2. Data for Hammett correlation (crp) with basic methylation ratios A of 
para-substituted 4-phenylimidazoles (I). 
X Ratio Log (II / III) CTp B 
( 4-p-X-Ph (I)) (II : III) 
Ik OCH3 4.7 1 0.672 -0.27 
Ij H 7.3 1 0.863 0.00 
Il Cl 9.6 1 0.982 0.23 
Im N02 17 1 1.231 0.78 
A NaOEt/EtOH conditions. 
B Substituent constants, cr, are taken from a literature compilation by R. A. Y. Jones 371 . 
Table Al.3. Data for Hammett correlation (crm, errand crp) with methylation 
ratios of 4,5-disubstituted imidazoles (IV). 
Substrate (IV) Ratio Log (V / VI) CTm A crrA crpA 
(5-X-4-NOi) (V: VI) 
IVa I 7.4 1 0.869 0.35 0.39 0.28 
IVb Br 6.4 1 0.806 0.39 0.44 0.23 
IVc SCH3 1 30 -1.477 0.15 0.23 0.00 
IVd SOCH3 0.52 0.50 0.49 
IVe S02CH3 B 0.60 0.59 0.72 
IVf SPh 1.7 : 1 0.230 0.30 C 0.02D 
A Substituent constants, cr, are taken from a literature compilation by R. A. Y. Jones 371. 
B 1-methyl-4-methylsulfonyl-5-nitroimidazole only. 
C M. Charton 383. 






Table Al.4. Atomic charge density data for N-1 and N-3 of the 4(5)-monosubstituted imidazole anions (I). 
Total Charges A PzChargesC 
Compound (I) N-1 N-3 acB N-1 N-3 GpzB 
MNDO CHARGE3 MNDO CHARGE3 
Ia 4-Cl -0.322 -0.894 -0.308 -0.395 0.045 -0.252 -0.252. 0.000 
lb 4-Br -0.323 -0.895 -0.302 -0.402 0.070 -0.252 -0.247 0.020 
le 4-I -0.322 -0.932 -0.292 -0.426 0.103 -0.249 -0.234 0.064 
Id 4-CH3 -0.332 -0.805 -0.311 -0.121 0.068 -0.253 -0.246 0.029 
le 4-CH20H -0.330 -0.805 -0.295 -0.119 0.119 -0.253 -0.234 0.081 
If 4-CHO -0.334 -0.952 -0.285 -0.441 0.172 -0.249 -0.223 0.117 
lg 4-C02CH3 -0.331 -0.961 -0.267 -0.439 0.240 -0.248 -0.212 0.170 
Ih 4-CONH2 -0.335 -0.966 -0.304 -0.440 0.102 -0.251 -0.238 0.055 
Ii 4-N02 -0.318 -1.048 -0.256 -0.447 0.242 -0.233 -0.206 0.131 
Ij 4-Ph -0.327 -0.977 -0.302 -0.454 0.083 -0.246 -0.230 0.070 
Ik 4-p-CH30Ph -0.329 -0.992 -0.303 -0.456 0.086 -0.248 -0.230 0.078 
11 4-p-ClPh -0.324 -0.986 -0.300 -0.455 0.080 -0.241 -0.228 0.057 
Im 4-p-N02Ph -0.312 -1.070 -0.291 -0.491 0.072 -0.230 -0.222 0.036 
In 2,4-(CH3)2 -0.307 -0.798 -0.287 -0.119 0.070 -0.243 -0.234 0.039 
A Total charges were calculated by MNDO (MOP AC v. 6 394) and CHARGE3 395 software for anion-analogue structures built using MacroModel (v. 2) (refer 
Appendix 4 for raw tabulative and illustrative data). MNDO charges for N-1 and N-3 above are the average densities obtained for the corresponding 
positions in the 4-X and 5-X analogues. CHARGE3 values are those obtained for the 4-X analogue. 
B crc and C5pz are substituent constants derived for irnidazole anions (I) from the ratio (N-1/N-3) of the total and Pz MNDO charges respectively: (N-1/N-3)-1. 












A,B,C Refer to key to Table Al.4. 




























N-3 O'c B N-1 N-3 
CHARGE3 
-0.445 0.124 -0.202 -0.188 
-0.440 0.175 -0.219 -0.196 
-0.440 0.135 -0.204 -0.190 
-0.438 0.013 -0.177 -0.179 
-0.428 0.157 -0.196 -0.173 
-0.440 0.148 -0.207 -0.191 











Table Al.6. Solvent accessible surface areas (hydration surfaces), S.A.S.A., for 
N-1 and N-3 of the 4(5)-monosubstituted imidazole anions (I). A 
Compound (I) S.A.S.A. O's B 
1A2 
N-1 N-3 
Ia 4-Cl 26 24 · 0.083 
lb 4-Br 26 21 0.238 
le 4-1 26 20 0.300 
Id 4-CH3 28 20 0.400 
le 4-CH20H 25 17 0.471 
If 4-CHO 26 22 0.182 
lg 4-C02CH3 25 22 0.136 
Ih 4-CONH2 26 15 0.733 
Ii 4-N02 27 18 0.500 
lj 4-Ph 24 13 0.846 
Ik 4-p-CH30Ph 25 13 0.923 
11 4-p-ClPh 24 13 0.846 
Im 4-p-N02Ph 25 13 0.923 
In 2,4-(CH3)2 25 17 0.471 
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A S.A. surface areas were calculated for anion-analogue structures built using MacroModel (v. 
2) (refer Appendix 3, Table 21 for raw tabulative data and methodology). 
B as is a steric substituent constant derived for imidazole anions (I) from the ratio (N-l/N-3) 
of the S.A.S.A.'s: (N-1/N-3)-1. 
Table Al.7. Solvent accessible surface areas (hydration surfaces), S.A.S.A., for 
N-1 and N-3 of the 4,5-disubstituted imidazole anions (IV). A 
Compound (IV) S.A.S.A. 0'5B 
1A2 
N-1 N-3 
IVa 5-N02-4-I 18 19 -0.053 
IVb 5-N02-4-Br 18 20 -0.100 
IVc 5-N02-4-SCH3 19 12 0.583 
IVd 5-N02-4-S0C:H3 18 12 0.500 
IVe 5-N02-4-S02CH3 17 9 0.889 
IVf 5-N02-4-SPh 17· 10 · 0.700 




Data for Hammett correlations A with neutral methylation ratios 
of 4(5)-monosubstituted imidazoles (I). 
Substrate (I) Ratio Log (II/III) 
(II : III) 
Ia 4-Cl 1 17 -1.230 
lb 4-Br 1 11.5 -1.061 
le 4-I 1 4.9 -0.690 
Id 4-CH3 1.4 1 0.146 
le 4-CH20H 1 1.6 -0.204 
If 4-CHO 1 3.6 -0.556 
lg 4-C02CH3 1 6.5 -0.813 
Ih 4-CONH2 1 1 0.000 
Ii 4-N02 1 =50 -1.699 
Ij 4-Ph 4.0 1 0.602 
T, 
4-p-CH30C6ii4 5.1 1 0.708 lK 
Il 4-p-ClC6lf4 3.2 1 0.505 
Im 4-p-N02C6H4 2.9 1 0.462 
A Substituent constants, cr, used in ratio correlations are those given in Table Al.1 
above. 
Data for Hammett correlation with neutral methylation ratios of 
4,5-disubstituted imidazoles (IV). 
Substrate (IV) Ratio Log (V / VI) 
(5-X-4-N02) (V: VI) 
IVa I 1 6.9 -0.839 
IVb Br 1 2.7 -0.431 
IVc SCHJ =1 50 -1.699 
IVd S0CH3 B 
IVe S02CH3 B 
IVf SPh B 
A Substituent constants, cr, used in ratio correlations are those given in Table Al.2 
above. 
















pKaH+ data for 4-substituted (I), 4-substituted-1-methyl- (II) and 




































A pKBH+ values calculated potentiometrically in water at 25°C (Appendix 5) unless 
otherwise specified. 
B Values taken from ref. 393. 
C Values taken from ref 89. 
"' 
Table Al.11. Atomic charge density data for N-1 and N-3 of the 4(5)-monosubstituted imidazole tautomers (I). 
Total Charges A PzChargesC 
Compound (I) N-1 (III-H) N-3 (11-H) cr'c B N-1 (111-H) N-3 (II-H) 0'1pz B 
MNDO CHARGE3 MNDO CHARGE3 
Ia 4-Cl -0.237 -0.399 -0.222 -0.357 0.068 -0.188 -0.187 0.005 
lb 4-Br -0.240 -0.400 -0.213 -0.364 0.127 -0.190 -0.181 0.050 
le 4-1 -0.244 -0.402 -0.205 -0.376 0.190 -0.192 -0.172 0.116 
Id 4-CH3 -0.243 -0.407 -0.228 -0.402 0.066 -0.188 -0.182 0.033 
le 4-CH20H -0.249 -0.407 -0.215 -0.398 0.158 -0.192 -0.173 0.110 
If 4-CHO -0.255 -0.397 -0.202 -0.389 0.262 -0.197 -0.163 0.209 
lg 4-C02CH3 -0.261 -0.398 -0.188 -0.385 0.388 -0.200 -0.154 0.299 
Ih 4-CONH2 -0.251 -0.399 -0.220 -0.386 0.141 -0.194 -0.175 0.109 
Ii 4-N02 -0.263 -0.391 -0.188 -0.375 0.399 -0.207 -0.160 0.294 
Ij 4-Ph -0.243 -0.401 -0.238 -0.397 0.021 -0.189 -0.185 0.022 
Ik 4-p-CH30Ph -0.242 -0.402 -0.241 -0.398 0.004 -0.188 -0.188 0.000 
11 4-p-ClPh -0.244 -0.402 -0.236 -0.397 0.034 -0.189 -0.184 0.027 
Im 4-p-N02Ph -0.246 -0.399 -0.228 -0.397 0.079 -0.193 -0.178 0.084 
In 2,4-(CH3)i -0.219 -0.402 -0.203 -0.398 0.079 -0.183 -0.178 0.028 
A Total charges were calculated by MNDO (MOP AC v. 6 394) and CHARGE3 395 software for tautomeric structures built using MacroModel (v. 2) (refer 
Appendix 4 for raw tabulative and illustrative data). MNDO and CHARGE3 charges for N-1 and N-3, above, are the densities obtained for the pyridine-
type nitrogens in the 3-H (111-H) and 1-H (11-H) tauton;i.ers respectively. 
B a'c and CJ1pz are substituent constants derived for the free bases (I) from the ratio (N-l/N-3) of the total and P2 MNOO charges respectively: (N-l/N-3)-1. 
C Pz values are excessive Il charges obtained from the total Il (MNOO) densities tabulated in Appendix 4. 
" 4- ;, -vi ... -, 
Table Al.12. Atomic charge density data for N-1 and N-3 of the 4,5-disubstituted imidazole tautomers (IV). 
Total Charges A PzChargesC 
Compound (IV) N-1 (III-H) N-3 (II-H) a'c B N-1 (III-H) N-3 (II-H) CJ'pz B 
MNDO CHARGE3 MNDO CHARGE3 
IVa 4-N02-5-I -0.234 -0.361 -0.199 -0.372 0.176 -0.192 -0.165 0.164 
IVb 4-N02-5-Br -0.242 -0.349 -0.196 -0.370 0.235 -0.202 -0.165 0.224 
IVc 4-N02-5-SCH3 -0.249 -0.360 -0.200 -0.371 0.245 -0.199 -0.164 0.213 
IVd 4-N02-5-S0CH3 -0.228 -0.364 -0.201 -0.371 0.134 -0.188 -0.166 0.133 
IVe 4-N02-5-S02CH3 · -0.224 -0.362 -0.203 -0.370 0.103 -0.185 -0.171 · 0.082 
IVf 4-N02-5-SPh -0.249 -0.360 -0.200 -0.371 0.245 -0.202 -0.164 0.232 
A,B,C Refer to key to Table Al.11 . 
.c_ 
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Table Al.13. Solvent accessible surface areas (hydration surfaces), S.A.S.A., for 
N-1 (III-H) and N-3 (II-H) of the 4(5)-monosubstituted imidazole 
tautomers (I). A 
Compound (I) S.A.S.A. a'sB 
1A2 
N-1 (III-H) N-3 (II-H) 
Ia 4-Cl 26 22 0.182 
lb 4-Br 26 21 0.238 
le 4-I 26 20 0.300 
Id 4-CH3 26 19 0.368 
le 4-CH20H 25 17 0.471 
If 4-CHO 23 22 0.045 
lg 4-C02CH3 25 21 0.190 
Ih 4-CONH2 27 14 0.929 
Ii 4-N02 26 17 0.529 
Ij 4-Ph 25 12 1.083 
Ik 4-p-CH30Ph 25 13 0.923 
Il 4-p-ClPh 25 12 1.083 
Im 4-p-N02Ph 25 13 0.923 
In 2,4-(CH3)2 21 18 0.167 
A S.A. surface areas were calculated for tautomer structures built using MacroModel (v. 2) 
(refer Appendix 3, Table A3.1 for raw tabulative data and methodology). 
B a's is a steric substituent constant derived for imidazole free bases (I) from the ratio (N-
1 /N-3) of the S.A.S.A.'s: (N-1/N-3)-1. 
Table Al.14. S.A.S.A.'s for N-1 (III-H) and N-3 (II-H) of the 4,5-disubstituted 
imidazole tautomers (IV). A 
Compound (IV) S.A.S.A. 
1A2 
a'sB 
N-1 (III-H) N-3 (II-H) 
!Va 5-N02-4-I 18 19 -0.053 
!Vb 5-N02-4-Br 18 20 -0.100 
!Ve 5-N02-4-SCH3 17 14 0.214 
IVd 5-N02-4-S0CH3 17 10 0.700 
!Ve 5-N02-4-S02CH3 17 9 0.889 -
IVf 5-N02-4-SPh 17 10 0.700 





Table Al.15. Data for Hammett correlations A with diazomethane ratios of 4(5)-
monosubstituted (I) and 4-nitro-5-substituted imidazoles (IV). 
Substrate Ratio Log (II (V)/111 (VI)) 
II (V) : III (VI) 
Ia 4-Cl 1 4.2 -0.623 
lb 4-Br 1 3.6 -0.556 
le 4-I 1 2.8 -0.447 
Id 4-CH3 1 1 0.000 
If 4-CHO 1 4.4 -0.644 
lg 4-C02CH3 1 6.0 -0.778 
Ih 4-CONH2 1 5.4 -0.732 
Ii 4-N02 1 16 -1.176 
Il 4-p-ClC6H4 1 1.1 -0.041 
Im 4-p-N02C6H4 1 1.4 -0.146 
IVa 5-I 1 6.1 -0.785 
IVb 5-Br 1 3.6 -0.556 
IVc 5-SCH3 1 17 -1.230 
IVd 5-SOCH3 4.5 1 0.653 
IVe 5-S02CH3 3.0 1 0.477 
IVf 5-SPh 1 5.8 -0.763 
A Substituent constants, cr, used in ratio correlations are those given in Table Al.1 
above. 
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Figure A2.1. Log (II/III) vs. cr1, methylation of 4-substituted 
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Log (II/III) vs. <Jp, methylation of 4-substituted 
imidazoles (I) under basic conditions. 
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Figure A2.3. Log (II/III) vs. <Jm, methylation of 4-substituted 
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Figure A2.4. Log (V /VI) vs. CJJ, methylation of 4,5-disubstituted 
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Figure A2.5. Log (V /VI) vs. Gm, p, methylation of 4,5-disubstituted 
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Figure A2.6. Log (II/III) vs. CJp (aryl), methylation of 4-p-X-C6H4 
substituted imidazoles (lj-m) under basic 
(NaOEt/EtOH) conditions. 
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Figure A2.7. Log (II/Ill) vs. CJp, methylation of para-substituted 4-
phenylimidazoles (lj-m) under basic (NaOEt/EtOH) 
conditions. 
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Figure A2.8. pKa vs. erm, acid dissociation of 4-substituted 
imidazoles in H20 at 25°C. pKa data taken from ref. 96. 
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Figure A2.9. ere vs. erp, Polar substituent parameter, ere, is defined 
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Figure A2.10. crc vs. O'J. Polar substituent parameter, crc, is defined in 
Table Al.4. 
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Figure A2.11. crc vs. apz. Polar substituent parameters, crc and O"pz, 
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Figure A212. Log (II/III) vs. crc, methylation of 4-substituted 




.--.. m - 0.9 ~ - CONH2 13 -.._ 
bl.) Cl 0 - m 13 Br 0.4 
m 



















Figure A213. Log (II/III) vs. apz, methyfation of 4-substituted 
im.idazoles (I) under basic conditions. 
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Figure A2.14. Log (II/III) vs. ac, methylation of para-substituted 4-
phenylirn.idazoles (Ij-m) under basic (NaOEt/EtOH) 
conditions. 
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Figure A2.15. Log (II/III) vs. Gpz, methylation of para-substituted 4-
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Figure A2.16. Log (II/III) vs. cr for the methylation of 4-
halogenoirn.idazoles (Ia-c) under basic conditions. The 
regression equations are as follows : 
log (II/III) = -1.74 + 4.85 cr1 ; R2 = 0.989 
log (II/III) = -0.93 + 6.00 crp ; R2 = 0.969 
log (II/III) = -2.14 + 6.73 crm ; R2 = 0.584 
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Figure A2.17. Adjusted Taft steric parameter,E5 vs. crs , steric 
substituent parameter (Table Al.6). AdjustedE5 
parameters were taken from ref. 371. 
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Figure A2.18. Charton's steric parameter, uvs. crs; steric substituent 
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Figure A2.19. Log (II/III) vs. crs, methylation of 4-substituted 
imidazoles (I) under basic conditions. 
log (II/ III) = -0.11 + l.22cr 1 , ~ = 0.657 
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Figure A2.20. Log (II/III) vs. cr1, methylation of 4-substituted 
imidazoles (I) under basic conditions, excluding points 
for lj and Ih cf. Figure A2.1 above. 
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Figure A2.21. Log (II/III) (R = ethyl)vs. O'p (aryl), ethylation of 4-p-X-
Ct,H4 substituted imidazoles (Ij-m) under basic 
(NaOEt/EtOH) conditions. 
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Figure A2.22. Log (11/111) vs. err, ethylation of 4-substituted 
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Figure A2.23. Log (II/Ill) (R = Methyl)vs. log (11/111) (R = Ethyl), 
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Figure A2.24. Log (II/Ill) (R = Methyl)vs. log (II/III) (R = Benzyl), 
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Figure A2.25. Correlation of pKBH+ with crm substituent constants. pKnH+ values for Ij, Ilj, Ii, Iii, Illi and imidazole are 
taken from ref. 393; values for Ia-d, Ila-d and Illa-d were calculated potentiometrically in water at 25°C 
(Appendix 5) and are presented in Table 14. 
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Figure A2.26. Log KTVS. crm. Log KT values were calculated using 
the equation log KT= pKsH+ (III) - pKBH+ (II); pKBH+ 
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Figure A2.27. Log (II/III) vs. Log (1/KT). The correlation equation 
was obtained using experimentally determined pKBH+ 
values (Figure A2.25 and Table 14). 
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Figure A2.28. Adjusted Taft steric parameter,E5 vs. cr's , steric 
substituent parameter (Table Al.13). AdjustedE5 
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Figure A2.29. Log (II/III) vs. cr1, methylation of 4-substituted 
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Figure A2.30. Log (II/III) vs. cr1, methylation of 4-substituted 
imidazoles (I) under neutral conditions, excluding 
points for Ij and Ih cf. Figure A2.29 above. 
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Figure A2.31. Log (II/III) vs. O"p (aryl), methylation of 4-p-X-C6H4 
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Figure A2.32. Log (II/III) vs. cr'c, methylation of 4-substituted 
imidazoles (I) under neutral conditions; data points 
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Figure A2.33. cr'c vs. cr'pz. Polar substituent parameters, cr'c and cr'pz, 
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Figure A234. Log (II/III) vs. cr'c, methylation of 4-p-X-C6H4 
substituted imidazoles. (Ij-m) under neutral 
conditions. 
log ( V /VI) = 1.66 + 1.51 log ( 1 / Ki, ) , -It = 0.973 
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Figure A2.35. Log (V /VI) vs. log (1/KT) for neutral methylation of 
4,5-disubstituted imidazoles (IV, 4-N02-5-X). Predicted 
KT values are given in Table 17. 
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log ( V /VI) = -3.07 + 5.88cr
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Figure A2.36. Log (V /VI) vs. CJJ, methylation of 4,5-disubstituted 
imidazoles (IV, 4-N02-5-X) under neutral conditions. 
log ( II/ III ) (R=Et) = 0.26 + 0.68 log ( 1 / KT ) 
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Figure A2.37. Log (11/111) (R=Ethyl)vs. Log (1/KT), cf. Figure A2.27. 
The correlation equation was obtained using 
experimentally determined pKBH+ values (Figure 
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Figure A2.38. Log (II/III) (R=Ethyl)vs. cr1, ethylation of 4-substituted 
imidazoles (I) under neutral conditions; correlation excludes 
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Figure A2.39. Log (II/III) (R=Ethyl)vs. crp (aryl), ethylation of 4-p-X-C61{4 
substituted imidazoles (Ij-m) under neutral conditions, cf. 
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Figure A2.40. Log (II/III) (R = Methyl)vs. log (II/III) (R = Ethyl, 
Benzyl), alkylation of 4-substituted imidazoles (I) 
under neutral conditions, cf. Figure A2.23 above. The 
correlation equations are given below : 
log (II/III)Me = -0.24 + 0.89 log (II/III)Et;; R2 = 0.972 
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Figure A2.41. Log (II/III) (R=Methyl, Ethyl, Benzyl)vs. Log (1/KT). 
The correlation equations were obtained u,sing 
experimentally determined pKBH+ values (Figure 
A2.25 and Table 14) and are given below : 
log (II/IIl)Me = 0.18 + 0.71 log (1/KT); R2 = 0.998 
log (II/IIl)Et = 0.26 + 0.68 log (1/KT); R2 = 0.986 
log (II/III)Bz = 0.25 + 0.51 log (1/KT); R2 = 0.960 
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Figure A2.42. Log (II/III) (R=Methyl)vs. solvent £25 (dielectric 
constant at 25°C). £25 values were taken from ref. 405. 
log(II/III) = 0.14+0.43log(l/KT),i =0.876 
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Figure A2.43. Log (II/III) vs. log (1/KT), diazomethane methylation 
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Figure A2.44. Log (II/III) vs. O"p, diazomethane methylation of 4-
substituted imidazoles (I). 



















Figure A2.45. Log (V /VI) vs. O"p, diazomethane methylation of 4-
nitro-5-substituted imidazoles (IV). 
232 
233 
APPENDIX3 Raw Data for SASA Determinations 
TableA3.1. Free Base Solvent Accessible Surface Areas (S.A.S.A.). A 
Substrate Conf. Energy S.A.S.A. Ili B Overall 
(Free Base) /KJmol·l 1A2 (%) S.A.S.A. C 
1A2 
4-Me 1 22.27 18.7 91.5 
2 28.16 20.9 8.5 19 
5-Me 1 23.91 26.4 91.9 
2 29.92 26.4 8.1 26 
2,4-Me2 1 16.96 17.6 84.5 
2 22.86 18.7 7.8 
3 23.10 17.6 7.1 
4 29.01 15.4 0.7 18 
2,5-Me2 1 18.69 20.9 84.8 
2 24.72 20.9 7.4 
3 24.84 20.9 7.1 
4 30.87 19.8 0.6 21 
4-0 27.58 22.0 100 22 
5-0 17.86 26.4 100 26 
4-Br 27.67 20.9 100 21 
5-Br 18.99 26.4 100 26 
4-1 26.21 20.4 100 20 
5-1 18.97 26.4 100 26 
4-N02 1 8.19 17.2 92.7 
2 14.47 19.8 7.3 17 
5-N02 1 -12.51 26.4 65.2 
2 -10.95 24.2 34.8 26 
4-CH20H JD 8.48 16.5 89.6 
2 13.81 18.7 10.4 17 
5-CH20H 1 16.45 25.3 67.9 
-
2 18.31 25.3 32.1 25 
~HO 1 62.45 22.0 95.0 
2 69.77 22.0 5.0 22 
5-CHO 1 59.33 23.1 89.1 
2 64.53 24.2 10.9 23 
4-CONH2 10 36.03 14.3 99.8 
2 51.70 20.9 0.2 14 
S-CONH2 1 35.71 27.5 93.0 
2 42.11 24.2 7.0 27 
4-C02Me 1 105.6 20.9 87.8 
2 111.8 18.7 7.2 
3 112.7 18.7 5.0 21 
S-C02Me 1 101.7 25.3 56.5 
2 102.9 24.2 34.8 
3 107.5 24.2 5.4 
4 108.8 24.2 3.2 25 
4-Ph 39.63 12.1 100 12 
5-Ph 39.20 25.3 100 25 -< -
4-pOCH3Ph 77.51 13.2 100 13 
S-pOCH3Ph 77.29 25.3 100 25 
4-pCIPh 40.36 12.1 100 12 
5-pCIPh 40.78 25.3 100 25 
4-pN02Ph 1 63.21 12.3 50.5 
2 63.26 13.2 49.5 13 
5-pN02Ph 1 64.08 25.2 50.1 
2 64.09 24.1 49.9 25 
4-N02-5-Br 1 -21.32 17.6 98.2 
2 -11.37 17.6 1.8 18 
5-N02-4-Br 1 -33.60 19.8 85.9 
2 -29.13 19.8 14.1 20 
4-N02-5-I 1 -14.11 17.6 98.3 
2 -4.05 17.6 1.7 18 
l-
5-NOz-4-1 1 -27.94 18.7 86.2 
2 -23.40 18.7 13.8 19 
4-N02-5-SMe 1 -27.27 16.5 97.7 
2 -17.96 18.7 2.3 17 
5-N02-4-SMe 1 -43.53 14.3 79.2 
2 -40.22 12.1 20.8 14 
4-N02-5-SPh 1 -14.02 15.4 20.7 
2 -13.80 17.6 18.9 
3 -13.58 17.6 17.3 
4 -13.16 16.5 14.6 
5 -13.16 16.5 14.6 
6E -13.05 18.7 14.0 17 
234 
5-N02-4-SPh 1 -31.04 9.9 21.5 
2 -30.76 8.8 19.2 
3 -30.13 8.8 14.9 
4 -29.31 9.9 10.7 
5 -27.77 11.0 5.8 
6 -27.73 8.8 5.7 
7 -27.18 14.3 4.5 
8 -27.01 16.5 4.2 
9 -26.86 12.1 4.0 
10 -26.86 14.3 4.0 
11 -26.41 8.8 3.3 
12 -25.28 13.2 2.1 10 
4-N02-5-S0Me 10 6.67 16.5 96.3 
2 15.41 15.4 2.8 
3D 18.88 18.7 0.7 
4 22.05 16.5 0.2 17 
5-N02-4-S0Me 1 -12.14 9.9 84.2 
2 -7.03 9.9 10.7 
3 -5.19 16.5 5.1 10 
4-N02-5-S02Me 1 65.85 16.5 42.8 
2 65.85 17.6 42.8 
3 68.56 16.5 14.3 17 
5-N02-4-S02Me 1E 42.91 8.8 100 9 
A Solvent accessible surface areas (hydration surfaces) were calculated for N-3 using Macromodel 
v. 2 396 software. The standard water probe radius (1.4 A) was used in conjunction with the 
highest dot density available (4x96 points/atom); the &reas calculated are approximate. 
Conformational searches (n=lOOO) were performed in Macromodel using a systematic Monte-
Carlo style method; associated minimizations were performed using the Polak-Ribiere first 
derivative (PRCG) method and the MacroModel adapted MM2 400 force field. Lowest energy 
conformations are depicted in the Charge density diagrams, Appendix 4. Conformations found 
fewer than 5 times during the conformational search were excluded from consideration. 
B The conformational population, ni, (as%) was determined: 
e-Ei /kT 
n 
L e-Ei /kT 
i =1 
(T = 298K) 
C A weighted average of the S.A.S. areas was calculated on the basis of conformational 
population, ni. 
D Hydrogen bonding was theorised to occur either between substituent Hand N-3 or substituent 0 
and N-1-H. 
E Further conformations though theorised, were excluded on the basis of energy considerations : 
conformations with energy separation ~ 10 kJmo1-l with respect to the global energy minimum 
were excluded. 
Table A3.2. Anion Solvent Accessible Surface Areas (S.A.S.A.). A 
Substate Conf. Energy S.A.S.A. niB Overall S.A.S.A. C 
(Anion) /kJmo1-1 1A2 (%) 1A2 
N-1 N-3 N-1 N-3 <. 
4-Me 1 39.05 27.5 19.7 91.5 
2 44.93 28.6 20.9 8.5 28 20 
2,4-Me2 1 33.53 25.2 16.6 84.7 
2 39.42 24.2 18.7 7.9 
3 39.54 25.3 17.6 7.5 25 17 
4-Cl 33.04 26.4 24.2 26 24 
4-Br 34.26 26.4 20.9 26 21 
4-1 34.52 26.4 20.2 26 20 
4-N02 1 -0.91 27.5 17.6 92.7 
2 5.39 24.2 19.8 7.3 27 18 
4-CH20H 1 26.14 25.3 16.5 87.9 
2 31.06 26.4 19.8 12.l 25 17 
4-CHO 1 79.56 26.4 22.0 95.5 
2 87.15 26.4 22.0 4.5 26 22 
4-CONH2 1D 52.30 26.4 15.4 99.8 
-
2 68.17 26.4 20.9 0.2 26 15 
4-CQiMe 1 122.27 25.3 22.0 87.7 
2 128.37 • 26.4 18.7 7.5 
3 129.48 26.4 18.7 4.8 25 22 
4-Ph 54.44 24.2 13.2 24 13 
4-pOCH3Ph 92.37 25.3 13.2 25 13 
4-pOPh 55.39 24.2 13.2 24 13 
4-pN02Ph 1 78.37 25.3 13.8 50.4 
2 78.41 24.2 13.2 49.6 25 13 
5-N02-4-Br 1 -82.01 17.6 19.8 95.8 
2 -74.24 18.7 20.9 4.2 18 20 
S-N02-4-I 1 -74.71 17.6 18.7 96.0 
2 -66.83 17.6 18.7 4.0 18 19 
S-N02-4-SMe 1 -90.69 18.7 12.1 93.4 
-
2 -84.14 19.8 11.0 6;6 19 12 
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5-N02-4-SPh 1 -78.17 17.6 8.8 21.9 
2 -77.70 16.5 11.0 18.1 
3 -77.50 17.6 5.5 16.7 
4 -77.38 16,.5 9.9 15.9 
5 -75.33 16.5 12.1 7.0 
6 -74.64 20.9 13.2 5.3 
7 -74.06 18.7 18.7 4.2 
8 -73.90 18.7 16.5 3.9 
9 -71.66 18.7 8.8 1.6 
10 -71.64 19.8 7.7 1.6 
11 -71.06 16.5 9.9 1.2 
12 -70.97 17.6 9.9 1.2 
13 -70.34 16.5 7.7 0.9 
14 -68.71 18.7 14.3 0.5 17 10 
5-N02-4- 1 -57.97 17.6 11.0 90.9 
SOMe 2 -51.19 15.4 19.8 5.9 
3 -49.69 19.8 12.1 3.2 18 12 
5-N02-4- 1E 0.64 16.5 8.8 100 17 9 
S02Me 
A Solvent accessible surface areas (hydration surfaces) were calculated for N-1 and N-3 of 
substituted imidazole anion-analogoues, (refer to key, Table A3.1), generated using Macromodel 
v. 2 396 software. Heteroaromatic anions were beyond the capabilities of the modelling 
software: tautomeric analogues were created where N-1 is a divalent nitrogen. Lowest energy 
conformations are depicted in the charge density diagrams, Appendix 4. Conformations found 
fewer than 5 times during the conformational search were excluded from consideration. 
B The conformational population, ni, (as%) was determined. 
C A weighted average of the S.A.S. areas was calculated on the basis of conformational 
population, ni. 
D Hydrogen bonding was postulated to occur between substituent N-H and N-3. 
E Further conformations though theorised, were excluded on the basis of energy considerations : 
conformations with energy separation ~ 10 kJmo1-l with respect to the global energy minimum 
were excluded. 
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APPEND1X4 Raw Data from MOP AC and CHARGE3 Calculations 
Table A4.1. Anion Atomic Charge Densities 
Imidazah: Ring f asitians A 
Imidazole Anion N-1 C-2 N-3 C-4 C-5 
lmidazole -0.322 -0.112 -0.342 -0.189 -0.162 
(-0.806) (-0.170) (-0.123) (-0.056) (-0.129) 
1.231 1.147 1.277 1.164 1.180 
5.322 4.112 5.342 4.189 4.162 
4-Me -0.340 -0.105 -0.303 -0.213 -0.159 
(-0.805) (-0.170) (-0.121) (-0.039) (-0.126) 
1.275 1.140 1.222 1.210 1.143 
5.340 4.105 5.303 4.213 4.159 
5-Me -0.319 -0.107 -0.323 -0.124 -0.242 
(-0.799) (-0.168) (-0.123) (-0.051) (-0.110) 
1.269 1.138 1.231 1.160 1.192 
5.319 4.107 5.323 4.124 4.242 
4-Cl -0.330 -0.089 -0.301 -0.085 -0.145 
(-0.894) (0.004) (-0.395) (0.240) (-0.144) 
1.273 1.133 1.231 1.236 1.140 
5.330 4.089 5.301 4.085 4.145 
5-Cl -0.314 -0.093 -0.314 -0.118 -0.116 
(-0.948) (-0.006) (-0.257) (-0.053) (0.079) 
1.272 1.133 1.230 1.157 1.223 
5.314 4.093 5.314 4.118 4.116 
4-Br -0.330 -0.088 -0.295 -0.125 -0.137 
(-0.895) (0.003) (-0.402) (0.234) (-0.149) 
1.273 1.133 1.227 1.244 1.132 
5.330 4.088 5.295 4.125 4.137 
5-Br -0.308 -0.092 -0.315 -0.109 -0.158 
(-0.960) (-0.008) (-0.258) (-0.056) (0.082) 
1.266 1.131 1.231 1.149 1.232 
5.308 4.092 5.315 4.109 4.158 
4-1 -0.328 -0.089 -0.285 -0.261 -0.128 
(-0.932) (0.003) (-0.426) (0.233) (-0.149) 
1.269 1.127 1.216 1.276 1.117 
5.328 4.089 5.285 4.261 4.128 
5-1 -0.298 -0.090 -0.315 -0.098 -0.297 
(-0.989) (-0.007) (-0.306) (-0.051) (0.089) 
1.255 1.124 1.229 1.312 1.266 
5.298 4.090 5.315 4.098 4.297 
4-N02 -0.319 -0.001 -0.263 -0.088 -0.006 
(-1.048) (-0.156) (-0.447) (0.087) (-0.189) 
1.248 1.017 1.195 1.195 0.955 
5.319 4.001 5.263 4.088 4.006 
S-N02 -0.248 -0.008 -0.317 0.032 -0.131 
(-0.997) (-0.148) (-0.463) (-0.097) (-0.024) 
1.216 1.017 1.217 0.965 1.189 
5.248 4.008 5.317 3.968 4.131 <.' 
4-p- OCH3Ph -0.333 -0.076 -0.298 -0.169 -0.116 
(-0.992) (-0.034) (-0.456) (0.106) (-0.135) 
1.268 1.106 1.212 1.217 1.088 
5.333 4.076 5.298 4.169 4.116 
5-p- OCH3Ph -0.308 -0.075 -0.323 -0.082 -0.204 
(-1.034) (-0.041) (-0.386) (-0.037) (-0.007) 
1.249 1.103 1.228 1.100 1.207 
5.308 4.075 5.323 4.082 4.204 
-< 
4-Ph -0.333 -0.076 -0.297 -0.172 -0.114 
(-0.977) (-0.017) (-0.454) (0.126) (-0.131) 
1.265 1.106 1.211 1.217 1.085 
5.333 4.076 5.297 4.172 4.114 
5-Ph -0.307 -0.076 -0.322 -0.079 -0.207 
(-1.032) (-0.027) (-0.365) (-0.033) (0.010) 
1.249 1.103 1.227 1.097 1.207 
5.307 4.076 5.322 4.079 4.207 
-, 
4-p- ClPh -0.329 -0.068 -0.296 -0.177 -0.105 
(-0.986) (-0.028) (-0.455) (0.112) (-0.135) 
1.258 1.096 1.210 1.221 1.075 
5.329 4.068 5.296 4.177 4.105 
5-p- ClPh -0.303 -0.067 -0.319 -0.069 -0.213 
(-1.033) (-0.036) (-0.377) (-0.037) (-0.001) 
1.246 1.093 1.224 1.085 1.212 
5.303 4.067 5.319 4.069 4.213 
4-p- N02Ph -0.313 -0.025 -0.291 -0.167 -0.062 
_. 
)-
(-1.070) (-0.197) (-0.491) (-0.088) (-0.224) 
1.245 1.043 1.207 1.201 1.016 
5.313 4.025 5.291 4.167 4.062 
5-p- N02Ph -0.290 -0.024 -0.311 -0.021 -0.209 
(-1.057) (-0.195) (-0.494) (-0.146) (-0.171) 
1.236 1.040 1.215 1.023 1.196 
5.290 4.024 5.311 4.021 4.209 
4-CHO -0.339 -0.079 -0.281 -0.269 -0.087 
; 
(-0.952) (0.010) (-0.441) (0.153) (-0.109) 
1.268 1.106 1.204 1.257 -1.054 
5.339 4.079 5.281 4.269 4.087 
5-CHO -0.289 -0.074 -0.329 -0.054 -0.303 
(-1.020) (-0.002) (-0.330) (-0.010) (0.032) 
1.242 1.100 1.230 1.066 1.247 
5.289 4.074 5.329 4.054 4.303 
237 
4-CONH2 -0.340 -0.082 -0.298 -0.245 -0.086 
(-0.966) (-0.008) (-0.440) (0.125) (-0.115) 
1.271 1.113 1.217 1.264 1.060 
5.340 4.082 5.298 4.245 4.086 
5-CONH2 -0.310 -0.076 -0.329 -0.055 -0.278 
(-1.016) (-0.017) (-0.349) (-0.018) (0.012) 
1.258 1.106 1.231 1.073 1.253 
5.310 4.076 5.329 4.055 4.278 
4-CH20H -0.338 -0.101 -0.291 -0.203 -0.149 
(-0.805) (-0.170) (-0.119) (-0.012) (-0.122) 
1.274 1.137 .1.214 1.225 1.135 
5.338 4.101 5.291 4.203 4.149 
5-CH20H -0.298 -0.105 -0.322 -0.116 -0.237 
(-0.792) (-0.167) (-0.122) (-0.047) (-0.087) 
1.254 1.135 1.231 1.155 1.210 
5.298 4.105 5.322 4.116 4.237 
4-C02Me -0.336 -0.080 -0.265 -0.224 -0.088 
(-0.961) (0.004) (-0.439) (0.137) (-0.109) 
1.267 1.109 1.194 1.272 1.058 
5.336 4.080 5.265 4.224 4.088 
5-C02Me -0.268 -0.079 -0.326 -0.054 -0.263 
(-1.014) (-0.006) (-0.342) (-0.011) (0.025) 
1.229 1.104 1.229 1.071 1.264 
5.268 4.079 5.326 4.054 4.263 
5-Br-4-N02 -0.284 -0.003 -0.255 -0.058 -0.017 
(-0.970) (-0.140) (-0.440) (0.100) (-0.110) 
1.231 1.028 1.188 1.199 1.042 
5.284 4.003 5.255 4.058 4.017 
4-Br-5-N02 -0.236 -0.008 -0.287 0.026 -0.104 
(-0.989) (-0.143) (-0.420) (0.009) (-0.010) 
1.204 1.039 1.206 1.051 1.194 
5.236 4.008 5.287 3.974 4.104 
5-I-4-N02 -0.270 -0.008 -0.252 -0.053 -0.158 
(-0.993) (-0.145) (-0.445) (0.100) (-0.095) 
1.214 1.029 1.181 1.189 1.075 
5.270 4.008 5.252 4.053 4.158 
4-I-5-N02 -0.231 -0.016 -0.273 -0.114 -0.101 
(-0.993) (-0.145) . (-0.436) (0.010) (-0.014) 
1.194 1.032 1.190 1.082 1.186 
5.231 4.016 5.273 4.114 4.101 
2,4-Me2 -0.321 -0.149 -0.272 -0.210 -0.156 
(-0.798) (-0.155) (-0.119) (-0.038) (-0.125) 
1.265 1.166 1.211 1.206 1.136 
5.321 4.149 5.272 4.210 4.156 
2,5-Me2 -0.301 -0.151 -0.293 -0.123 -0.238 
(-0.792) (-0.154) (-0.121) (-0.051) (-0.108) 
1.257 1.164 1.220 1.157 1.184 
5.301 4.151 5.293 4.123 4.238 
5-SMe-4-N02 -0.271 -0.009 -0.254 -0.058 -0.155 
(-0.991) (-0.144) (-0.440) (0.102) (-0.113) 
1.212 1.027 1.183 1.187 1.053 
5.271 4.009 5.254 4.058 4.155 
4-SMe-5-N02 -0.235 -0.016 -0.285 -0.111 -0.101 
(-0.990) (-0.144) (-0.429) (-0.009) (-0.011) 
1.197 1.032 1.195 1.063 1.183 
5.235 4.016 5.285 4.111 4.101 
5-SPh-4-N02 -0.275 -0.007 -0.254 -0.052 -0.158 
(-0.990) (-0.144) (-0.440) (0.102) (-0.106) 
1.215 1.028 1.182 1.187 1.060 
5.275 4.007 5.254 4.052 4.158 
4-SPh-5-N02 -0.234 -0.011 -0.284 -0.114 -0.100 
(-0.991) (-0.144) (-0.430) (0.003) c.:.0.011> 
1.200 1.027 1.198 1.061 1.183 
5.234 4.011 5.284 4.114 4.100 
<-
5-SOMe-4-NOz -0.213 -0.007 -0.246 -0.038 -0.352 
(-0.996) (-0.139) (-0.438) (0.116) (-0.064) 
1.170 1.022 1.174 1.179 1.108 
5.213 4.007 5.246 4.038 4.352 
4-S0Me-5-N02 -0.222 -0.020 -0.261 -0.303 -0.077 
(-0.990) (-0.139) (-0.429) (0.037) (-0.001) 
1.184 1.037 1.183 1.119 1.171 
5.222 4.020 5.261 4.303 4.077 
·k: 
5-S02Me-4-N02 -0.256 -0.004 -0.236 0.003 -0.377 
(-0.982) (-0.120) (-0.428) (0.132) (-0.029) 
1.206 1.035 1.169 1.159 1.182 
5.256 4.004 5.236 3.997 4.377 
4-S02Me-S-N02 -0.210 -0.016 -0.260 -0.330 -0.043 
(-0.983) (-0.120) (-0.417) (0.074) (0.014) 
1.177 1.042 1.185 1.187 1.156 
5.210 4.016 5.260 4.330 4.043 
./ 
)" 
A Charge densities are expressed as follows : 
-0.322 Atomic charge calculated by MOP AC v. 6.0 (MNDO) 394 
(-0.806) Atomic charge calculated by CHARGE3 395 
1.231 Atomic Pi density obtained from MOP AC density matrix 
5.322 Total atomic electron density calculated by MOP AC 
Anion-analogue structures were built using Macromodel v. 2 396 software. Lowest energy 
conformations were determined (refer to key, Table A3.2), and the geometries of these minimized 
structures were submitted for charge analysis (MOP AC 394 and CHARGE3 395) as the 
appropriately formatted Z-matrix data files. For CHARGE3 calculations, the negative charge was 
localised on N-1 in the tautomeric analogues. The minimum energy conformations with associated 
atomic charges are illustrated in this Appendix. 
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Table A4.2. Free Base Atomic Charge Densities 
lmidi!Zolt: Ring PQ!!illQ!Y! A 
Imidazole Free Base N-1 C-2 N-3 C-4. C-5 
Imidazole -0.185 0.027 -0.238 -0.041 -0.110 
(-0.106) (0.125) (-0.407) (-0.092) (-0.033) 
1.585 1.055 1.185 1.048 1.127 
5.185 3.973 5.238 4.041 4.110 
r 
4-Me -0.184 0.029 -0.228 -0.077 -0.091 
(-0.105) (0.125) (-0.402) (-0.079) (-0.030) 
1.584 1.055 1.182 1.066 1.117 
5.184 3.971 5.228 4.077 4.091 
5-Me -0.180 0.032 -0.243 -0.011 -0.145 
(-0.104) (0.125) (-0.407) (-0.088) (-0.018) 
1.584 1.048 1.188 1.037 1.145 
5.180 3.968 5.243 4.011 4.145 
4-Cl -0.183 0.045 -0.222 0.011 -0.074 
(-0.104) (0.128) (-0.357) {(I ""':I.\ (0.015) \V•V-'"-'/ 
1.581 1.047 1.187 1.100 1.108 
5.183 3.955 5.222 3.989 4.074 
5-Cl -0.176 0.050 -0.237 0.003 -0.071 
(-0.090) (0.120) (-0.399) (-0.067) (0.107) 
1.586 1.036 1.188 1.024 1.188 
5.176 3.950 5.237 3.997 4.071 
4-Br -0.183 0.041 -0.213 -0.048 -0.064 
(-0.104) (0.127) (-0.364) (0.011) (-0.018) 
1.581 1.050 1.181 1.106 1.098 
5.183 3.960 5.213 4.048 4.064 
5-Br -0.170 0.050 -0.240 0.010 -0.130 
(-0.092) (0.119) (-0.400) (-0.072) (0.092) 
1.582 1.033 1.190 1.015 1.194 
5.170 3.950 5.240 3.990 4.130 
4-1 -0.181 0.035 -0.205 -0.189 -0.053 
(-0.106) (0.125) (-0.376) (0.005) (-0.030) 
1.578 1.049 1.172 1.129 1.082 
5.181 3.966 5.205 4.189 4.053 
5-1 -0.163 0.056 -0.244 0.021 -0.273 
(-0.096) (0.115) (-0.402) (-0.085) (0.082) 
1.576 1.022 1.192 0.998. 1.222 
5.163 3.944 5.244 3.979 4.273 
4-N02 -0.185 0.068 -0.188 -0.020 0.044 
(-0.098) (0.135) (-0.375) (0.132) (0.017) 
1.564 1.018 1.160 1.151 0.967 
5.185 3.932 5.188 4.020 3.956 
S-N02 -0.172 0.156 -0.263 0.135 -0.089 
(-0.101) (0.164) (-0.391) (-0.042) (0.186) 
1.575 0.910 1.207 0.867 1.219 
5.172 3.844 5.263 3.865 4.089 
4-p- OCH3Ph -0.185 0.035 -0.241 0.002 -0.087 
(-0.102) (0.129) (-0.398) (-0.019) (-0.012) 
1.584 1.050 1.188 1.066 1.112 
5.185 3.965 5.241 3.998 4.087 ~ 
5-p- OCH3Ph -0.181 0.042 -0.242 -0.015 -0.065 
(-0.108) (0.136) (-0.402) (-0.071) (0.031) 
1.589 1.039 1.188 1.030 1.140 
5.181 3.958 5.242 4.015 4.065 
4-Ph -0.185 0.035 -0.238 -0.005 -0.082 
(-0.101) (0.130) (-0.397) (-0.018) (-0.005) 
1.583 1.050 1.185 1.070 1.106 
5.185 3.965 5.238 4.005 4.082 
, 
1' 
5-Ph -0.180 0.046 -0.243 -0.009 -0.074 
(-0.107) (0.141) (-0.401) (-0.064) (0.032) 
1.588 1.035 1.189 1.023 1.145 
5.180 3.954 5.243 4.009 4.074 
4-p- ClPh -0.184 0.038 -0.236 -0.014 -0.075 
(-0.101) (0.130) (-0.397) (-0.018) (-0.008) 
1.581 1.047 1.184 1.078 1.099 
5.184 3.962 5.236 4.014 4.075 
5-p- ClPh -0.179 0.054 -0.244 0.000 -0.085 
(-0.107) (0.139) (-0.402) (-0.067) (0.031) 
1.587 1.026 1.189 1.013 1.157 
5.179 3.946 5.244 4.000 4.085 
4-p- N02Ph -0.180 0.048 -0.228 -0.045 -0.047 
(-0.100) (0.132) (-0.397) (-0.013) (0.004) 
1.573 1.037 1.178 1.105 1.066 
5.180 3.952 5.228 4.045 4.047 
5-p- N02Ph -0.176 0.083 -0.246 0.035 -0.121 --{ 
(-0.107) (0.150) (-0.399) (-0.056) (0.036) 
1.582 0.992 1.193 0.974 1.189 
5.176 3.917 5.246 3.965 4.121 
4-CHO -0.186 0.033 -0.202 -0.147 -0.019 
(-0.096) (0.138) (-0.389) (0.013) (0.040) 
1.575 1.050 1.163 1.136 1.031 
5.186 3.967 5.202 4.147 4.019 
5-CHO -0.151 0.077 -0.255 0.038 -0.217 
; 
(-0.103) (0.171) (-0.397) (-0.020) (0.054) 
1.562 0.998 1.197 0.970 - 1.214 
5.151 3.923 5.255 3.962 4.217 
4-CONH2 -0.186 0.033 -0.220 -0.116 -0.015 
(-0.097) (0.136) (-0.386) . (0.016) (0.031) 
1.577 1.052 1.175 1.135 1.033 
5.186 3.967 5.220 4.116 4.015 
239 
S-CONH2 -0.145 0.069 -0.251 0.017 -0.175 
(-0.102) (0.161) (-0.399) (-0.028) (0.057) 
1.559 1.008 1.194 0.994 1.207 
5.145 3.931 5.251 3.983 4.175 
4-CH20H -0.184 0.030 · -0.215 -0.068 -0.079 
(-0.105) (0.126) (-0.398) (-0.051) (.;0.026) 
1.583 1.055 1.173 1.080 1.105 
5.184 3.970 5.215 4.068 4.079 
S-CH20H -0.184 0.041 -0.249 0.021 -0.150 
(-0.102) (0.125) (-0.407) (-0.083) (0.006) 
1.590 1.040 1.192 1.006 1.171 
5.184 3.959 5.249 3.979 4.150 
4-C02Me -0.186 0.031 -0.188 -0.095 -0.019 
(-0.096) (0.137) (-0.385) (0.021) (0.036) 
1.578 1.053 1.154 1.145 1.034 
5.186 3.969 5.188 4.095. 4.019 
S-C02Me -0.152 0.080 -0.261 0.059 -0.179 
(-0.101) (0.166) (-0.398) (-0.023) (0.060) 
1.567 0.996 1.200 0.951 1.233 
5.152 3.920 5.261 3.941 4.179 
5-Br-4-N02 -0.170 0.082 -0.196 0.030 -0.005 
(-0.085) (0.131) (-0.370) (0.145) (0.161) 
1.561 1.006 1.165 1.278 1.051 
5.170 3.918 5.196 3.970 4.005 
4-Br-5-N02 -0.170 0.156 -0.242 0.097 -0.049 
(-0.100) (0.165) (-0.349) (0.077) (0.201) 
1.569 0.918 1.202 0.938 1.209 
5.170 3.844 5.242 3.903 4.049 
5-I-4-N02 -0.162 0.084 -0.199 0.038 -0.146 
(-0.090) (0.128) (-0.372) (0.140) (0.148) 
1.553 0.999 1.165 1.114 1.075 
5.162 3.916 5.199 3.962 4.146 
2- 4-I-5-N02 -0.167 0.147 -0.234 -0.042 -0.042 
(-0.102) (0.163) (-0.361) (0.069) (0.195) 
1.564 0.920 1.192 0.957 1.197 
5.167 3.853 5.234 4.042 4.042 
2,4-Me2 -0.181 0.003 -0.203 -0.080 -0.087 
(-0.104) (0.134) (-0.398) (-0.078) (-0.030) 
1.581 1.071 1.178 1.069 1.109 
5.181 3.997 5.203 4.080 4.087 
2,5-Me2 -0.177 0.006 -0.219 -0.014 -0.140 
(-0.102) (0.134) (-0.402) (-0.087) (-0.018) 
1.580 1.064 1.183 1.040 1.137 
5.177 3.994 5.219 4.014 4.140 
5-SMe-4-N02 -0.163 0.080 -0.200 0.027 -0.122 
(-0.087) (0.136) (-0.371) (0.147) (0.126) 
I 1.557 1.005 1.164 1.122 1.050 -
5.163 3.920 5.200 3.973 4.122 
4-SMe-5-N02 -0.170 0.149 -0.249 -0.022 -0.046 
(-0.100) (0.166) (-0.360) (0.053) (0.204) 
1.098 0.921 1.199 0.940 1.199 
5.170 3.851 5.249 4.022 4.046 
5-SPh-4-N02 -0.168 0.078 -0.200 0.027 -0.119 
(-0.087) (0.135) (-0.371) (0.147) (0.134) 
1.557 1.008 1.164 1.126 1.041 
5.168 3.922 5.200 3.973 4.119 / ..,.'-~"" 
4-SPh-5-N02 -0.172 0.152 -0.249 -0.022 -0.051 
(-0.100) (0.166) (-0.360) (0.063) (0.209) 
1.573 0.918 1.202 0.932 1.204 
5.172 3.848 5.249 4.022 4.051 
5-S0Me-4-N02 -0.132 0.092 -0.201 0.050 -0.322 
(-0.089) (0.147) (-0.371) (0.160) (0.145) 
1.529 0.989 1.166 1.109 1.090 
5.132 3.908 5.201 3.950 4.322 ---
4-S0Me-5-N02 -0.162 0.141 -0.228 -0.222 -0.012 
(-0.100) (0.168) (-0.364) (0.084) (0.227) 
1.558 0.929 1.188 0.982 1.175 
5.162 3.859 5.228 4.222 4.012 
5-S02Me-4-N02 -0.152 0.113 -0.203 0.122 -0.394 
(-0.090) (0.157) (-0.370) (0.167) (0.158) 
1.559 0.972 1.171 1.047 1.180 
5.152 3.887 5.203 3.878 4.394 
'.£~ 
4-S02Me-5-N02 -0.154 0.136 -0.224 -0.279 0.034 
(-0.101) (0.169) (-0.362) (0.097) (0.232) 
1.550 0.942 1.185 1.047 1.141 
5.154 3.864 5.224 4.279 3.966 
A Charge densities are expressed as decribed in the key to Table A4.1. 
The tautomeric structures were built using Macromodel v. 2 396 software. Lowest energy 
conformations were determined (refer Table A3.1), and the geometries of these minimized structures 
were submitted for charge analysis (MOP AC 394 and CHARGE3 395) as the appropriately 
formatted Z-matrix data files. The minimum energy conformations with associated atomic charges 
are illustrated in this Appendix . 
APPENDIX 4 contd. 
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Atomic Charges for Tautomeric Imidazoles calculated by CHARGE3 395 (Bold) 
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I pK Determination for 4-Chloroimidazole '<:fl N 
Titrant pH Total [] [BH+] [B] {H+} [BH+]-{H+} log [] pKa 
(0.100M HCl) [B]+{H+} 
0.00 2.119E-02 
0.10 4.82 2.098E-02 9.901E-04 l.999E-02 l.514E-05 0.0487 -1.312 3.51 
0.20 4.48 2.077E-02 l.961E-03 l.881E-02 3.311E-05 0.1023 -0.990 3.49 
0.30 4.28 2.057E-02 2.913E-03 1.766E-02 5.248E-05 0.1615 -0.792 3.49 
0.40 4.12 2.038E-02 3.846E-03 1.653E-02 7.586E-05 0.2270 -0.644 3.48 
0.50 4.00 2.018E-02 4.762E-03 1.542E-02 l.OOOE-04 0.3004 -0.522 3.48 
0.60 . 3.90 1.999E-02 5.660E-03 1.433E-02 1.259E-04 0.3828 -0.417 3.48 
0.70 3.80 1.980E-02 6.542E-03 l.326E-02 l.585E-04 · 0.4758 -0.323 3.48 
0.80 3.71 l.962E-02 7.407E-03 1.221E-02 1.950E-04 0.5812 -0.236 3.47 
! 0.90 3.62 l.944E-02 8.257E-03 1.118E-02 2.399E-04 0.7018 -0.154 3.47 
0 1.00 3.54 1.926E-02 9.091E-03 l.017E-02 2.884E-04 0.8418 -0.075 3.47 .... 
.w 
1.10 3.47 l.909E-02 9.910E-03 9.180E-03 3.388E-04 1.0055 0.002 3.47 n:I 
"a 1.20 3.39 l.892E-02 l.071E-02 8.210E-03 4.074E-04 1.1956 0.078 3.47 u 
"a 1.30 3.31 1.875E-02 l.150E-02 7.250E-03 4.898E-04 1.4225 0.153 3.46 u 
+ 1.40 3.23 1.859E-02 1.228E-02 6.310E-03. 5.888E-04 1.6947 0.229 3.46 = ; 1.50 3.15 1.843E-02 1.304E-02 5.390E-03 7.079E-04 2.0223 0.306 3.46 
~ 1.60 3.07 l.827E-02 l.379E-02 4.480E-03 8.511E-04 2.4270 0.385 3.46 
1.70 2.99 l.811E-02 1.453E-02 3.580E-03 1.023E-03 2.9341 0.467 3.46 
1.80 2.90 1.796E-02 1.525E-02 2.710E-03 1.259E-03 3.5252 0.547 3.45 ~, 1.90 2.81 1.781E-02 1.597E-02 1.840E-03 1.549E-03 4.2555 0.629 3.44 2.00 2.67 1.766E-02 1.667E-02 9.900E-04 2.138E-03 4.6458 0.667 3.34 0 z 
~I Mean (ALL) 3.46 I Mean 3.47 Uncertainty 0.03 
pK Determination for 4-Chloro-1-methylimidazole 
Titrant pH Total [] [BH+] [B] {H+} [BH+]-{H+} log [] pKa 
(0.100M HCI) [B]+{H+} 
0.00 2.233E-02 
0.10 4.44 2.211E-02 9.901E-04 2.112E-02 3.631E-05 0.0451 -1.346 3.09 
0.20 4.14 2.189E-02 1.961E-03 1.993E-02 7.244E-05 0.0944 -1.025 3.12 
0.30 3.96 2.168E-02 2.913E-03 1.877E-02 1.096E-04 0.1485 -0.828 3.13 
0.40 3.81 2.147E-02 3.846E-03 1.762E-02 l.549E-04 0.2076 -0.683 3.13 
0.50 3.69 2.127E-02 4.762E-03 1.651E-02 2.042E-04 0.2727 -0.564 3.13 
0.60 3.59 2.107E-02 5.660E-03 1.541E-02 2.570E-04 0.3449 -0.462 3.13 
0.70 3.50 2.087E-02 6.542E-03 1.433E-02 3.162E-04 ·0.4251 -0.371 3.13 
0.80 3.42 2.068E-02 7.407E-03 1.327E-02 3.802E-04 0.5147 -0.288 3.13 
0.90 3.34 2.049E-02 8.257E-03 1.223E-02 4.571E-04 0.6146 -0.211 3.13 
1.00 3.27 2.030E-02 9.091E-03 l.121E-02 5.370E-04 0.7282 -0.138 3.13 
1.10 3.20 2.012E-02 9.910E-03 1.021E-02 6.310E-04 0.8559 -0.068 3.13 
1.20 3.13 1.994E-02 1.071E-02 9.230E-03 7.413E-04 0.9997 0.000 3.13 
1.30 3.06 1.976E-02 l.150E-02 8.260E-03 8.710E-04 1.1641 0.066 3.13 
1.40 3.00 1.959E-02 1.228E-02 7.310E-03 1.000E-03 1.3574 0.133 3.13 
1.50 2.93 1.942E-02 1.304E-02 6.380E-03 1.175E-03 1.5705 0.196 3.13 
1.60 2.87 1.925E-02 1.379E-02 5.460E-03 1.349E-03 1.8272 0.262 3.13 
1.70 2.80 1.909E-02 1.453E-02 4.560E-03 1.585E-03 2.1066 0.324 3.12 
1.80 2.74 1.892E-02 1.525E-02 3.670E-03 l.820E-03 2.4465 0.389 3.13 
1.90 2.68 1.876E-02 1.597E-02 2.790E-03 2.089E-03 2.8448 0.454 3.13 
2.00 2.60 1.861E-02 1.667E-02 1.940E-03 2.512E-03 3.1803 0.502 3.10 




0\ pK Determination for 5-Chloro-1-methylimidazole ~ 
Titrant pH Total [] [BH+] [B] [BH+] log [] pKa 
(0.100M HCI) [B] 
0.00 2.017E-02 
0.10 6.36 1.997E-02 9.901E-04 1.898E-02 0.0522 -1.283 5.08 
0.20 6.05 1.977E-02 1.961E-03 1.781E-02 0.1101 -0.958 5.09 
0.30 5.85 1.958E-02 2.913E-03 1.667E-02 0.1748 -0.758 5.09 
0.40 5.70 1.939E-02 3.846E-03 1.554E-02 0.2474 -0.607 5.09 
0.50 5.57 1.921E-02 4.762E-03 1.445E-02 0.3296 -0.482 5.09 
0.60 5.46 l.903E-02 · 5.660E-03 l.337E-02. 0.4233 -0.373 5.09 
0.70 5.36 · l.885E-02 6.542E-03 l.231E-02 0.5315 -0.274 5.09 
0.80 5.27 1.868E-02 7.407E-03 l.127E-02 0.6571 -0.182 5.09 
0.90 5.18 l.850E-02 8.257E-03 l.024E-02 0.8061 -0.094 5.09 
1.00 5.09 l.834E-02 9.091E-03 9.249E-03 0.9829 -0.007 5.08 
1.10 5.00 l.817E-02 9.910E-03 8.260E-03 1.1998 0.079 5.08 
1.20 4.91 l.801E-02 l.071E-02 7.300E-03 1.4671 0.166 5.08 
1.30 4.82 l.785E-02 l.150E-02 6.350E-03 1.8110 0.258 5.08 
1.40 4.72 l.769E-02 l.228E-02 5.410E-03 2.2699 0.356 5.08 
1.50 4.61 l.754E-02 l.304E-02 4.500E-03 2.8978 0.462 5.07 
1.60 4.48 1.739E-02 l.379E-02 3.600E-03 3.8306 0.583 5.06 
1.70 4.33 1.724E-02 1.453E-02 2.710E-03 5.3616 0.729 5.06 
1.80 4.14 l.709E-02 1.525E-02 l.840E-03 8.2880 0.918 5.06 
1.90 3.83 l.695E-02 l.597E-02 9.800E-04 16.2959 1.212 5.04 
2.00 2.87 1.681E-02 1.667E-02 1.400E-04 119.0714 2.076 4.95 
Mean (ALL) 5.07 I Mean 5.08 
Uncert 0.04 
pK Determination for 4-Bromoimidazole 
Titrant pH Total [] [BH+] [B] {H+} [BH+]-{H+} log [] pKa 
(0.100M HCl) [B]+{H+} 
0.00 l.OOOE-02 
0.10 4.55 9.901E-03 9.901E-04 8.911E-03 2.818E-05 0.1076 -0.968 3.58 
0.20 4.21 9.804E-03 1.961E-03 7.843E-03 6.166E-05 0.2403 -0.619 3.59 
0.30 3.97 9.709E-03 2.913E-03 6.796E-03 1.072E-04 0.4065 -0.391 3.58 
0.40 3.80 9.615E-03 3.846E-03 5.769E-03 1.585E-04 0.6221 -0.206 3.59 
0.50 3.64 9.524E-03 4.762E-03 4.762E-03 2.291E-04 0.9082 -0.042 3.60 
0.60 3.49 9.434E-03 5.660E-03 3.774E-03 3.236E-04 1.3023 . 0.115 3.60 
0.70 3.32 9.346E-03 6.542E-03 2.804E-03 4.786E-04 1.8471 0.266 · 3.59 
0.80 3.16 9.259E-03 7.407E-03 l.852E-03 6.918E-04 2.6398 0.422 3.58 
0.90 2.99 9.174E-03 8.257E-03 9.170E-04 l.023E-03 3.7282 0.571 3.56 
Mean (ALL) 3.59 
Uncertainty 0.03 
,_', l ----.(. ·" 
0 pK Determination for 4-Bromo-1-methylimidazole Lt') 
N 
Titrant pH Total [] [BH+] [B] {H+} [BH+]-{H+} log [] pKa 
(0.100M HCl) [B]+{H+} 
0.00 1.049E-02 
0.10 4.35 1.039E-02 9.901E-04 9.400E-03 4.467E-05 0.1001 -1.000 3.35 
0.20 4.03 1.028E-02 l.961E-03 8.319E-03 9.333E-05 0.2220 -0.654 3.38 
0.30 3.79 1.018E-02 2.913E-03 7.267E-03 l.622E-04 0.3703 -0.431 3.36 
0.40 3.60 1.009E-02 3.846E-03 6.244E-03 2.512E-04 0.5535 -0.257 3.34 
0.50 3.46 9.990E-03 4.762E-03 5.228E-03 3.467E-04 0.7920 -0.101 3.36 
. 0.60 3.33 9.896E-03 5.660E-03 4.236E-03 4.677E-04 1.1039 0.043 3.37 . 
0.70 3.20 9.804E-03 6.542E-03 3.262E-03 6.310E-04 1.5184 0.181 3.38 
0.80 3.07 9.713E-03 7.407E-03 2.306E-03 8.511E-04 2.0765 0.317 3.39 
0.90 2.94 9.624E-03 8.257E-03 l.367E-03 1.148E-03 2.8264 0.451 3.39 
1.00 2.83 9.536E-03 9.091E-03 4.450E-04 l.479E-03 3.9561 0.597 3.43 







































































































t""1 pK Determination for 4-Iodoimidazole l.t') 
N 
Titrant pH Total [] [BH+] [B] {H+} [BH+]-{H+} log [] pKa 
(0.100M HCI) [B]+{H+} 
0.00 2.103E-02 
0.10 6.26 2.082E-02 9.901E-04 1.983E-02 5.495E-07 0.0499 -1.302 4.96 
0.20 5.68 2.062E-02 1.961E-03 1.866E-02 2.089E-06 0.1050 -0.979 4.70 
0.30 5.41 2.042E-02 2.913E-03 1.751E-02 3.890E-06 0.1661 -0.780 4.63 
0.40 5.24 2.022E-02 3.846E-03 1.637E-02 5.754E-06 0.2345 -0.630 4.61 
0.50 5.11 2.003E-02 4.762E-03 1.527E-02 7.762E-06 0.3112 -0.507 4.60 
0.60 4.99 1.984E-02 5.660E-03 1.418E-02 1.023E-05 0.3981 -0.400 4.59 
0.70 4.89 1.965E-02 6.542E-03 1.311E-02 1.288E-05 0.4976 -0.303 4;59 
0.80 4.79 1.947E-02 7.407E-03 l.206E-02 1.622E-05 0.6119 -0.213 4.58 
0.90 4.70 l.929E-02 8.257E-03 1.103E-02 1.995E-05 0.7452 -0.128 4.57 
1.00 4.61 1.912E-02 9.091E-03 1.003E-02 2.455E-05 0.9018 -0.045 4.57 
1.10 4.53 1.895E-02 9.910E-03 9.040E-03 2.951E-05 1.0894 0.037 4.57 
1.20 4.45 l.878E-02 1.071E-02 8.070E-03 3.548E-05 1.3170 0.120 4.57 
1.30 4.37 1.861E-02 1.150E-02 7.llOE-03 4.266E-05 1.6018 0.205 4.57 
1.40 4.28 1.845E-02 1.228E-02 6.170E-03 5.248E-05 1.9651 0.293 4.57 
1.50 4.19 l.829E-02 l.304E-02 5.250E-03 6.457E-05 2.4415 0.388 4.58 
1.60 4.09 1.813E-02 1.379E-02 4.340E-03 8.128E-05 3.1006 0.491 4.58 
1.70 3.98 1.797E-02 1.453E-02 3.440E-03 1.047E-04 4.0695 0.610 4.59 
1.80 3.85 1.782E-02 l.525E-·02 2.570E-03 1.413E-04 5.5726 0.746 4.60 
1.90 3.69 1.767E-02 l.597E-·02 1.700E-03 2.042E-04 8.2796 0.918 4.61 
2.00 3.59 1.753E-02 1.667E--02 8.600E-04 2.570E-04 14.6933 1.167 4.76 
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N pK Determination for 5-lodo-1-methylimidazole 
I.I') 
N 
Titrant pH Total[] [BH+] [B] [BH+] log [] pKa 
(0.100M HCI) [B] 
0.00 1.170E-02 
0.10 6.43 1.158E-02 9.901E-04 l.059E-02 0.0935 -1.029 5.40 
0.20 6.13 1.147E-02 1.961E-03 9.509E-03 0.2062 -0.686 5.44 
0.30 5.91 1.136E-02 2.913E-03 8.447E-03 0.3449 -0.462 5.45 
0.40 5.74 1.125E-02 3.846E-03 7.404E-03 0.5194 -0.284 5.46 
0.50 5.59 1.114E-02 4.762E-03 6.378E-03 0.7466 -0.127 5.46 
0.60 5.44 1.104E-02 5.660E-03 5.380E-03 · 1.0520 0.022 5.46 
0.70 5.30 1.093E-02 6.542E-03 4388E-03 1.4909 0.173 5.47 
0.80 5.13 1.083E-02 7.407E-03 3.423E-03 2.1639 0.335 5.47 
0.90 4.96 l.073E-02 8.257E-03 2.473E-03 3.3389 0.524 5.48 
1.00 4.73 1.064E-02 9.091E-03 1.549E-03 5.8689 0.769 5.50 
1.10 4.40 1.054E-02 9.910E-03 6.300E-04 15.7302 1.197 5.60 
Mean (ALL) 5.47 I Mean 5.47 
Uncert 0.03 
v· 
pK Determination for 4-Methylimidazole 
Titrant pH Total [] [BH+] [B] [BH+] log [] pKa 
(0.100M HCI) [B] 
0.00 1.979E-02 
0.10 8.63 1.959E-02 9.901E-04 1.860E-02 0.0532 -1.274 7.36 
0.20 8.39 1.940E-02 1.961E-03 1.744E-02 0.1124 -0.949 7.44 
0.30 8.22 1.921E-02 2.913E-03 1.630E-02 0.1787 -0.748 7.47 
0.40 8.07 1.903E-02 3.846E-03 1.518E-02 0.2533 -0.596 7.47 
0.50 7.95 1.885E-02 4.762E-03 1.409E-02 0.3380 -0.471 7.48 
0.60 7.84 1.867E-02 5.660E-03 1.301E-02 0.4350 -0.361 7.48 
0.70 7.74 1.850E-02 6.542E-03 1.196E-02 0.5471 -0.262 7.48 
0.80 7.64 1.832E-02 7.407E-03 1.091E-02 0.6787 -0.168 7.47 
0.90 7.55 1.816E-02 8.257E-03 9.903E-03 0.8338 -0.079 7.47 
1.00 7.46 1.799E-02 9.091E-03 8.899E-03 1.0216 0.009 7.47 
1.10 7.37 1.783E-02 9.910E-03 7.920E-03 1.2513 0.097 7.47 
1.20 7.27 1.767E-02 1.071E-02 6.960E-03 1.5388 0.187 7.46 
1.30 7.17 1.751E-02 1.150E-02 6.0lOE-03 1.9135 0.282 7.45 
1.40 7.08 1.736E-02 1.228E-02 5.080E-03 2.4173 0.383 7.46 
1.50 6.95 1.721E-02 1.304E-02 4.170E-03 3.1271 0.495 7.45 
1.60 6.81 1.706E-02 1.379E-02 3.270E-03 4.2171 0.625 7.44 
1.70 6.62 1.691E-02 1.453E-02 2.380E-03 6.1050 0.786 7.41 
1.80 6.34 1.677E-02 1.525E-02 1.520E-03 10.0329 1.001 7.34 
1.90 5.90 l.663E-02 1.597E-02 6.600E-04 24.1970 1.384 7.28 
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Ct) 
pK Determination for 1,4-Dimethylimidazole lt) 
N 
Titrant pH Total [] [BH+] [B] [BH+] log [ 1 pKa 
(0.100M HCI) [B] 
0.00 1.094E-02 
0.10 8.52 1.083E-02 9.901E-04 9.842E-03 0.1006 -0.997 7.52 
0.20 8.18 1.073E-02 1.961E-03 8.764E-03 0.2238 -0.650 7.53 
0.30 7.95 1.062E-02 2.913E-03 7.708E-03 0.3779 -0.423 7.53 
0.40 7.77 1.052E-02 3.846E-03 6.673E-03 0.5764 -0.239 7.53 
0.50 7.59 1.042E-02 4.762E-03 5.657E-03 0.8418 -0.075 7.52 
0.60 7.43 1.032E-02 5.660E-03 4.661E-03 1.2143 0.084 7.51 
0.70 7.26 1.022E-02 6.542E-03 3.682E-03 1.7768 0.250 7.51 
0.80 7.07 1.013E-02 7.407E-03 2.723E-03 2.7202 0.435 7.50 
0.90 6.81 1.004E-02 8.257E-03 1.780E-03 4.6388 0.666 7.48 
1.00 6.35 9.946E-03 9.091E-03 8.545E-04 10.6390 1.027 7.38 
Mean (ALL) 7.50 I Mean 7.51 I 
Uncert 0.04 
,, 
pK Determination for 1,5-Dimethylimidazole 
Titrant pH Total [] [BH+] [BJ [BH+] log [] pKa 
(0.100M HCl) [BJ 
0.00 1.046E-02 
0.10 8.54 1.036E-02 9.901E-04 9.370E-03 0.1057 -0.976 7.56 
0.20 8.21 1.025E-02 1.961E-03 8.289E-03 0.2366 -0.626 7.58 
0.30 7.98 1.016E-02 2.913E-03 7.247E-03 0.4020 -0.396 7.58 
0.40 7.77 1.006E-02 3.846E-03 6.214E-03 0.6189 -0.208 7.56 
0.50 7.61 9.962E-03 4.762E-03 5.200E-03 0.9158 -0.038 7.57 
0.60 7.43 9.868E-03 5.660E-03 4.208E-03 1.3451 0.129 7.56 
0.70 7.23 9.776E-03 6.542E-03 3.234E-03 2.0229 0.306 7.54 
0.80 7.02 9.685E-03 7.407E-03 2.278E-03 3.2515 0.512 7.53 
0.90 6.72 9.596E-03 8.257E-03 1.339E-03 6.1665 0.790 7.51 
1.00 5.86 9.509E-03 9.091E-03 4.180E-04 21.7488 1.337 7.20 
Mean (ALL) 7.52 I Mean 7.56 
Uncertainty 0.05 
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